Document and Entity Information
Document and Entity Information - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Feb. 23, 2023 | Jun. 30, 2022 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2022 | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Entity Registrant Name | Goldman Sachs BDC, Inc. | ||
Entity Central Index Key | 0001572694 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Interactive Data Current | Yes | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Shell Company | false | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
Title of 12(b) Security | Common Stock, par value$0.001 per share | ||
Trading Symbol | GSBD | ||
Security Exchange Name | NYSE | ||
Entity File Number | 814-00998 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 46-2176593 | ||
Entity Address, Address Line One | 200 West Street | ||
Entity Address, City or Town | New York | ||
Entity Address, State or Province | NY | ||
Entity Address, Postal Zip Code | 10282 | ||
City Area Code | 212 | ||
Local Phone Number | 902-0300 | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Common Stock, Shares Outstanding | 102,963,144 | ||
Entity Public Float | $ 1,603,820 | ||
Documents Incorporated by Reference | Portions of Goldman Sachs BDC, Inc.’s Proxy Statement for its 2023 Annual Meeting of Stockholders are incorporated by reference in the Annual Report on Form 10-K in response to Part III, Items 10, 11, 12, 13 and 14. | ||
Auditor Name | PricewaterhouseCoopers LLP | ||
Auditor Firm ID | 238 | ||
Auditor Location | Boston, Massachusetts |
Consolidated Statements of Asse
Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | |
Investments, at fair value | |||
Non-controlled/non-affiliated investments (cost of $3,598,963 and $3,416,195) | $ 3,465,225 | $ 3,427,249 | |
Non-controlled affiliated investments (cost of $69,712 and $58,221) | 40,991 | 32,819 | |
Controlled affiliated investments (cost of $22,366 and $33,374) | 18,375 | ||
Total investments, at fair value (cost of $3,691,041 and $3,507,790) | 3,506,216 | 3,478,443 | |
Cash | 39,602 | 33,764 | |
Unrealized appreciation on foreign currency forward contracts | 100 | ||
Interest and dividends receivable | 31,779 | 23,278 | |
Deferred financing costs | 12,772 | 12,631 | |
Other assets | 942 | 2,775 | |
Total assets | 3,591,311 | 3,550,991 | |
Liabilities | |||
Debt (net of debt issuance costs of $8,741 and $12,296) | 2,012,660 | 1,861,426 | |
Interest and other debt expenses payable | 13,309 | 14,936 | |
Management fees payable | 9,063 | 8,370 | |
Incentive fees payable | 0 | 760 | |
Distribution payable | 46,283 | 45,818 | |
Unrealized depreciation on foreign currency forward contracts | 484 | ||
Accrued expenses and other liabilities | 7,118 | 5,281 | |
Total liabilities | 2,088,917 | 1,936,591 | |
Commitments and contingencies (Note 8) | |||
Net assets | |||
Preferred stock, par value $0.001 per share (1,000,000 shares authorized, no shares issued and outstanding) | |||
Common stock, par value $0.001 per share (200,000,000 shares authorized, 102,850,589 and 101,818,811 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively) | 103 | 102 | |
Paid-in capital in excess of par | 1,709,914 | 1,670,742 | |
Distributable earnings | (206,202) | (55,023) | |
Allocated income tax expense | (1,421) | (1,421) | |
Total net assets | 1,502,394 | 1,614,400 | |
Total liabilities and net assets | $ 3,591,311 | $ 3,550,991 | |
Net asset value per share | [1] | $ 14.61 | $ 15.86 |
[1] The per share data was derived by using the weighted average shares outstanding during the applicable period, except for distributions declared and issuance of common stock in connection with the Merger , which reflects the actual amount per share for the applicable period. |
Consolidated Statements of As_2
Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Statement Of Financial Position [Abstract] | ||
Non-controlled/non-affiliated investments at cost | $ 3,598,963 | $ 3,416,195 |
Non-controlled affiliated investments at cost | 69,712 | 58,221 |
Controlled affiliated investments at cost | 22,366 | 33,374 |
Investments at cost | 3,691,041 | 3,507,790 |
Debt issuance costs | $ 8,741 | $ 12,296 |
Preferred stock, par value | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 200,000,000 | 200,000,000 |
Common stock, shares issued | 102,850,589 | 101,818,811 |
Common stock, shares outstanding | 102,850,589 | 101,818,811 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Net Investment Income [Line Items] | |||
Total investment income | $ 357,452 | $ 346,980 | $ 172,959 |
Expenses: | |||
Interest and other debt expenses | 79,464 | 58,988 | 39,900 |
Incentive fees | 12,023 | 40,697 | 35,845 |
Management fees | 35,996 | 32,611 | 16,846 |
Professional fees | 3,466 | 3,259 | 2,512 |
Directors' fees | 833 | 934 | 640 |
Other general and administrative expenses | 4,370 | 3,411 | 2,877 |
Total expenses | 136,152 | 139,900 | 98,620 |
Fee waivers | (11,724) | (31,578) | (36,986) |
Net expenses | 124,428 | 108,322 | 61,634 |
Net investment income before taxes | 233,024 | 238,658 | 111,325 |
Income tax expense, including excise tax | 4,453 | 1,283 | 1,429 |
Net investment income after taxes | 228,571 | 237,375 | 109,896 |
Net realized gain (loss) from: | |||
Non-controlled/non-affiliated investments | (4,548) | 4,627 | (6,611) |
Non-controlled affiliated investments | 35,160 | 3,545 | |
Controlled affiliated investments | (14,414) | (40,688) | |
Foreign currency forward contracts | 283 | (234) | 82 |
Foreign currency and other transactions | (2,585) | 304 | 63 |
Net change in unrealized appreciation (depreciation) from: | |||
Non-controlled/non-affiliated investments | (144,792) | (35,210) | 86,400 |
Non-controlled affiliated investments | (3,319) | (47,914) | 23,391 |
Controlled affiliated investments | (7,367) | (6,409) | 5,990 |
Foreign currency forward contracts | (584) | 455 | (388) |
Foreign currency translations and other transactions | 3,997 | 4,629 | (5,563) |
Net realized and unrealized gains (losses) | (173,329) | (44,592) | 66,221 |
(Provision) benefit for taxes on realized gain/loss on investments | 53 | (96) | |
(Provision) benefit for taxes on unrealized appreciation/depreciation on investments | (239) | (409) | 92 |
Net increase (decrease) in net assets from operations | $ 55,003 | $ 192,427 | $ 176,113 |
Weighted average shares outstanding | 102,258,701 | 101,691,076 | 53,940,573 |
Net investment income per share (basic and diluted) | $ 2.24 | $ 2.33 | $ 2.04 |
Earnings per share basic | 0.54 | 1.89 | 3.26 |
Earnings per share diluted | $ 0.54 | $ 1.89 | $ 3.26 |
From Non-controlled/ Non-affiliated Investments | |||
Net Investment Income [Line Items] | |||
Interest income | $ 329,641 | $ 325,559 | $ 157,610 |
Payment-in-kind | 20,415 | 13,914 | 4,864 |
Other income | 4,933 | 3,873 | 1,081 |
From Non-controlled Affiliated Investments | |||
Net Investment Income [Line Items] | |||
Dividend income | 382 | 996 | 198 |
Interest income | 1,236 | 378 | 4,931 |
Payment-in-kind | 547 | 774 | 1,127 |
Other income | 23 | 1,311 | |
From controlled Affiliated Investments | |||
Net Investment Income [Line Items] | |||
Interest income | 16 | 94 | 232 |
Payment-in-kind | $ 259 | $ 1,392 | $ 1,605 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Net Assets - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statement Of Partners Capital [Abstract] | |||
Net assets at beginning of period | $ 1,614,400 | $ 1,615,141 | $ 676,125 |
Increase (decrease) in net assets from operations: | |||
Net investment income | 228,571 | 237,375 | 109,896 |
Net realized gain (loss) | (21,264) | 39,857 | (43,609) |
Net change in unrealized appreciation (depreciation) | (152,065) | (84,449) | 109,830 |
(Provision) benefit for taxes on realized gain/loss on investments | 53 | (96) | |
(Provision) benefit for taxes on unrealized appreciation/depreciation on investments | (239) | (409) | 92 |
Net increase (decrease) in net assets from operations | 55,003 | 192,427 | 176,113 |
Distributions to stockholders from: | |||
Distributable earnings | (184,315) | (198,332) | (100,254) |
Total distributions to stockholders | (184,315) | (198,332) | (100,254) |
Capital transactions: | |||
Issuance of common stock (net of offering and underwriting costs) | 13,457 | 861,031 | |
Reinvestment of stockholder distributions | 3,849 | 5,164 | 2,126 |
Net increase in net assets from capital transactions | 17,306 | 5,164 | 863,157 |
Total increase (decrease) in net assets | (112,006) | (741) | 939,016 |
Net assets at end of period | $ 1,502,394 | $ 1,614,400 | $ 1,615,141 |
Distributions per share | $ 1.80 | $ 1.95 | $ 1.80 |
Consolidated Statements of Cash
Consolidated Statements of Cashflows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Cash flows from operating activities: | |||
Net increase in net assets from operations: | $ 55,003 | $ 192,427 | $ 176,113 |
Adjustments to reconcile net increase (decrease) in net assets from operations to net cash provided by (used for) operating activities: | |||
Purchases of Investments | (712,708) | (1,717,222) | (443,161) |
Payment-in-kind interest capitalized | (20,879) | (17,148) | (6,619) |
Proceeds from sales of investments and principal repayments | 570,951 | 1,537,804 | 362,738 |
Net realized (gain) loss | 19,005 | (40,485) | 43,754 |
Net change in unrealized (appreciation) depreciation on investments | 155,478 | 89,533 | (115,781) |
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts and transactions | 437 | (244) | 333 |
Amortization of premium and accretion of discount, net | (39,620) | (88,159) | (22,154) |
Amortization of deferred financing and debt issuance costs | 6,292 | 7,338 | 4,690 |
Amortization of original issue discount on convertible notes | 118 | 469 | 446 |
Cash acquired in merger | 177,576 | ||
Change in operating assets and liabilities: | |||
(Increase) decrease in receivable for investments sold | 2,511 | (2,164) | |
(Increase) decrease in interest and dividends receivable | (8,501) | (1,685) | (1,950) |
(Increase) decrease in other assets | 1,833 | (770) | (1,300) |
Increase (decrease) in interest and other debt expenses payable | (1,740) | 5,317 | 6,426 |
Increase (decrease) in management fees payable | 693 | 2,425 | (1,867) |
Increase (decrease) in incentive fees payable | (760) | (1,905) | (5,857) |
Increase (decrease) in accrued expenses and other liabilities | 1,837 | (62) | (5,440) |
Net cash provided by (used for) operating activities | 27,439 | (29,856) | 165,783 |
Cash flows from financing activities: | |||
Proceeds from issuance of common stock (net of underwriting costs) | 14,014 | ||
Offering costs paid | (557) | ||
Distributions paid | (180,001) | (193,040) | (145,603) |
Deferred financing and debt issuance costs paid | (2,883) | (4,605) | (24,781) |
Borrowings on debt | 846,179 | 1,127,532 | 1,289,450 |
Repayments of debt | (698,500) | (898,193) | (1,262,176) |
Net cash provided by (used for) financing activities | (21,748) | 31,694 | (143,110) |
Net increase (decrease) in cash | 5,691 | 1,838 | 22,673 |
Effect of foreign exchange rate changes on cash and cash equivalents | 147 | (211) | 55 |
Cash, beginning of period | 33,764 | 32,137 | 9,409 |
Cash, end of period | 39,602 | 33,764 | 32,137 |
Supplemental and non-cash activities | |||
Interest expense paid | 71,957 | 41,888 | 27,207 |
Accrued but unpaid excise tax expense | 3,494 | 1,356 | 1,638 |
Accrued but unpaid distributions | 46,283 | 45,818 | 45,690 |
Reinvestment of stockholder distributions | 3,849 | 5,164 | 2,126 |
Non-cash purchases of investments | 153,310 | 9,469 | (1,670,802) |
Non-cash sales of investments | $ (153,310) | $ (9,469) | 63,499 |
Issuance of shares in connection with the Merger (refer to Note 13 "Merger with GS MMLC") | $ 861,031 |
Consolidated Statements of Ca_2
Consolidated Statements of Cashflows (Parenthetical) $ in Thousands | Oct. 12, 2020 USD ($) |
Goldman Sach Middle Market Lending Corp | |
Acquired net assets | $ 950,161 |
Consolidated Schedule of Invest
Consolidated Schedule of Investments € in Thousands, £ in Thousands, Contract in Thousands, $ in Thousands, $ in Thousands | 12 Months Ended | |||||||||||||||||
Dec. 31, 2022 USD ($) Contract shares | Dec. 31, 2021 USD ($) Contract shares | Dec. 31, 2022 CAD ($) Contract shares | Dec. 31, 2022 GBP (£) Contract shares | Dec. 31, 2022 EUR (€) Contract shares | Dec. 31, 2021 CAD ($) Contract shares | Dec. 31, 2021 GBP (£) Contract shares | Dec. 31, 2021 EUR (€) Contract shares | Dec. 31, 2020 USD ($) | ||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | $ 3,691,041 | $ 3,507,790 | [1] | |||||||||||||||
Fair Value | 3,506,216 | 3,478,443 | [1] | |||||||||||||||
Unrealized Appreciation (Depreciation) | (168,797) | (13,476) | $ 72,545 | |||||||||||||||
Foreign Currency Forward Contracts | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Unrealized Appreciation (Depreciation) | $ (484) | $ 100 | ||||||||||||||||
Bank of America, N.A. | Foreign Currency Forward Contracts | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Settlement | Oct. 04, 2024 | Jan. 06, 2022 | ||||||||||||||||
Unrealized Appreciation (Depreciation) | $ (321) | $ 26 | ||||||||||||||||
Bank of America, N.A. | U.S. Dollar | Foreign Currency Forward Contracts | Currency Purchased | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Currency Purchased | Contract | 3,648 | 624 | 3,648 | 3,648 | 3,648 | 624 | 624 | 624 | ||||||||||
Bank of America, N.A. | Euro | Foreign Currency Forward Contracts | Currency Sold | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Currency Purchased | Contract | 3,606 | 525 | 3,606 | 3,606 | 3,606 | 525 | 525 | 525 | ||||||||||
Bank of America, N.A. | Foreign Currency Forward Contracts | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Settlement | Oct. 04, 2024 | Apr. 06, 2022 | ||||||||||||||||
Unrealized Appreciation (Depreciation) | $ (163) | $ 25 | ||||||||||||||||
Bank of America, N.A. | U.S. Dollar | Foreign Currency Forward Contracts | Currency Purchased | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Currency Purchased | Contract | 1,440 | 611 | 1,440 | 1,440 | 1,440 | 611 | 611 | 611 | ||||||||||
Bank of America, N.A. | Euro | Foreign Currency Forward Contracts | Currency Sold | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Currency Purchased | Contract | 514 | 514 | 514 | 514 | ||||||||||||||
Bank of America, N.A. | GBP | Foreign Currency Forward Contracts | Currency Sold | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Currency Purchased | Contract | 1,322 | 1,322 | 1,322 | 1,322 | ||||||||||||||
Bank of America, N.A. | Foreign Currency Forward Contracts | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Settlement | Jan. 15, 2026 | Jul. 06, 2022 | ||||||||||||||||
Unrealized Appreciation (Depreciation) | $ 25 | |||||||||||||||||
Bank of America, N.A. | U.S. Dollar | Foreign Currency Forward Contracts | Currency Purchased | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Currency Purchased | Contract | 2,661 | 619 | 2,661 | 2,661 | 2,661 | 619 | 619 | 619 | ||||||||||
Bank of America, N.A. | Euro | Foreign Currency Forward Contracts | Currency Sold | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Currency Purchased | Contract | 520 | 520 | 520 | 520 | ||||||||||||||
Bank of America, N.A. | GBP | Foreign Currency Forward Contracts | Currency Sold | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Currency Purchased | Contract | 2,161 | 2,161 | 2,161 | 2,161 | ||||||||||||||
Bank of America, N.A. | Foreign Currency Forward Contracts | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Settlement | Oct. 06, 2022 | |||||||||||||||||
Unrealized Appreciation (Depreciation) | $ 24 | |||||||||||||||||
Bank of America, N.A. | U.S. Dollar | Foreign Currency Forward Contracts | Currency Purchased | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Currency Purchased | Contract | 627 | 627 | 627 | 627 | ||||||||||||||
Bank of America, N.A. | Euro | Foreign Currency Forward Contracts | Currency Sold | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Currency Purchased | Contract | 525 | 525 | 525 | 525 | ||||||||||||||
Preferred Stock - 2.82% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | $ 48,258 | |||||||||||||||||
Fair Value | 42,377 | |||||||||||||||||
Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | 82,006 | |||||||||||||||||
Fair Value | 35,490 | |||||||||||||||||
Warrants - 0.04% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | 1,849 | |||||||||||||||||
Fair Value | $ 611 | |||||||||||||||||
Preferred Stock - 3.26% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | [1] | $ 48,258 | ||||||||||||||||
Fair Value | [1] | 52,655 | ||||||||||||||||
Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | [1] | 71,777 | ||||||||||||||||
Fair Value | [1] | 30,784 | ||||||||||||||||
Warrants - 0.11% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | [1] | 1,849 | ||||||||||||||||
Fair Value | [1] | $ 1,850 | ||||||||||||||||
Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) | Software | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Mar. 10, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 29,326 | 29,326 | 29,326 | 29,326 | |||||||||||||
Cost | [2],[3],[5],[6],[8] | $ 2,933 | ||||||||||||||||
Fair Value | [2],[3],[5],[6],[8] | $ 2,346 | ||||||||||||||||
Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) | Software | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Mar. 10, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 29,326 | 29,326 | 29,326 | 29,326 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 2,933 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 3,065 | ||||||||||||||||
Broadway Parent, LLC | Diversified Financial Services | Preferred Stock - 2.82% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Jan. 25, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 4,000,000 | 4,000,000 | 4,000,000 | 4,000,000 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 4,019 | ||||||||||||||||
Fair Value | [2],[3],[5],[6] | $ 5,429 | ||||||||||||||||
Broadway Parent, LLC | Diversified Financial Services | Preferred Stock - 3.26% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Jan. 25, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 4,000,000 | 4,000,000 | 4,000,000 | 4,000,000 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 4,019 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 4,720 | ||||||||||||||||
CloudBees, Inc. | Software | Preferred Stock - 3.26% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[12] | Nov. 24, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[12],[13] | 1,152,957 | 1,152,957 | 1,152,957 | 1,152,957 | |||||||||||||
Cost | [1],[9],[12] | $ 12,899 | ||||||||||||||||
Fair Value | [1],[9],[12] | $ 12,901 | ||||||||||||||||
Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Class B | Health Care Providers & Services | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [3],[4],[5],[6],[14] | Mar. 30, 2018 | ||||||||||||||||
Par/Shares (++) | shares | [3],[5],[6],[7],[14] | 20,183 | 20,183 | 20,183 | 20,183 | |||||||||||||
Cost | [3],[5],[6],[14] | $ 2,916 | ||||||||||||||||
Fair Value | [3],[5],[6],[14] | $ 3,761 | ||||||||||||||||
Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Class B | Health Care Providers & Services | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[10],[11],[12],[15] | Mar. 30, 2018 | ||||||||||||||||
Par/Shares (++) | shares | [1],[11],[12],[13],[15] | 20,183 | 20,183 | 20,183 | 20,183 | |||||||||||||
Cost | [1],[11],[12],[15] | $ 2,916 | ||||||||||||||||
Fair Value | [1],[11],[12],[15] | $ 4,071 | ||||||||||||||||
Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Performance Units | Health Care Providers & Services | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [3],[4],[5],[6],[8],[14] | Mar. 30, 2018 | ||||||||||||||||
Par/Shares (++) | shares | [3],[5],[6],[7],[8],[14] | 19,048 | 19,048 | 19,048 | 19,048 | |||||||||||||
Cost | [3],[5],[6],[8],[14] | $ 514 | ||||||||||||||||
Fair Value | [3],[5],[6],[8],[14] | $ 1,165 | ||||||||||||||||
Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Performance Units | Health Care Providers & Services | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12],[15],[16] | Mar. 30, 2018 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13],[15],[16] | 19,048 | 19,048 | 19,048 | 19,048 | |||||||||||||
Cost | [1],[9],[11],[12],[15],[16] | $ 514 | ||||||||||||||||
Fair Value | [1],[9],[11],[12],[15],[16] | $ 1,420 | ||||||||||||||||
Conergy Asia & ME Pte. LTD. | Construction & Engineering | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[16],[17] | Jan. 11, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[13],[16],[17] | 3,126,780 | 3,126,780 | 3,126,780 | 3,126,780 | |||||||||||||
Cost | [1],[9],[11],[16],[17] | $ 5,300 | ||||||||||||||||
Country Fresh Holding Company Inc. | Food Products | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Apr. 29, 2019 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 1,514 | 1,514 | 1,514 | 1,514 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 888 | ||||||||||||||||
Country Fresh Holding Company Inc. | Food Products | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Apr. 29, 2019 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 1,514 | 1,514 | 1,514 | 1,514 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 888 | ||||||||||||||||
Elah Holdings, Inc. | Capital Markets | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6],[14] | May 09, 2018 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7],[14] | 111,650 | 111,650 | 111,650 | 111,650 | |||||||||||||
Cost | [2],[3],[5],[6],[14] | $ 5,238 | ||||||||||||||||
Fair Value | [2],[3],[5],[6],[14] | $ 5,396 | ||||||||||||||||
Elah Holdings, Inc. | Capital Markets | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12],[17] | May 09, 2018 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13],[17] | 111,650 | 111,650 | 111,650 | 111,650 | |||||||||||||
Cost | [1],[9],[11],[12],[17] | $ 5,238 | ||||||||||||||||
Fair Value | [1],[9],[11],[12],[17] | $ 5,396 | ||||||||||||||||
Exostar LLC - Class B | Aerospace & Defense | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Jul. 06, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 31,407 | 31,407 | 31,407 | 31,407 | |||||||||||||
Fair Value | [2],[3],[5],[6] | $ 27 | ||||||||||||||||
Exostar LLC - Class B | Aerospace & Defense | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Jul. 06, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 31,407 | 31,407 | 31,407 | 31,407 | |||||||||||||
Fair Value | [1],[9],[11],[12] | $ 25 | ||||||||||||||||
Foundation Software - Class B | Construction & Engineering | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Aug. 31, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 11,826 | 11,826 | 11,826 | 11,826 | |||||||||||||
Fair Value | [2],[3],[5],[6] | $ 10 | ||||||||||||||||
Foundation Software - Class B | Construction & Engineering | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Aug. 31, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 11,826 | 11,826 | 11,826 | 11,826 | |||||||||||||
Fair Value | [1],[9],[11],[12] | $ 9 | ||||||||||||||||
Governmentjobs.com, Inc. (dba NeoGov) | Software | Preferred Stock - 2.82% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Dec. 02, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 10,597 | 10,597 | 10,597 | 10,597 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 10,332 | ||||||||||||||||
Fair Value | [2],[3],[5],[6] | $ 11,555 | ||||||||||||||||
Governmentjobs.com, Inc. (dba NeoGov) | Software | Preferred Stock - 3.26% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[12] | Dec. 02, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[12],[13] | 10,597 | 10,597 | 10,597 | 10,597 | |||||||||||||
Cost | [1],[9],[12] | $ 10,332 | ||||||||||||||||
Fair Value | [1],[9],[12] | $ 10,332 | ||||||||||||||||
Iracore International Holdings, Inc. | Energy Equipment & Services | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[4],[5],[6],[14] | Apr. 13, 2017 | ||||||||||||||||
Par/Shares (++) | shares | [2],[5],[6],[7],[14] | 28,898 | 28,898 | 28,898 | 28,898 | |||||||||||||
Cost | [2],[5],[6],[14] | $ 7,003 | ||||||||||||||||
Fair Value | [2],[5],[6],[14] | $ 6,298 | ||||||||||||||||
Iracore International Holdings, Inc. | Energy Equipment & Services | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[17] | Apr. 13, 2017 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[13],[17] | 28,898 | 28,898 | 28,898 | 28,898 | |||||||||||||
Cost | [1],[9],[11],[17] | $ 7,003 | ||||||||||||||||
Fair Value | [1],[9],[11],[17] | $ 5,235 | ||||||||||||||||
Jill Acquisition LLC (dba J. Jill) | Specialty Retail | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[4],[6] | Sep. 30, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [2],[6],[7] | 26,687 | 26,687 | 26,687 | 26,687 | |||||||||||||
Cost | [2],[6] | $ 206 | ||||||||||||||||
Fair Value | [2],[6] | $ 662 | ||||||||||||||||
Jill Acquisition LLC (dba J. Jill) | Specialty Retail | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10] | Sep. 30, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[13] | 18,869 | 18,869 | 18,869 | 18,869 | |||||||||||||
Cost | [1],[9] | $ 56 | ||||||||||||||||
Fair Value | [1],[9] | $ 362 | ||||||||||||||||
Kawa Solar Holdings Limited | Construction & Engineering | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[16],[17] | Aug. 17, 2016 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[13],[16],[17] | 1,399,556 | 1,399,556 | 1,399,556 | 1,399,556 | |||||||||||||
MedeAnalytics, Inc. | Health Care Technology | Preferred Stock - 2.82% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Oct. 09, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 42,600 | 42,600 | 42,600 | 42,600 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 41 | ||||||||||||||||
MedeAnalytics, Inc. | Health Care Technology | Preferred Stock - 3.26% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Oct. 09, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 42,600 | 42,600 | 42,600 | 42,600 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 41 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 40 | ||||||||||||||||
Southeast Mechanical, LLC (dba. SEM Holdings, LLC) | Diversified Consumer Services | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6],[14] | Jul. 06, 2022 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7],[14] | 1,100 | 1,100 | 1,100 | 1,100 | |||||||||||||
Cost | [2],[3],[5],[6],[14] | $ 1,100 | ||||||||||||||||
Fair Value | [2],[3],[5],[6],[14] | $ 1,347 | ||||||||||||||||
WhiteWater Holding Company LLC | Diversified Consumer Services | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Dec. 21, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 23,400 | 23,400 | 23,400 | 23,400 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 2,340 | ||||||||||||||||
Fair Value | [2],[3],[5],[6] | $ 2,410 | ||||||||||||||||
WhiteWater Holding Company LLC | Diversified Consumer Services | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[12] | Dec. 21, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[12],[13] | 23,400 | 23,400 | 23,400 | 23,400 | |||||||||||||
Cost | [1],[9],[12] | $ 2,340 | ||||||||||||||||
Fair Value | [1],[9],[12] | $ 2,340 | ||||||||||||||||
Wine.com, LLC | Beverages | Preferred Stock - 2.82% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Mar. 03, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 124,040 | 124,040 | 124,040 | 124,040 | |||||||||||||
Cost | [2],[3],[5],[6],[8] | $ 3,067 | ||||||||||||||||
Fair Value | [2],[3],[5],[6],[8] | $ 3,680 | ||||||||||||||||
Wine.com, LLC | Beverages | Preferred Stock - 3.26% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Mar. 03, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 124,040 | 124,040 | 124,040 | 124,040 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 3,067 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 3,329 | ||||||||||||||||
Wine.com, LLC | Beverages | Preferred Stock - 2.82% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Nov. 14, 2018 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 535,226 | 535,226 | 535,226 | 535,226 | |||||||||||||
Cost | [2],[3],[5],[6],[8] | $ 8,225 | ||||||||||||||||
Fair Value | [2],[3],[5],[6],[8] | $ 343 | ||||||||||||||||
Wine.com, LLC | Beverages | Preferred Stock - 3.26% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Nov. 14, 2018 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 535,226 | 535,226 | 535,226 | 535,226 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 8,225 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 12,432 | ||||||||||||||||
WSO2, Inc. | IT Services | Preferred Stock - 2.82% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Nov. 04, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 561,918 | 561,918 | 561,918 | 561,918 | |||||||||||||
Cost | [2],[3],[5],[6],[8] | $ 8,876 | ||||||||||||||||
Fair Value | [2],[3],[5],[6],[8] | $ 8,684 | ||||||||||||||||
WSO2, Inc. | IT Services | Preferred Stock - 3.26% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[12] | Nov. 04, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[12],[13] | 561,918 | 561,918 | 561,918 | 561,918 | |||||||||||||
Cost | [1],[9],[12] | $ 8,876 | ||||||||||||||||
Fair Value | [1],[9],[12] | $ 8,876 | ||||||||||||||||
Bolttech Mannings, Inc. | Commercial Services & Supplies | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[4],[5],[6],[18] | Dec. 22, 2017 | ||||||||||||||||
Par/Shares (++) | shares | [2],[5],[6],[7],[18] | 4,145,602 | 4,145,602 | 4,145,602 | 4,145,602 | |||||||||||||
Cost | [2],[5],[6],[18] | $ 22,366 | ||||||||||||||||
Bolttech Mannings, Inc. | Commercial Services & Supplies | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[19] | Dec. 22, 2017 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[13],[19] | 309,142 | 309,142 | 309,142 | 309,142 | |||||||||||||
Cost | [1],[9],[11],[19] | $ 14,885 | ||||||||||||||||
Fair Value | [1],[9],[11],[19] | $ 727 | ||||||||||||||||
National Spine and Pain Centers, LLC | Health Care Providers & Services | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Jun. 02, 2017 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 1,100 | 1,100 | 1,100 | 1,100 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 883 | ||||||||||||||||
National Spine and Pain Centers, LLC | Health Care Providers & Services | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Jun. 02, 2017 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 1,100 | 1,100 | 1,100 | 1,100 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 883 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 546 | ||||||||||||||||
Conergy Asia & ME Pte. LTD. | Construction & Engineering | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[4],[5],[6],[8],[14] | Jan. 11, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[5],[6],[7],[8],[14] | 3,126,780 | 3,126,780 | 3,126,780 | 3,126,780 | |||||||||||||
Cost | [2],[5],[6],[8],[14] | $ 5,300 | ||||||||||||||||
CloudBees, Inc. | Software | Preferred Stock - 2.82% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Nov. 24, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 1,152,957 | 1,152,957 | 1,152,957 | 1,152,957 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 12,899 | ||||||||||||||||
Fair Value | [2],[3],[5],[6] | $ 12,659 | ||||||||||||||||
Foundation Software | Construction & Engineering | Preferred Stock - 2.82% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Aug. 31, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 22 | 22 | 22 | 22 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 21 | ||||||||||||||||
Fair Value | [2],[3],[5],[6] | $ 27 | ||||||||||||||||
Foundation Software | Construction & Engineering | Preferred Stock - 3.26% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Aug. 31, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 22 | 22 | 22 | 22 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 21 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 25 | ||||||||||||||||
Kawa Solar Holdings Limited | Construction & Engineering | Preferred Stock - 2.82% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [5],[6],[8],[14],[20] | 8% | 8% | 8% | 8% | |||||||||||||
Initial Acquisition Date | [4],[5],[6],[8],[14],[20] | Oct. 25, 2016 | ||||||||||||||||
Par/Shares (++) | shares | [5],[6],[7],[8],[14],[20] | 80,299 | 80,299 | 80,299 | 80,299 | |||||||||||||
Cost | [5],[6],[8],[14],[20] | $ 778 | ||||||||||||||||
Kawa Solar Holdings Limited | Construction & Engineering | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[4],[5],[6],[8],[14] | Aug. 17, 2016 | ||||||||||||||||
Par/Shares (++) | shares | [2],[5],[6],[7],[8],[14] | 1,399,556 | 1,399,556 | 1,399,556 | 1,399,556 | |||||||||||||
Kawa Solar Holdings Limited | Construction & Engineering | Preferred Stock - 3.26% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [1],[11],[16],[17],[21] | 8% | 8% | 8% | 8% | |||||||||||||
Initial Acquisition Date | [1],[10],[11],[16],[17],[21] | Oct. 25, 2016 | ||||||||||||||||
Par/Shares (++) | shares | [1],[11],[13],[16],[17],[21] | 74,168 | 74,168 | 74,168 | 74,168 | |||||||||||||
Cost | [1],[11],[16],[17],[21] | $ 778 | ||||||||||||||||
Animal Supply Holdings, LLC | Distributors | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[4],[5],[6],[14] | Aug. 14, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [2],[5],[6],[7],[14] | 83,333 | 83,333 | 83,333 | 83,333 | |||||||||||||
Cost | [2],[5],[6],[14] | $ 13,745 | ||||||||||||||||
Animal Supply Holdings, LLC | Distributors | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[17] | Aug. 14, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[13],[17] | 37,500 | 37,500 | 37,500 | 37,500 | |||||||||||||
Cost | [1],[9],[11],[17] | $ 126 | ||||||||||||||||
Animal Supply Holdings, LLC | Distributors | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[4],[5],[6],[14] | Aug. 14, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [2],[5],[6],[7],[14] | 37,500 | 37,500 | 37,500 | 37,500 | |||||||||||||
Cost | [2],[5],[6],[14] | $ 126 | ||||||||||||||||
Animal Supply Holdings, LLC | Distributors | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[17] | Aug. 14, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[13],[17] | 83,333 | 83,333 | 83,333 | 83,333 | |||||||||||||
Cost | [1],[9],[11],[17] | $ 13,745 | ||||||||||||||||
ATX Parent Holdings, LLC - Class A Units | Communications Equipment | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[4],[5],[6],[8],[14] | Sep. 01, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[5],[6],[7],[8],[14] | 332 | 332 | 332 | 332 | |||||||||||||
Cost | [2],[5],[6],[8],[14] | $ 167 | ||||||||||||||||
Fair Value | [2],[5],[6],[8],[14] | $ 3,659 | ||||||||||||||||
ATX Parent Holdings, LLC - Class A Units | Communications Equipment | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[16],[17] | Sep. 01, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[13],[16],[17] | 332 | 332 | 332 | 332 | |||||||||||||
Cost | [1],[9],[11],[16],[17] | $ 167 | ||||||||||||||||
Fair Value | [1],[9],[11],[16],[17] | $ 577 | ||||||||||||||||
Prairie Provident Resources, Inc. | Oil, Gas & Consumable Fuels | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Par/Shares (++) | shares | [2],[6],[7],[8] | 3,579,988 | 3,579,988 | 3,579,988 | 3,579,988 | |||||||||||||
Cost | [2],[6],[8] | $ 9,237 | ||||||||||||||||
Fair Value | [2],[6],[8] | $ 331 | ||||||||||||||||
Prairie Provident Resources, Inc. | Oil, Gas & Consumable Fuels | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Par/Shares (++) | shares | [1],[9],[13],[16] | 3,579,988 | 3,579,988 | 3,579,988 | 3,579,988 | |||||||||||||
Cost | [1],[9],[16] | $ 9,237 | ||||||||||||||||
Fair Value | [1],[9],[16] | $ 322 | ||||||||||||||||
Total Vision LLC | Health Care Providers & Services | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Jul. 15, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 122,571 | 122,571 | 122,571 | 122,571 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 2,270 | ||||||||||||||||
Fair Value | [2],[3],[5],[6] | $ 2,084 | ||||||||||||||||
Total Vision LLC | Health Care Providers & Services | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Jul. 15, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 72,571 | 72,571 | 72,571 | 72,571 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 1,270 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 1,306 | ||||||||||||||||
Volt Bidco, Inc. (aka Power Factors) | Independent Power & Renewable Electricity Producers | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Aug. 11, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 3,355 | 3,355 | 3,355 | 3,355 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 3,406 | ||||||||||||||||
Fair Value | [2],[3],[5],[6] | $ 3,047 | ||||||||||||||||
Volt Bidco, Inc. (aka Power Factors) | Independent Power & Renewable Electricity Producers | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Aug. 11, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 2,908 | 2,908 | 2,908 | 2,908 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 2,908 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 3,057 | ||||||||||||||||
Yasso, Inc. | Food Products | Common Stock - 2.36% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Mar. 23, 2017 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 1,640 | 1,640 | 1,640 | 1,640 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 1,368 | ||||||||||||||||
Fair Value | [2],[3],[5],[6] | $ 2,947 | ||||||||||||||||
Yasso, Inc. | Food Products | Common Stock - 1.91% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Mar. 23, 2017 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 1,640 | 1,640 | 1,640 | 1,640 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 1,368 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 2,326 | ||||||||||||||||
CloudBees, Inc. | Software | Warrants - 0.04% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Nov. 24, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 333,980 | 333,980 | 333,980 | 333,980 | |||||||||||||
Cost | [2],[3],[5],[6] | $ 1,849 | ||||||||||||||||
Fair Value | [2],[3],[5],[6] | $ 611 | ||||||||||||||||
CloudBees, Inc. | Software | Warrants - 0.11% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Nov. 24, 2021 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 333,980 | 333,980 | 333,980 | 333,980 | |||||||||||||
Cost | [1],[9],[11],[12] | $ 1,849 | ||||||||||||||||
Fair Value | [1],[9],[11],[12] | $ 1,850 | ||||||||||||||||
KDOR Holdings Inc. (dba Senneca Holdings) | Building Products | Warrants - 0.04% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | Jun. 22, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 59 | 59 | 59 | 59 | |||||||||||||
KDOR Holdings Inc. (dba Senneca Holdings) | Building Products | Warrants - 0.11% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | May 29, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 147 | 147 | 147 | 147 | |||||||||||||
KDOR Holdings Inc. (dba Senneca Holdings) | Building Products | Warrants - 0.04% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | May 29, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 2,812 | 2,812 | 2,812 | 2,812 | |||||||||||||
KDOR Holdings Inc. (dba Senneca Holdings) | Building Products | Warrants - 0.11% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | Jun. 22, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 30 | 30 | 30 | 30 | |||||||||||||
KDOR Holdings Inc. (dba Senneca Holdings) | Building Products | Warrants - 0.04% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [2],[3],[4],[5],[6] | May 29, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [2],[3],[5],[6],[7] | 294 | 294 | 294 | 294 | |||||||||||||
KDOR Holdings Inc. (dba Senneca Holdings) | Building Products | Warrants - 0.11% | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Initial Acquisition Date | [1],[9],[10],[11],[12] | May 29, 2020 | ||||||||||||||||
Par/Shares (++) | shares | [1],[9],[11],[12],[13] | 1,406 | 1,406 | 1,406 | 1,406 | |||||||||||||
1st Lien/Senior Secured Debt | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | $ 3,174,534 | $ 2,930,047 | [1] | |||||||||||||||
Fair Value | $ 3,129,552 | $ 2,945,368 | [1] | |||||||||||||||
1st Lien/Senior Secured Debt | 1272775 B.C. LTD. (dba Everest Clinical Research) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.73% | [3],[5],[6],[8],[22] | 6.75% | [1],[11],[12],[16],[23] | 10.73% | [3],[5],[6],[8],[22] | 10.73% | [3],[5],[6],[8],[22] | 10.73% | [3],[5],[6],[8],[22] | 6.75% | [1],[11],[12],[16],[23] | 6.75% | [1],[11],[12],[16],[23] | 6.75% | [1],[11],[12],[16],[23] | ||
Floor (+) | [1],[11],[12],[16],[23] | 1% | ||||||||||||||||
Maturity | Nov. 06, 2026 | [3],[5],[6],[8] | Nov. 06, 2026 | [1],[11],[12],[16] | Nov. 06, 2026 | [3],[5],[6],[8] | Nov. 06, 2026 | [3],[5],[6],[8] | Nov. 06, 2026 | [3],[5],[6],[8] | Nov. 06, 2026 | [1],[11],[12],[16] | Nov. 06, 2026 | [1],[11],[12],[16] | Nov. 06, 2026 | [1],[11],[12],[16] | ||
Par (++) | $ 9,241 | [3],[5],[6],[7],[8] | $ 9,336 | [1],[11],[12],[13],[16] | ||||||||||||||
Cost | 9,146 | [3],[5],[6],[8] | 9,219 | [1],[11],[12],[16] | ||||||||||||||
Fair Value | $ 9,126 | [3],[5],[6],[8] | $ 9,196 | [1],[11],[12],[16] | ||||||||||||||
1st Lien/Senior Secured Debt | 1272775 B.C. LTD. (dba Everest Clinical Research) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[16],[23] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | 1272775 B.C. LTD. (dba Everest Clinical Research) | Professional Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[8],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | 1272775 B.C. LTD. (dba Everest Clinical Research) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.46% | [3],[5],[6],[8],[22],[24] | 7.20% | [1],[11],[12],[16],[23] | 11.46% | [3],[5],[6],[8],[22],[24] | 11.46% | [3],[5],[6],[8],[22],[24] | 11.46% | [3],[5],[6],[8],[22],[24] | 7.20% | [1],[11],[12],[16],[23] | 7.20% | [1],[11],[12],[16],[23] | 7.20% | [1],[11],[12],[16],[23] | ||
Maturity | Nov. 06, 2026 | [3],[5],[6],[8],[24] | Nov. 06, 2026 | [1],[11],[12],[16] | Nov. 06, 2026 | [3],[5],[6],[8],[24] | Nov. 06, 2026 | [3],[5],[6],[8],[24] | Nov. 06, 2026 | [3],[5],[6],[8],[24] | Nov. 06, 2026 | [1],[11],[12],[16] | Nov. 06, 2026 | [1],[11],[12],[16] | Nov. 06, 2026 | [1],[11],[12],[16] | ||
Par (++) | $ 919 | [3],[5],[6],[7],[8],[24] | $ 139 | [1],[11],[12],[13],[16] | ||||||||||||||
Cost | 747 | [3],[5],[6],[8],[24] | 109 | [1],[11],[12],[16] | ||||||||||||||
Fair Value | $ 745 | [3],[5],[6],[8],[24] | $ 108 | [1],[11],[12],[16] | ||||||||||||||
1st Lien/Senior Secured Debt | 1272775 B.C. LTD. (dba Everest Clinical Research) | Professional Services | U.S. Prime Rate | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[8],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | 1272775 B.C. LTD. (dba Everest Clinical Research) | Professional Services | Canadian Prime Rate | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[16],[23] | 4.75% | 4.75% | 4.75% | 4.75% | |||||||||||||
1st Lien/Senior Secured Debt | 1272775 B.C. LTD. (dba Everest Clinical Research) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[8],[22] | 11.45% | 11.45% | 11.45% | 11.45% | |||||||||||||
Floor (+) | [1],[11],[12],[16],[23],[25] | 1% | ||||||||||||||||
Maturity | Nov. 06, 2026 | [3],[5],[6],[8] | Nov. 06, 2026 | [1],[11],[12],[16],[25] | Nov. 06, 2026 | [3],[5],[6],[8] | Nov. 06, 2026 | [3],[5],[6],[8] | Nov. 06, 2026 | [3],[5],[6],[8] | Nov. 06, 2026 | [1],[11],[12],[16],[25] | Nov. 06, 2026 | [1],[11],[12],[16],[25] | Nov. 06, 2026 | [1],[11],[12],[16],[25] | ||
Par (++) | $ 1,151 | [1],[11],[12],[13],[16],[25] | $ 454 | [3],[5],[6],[7],[8] | ||||||||||||||
Cost | (14) | [1],[11],[12],[16],[25] | 339 | [3],[5],[6],[8] | ||||||||||||||
Fair Value | $ (17) | [1],[11],[12],[16],[25] | $ 331 | [3],[5],[6],[8] | ||||||||||||||
1st Lien/Senior Secured Debt | 1272775 B.C. LTD. (dba Everest Clinical Research) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[16],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | 1272775 B.C. LTD. (dba Everest Clinical Research) | Professional Services | Canadian Prime Rate | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[8],[22] | 4.75% | 4.75% | 4.75% | 4.75% | |||||||||||||
1st Lien/Senior Secured Debt | 3SI Security Systems, Inc. | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.24% | [5],[6],[22] | 6.75% | [1],[11],[23] | 11.24% | [5],[6],[22] | 11.24% | [5],[6],[22] | 11.24% | [5],[6],[22] | 6.75% | [1],[11],[23] | 6.75% | [1],[11],[23] | 6.75% | [1],[11],[23] | ||
Floor (+) | [1],[11],[23] | 1% | ||||||||||||||||
Maturity | Dec. 16, 2024 | [5],[6] | Jun. 16, 2023 | [1],[11] | Dec. 16, 2024 | [5],[6] | Dec. 16, 2024 | [5],[6] | Dec. 16, 2024 | [5],[6] | Jun. 16, 2023 | [1],[11] | Jun. 16, 2023 | [1],[11] | Jun. 16, 2023 | [1],[11] | ||
Par (++) | $ 13,420 | [5],[6],[7] | $ 13,982 | [1],[11],[13] | ||||||||||||||
Cost | 13,287 | [5],[6] | 13,928 | [1],[11] | ||||||||||||||
Fair Value | $ 12,983 | [5],[6] | $ 13,912 | [1],[11] | ||||||||||||||
1st Lien/Senior Secured Debt | 3SI Security Systems, Inc. | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [5],[6],[22] | 5.75% | [1],[11],[23] | 6.50% | [5],[6],[22] | 6.50% | [5],[6],[22] | 6.50% | [5],[6],[22] | 5.75% | [1],[11],[23] | 5.75% | [1],[11],[23] | 5.75% | [1],[11],[23] | ||
1st Lien/Senior Secured Debt | 3SI Security Systems, Inc. | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.24% | [5],[6],[22] | 6.75% | [1],[11],[23] | 11.24% | [5],[6],[22] | 11.24% | [5],[6],[22] | 11.24% | [5],[6],[22] | 6.75% | [1],[11],[23] | 6.75% | [1],[11],[23] | 6.75% | [1],[11],[23] | ||
Floor (+) | [1],[11],[23] | 1% | ||||||||||||||||
Maturity | Dec. 16, 2024 | [5],[6] | Jun. 16, 2023 | [1],[11] | Dec. 16, 2024 | [5],[6] | Dec. 16, 2024 | [5],[6] | Dec. 16, 2024 | [5],[6] | Jun. 16, 2023 | [1],[11] | Jun. 16, 2023 | [1],[11] | Jun. 16, 2023 | [1],[11] | ||
Par (++) | $ 2,044 | [5],[6],[7] | $ 2,129 | [1],[11],[13] | ||||||||||||||
Cost | 1,979 | [5],[6] | 2,045 | [1],[11] | ||||||||||||||
Fair Value | $ 1,977 | [5],[6] | $ 2,118 | [1],[11] | ||||||||||||||
1st Lien/Senior Secured Debt | 3SI Security Systems, Inc. | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [5],[6],[22] | 5.75% | [1],[11],[23] | 6.50% | [5],[6],[22] | 6.50% | [5],[6],[22] | 6.50% | [5],[6],[22] | 5.75% | [1],[11],[23] | 5.75% | [1],[11],[23] | 5.75% | [1],[11],[23] | ||
1st Lien/Senior Secured Debt | A Place For Mom, Inc. | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 8.88% | [6],[22] | 5.50% | [1],[23] | 8.88% | [6],[22] | 8.88% | [6],[22] | 8.88% | [6],[22] | 5.50% | [1],[23] | 5.50% | [1],[23] | 5.50% | [1],[23] | ||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [1] | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [1] | Feb. 10, 2026 | [1] | Feb. 10, 2026 | [1] | ||
Par (++) | $ 7,323 | [6],[7] | $ 8,661 | [1],[13] | ||||||||||||||
Cost | 7,305 | [6] | 8,657 | [1] | ||||||||||||||
Fair Value | $ 7,012 | [6] | $ 8,488 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | A Place For Mom, Inc. | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 4.50% | [6],[22] | 4.50% | [1],[23] | 4.50% | [6],[22] | 4.50% | [6],[22] | 4.50% | [6],[22] | 4.50% | [1],[23] | 4.50% | [1],[23] | 4.50% | [1],[23] | ||
1st Lien/Senior Secured Debt | Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.99% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 9.99% | [3],[5],[6],[22] | 9.99% | [3],[5],[6],[22] | 9.99% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Mar. 10, 2027 | [3],[5],[6] | Mar. 10, 2027 | [1],[11],[12] | Mar. 10, 2027 | [3],[5],[6] | Mar. 10, 2027 | [3],[5],[6] | Mar. 10, 2027 | [3],[5],[6] | Mar. 10, 2027 | [1],[11],[12] | Mar. 10, 2027 | [1],[11],[12] | Mar. 10, 2027 | [1],[11],[12] | ||
Par (++) | $ 16,223 | [3],[5],[6],[7] | $ 16,388 | [1],[11],[12],[13] | ||||||||||||||
Cost | 15,921 | [3],[5],[6] | 16,024 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 15,898 | [3],[5],[6] | $ 16,593 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.99% | [3],[5],[6],[22],[24] | 7.25% | [1],[11],[12],[23],[25] | 9.99% | [3],[5],[6],[22],[24] | 9.99% | [3],[5],[6],[22],[24] | 9.99% | [3],[5],[6],[22],[24] | 7.25% | [1],[11],[12],[23],[25] | 7.25% | [1],[11],[12],[23],[25] | 7.25% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Mar. 10, 2027 | [3],[5],[6],[24] | Mar. 10, 2027 | [1],[11],[12],[25] | Mar. 10, 2027 | [3],[5],[6],[24] | Mar. 10, 2027 | [3],[5],[6],[24] | Mar. 10, 2027 | [3],[5],[6],[24] | Mar. 10, 2027 | [1],[11],[12],[25] | Mar. 10, 2027 | [1],[11],[12],[25] | Mar. 10, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 3,037 | [3],[5],[6],[7],[24] | $ 1,220 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 1,670 | [3],[5],[6],[24] | 156 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 1,636 | [3],[5],[6],[24] | $ 198 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.64% | 10.64% | 10.64% | 10.64% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Mar. 10, 2027 | [3],[5],[6],[24] | Mar. 10, 2027 | [1],[11],[12],[25] | Mar. 10, 2027 | [3],[5],[6],[24] | Mar. 10, 2027 | [3],[5],[6],[24] | Mar. 10, 2027 | [3],[5],[6],[24] | Mar. 10, 2027 | [1],[11],[12],[25] | Mar. 10, 2027 | [1],[11],[12],[25] | Mar. 10, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 1,220 | [3],[5],[6],[7],[24] | $ 3,046 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 588 | [3],[5],[6],[24] | (33) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 586 | [3],[5],[6],[24] | $ 38 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Acquia, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.74% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 10.74% | [3],[5],[6],[22] | 10.74% | [3],[5],[6],[22] | 10.74% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Oct. 31, 2025 | [3],[5],[6] | Oct. 31, 2025 | [1],[11],[12] | Oct. 31, 2025 | [3],[5],[6] | Oct. 31, 2025 | [3],[5],[6] | Oct. 31, 2025 | [3],[5],[6] | Oct. 31, 2025 | [1],[11],[12] | Oct. 31, 2025 | [1],[11],[12] | Oct. 31, 2025 | [1],[11],[12] | ||
Par (++) | $ 42,164 | [3],[5],[6],[7] | $ 42,164 | [1],[11],[12],[13] | ||||||||||||||
Cost | 40,929 | [3],[5],[6] | 40,565 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 41,216 | [3],[5],[6] | $ 41,427 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Acquia, Inc. | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Acquia, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 12.16% | 12.16% | 12.16% | 12.16% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Oct. 31, 2025 | [3],[5],[6],[24] | Oct. 31, 2025 | [1],[11],[12],[25] | Oct. 31, 2025 | [3],[5],[6],[24] | Oct. 31, 2025 | [3],[5],[6],[24] | Oct. 31, 2025 | [3],[5],[6],[24] | Oct. 31, 2025 | [1],[11],[12],[25] | Oct. 31, 2025 | [1],[11],[12],[25] | Oct. 31, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 3,268 | [3],[5],[6],[7],[24] | $ 3,268 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 1,870 | [3],[5],[6],[24] | (69) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 1,848 | [3],[5],[6],[24] | $ (57) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Acquia, Inc. | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22],[24] | 7% | [1],[11],[12],[23],[25] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 7% | [1],[11],[12],[23],[25] | 7% | [1],[11],[12],[23],[25] | 7% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Acquia, Inc. | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 9.93% | 9.93% | 9.93% | 9.93% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jan. 10, 2025 | Jan. 10, 2025 | Jan. 10, 2025 | Jan. 10, 2025 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 5,385 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 3,192 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 3,177 | ||||||||||||||||
1st Lien/Senior Secured Debt | Acquia, Inc. | IT Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Admiral Buyer, Inc. (dba Fidelity Payment Services) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.08% | 10.08% | 10.08% | 10.08% | |||||||||||||
Maturity | [3],[5],[6] | May 08, 2028 | May 08, 2028 | May 08, 2028 | May 08, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 26,394 | ||||||||||||||||
Cost | [3],[5],[6] | 25,912 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 25,866 | ||||||||||||||||
1st Lien/Senior Secured Debt | Admiral Buyer, Inc. (dba Fidelity Payment Services) | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Admiral Buyer, Inc. (dba Fidelity Payment Services) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | May 08, 2028 | May 08, 2028 | May 08, 2028 | May 08, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,530 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (45) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (51) | ||||||||||||||||
1st Lien/Senior Secured Debt | Admiral Buyer, Inc. (dba Fidelity Payment Services) | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Admiral Buyer, Inc. (dba Fidelity Payment Services) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | May 08, 2028 | May 08, 2028 | May 08, 2028 | May 08, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 7,120 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (64) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (142) | ||||||||||||||||
1st Lien/Senior Secured Debt | Admiral Buyer, Inc. (dba Fidelity Payment Services) | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Ansira Partners, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[23] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Dec. 20, 2024 | [6],[20] | Dec. 20, 2024 | [1] | Dec. 20, 2024 | [6],[20] | Dec. 20, 2024 | [6],[20] | Dec. 20, 2024 | [6],[20] | Dec. 20, 2024 | [1] | Dec. 20, 2024 | [1] | Dec. 20, 2024 | [1] | ||
Par (++) | $ 5,467 | [6],[7],[20] | $ 5,115 | [1],[13] | ||||||||||||||
Cost | 5,287 | [6],[20] | 5,098 | [1] | ||||||||||||||
Fair Value | $ 3,198 | [6],[20] | $ 2,992 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | Ansira Partners, Inc. | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | 6.50% | [6],[20],[22] | 6.50% | [1],[23] | 6.50% | [6],[20],[22] | 6.50% | [6],[20],[22] | 6.50% | [6],[20],[22] | 6.50% | [1],[23] | 6.50% | [1],[23] | 6.50% | [1],[23] | ||
1st Lien/Senior Secured Debt | Ansira Partners, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[23] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Dec. 20, 2024 | [6],[20] | Dec. 20, 2024 | [1] | Dec. 20, 2024 | [6],[20] | Dec. 20, 2024 | [6],[20] | Dec. 20, 2024 | [6],[20] | Dec. 20, 2024 | [1] | Dec. 20, 2024 | [1] | Dec. 20, 2024 | [1] | ||
Par (++) | $ 338 | [6],[7],[20] | $ 315 | [1],[13] | ||||||||||||||
Cost | 328 | [6],[20] | 314 | [1] | ||||||||||||||
Fair Value | $ 197 | [6],[20] | $ 184 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | Ansira Partners, Inc. | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | 6.50% | [6],[20],[22] | 6.50% | [1],[23] | 6.50% | [6],[20],[22] | 6.50% | [6],[20],[22] | 6.50% | [6],[20],[22] | 6.50% | [1],[23] | 6.50% | [1],[23] | 6.50% | [1],[23] | ||
1st Lien/Senior Secured Debt | Ansira Partners, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[6],[22],[24],[26] | 14.41% | 14.41% | 14.41% | 14.41% | |||||||||||||
Maturity | [3],[6],[24],[26] | Dec. 20, 2024 | Dec. 20, 2024 | Dec. 20, 2024 | Dec. 20, 2024 | |||||||||||||
Par (++) | [3],[6],[7],[24],[26] | $ 158 | ||||||||||||||||
Cost | [3],[6],[24],[26] | 33 | ||||||||||||||||
Fair Value | [3],[6],[24],[26] | $ 32 | ||||||||||||||||
1st Lien/Senior Secured Debt | Ansira Partners, Inc. | Professional Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [3],[6],[22],[24],[26] | 10% | 10% | 10% | 10% | |||||||||||||
1st Lien/Senior Secured Debt | Apptio, Inc. | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.94% | [3],[5],[6],[22] | 8.25% | [1],[11],[12],[23] | 9.94% | [3],[5],[6],[22] | 9.94% | [3],[5],[6],[22] | 9.94% | [3],[5],[6],[22] | 8.25% | [1],[11],[12],[23] | 8.25% | [1],[11],[12],[23] | 8.25% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jan. 10, 2025 | [3],[5],[6] | Jan. 10, 2025 | [1],[11],[12] | Jan. 10, 2025 | [3],[5],[6] | Jan. 10, 2025 | [3],[5],[6] | Jan. 10, 2025 | [3],[5],[6] | Jan. 10, 2025 | [1],[11],[12] | Jan. 10, 2025 | [1],[11],[12] | Jan. 10, 2025 | [1],[11],[12] | ||
Par (++) | $ 79,154 | [3],[5],[6],[7] | $ 79,154 | [1],[11],[12],[13] | ||||||||||||||
Cost | 77,328 | [3],[5],[6] | 76,540 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 78,362 | [3],[5],[6] | $ 79,154 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Apptio, Inc. | IT Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 6% | [3],[5],[6],[22] | 6% | [3],[5],[6],[22] | 6% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Apptio, Inc. | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23],[25] | 8.25% | 8.25% | 8.25% | 8.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Jan. 10, 2025 | Jan. 10, 2025 | Jan. 10, 2025 | Jan. 10, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 5,385 | ||||||||||||||||
Cost | [1],[11],[12],[25] | 2,096 | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ 2,154 | ||||||||||||||||
1st Lien/Senior Secured Debt | Apptio, Inc. | IT Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.03% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 10.03% | [3],[5],[6],[22] | 10.03% | [3],[5],[6],[22] | 10.03% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 01, 2026 | [3],[5],[6] | Jul. 01, 2026 | [1],[11],[12] | Jul. 01, 2026 | [3],[5],[6] | Jul. 01, 2026 | [3],[5],[6] | Jul. 01, 2026 | [3],[5],[6] | Jul. 01, 2026 | [1],[11],[12] | Jul. 01, 2026 | [1],[11],[12] | Jul. 01, 2026 | [1],[11],[12] | ||
Par (++) | $ 39,210 | [3],[5],[6],[7] | $ 32,010 | [1],[11],[12],[13] | ||||||||||||||
Cost | 38,608 | [3],[5],[6] | 31,423 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 38,034 | [3],[5],[6] | $ 31,450 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.01% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23],[25] | 12.01% | [3],[5],[6],[22] | 12.01% | [3],[5],[6],[22] | 12.01% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23],[25] | 8% | [1],[11],[12],[23],[25] | 8% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jul. 01, 2026 | [3],[5],[6] | Jul. 01, 2026 | [1],[11],[12],[25] | Jul. 01, 2026 | [3],[5],[6] | Jul. 01, 2026 | [3],[5],[6] | Jul. 01, 2026 | [3],[5],[6] | Jul. 01, 2026 | [1],[11],[12],[25] | Jul. 01, 2026 | [1],[11],[12],[25] | Jul. 01, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 2,339 | [3],[5],[6],[7] | $ 4,570 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 2,339 | [3],[5],[6] | 1,197 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 2,333 | [3],[5],[6] | $ 1,200 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 8% | 8% | 8% | 8% | |||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.35% | [3],[5],[6],[22],[24] | 9% | [1],[11],[12],[23],[25] | 12.35% | [3],[5],[6],[22],[24] | 12.35% | [3],[5],[6],[22],[24] | 12.35% | [3],[5],[6],[22],[24] | 9% | [1],[11],[12],[23],[25] | 9% | [1],[11],[12],[23],[25] | 9% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jul. 01, 2026 | [3],[5],[6],[24] | Jul. 01, 2026 | [1],[11],[12],[25] | Jul. 01, 2026 | [3],[5],[6],[24] | Jul. 01, 2026 | [3],[5],[6],[24] | Jul. 01, 2026 | [3],[5],[6],[24] | Jul. 01, 2026 | [1],[11],[12],[25] | Jul. 01, 2026 | [1],[11],[12],[25] | Jul. 01, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 6,600 | [3],[5],[6],[7],[24] | $ 11,560 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 2,282 | [3],[5],[6],[24] | 662 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 2,265 | [3],[5],[6],[24] | $ 777 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 8% | 8% | 8% | 8% | |||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 8% | 8% | 8% | 8% | |||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Jul. 01, 2026 | Jul. 01, 2026 | Jul. 01, 2026 | Jul. 01, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 4,570 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (65) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (137) | ||||||||||||||||
1st Lien/Senior Secured Debt | AQ Helios Buyer, Inc. (dba SurePoint) | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Argos Health Holdings, Inc | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.72% | [3],[5],[6],[22] | 6.50% | [1],[12],[23] | 9.72% | [3],[5],[6],[22] | 9.72% | [3],[5],[6],[22] | 9.72% | [3],[5],[6],[22] | 6.50% | [1],[12],[23] | 6.50% | [1],[12],[23] | 6.50% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Dec. 03, 2027 | [3],[5],[6] | Dec. 03, 2027 | [1],[12] | Dec. 03, 2027 | [3],[5],[6] | Dec. 03, 2027 | [3],[5],[6] | Dec. 03, 2027 | [3],[5],[6] | Dec. 03, 2027 | [1],[12] | Dec. 03, 2027 | [1],[12] | Dec. 03, 2027 | [1],[12] | ||
Par (++) | $ 21,780 | [3],[5],[6],[7] | $ 22,000 | [1],[12],[13] | ||||||||||||||
Cost | 21,410 | [3],[5],[6] | 21,565 | [1],[12] | ||||||||||||||
Fair Value | $ 21,127 | [3],[5],[6] | $ 21,560 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Argos Health Holdings, Inc | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[5],[6],[22] | 5.75% | [1],[12],[23] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.75% | [1],[12],[23] | 5.75% | [1],[12],[23] | 5.75% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | Aria Systems, Inc. | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.44% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 11.44% | [3],[5],[6],[22] | 11.44% | [3],[5],[6],[22] | 11.44% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jun. 30, 2026 | [3],[5],[6] | Jun. 30, 2026 | [1],[11],[12] | Jun. 30, 2026 | [3],[5],[6] | Jun. 30, 2026 | [3],[5],[6] | Jun. 30, 2026 | [3],[5],[6] | Jun. 30, 2026 | [1],[11],[12] | Jun. 30, 2026 | [1],[11],[12] | Jun. 30, 2026 | [1],[11],[12] | ||
Par (++) | $ 27,084 | [3],[5],[6],[7] | $ 16,517 | [1],[11],[12],[13] | ||||||||||||||
Cost | 26,727 | [3],[5],[6] | 16,290 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 26,204 | [3],[5],[6] | $ 16,311 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Aria Systems, Inc. | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Aria Systems, Inc. | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Aria Systems, Inc. | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23],[25] | 8% | 8% | 8% | 8% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Jun. 30, 2026 | Jun. 30, 2026 | Jun. 30, 2026 | Jun. 30, 2026 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 4,160 | ||||||||||||||||
Cost | [1],[11],[12],[25] | 2,234 | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ 2,215 | ||||||||||||||||
1st Lien/Senior Secured Debt | Aria Systems, Inc. | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Assembly Intermediate LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.23% | [3],[5],[6],[22] | 8% | [1],[12],[23] | 11.23% | [3],[5],[6],[22] | 11.23% | [3],[5],[6],[22] | 11.23% | [3],[5],[6],[22] | 8% | [1],[12],[23] | 8% | [1],[12],[23] | 8% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Oct. 19, 2027 | [3],[5],[6] | Oct. 19, 2027 | [1],[12] | Oct. 19, 2027 | [3],[5],[6] | Oct. 19, 2027 | [3],[5],[6] | Oct. 19, 2027 | [3],[5],[6] | Oct. 19, 2027 | [1],[12] | Oct. 19, 2027 | [1],[12] | Oct. 19, 2027 | [1],[12] | ||
Par (++) | $ 43,991 | [3],[5],[6],[7] | $ 43,991 | [1],[12],[13] | ||||||||||||||
Cost | 43,254 | [3],[5],[6] | 43,135 | [1],[12] | ||||||||||||||
Fair Value | $ 43,331 | [3],[5],[6] | $ 43,111 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Assembly Intermediate LLC | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [3],[5],[6],[22] | 7% | [1],[12],[23] | 6.50% | [3],[5],[6],[22] | 6.50% | [3],[5],[6],[22] | 6.50% | [3],[5],[6],[22] | 7% | [1],[12],[23] | 7% | [1],[12],[23] | 7% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | Assembly Intermediate LLC | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.77% | 10.77% | 10.77% | 10.77% | |||||||||||||
1st Lien/Senior Secured Debt | Assembly Intermediate LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[12],[23],[25] | 8% | 8% | 8% | 8% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Oct. 19, 2027 | [3],[5],[6],[24] | Oct. 19, 2027 | [1],[12],[25] | Oct. 19, 2027 | [3],[5],[6],[24] | Oct. 19, 2027 | [3],[5],[6],[24] | Oct. 19, 2027 | [3],[5],[6],[24] | Oct. 19, 2027 | [1],[12],[25] | Oct. 19, 2027 | [1],[12],[25] | Oct. 19, 2027 | [1],[12],[25] | ||
Par (++) | $ 10,998 | [3],[5],[6],[7],[24] | $ 10,998 | [1],[12],[13],[25] | ||||||||||||||
Cost | 6,014 | [3],[5],[6],[24] | 2,507 | [1],[12],[25] | ||||||||||||||
Fair Value | $ 5,994 | [3],[5],[6],[24] | $ 2,529 | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Assembly Intermediate LLC | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [3],[5],[6],[22],[24] | 7% | [1],[12],[23],[25] | 6.50% | [3],[5],[6],[22],[24] | 6.50% | [3],[5],[6],[22],[24] | 6.50% | [3],[5],[6],[22],[24] | 7% | [1],[12],[23],[25] | 7% | [1],[12],[23],[25] | 7% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Assembly Intermediate LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 11.05% | 11.05% | 11.05% | 11.05% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Oct. 19, 2027 | [3],[5],[6],[24] | Oct. 19, 2027 | [1],[12],[25] | Oct. 19, 2027 | [3],[5],[6],[24] | Oct. 19, 2027 | [3],[5],[6],[24] | Oct. 19, 2027 | [3],[5],[6],[24] | Oct. 19, 2027 | [1],[12],[25] | Oct. 19, 2027 | [1],[12],[25] | Oct. 19, 2027 | [1],[12],[25] | ||
Par (++) | $ 4,399 | [3],[5],[6],[7],[24] | $ 4,399 | [1],[12],[13],[25] | ||||||||||||||
Cost | 1,689 | [3],[5],[6],[24] | (85) | [1],[12],[25] | ||||||||||||||
Fair Value | $ 1,694 | [3],[5],[6],[24] | $ (88) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Assembly Intermediate LLC | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [3],[5],[6],[22],[24] | 7% | [1],[12],[23],[25] | 6.50% | [3],[5],[6],[22],[24] | 6.50% | [3],[5],[6],[22],[24] | 6.50% | [3],[5],[6],[22],[24] | 7% | [1],[12],[23],[25] | 7% | [1],[12],[23],[25] | 7% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | ATX Networks Corp. | Communications Equipment | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.23% | [5],[6],[8],[14],[22] | 8.50% | [1],[11],[16],[17],[23] | 12.23% | [5],[6],[8],[14],[22] | 12.23% | [5],[6],[8],[14],[22] | 12.23% | [5],[6],[8],[14],[22] | 8.50% | [1],[11],[16],[17],[23] | 8.50% | [1],[11],[16],[17],[23] | 8.50% | [1],[11],[16],[17],[23] | ||
Reference Rate and Spread (+), PIK | [1],[11],[16],[17],[23] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Floor (+) | [1],[11],[16],[17],[23] | 1% | ||||||||||||||||
Maturity | Sep. 01, 2026 | [5],[6],[8],[14] | Sep. 01, 2026 | [1],[11],[16],[17] | Sep. 01, 2026 | [5],[6],[8],[14] | Sep. 01, 2026 | [5],[6],[8],[14] | Sep. 01, 2026 | [5],[6],[8],[14] | Sep. 01, 2026 | [1],[11],[16],[17] | Sep. 01, 2026 | [1],[11],[16],[17] | Sep. 01, 2026 | [1],[11],[16],[17] | ||
Par (++) | $ 3,866 | [5],[6],[7],[8],[14] | $ 4,463 | [1],[11],[13],[16],[17] | ||||||||||||||
Cost | 3,866 | [5],[6],[8],[14] | 4,463 | [1],[11],[16],[17] | ||||||||||||||
Fair Value | $ 3,798 | [5],[6],[8],[14] | $ 4,129 | [1],[11],[16],[17] | ||||||||||||||
1st Lien/Senior Secured Debt | ATX Networks Corp. | Communications Equipment | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [5],[6],[8],[14],[22] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
1st Lien/Senior Secured Debt | Badger Sportswear, Inc. | Textiles, Apparel & Luxury Goods | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.06% | [6],[22] | 5.75% | [1],[23] | 9.06% | [6],[22] | 9.06% | [6],[22] | 9.06% | [6],[22] | 5.75% | [1],[23] | 5.75% | [1],[23] | 5.75% | [1],[23] | ||
Floor (+) | [1],[23] | 1.25% | ||||||||||||||||
Maturity | Dec. 24, 2023 | [6] | Sep. 11, 2023 | [1] | Dec. 24, 2023 | [6] | Dec. 24, 2023 | [6] | Dec. 24, 2023 | [6] | Sep. 11, 2023 | [1] | Sep. 11, 2023 | [1] | Sep. 11, 2023 | [1] | ||
Par (++) | $ 7,023 | [6],[7] | $ 7,054 | [1],[13] | ||||||||||||||
Cost | 7,011 | [6] | 7,026 | [1] | ||||||||||||||
Fair Value | $ 6,812 | [6] | $ 6,878 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | Badger Sportswear, Inc. | Textiles, Apparel & Luxury Goods | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 4.50% | [6],[22] | 4.50% | [1],[23] | 4.50% | [6],[22] | 4.50% | [6],[22] | 4.50% | [6],[22] | 4.50% | [1],[23] | 4.50% | [1],[23] | 4.50% | [1],[23] | ||
1st Lien/Senior Secured Debt | Bigchange Group Limited | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.43% | [3],[5],[6],[8],[22] | 7% | [1],[12],[16],[23] | 9.43% | [3],[5],[6],[8],[22] | 9.43% | [3],[5],[6],[8],[22] | 9.43% | [3],[5],[6],[8],[22] | 7% | [1],[12],[16],[23] | 7% | [1],[12],[16],[23] | 7% | [1],[12],[16],[23] | ||
Floor (+) | [1],[12],[16],[23] | 1% | ||||||||||||||||
Maturity | Dec. 23, 2026 | [3],[5],[6],[8] | Dec. 23, 2026 | [1],[12],[16] | Dec. 23, 2026 | [3],[5],[6],[8] | Dec. 23, 2026 | [3],[5],[6],[8] | Dec. 23, 2026 | [3],[5],[6],[8] | Dec. 23, 2026 | [1],[12],[16] | Dec. 23, 2026 | [1],[12],[16] | Dec. 23, 2026 | [1],[12],[16] | ||
Par (++) | £ | £ 11,990 | [3],[5],[6],[7],[8] | £ 11,990 | [1],[12],[16],[23] | ||||||||||||||
Cost | £ | 15,822 | [3],[5],[6],[8] | 15,770 | [1],[12],[16] | ||||||||||||||
Fair Value | £ | £ 14,169 | [3],[5],[6],[8] | £ 15,904 | [1],[12],[16] | ||||||||||||||
1st Lien/Senior Secured Debt | Bigchange Group Limited | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[16],[23] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Bigchange Group Limited | Software | SONIA | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[8],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Bigchange Group Limited | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[8],[22],[24] | 9.43% | 9.43% | 9.43% | 9.43% | |||||||||||||
Floor (+) | [1],[12],[16],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 23, 2026 | [3],[5],[6],[8],[24] | Dec. 23, 2026 | [1],[12],[16],[25] | Dec. 23, 2026 | [3],[5],[6],[8],[24] | Dec. 23, 2026 | [3],[5],[6],[8],[24] | Dec. 23, 2026 | [3],[5],[6],[8],[24] | Dec. 23, 2026 | [1],[12],[16],[25] | Dec. 23, 2026 | [1],[12],[16],[25] | Dec. 23, 2026 | [1],[12],[16],[25] | ||
Par (++) | £ | £ 870 | [3],[5],[6],[7],[8],[24] | £ 870 | [1],[12],[16],[23],[25] | ||||||||||||||
Cost | £ | [3],[5],[6],[8],[24] | 499 | ||||||||||||||||
Fair Value | £ | [3],[5],[6],[8],[24] | £ 470 | ||||||||||||||||
1st Lien/Senior Secured Debt | Bigchange Group Limited | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[16],[23],[25] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Bigchange Group Limited | Software | SONIA | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[8],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Bigchange Group Limited | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[16],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 23, 2026 | [3],[5],[6],[8],[24] | Dec. 23, 2026 | [1],[12],[16],[25] | Dec. 23, 2026 | [3],[5],[6],[8],[24] | Dec. 23, 2026 | [3],[5],[6],[8],[24] | Dec. 23, 2026 | [3],[5],[6],[8],[24] | Dec. 23, 2026 | [1],[12],[16],[25] | Dec. 23, 2026 | [1],[12],[16],[25] | Dec. 23, 2026 | [1],[12],[16],[25] | ||
Par (++) | £ | £ 2,400 | [3],[5],[6],[7],[8],[24] | £ 2,400 | [1],[12],[16],[23],[25] | ||||||||||||||
Cost | £ | (54) | [3],[5],[6],[8],[24] | (64) | [1],[12],[16],[25] | ||||||||||||||
Fair Value | £ | £ (65) | [3],[5],[6],[8],[24] | £ (65) | [1],[12],[16],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Bigchange Group Limited | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[16],[23],[25] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Bigchange Group Limited | Software | SONIA | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[8],[22],[24] | (6.00%) | (6.00%) | (6.00%) | (6.00%) | |||||||||||||
1st Lien/Senior Secured Debt | Broadway Technology, LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.34% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 11.34% | [3],[5],[6],[22] | 11.34% | [3],[5],[6],[22] | 11.34% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jan. 08, 2026 | [3],[5],[6] | Jan. 08, 2026 | [1],[11],[12] | Jan. 08, 2026 | [3],[5],[6] | Jan. 08, 2026 | [3],[5],[6] | Jan. 08, 2026 | [3],[5],[6] | Jan. 08, 2026 | [1],[11],[12] | Jan. 08, 2026 | [1],[11],[12] | Jan. 08, 2026 | [1],[11],[12] | ||
Par (++) | $ 25,643 | [3],[5],[6],[7] | $ 25,904 | [1],[11],[12],[23] | ||||||||||||||
Cost | 25,280 | [3],[5],[6] | 25,473 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 25,387 | [3],[5],[6] | $ 25,645 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Broadway Technology, LLC | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Broadway Technology, LLC | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Broadway Technology, LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Jan. 08, 2026 | Jan. 08, 2026 | Jan. 08, 2026 | Jan. 08, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 1,090 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (17) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (11) | ||||||||||||||||
1st Lien/Senior Secured Debt | Broadway Technology, LLC | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | BSI3 Menu Buyer, Inc (dba Kydia) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.44% | 10.44% | 10.44% | 10.44% | |||||||||||||
Maturity | [3],[5],[6] | Jan. 25, 2028 | Jan. 25, 2028 | Jan. 25, 2028 | Jan. 25, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 962 | ||||||||||||||||
Cost | [3],[5],[6] | 947 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 924 | ||||||||||||||||
1st Lien/Senior Secured Debt | BSI3 Menu Buyer, Inc (dba Kydia) | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | BSI3 Menu Buyer, Inc (dba Kydia) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Jan. 25, 2028 | Jan. 25, 2028 | Jan. 25, 2028 | Jan. 25, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 38 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (1) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (2) | ||||||||||||||||
1st Lien/Senior Secured Debt | BSI3 Menu Buyer, Inc (dba Kydia) | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [1],[11],[12] | ||
Par (++) | $ 26,291 | [3],[5],[6],[7] | $ 26,562 | [1],[11],[12],[23] | ||||||||||||||
Cost | 25,479 | [3],[5],[6] | 25,563 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 25,896 | [3],[5],[6] | $ 26,429 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [1],[11],[12] | ||
Par (++) | $ 4,682 | [3],[5],[6],[7] | $ 1,462 | [1],[11],[12],[23] | ||||||||||||||
Cost | 4,663 | [3],[5],[6] | 1,455 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 4,611 | [3],[5],[6] | $ 1,455 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [1],[11],[12] | ||
Par (++) | $ 1,217 | [3],[5],[6],[7] | $ 1,229 | [1],[11],[12],[23] | ||||||||||||||
Cost | 1,204 | [3],[5],[6] | 1,213 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 1,198 | [3],[5],[6] | $ 1,223 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[12],[23] | 10.48% | [3],[5],[6],[22],[24] | 10.48% | [3],[5],[6],[22],[24] | 10.48% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Sep. 30, 2026 | [3],[5],[6],[24] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [3],[5],[6],[24] | Sep. 30, 2026 | [3],[5],[6],[24] | Sep. 30, 2026 | [3],[5],[6],[24] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [1],[11],[12] | ||
Par (++) | $ 1,344 | [3],[5],[6],[7],[24] | $ 551 | [1],[11],[12],[23] | ||||||||||||||
Cost | 604 | [3],[5],[6],[24] | 530 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 598 | [3],[5],[6],[24] | $ 548 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [1],[11],[12] | Sep. 30, 2026 | [1],[11],[12] | ||
Par (++) | $ 545 | [3],[5],[6],[7] | $ 439 | [1],[11],[12],[23] | ||||||||||||||
Cost | 528 | [3],[5],[6] | 423 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 537 | [3],[5],[6] | $ 437 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.48% | 10.48% | 10.48% | 10.48% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [1],[11],[12],[25] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [3],[5],[6] | Sep. 30, 2026 | [1],[11],[12],[25] | Sep. 30, 2026 | [1],[11],[12],[25] | Sep. 30, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 435 | [3],[5],[6],[7] | $ 1,344 | [1],[11],[12],[23],[25] | ||||||||||||||
Cost | 421 | [3],[5],[6] | (17) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 428 | [3],[5],[6] | $ (7) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Sep. 30, 2026 | Sep. 30, 2026 | Sep. 30, 2026 | Sep. 30, 2026 | |||||||||||||
Par (++) | [1],[11],[12],[23],[25] | $ 3,257 | ||||||||||||||||
Cost | [1],[11],[12],[25] | (16) | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ (16) | ||||||||||||||||
1st Lien/Senior Secured Debt | Bullhorn, Inc. | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Businessolver.com, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.67% | [3],[5],[6],[22] | 6.50% | [1],[12],[23] | 9.67% | [3],[5],[6],[22] | 9.67% | [3],[5],[6],[22] | 9.67% | [3],[5],[6],[22] | 6.50% | [1],[12],[23] | 6.50% | [1],[12],[23] | 6.50% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Dec. 01, 2027 | [3],[5],[6] | Dec. 01, 2027 | [1],[12] | Dec. 01, 2027 | [3],[5],[6] | Dec. 01, 2027 | [3],[5],[6] | Dec. 01, 2027 | [3],[5],[6] | Dec. 01, 2027 | [1],[12] | Dec. 01, 2027 | [1],[12] | Dec. 01, 2027 | [1],[12] | ||
Par (++) | $ 18,529 | [3],[5],[6],[7] | $ 18,669 | [1],[12],[23] | ||||||||||||||
Cost | 18,371 | [3],[5],[6] | 18,484 | [1],[12] | ||||||||||||||
Fair Value | $ 18,344 | [3],[5],[6] | $ 18,482 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Businessolver.com, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[5],[6],[22] | 5.75% | [1],[12],[23] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.75% | [1],[12],[23] | 5.75% | [1],[12],[23] | 5.75% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | Businessolver.com, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 9.88% | 9.88% | 9.88% | 9.88% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Dec. 01, 2027 | [3],[5],[6],[24] | Dec. 01, 2027 | [1],[12],[25] | Dec. 01, 2027 | [3],[5],[6],[24] | Dec. 01, 2027 | [3],[5],[6],[24] | Dec. 01, 2027 | [3],[5],[6],[24] | Dec. 01, 2027 | [1],[12],[25] | Dec. 01, 2027 | [1],[12],[25] | Dec. 01, 2027 | [1],[12],[25] | ||
Par (++) | $ 5,025 | [3],[5],[6],[7],[24] | $ 5,026 | [1],[12],[23],[25] | ||||||||||||||
Cost | 407 | [3],[5],[6],[24] | (25) | [1],[12],[25] | ||||||||||||||
Fair Value | $ 379 | [3],[5],[6],[24] | $ (25) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Businessolver.com, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[5],[6],[22],[24] | 5.75% | [1],[12],[23],[25] | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [3],[5],[6],[22],[24] | 5.75% | [1],[12],[23],[25] | 5.75% | [1],[12],[23],[25] | 5.75% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Capitol Imaging Acquisition Corp. | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.38% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 11.38% | [3],[5],[6],[22] | 11.38% | [3],[5],[6],[22] | 11.38% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Oct. 01, 2026 | [3],[5],[6] | Oct. 01, 2026 | [1],[11],[12] | Oct. 01, 2026 | [3],[5],[6] | Oct. 01, 2026 | [3],[5],[6] | Oct. 01, 2026 | [3],[5],[6] | Oct. 01, 2026 | [1],[11],[12] | Oct. 01, 2026 | [1],[11],[12] | Oct. 01, 2026 | [1],[11],[12] | ||
Par (++) | $ 17,836 | [3],[5],[6],[7] | $ 18,017 | [1],[11],[12],[23] | ||||||||||||||
Cost | 17,559 | [3],[5],[6] | 17,676 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 17,301 | [3],[5],[6] | $ 17,837 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Capitol Imaging Acquisition Corp. | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Capitol Imaging Acquisition Corp. | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Capitol Imaging Acquisition Corp. | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.38% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 11.38% | [3],[5],[6],[22] | 11.38% | [3],[5],[6],[22] | 11.38% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Oct. 01, 2026 | [3],[5],[6] | Oct. 01, 2026 | [1],[11],[12] | Oct. 01, 2026 | [3],[5],[6] | Oct. 01, 2026 | [3],[5],[6] | Oct. 01, 2026 | [3],[5],[6] | Oct. 01, 2026 | [1],[11],[12] | Oct. 01, 2026 | [1],[11],[12] | Oct. 01, 2026 | [1],[11],[12] | ||
Par (++) | $ 798 | [3],[5],[6],[7] | $ 806 | [1],[11],[12],[23] | ||||||||||||||
Cost | 773 | [3],[5],[6] | 776 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 774 | [3],[5],[6] | $ 798 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Capitol Imaging Acquisition Corp. | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Capitol Imaging Acquisition Corp. | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Capitol Imaging Acquisition Corp. | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 13% | 13% | 13% | 13% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Oct. 01, 2025 | [3],[5],[6],[24] | Oct. 01, 2025 | [1],[11],[12],[25] | Oct. 01, 2025 | [3],[5],[6],[24] | Oct. 01, 2025 | [3],[5],[6],[24] | Oct. 01, 2025 | [3],[5],[6],[24] | Oct. 01, 2025 | [1],[11],[12],[25] | Oct. 01, 2025 | [1],[11],[12],[25] | Oct. 01, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 180 | [3],[5],[6],[7],[24] | $ 180 | [1],[11],[12],[23],[25] | ||||||||||||||
Cost | 140 | [3],[5],[6],[24] | (3) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 137 | [3],[5],[6],[24] | $ (2) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Capitol Imaging Acquisition Corp. | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Capitol Imaging Acquisition Corp. | Health Care Providers & Services | U.S. Prime Rate | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | CFS Management, LLC (dba Center for Sight Management) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.84% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 11.84% | [3],[5],[6],[22] | 11.84% | [3],[5],[6],[22] | 11.84% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[27] | 0.75% | 0.75% | 0.75% | 0.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [1],[11],[12] | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [1],[11],[12] | Jul. 01, 2024 | [1],[11],[12] | Jul. 01, 2024 | [1],[11],[12] | ||
Par (++) | $ 19,648 | [3],[5],[6],[7] | $ 19,830 | [1],[11],[12],[23] | ||||||||||||||
Cost | 19,310 | [3],[5],[6] | 19,285 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 18,174 | [3],[5],[6] | $ 19,582 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | CFS Management, LLC (dba Center for Sight Management) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | CFS Management, LLC (dba Center for Sight Management) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | CFS Management, LLC (dba Center for Sight Management) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.84% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 11.84% | [3],[5],[6],[22] | 11.84% | [3],[5],[6],[22] | 11.84% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[27] | 0.75% | 0.75% | 0.75% | 0.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [1],[11],[12] | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [1],[11],[12] | Jul. 01, 2024 | [1],[11],[12] | Jul. 01, 2024 | [1],[11],[12] | ||
Par (++) | $ 3,410 | [3],[5],[6],[7] | $ 3,441 | [1],[11],[12],[23] | ||||||||||||||
Cost | 3,327 | [3],[5],[6] | 3,307 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 3,154 | [3],[5],[6] | $ 3,398 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | CFS Management, LLC (dba Center for Sight Management) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | CFS Management, LLC (dba Center for Sight Management) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | CFS Management, LLC (dba Center for Sight Management) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.84% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23],[25] | 11.84% | [3],[5],[6],[22] | 11.84% | [3],[5],[6],[22] | 11.84% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[27] | 0.75% | 0.75% | 0.75% | 0.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [1],[11],[12],[25] | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [3],[5],[6] | Jul. 01, 2024 | [1],[11],[12],[25] | Jul. 01, 2024 | [1],[11],[12],[25] | Jul. 01, 2024 | [1],[11],[12],[25] | ||
Par (++) | $ 2,007 | [3],[5],[6],[7] | $ 2,017 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 1,993 | [3],[5],[6] | 937 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 1,856 | [3],[5],[6] | $ 934 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | CFS Management, LLC (dba Center for Sight Management) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | CFS Management, LLC (dba Center for Sight Management) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Checkmate Finance Merger Sub, LLC | Entertainment | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.23% | [3],[5],[6],[22] | 7.50% | [1],[12],[23] | 11.23% | [3],[5],[6],[22] | 11.23% | [3],[5],[6],[22] | 11.23% | [3],[5],[6],[22] | 7.50% | [1],[12],[23] | 7.50% | [1],[12],[23] | 7.50% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 31, 2027 | [3],[5],[6] | Dec. 31, 2027 | [1],[12] | Dec. 31, 2027 | [3],[5],[6] | Dec. 31, 2027 | [3],[5],[6] | Dec. 31, 2027 | [3],[5],[6] | Dec. 31, 2027 | [1],[12] | Dec. 31, 2027 | [1],[12] | Dec. 31, 2027 | [1],[12] | ||
Par (++) | $ 31,179 | [3],[5],[6],[7] | $ 31,415 | [1],[12],[13] | ||||||||||||||
Cost | 30,640 | [3],[5],[6] | 30,787 | [1],[12] | ||||||||||||||
Fair Value | $ 30,244 | [3],[5],[6] | $ 30,787 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Checkmate Finance Merger Sub, LLC | Entertainment | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [3],[5],[6],[22] | 6.50% | [1],[12],[23] | 6.50% | [3],[5],[6],[22] | 6.50% | [3],[5],[6],[22] | 6.50% | [3],[5],[6],[22] | 6.50% | [1],[12],[23] | 6.50% | [1],[12],[23] | 6.50% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | Checkmate Finance Merger Sub, LLC | Entertainment | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 31, 2027 | [3],[5],[6],[24] | Dec. 31, 2027 | [1],[12],[25] | Dec. 31, 2027 | [3],[5],[6],[24] | Dec. 31, 2027 | [3],[5],[6],[24] | Dec. 31, 2027 | [3],[5],[6],[24] | Dec. 31, 2027 | [1],[12],[25] | Dec. 31, 2027 | [1],[12],[25] | Dec. 31, 2027 | [1],[12],[25] | ||
Par (++) | $ 3,140 | [3],[5],[6],[7],[24] | $ 3,140 | [1],[12],[13],[25] | ||||||||||||||
Cost | (53) | [3],[5],[6],[24] | (63) | [1],[12],[25] | ||||||||||||||
Fair Value | $ (94) | [3],[5],[6],[24] | $ (63) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Checkmate Finance Merger Sub, LLC | Entertainment | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [3],[5],[6],[22],[24] | 6.50% | [1],[12],[23],[25] | 6.50% | [3],[5],[6],[22],[24] | 6.50% | [3],[5],[6],[22],[24] | 6.50% | [3],[5],[6],[22],[24] | 6.50% | [1],[12],[23],[25] | 6.50% | [1],[12],[23],[25] | 6.50% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.83% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 10.83% | [3],[5],[6],[22] | 10.83% | [3],[5],[6],[22] | 10.83% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | May 18, 2029 | [3],[5],[6] | Nov. 14, 2025 | [1],[11],[12] | May 18, 2029 | [3],[5],[6] | May 18, 2029 | [3],[5],[6] | May 18, 2029 | [3],[5],[6] | Nov. 14, 2025 | [1],[11],[12] | Nov. 14, 2025 | [1],[11],[12] | Nov. 14, 2025 | [1],[11],[12] | ||
Par (++) | $ 45,968 | [3],[5],[6],[7] | $ 16,954 | [1],[11],[12],[13] | ||||||||||||||
Cost | 44,292 | [3],[5],[6] | 16,193 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 44,589 | [3],[5],[6] | $ 16,912 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 7% | 7% | 7% | 7% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | May 18, 2029 | [3],[5],[6],[24] | Nov. 14, 2025 | [1],[11],[12] | May 18, 2029 | [3],[5],[6],[24] | May 18, 2029 | [3],[5],[6],[24] | May 18, 2029 | [3],[5],[6],[24] | Nov. 14, 2025 | [1],[11],[12] | Nov. 14, 2025 | [1],[11],[12] | Nov. 14, 2025 | [1],[11],[12] | ||
Par (++) | $ 4,753 | [3],[5],[6],[7],[24] | $ 11,258 | [1],[11],[12],[13] | ||||||||||||||
Cost | (100) | [3],[5],[6],[24] | 11,032 | [1],[11],[12] | ||||||||||||||
Fair Value | $ (143) | [3],[5],[6],[24] | $ 11,229 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23],[25] | 7% | 7% | 7% | 7% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Nov. 14, 2025 | Nov. 14, 2025 | Nov. 14, 2025 | Nov. 14, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 11,077 | ||||||||||||||||
Cost | [1],[11],[12],[25] | 8,750 | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ 8,891 | ||||||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 7% | 7% | 7% | 7% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Nov. 14, 2025 | Nov. 14, 2025 | Nov. 14, 2025 | Nov. 14, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 7,141 | ||||||||||||||||
Cost | [1],[11],[12] | 6,819 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 7,123 | ||||||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Nov. 14, 2025 | Nov. 14, 2025 | Nov. 14, 2025 | Nov. 14, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 2,180 | ||||||||||||||||
Cost | [1],[11],[12],[25] | (41) | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ (5) | ||||||||||||||||
1st Lien/Senior Secured Debt | Chronicle Bidco Inc. (dba Lexitas) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | CivicPlus LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 11.48% | [3],[5],[6],[22] | 11.48% | [3],[5],[6],[22] | 11.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 2.50% | 2.50% | 2.50% | 2.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [1],[11],[12] | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [1],[11],[12] | Aug. 24, 2027 | [1],[11],[12] | Aug. 24, 2027 | [1],[11],[12] | ||
Par (++) | $ 6,327 | [3],[5],[6],[7] | $ 6,300 | [1],[11],[12],[13] | ||||||||||||||
Cost | 6,210 | [3],[5],[6] | 6,180 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 6,169 | [3],[5],[6] | $ 6,158 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | CivicPlus LLC | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23] | 6% | [1],[11],[12],[23] | 6% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | CivicPlus LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 11.48% | 11.48% | 11.48% | 11.48% | |||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 2.50% | 2.50% | 2.50% | 2.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [1],[11],[12],[25] | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [1],[11],[12],[25] | Aug. 24, 2027 | [1],[11],[12],[25] | Aug. 24, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 6,273 | [3],[5],[6],[7] | $ 592 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 6,160 | [3],[5],[6] | (11) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 6,117 | [3],[5],[6] | $ (13) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | CivicPlus LLC | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23],[25] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23],[25] | 6% | [1],[11],[12],[23],[25] | 6% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | CivicPlus LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 11.48% | 11.48% | 11.48% | 11.48% | |||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 2.50% | 2.50% | 2.50% | 2.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [1],[11],[12],[25] | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [3],[5],[6] | Aug. 24, 2027 | [1],[11],[12],[25] | Aug. 24, 2027 | [1],[11],[12],[25] | Aug. 24, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 2,973 | [3],[5],[6],[7] | $ 2,960 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 2,915 | [3],[5],[6] | (28) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 2,898 | [3],[5],[6] | $ (67) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | CivicPlus LLC | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23],[25] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23],[25] | 6% | [1],[11],[12],[23],[25] | 6% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | CivicPlus LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[24] | 2.50% | 2.50% | 2.50% | 2.50% | |||||||||||||
Maturity | [3],[5],[6],[24] | Aug. 24, 2027 | Aug. 24, 2027 | Aug. 24, 2027 | Aug. 24, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 1,217 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (22) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (30) | ||||||||||||||||
1st Lien/Senior Secured Debt | CivicPlus LLC | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Clearcourse Partnership Acquireco Finance Limited | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[8],[22] | 10.69% | 10.69% | 10.69% | 10.69% | |||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[8],[22] | 0.75% | 0.75% | 0.75% | 0.75% | |||||||||||||
Maturity | [3],[5],[6],[8] | Jul. 25, 2028 | Jul. 25, 2028 | Jul. 25, 2028 | Jul. 25, 2028 | |||||||||||||
Par (++) | £ | [3],[5],[6],[7],[8] | £ 12,910 | ||||||||||||||||
Cost | £ | [3],[5],[6],[8] | 15,177 | ||||||||||||||||
Fair Value | £ | [3],[5],[6],[8] | £ 15,217 | ||||||||||||||||
1st Lien/Senior Secured Debt | Clearcourse Partnership Acquireco Finance Limited | IT Services | SONIA | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[8],[22] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
1st Lien/Senior Secured Debt | Clearcourse Partnership Acquireco Finance Limited | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[8],[22],[24] | 9.55% | 9.55% | 9.55% | 9.55% | |||||||||||||
Maturity | [3],[5],[6],[8],[24] | Jul. 25, 2028 | Jul. 25, 2028 | Jul. 25, 2028 | Jul. 25, 2028 | |||||||||||||
Par (++) | £ | [3],[5],[6],[7],[8],[24] | £ 11,450 | ||||||||||||||||
Cost | £ | [3],[5],[6],[8],[24] | 4,619 | ||||||||||||||||
Fair Value | £ | [3],[5],[6],[8],[24] | £ 4,546 | ||||||||||||||||
1st Lien/Senior Secured Debt | Clearcourse Partnership Acquireco Finance Limited | IT Services | SONIA | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[8],[22],[24] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
1st Lien/Senior Secured Debt | CloudBees, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.39% | [3],[5],[6],[22] | 8% | [1],[12],[23] | 11.39% | [3],[5],[6],[22] | 11.39% | [3],[5],[6],[22] | 11.39% | [3],[5],[6],[22] | 8% | [1],[12],[23] | 8% | [1],[12],[23] | 8% | [1],[12],[23] | ||
Reference Rate and Spread (+), PIK | 2.50% | [3],[5],[6],[22] | 2.50% | [1],[12],[23] | 2.50% | [3],[5],[6],[22] | 2.50% | [3],[5],[6],[22] | 2.50% | [3],[5],[6],[22] | 2.50% | [1],[12],[23] | 2.50% | [1],[12],[23] | 2.50% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 24, 2026 | [3],[5],[6] | Nov. 24, 2026 | [1],[12] | Nov. 24, 2026 | [3],[5],[6] | Nov. 24, 2026 | [3],[5],[6] | Nov. 24, 2026 | [3],[5],[6] | Nov. 24, 2026 | [1],[12] | Nov. 24, 2026 | [1],[12] | Nov. 24, 2026 | [1],[12] | ||
Par (++) | $ 28,738 | [3],[5],[6],[7] | $ 28,022 | [1],[12],[13] | ||||||||||||||
Cost | 27,263 | [3],[5],[6] | 26,231 | [1],[12] | ||||||||||||||
Fair Value | $ 28,235 | [3],[5],[6] | $ 27,461 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | CloudBees, Inc. | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22] | 7% | [1],[12],[23] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [1],[12],[23] | 7% | [1],[12],[23] | 7% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | CloudBees, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 11.39% | 11.39% | 11.39% | 11.39% | |||||||||||||
Reference Rate and Spread (+), PIK | 2.50% | [3],[5],[6],[22],[24] | 2.50% | [1],[12],[23],[25] | 2.50% | [3],[5],[6],[22],[24] | 2.50% | [3],[5],[6],[22],[24] | 2.50% | [3],[5],[6],[22],[24] | 2.50% | [1],[12],[23],[25] | 2.50% | [1],[12],[23],[25] | 2.50% | [1],[12],[23],[25] | ||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Nov. 24, 2026 | [3],[5],[6],[24] | Nov. 24, 2026 | [1],[12],[25] | Nov. 24, 2026 | [3],[5],[6],[24] | Nov. 24, 2026 | [3],[5],[6],[24] | Nov. 24, 2026 | [3],[5],[6],[24] | Nov. 24, 2026 | [1],[12],[25] | Nov. 24, 2026 | [1],[12],[25] | Nov. 24, 2026 | [1],[12],[25] | ||
Par (++) | $ 13,019 | [3],[5],[6],[7],[24] | $ 12,900 | [1],[12],[13],[25] | ||||||||||||||
Cost | 11,592 | [3],[5],[6],[24] | $ (572) | [1],[12],[25] | ||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 12,053 | ||||||||||||||||
1st Lien/Senior Secured Debt | CloudBees, Inc. | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22],[24] | 7% | [1],[12],[23],[25] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 7% | [1],[12],[23],[25] | 7% | [1],[12],[23],[25] | 7% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Coding Solutions Acquisition, Inc. | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 9.82% | 9.82% | 9.82% | 9.82% | |||||||||||||
Maturity | [3],[5],[6] | May 11, 2028 | May 11, 2028 | May 11, 2028 | May 11, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 14,829 | ||||||||||||||||
Cost | [3],[5],[6] | 14,554 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 14,459 | ||||||||||||||||
1st Lien/Senior Secured Debt | Coding Solutions Acquisition, Inc. | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Coding Solutions Acquisition, Inc. | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 9.82% | 9.82% | 9.82% | 9.82% | |||||||||||||
Maturity | [3],[5],[6],[24] | May 11, 2028 | May 11, 2028 | May 11, 2028 | May 11, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,120 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 387 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 371 | ||||||||||||||||
1st Lien/Senior Secured Debt | Coding Solutions Acquisition, Inc. | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Coding Solutions Acquisition, Inc. | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | May 11, 2028 | May 11, 2028 | May 11, 2028 | May 11, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 4,460 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (41) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (112) | ||||||||||||||||
1st Lien/Senior Secured Debt | Coding Solutions Acquisition, Inc. | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Computer Services, Inc. | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[6],[22] | 11.15% | 11.15% | 11.15% | 11.15% | |||||||||||||
Maturity | [3],[6] | Nov. 15, 2029 | Nov. 15, 2029 | Nov. 15, 2029 | Nov. 15, 2029 | |||||||||||||
Par (++) | [3],[6],[7] | $ 1,000 | ||||||||||||||||
Cost | [3],[6] | 970 | ||||||||||||||||
Fair Value | [3],[6] | $ 970 | ||||||||||||||||
1st Lien/Senior Secured Debt | Computer Services, Inc. | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Convene 237 Park Avenue, LLC (dba Convene) | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [1],[11],[12],[21],[23] | 2% | 2% | 2% | 2% | |||||||||||||
Floor (+) | [1],[11],[12],[21],[23] | 1.50% | ||||||||||||||||
Maturity | [1],[11],[12],[21] | Aug. 30, 2024 | Aug. 30, 2024 | Aug. 30, 2024 | Aug. 30, 2024 | |||||||||||||
Par (++) | [1],[11],[12],[13],[21] | $ 59,216 | ||||||||||||||||
Cost | [1],[11],[12],[21] | 53,038 | ||||||||||||||||
Fair Value | [1],[11],[12],[21] | $ 46,188 | ||||||||||||||||
1st Lien/Senior Secured Debt | Convene 237 Park Avenue, LLC (dba Convene) | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[21],[23] | 9.50% | 9.50% | 9.50% | 9.50% | |||||||||||||
1st Lien/Senior Secured Debt | Convene 237 Park Avenue, LLC (dba Convene) | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [1],[11],[12],[21],[23] | 2% | 2% | 2% | 2% | |||||||||||||
Floor (+) | [1],[11],[12],[21],[23] | 1.50% | ||||||||||||||||
Maturity | [1],[11],[12],[21] | Aug. 30, 2024 | Aug. 30, 2024 | Aug. 30, 2024 | Aug. 30, 2024 | |||||||||||||
Par (++) | [1],[11],[12],[13],[21] | $ 17,408 | ||||||||||||||||
Cost | [1],[11],[12],[21] | 15,534 | ||||||||||||||||
Fair Value | [1],[11],[12],[21] | $ 13,578 | ||||||||||||||||
1st Lien/Senior Secured Debt | Convene 237 Park Avenue, LLC (dba Convene) | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[21],[23] | 9.50% | 9.50% | 9.50% | 9.50% | |||||||||||||
1st Lien/Senior Secured Debt | Convene 237 Park Avenue, LLC (dba Convene) | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[23],[25] | 1.50% | ||||||||||||||||
Maturity | [1],[12],[25] | Aug. 30, 2024 | Aug. 30, 2024 | Aug. 30, 2024 | Aug. 30, 2024 | |||||||||||||
Par (++) | [1],[12],[13],[25] | $ 6,100 | ||||||||||||||||
Fair Value | [1],[12],[25] | $ (122) | ||||||||||||||||
1st Lien/Senior Secured Debt | Convene 237 Park Avenue, LLC (dba Convene) | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23],[25] | 15% | 15% | 15% | 15% | |||||||||||||
1st Lien/Senior Secured Debt | CORA Health Holdings Corp | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jun. 15, 2027 | [3],[5],[6] | Jun. 15, 2027 | [1],[11],[12] | Jun. 15, 2027 | [3],[5],[6] | Jun. 15, 2027 | [3],[5],[6] | Jun. 15, 2027 | [3],[5],[6] | Jun. 15, 2027 | [1],[11],[12] | Jun. 15, 2027 | [1],[11],[12] | Jun. 15, 2027 | [1],[11],[12] | ||
Par (++) | $ 22,435 | [3],[5],[6],[7] | $ 22,663 | [1],[11],[12],[13] | ||||||||||||||
Cost | 22,172 | [3],[5],[6] | 22,349 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 19,967 | [3],[5],[6] | $ 22,380 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | CORA Health Holdings Corp | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | CORA Health Holdings Corp | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.31% | 10.31% | 10.31% | 10.31% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jun. 15, 2027 | [3],[5],[6],[24] | Jun. 15, 2027 | [1],[11],[12],[25] | Jun. 15, 2027 | [3],[5],[6],[24] | Jun. 15, 2027 | [3],[5],[6],[24] | Jun. 15, 2027 | [3],[5],[6],[24] | Jun. 15, 2027 | [1],[11],[12],[25] | Jun. 15, 2027 | [1],[11],[12],[25] | Jun. 15, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 8,895 | [3],[5],[6],[7],[24] | $ 8,897 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 328 | [3],[5],[6],[24] | (61) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (598) | [3],[5],[6],[24] | $ (111) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | CORA Health Holdings Corp | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Cordeagle US Finco, Inc. (dba Condeco) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[16],[23] | 7.75% | 7.75% | 7.75% | 7.75% | |||||||||||||
Floor (+) | [1],[11],[12],[16],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[16] | Jul. 30, 2027 | Jul. 30, 2027 | Jul. 30, 2027 | Jul. 30, 2027 | |||||||||||||
Par (++) | [1],[11],[12],[13],[16] | $ 15,993 | ||||||||||||||||
Cost | [1],[11],[12],[16] | 15,691 | ||||||||||||||||
Fair Value | [1],[11],[12],[16] | $ 15,673 | ||||||||||||||||
1st Lien/Senior Secured Debt | Cordeagle US Finco, Inc. (dba Condeco) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[16],[23] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Cordeagle US Finco, Inc. (dba Condeco) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[16],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[12],[16],[25] | Jul. 30, 2027 | Jul. 30, 2027 | Jul. 30, 2027 | Jul. 30, 2027 | |||||||||||||
Par (++) | [1],[12],[13],[16],[25] | $ 9,230 | ||||||||||||||||
1st Lien/Senior Secured Debt | Cordeagle US Finco, Inc. (dba Condeco) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[16],[23],[25] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Cordeagle US Finco, Inc. (aka Condeco) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[16],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[16],[25] | Jul. 30, 2027 | Jul. 30, 2027 | Jul. 30, 2027 | Jul. 30, 2027 | |||||||||||||
Par (++) | [1],[11],[12],[13],[16],[25] | $ 2,461 | ||||||||||||||||
Cost | [1],[11],[12],[16],[25] | (46) | ||||||||||||||||
Fair Value | [1],[11],[12],[16],[25] | $ (49) | ||||||||||||||||
1st Lien/Senior Secured Debt | Cordeagle US Finco, Inc. (aka Condeco) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[16],[23],[25] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | CorePower Yoga LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.73% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 11.73% | [3],[5],[6],[22] | 11.73% | [3],[5],[6],[22] | 11.73% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+), PIK | 5% | [3],[5],[6],[22] | 5% | [1],[11],[12],[23] | 5% | [3],[5],[6],[22] | 5% | [3],[5],[6],[22] | 5% | [3],[5],[6],[22] | 5% | [1],[11],[12],[23] | 5% | [1],[11],[12],[23] | 5% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | May 14, 2025 | [3],[5],[6] | May 14, 2025 | [1],[11],[12] | May 14, 2025 | [3],[5],[6] | May 14, 2025 | [3],[5],[6] | May 14, 2025 | [3],[5],[6] | May 14, 2025 | [1],[11],[12] | May 14, 2025 | [1],[11],[12] | May 14, 2025 | [1],[11],[12] | ||
Par (++) | $ 26,267 | [3],[5],[6],[7] | $ 24,980 | [1],[11],[12],[13] | ||||||||||||||
Cost | 24,576 | [3],[5],[6] | 22,711 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 21,474 | [3],[5],[6] | $ 20,421 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | CorePower Yoga LLC | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | CorePower Yoga LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 11.72% | 11.72% | 11.72% | 11.72% | |||||||||||||
Reference Rate and Spread (+), PIK | 5% | [3],[5],[6],[22],[24] | 5% | [1],[11],[12],[23],[25] | 5% | [3],[5],[6],[22],[24] | 5% | [3],[5],[6],[22],[24] | 5% | [3],[5],[6],[22],[24] | 5% | [1],[11],[12],[23],[25] | 5% | [1],[11],[12],[23],[25] | 5% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | May 14, 2025 | [3],[5],[6],[24] | May 14, 2025 | [1],[11],[12],[25] | May 14, 2025 | [3],[5],[6],[24] | May 14, 2025 | [3],[5],[6],[24] | May 14, 2025 | [3],[5],[6],[24] | May 14, 2025 | [1],[11],[12],[25] | May 14, 2025 | [1],[11],[12],[25] | May 14, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 1,687 | [3],[5],[6],[7],[24] | $ 1,687 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 465 | [3],[5],[6],[24] | (123) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 254 | [3],[5],[6],[24] | $ (308) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | CorePower Yoga LLC | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22],[24] | 7% | [1],[11],[12],[23],[25] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 7% | [1],[11],[12],[23],[25] | 7% | [1],[11],[12],[23],[25] | 7% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Coretrust Purchasing Group LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.84% | 10.84% | 10.84% | 10.84% | |||||||||||||
Maturity | [3],[5],[6] | Oct. 01, 2029 | Oct. 01, 2029 | Oct. 01, 2029 | Oct. 01, 2029 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 774 | ||||||||||||||||
Cost | [3],[5],[6] | 752 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 751 | ||||||||||||||||
1st Lien/Senior Secured Debt | Coretrust Purchasing Group LLC | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Coretrust Purchasing Group LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Oct. 01, 2029 | Oct. 01, 2029 | Oct. 01, 2029 | Oct. 01, 2029 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 113 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (3) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (3) | ||||||||||||||||
1st Lien/Senior Secured Debt | Coretrust Purchasing Group LLC | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Coretrust Purchasing Group LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Oct. 01, 2029 | Oct. 01, 2029 | Oct. 01, 2029 | Oct. 01, 2029 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 113 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (2) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (3) | ||||||||||||||||
1st Lien/Senior Secured Debt | Coretrust Purchasing Group LLC | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | CST Buyer Company (dba Intoxalock) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.97% | [3],[6],[22] | 6.50% | [1],[11],[12],[23] | 10.97% | [3],[6],[22] | 10.97% | [3],[6],[22] | 10.97% | [3],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 01, 2028 | [3],[6] | Oct. 03, 2025 | [1],[11],[12] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [3],[6] | Oct. 03, 2025 | [1],[11],[12] | Oct. 03, 2025 | [1],[11],[12] | Oct. 03, 2025 | [1],[11],[12] | ||
Par (++) | $ 914 | [3],[6],[7] | $ 28,301 | [1],[11],[12],[13] | ||||||||||||||
Cost | 887 | [3],[6] | 27,482 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 886 | [3],[6] | $ 28,159 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | CST Buyer Company (dba Intoxalock) | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | CST Buyer Company (dba Intoxalock) | Diversified Consumer Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | CST Buyer Company (dba Intoxalock) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.97% | [3],[6],[22],[24] | 6.50% | [1],[11],[12],[23] | 10.97% | [3],[6],[22],[24] | 10.97% | [3],[6],[22],[24] | 10.97% | [3],[6],[22],[24] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 01, 2028 | [3],[6],[24] | Oct. 27, 2025 | [1],[11],[12] | Nov. 01, 2028 | [3],[6],[24] | Nov. 01, 2028 | [3],[6],[24] | Nov. 01, 2028 | [3],[6],[24] | Oct. 27, 2025 | [1],[11],[12] | Oct. 27, 2025 | [1],[11],[12] | Oct. 27, 2025 | [1],[11],[12] | ||
Par (++) | $ 86 | [3],[6],[7],[24] | $ 14,967 | [1],[11],[12],[13] | ||||||||||||||
Cost | 6 | [3],[6],[24] | 14,697 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 6 | [3],[6],[24] | $ 14,892 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | CST Buyer Company (dba Intoxalock) | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | CST Buyer Company (dba Intoxalock) | Diversified Consumer Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[22],[24] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | CST Buyer Company (dba Intoxalock) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Oct. 03, 2025 | Oct. 03, 2025 | Oct. 03, 2025 | Oct. 03, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 2,170 | ||||||||||||||||
Cost | [1],[11],[12],[25] | (11) | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ (11) | ||||||||||||||||
1st Lien/Senior Secured Debt | CST Buyer Company (dba Intoxalock) | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | DECA Dental Holdings LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Aug. 28, 2028 | [3],[5],[6] | Aug. 28, 2028 | [1],[11],[12] | Aug. 28, 2028 | [3],[5],[6] | Aug. 28, 2028 | [3],[5],[6] | Aug. 28, 2028 | [3],[5],[6] | Aug. 28, 2028 | [1],[11],[12] | Aug. 28, 2028 | [1],[11],[12] | Aug. 28, 2028 | [1],[11],[12] | ||
Par (++) | $ 21,399 | [3],[5],[6],[7] | $ 21,615 | [1],[11],[12],[13] | ||||||||||||||
Cost | 21,037 | [3],[5],[6] | 21,200 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 20,329 | [3],[5],[6] | $ 21,183 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | DECA Dental Holdings LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | DECA Dental Holdings LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22],[24] | 6.50% | [1],[11],[12],[23],[25] | 10.48% | [3],[5],[6],[22],[24] | 10.48% | [3],[5],[6],[22],[24] | 10.48% | [3],[5],[6],[22],[24] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Aug. 28, 2028 | [3],[5],[6],[24] | Aug. 28, 2028 | [1],[11],[12],[25] | Aug. 28, 2028 | [3],[5],[6],[24] | Aug. 28, 2028 | [3],[5],[6],[24] | Aug. 28, 2028 | [3],[5],[6],[24] | Aug. 28, 2028 | [1],[11],[12],[25] | Aug. 28, 2028 | [1],[11],[12],[25] | Aug. 28, 2028 | [1],[11],[12],[25] | ||
Par (++) | $ 7,385 | [3],[5],[6],[7],[24] | $ 7,408 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 2,172 | [3],[5],[6],[24] | 2,182 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 1,883 | [3],[5],[6],[24] | $ 2,127 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | DECA Dental Holdings LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | DECA Dental Holdings LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.48% | 10.48% | 10.48% | 10.48% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Aug. 26, 2027 | [3],[5],[6],[24] | Aug. 26, 2027 | [1],[11],[12],[25] | Aug. 26, 2027 | [3],[5],[6],[24] | Aug. 26, 2027 | [3],[5],[6],[24] | Aug. 26, 2027 | [3],[5],[6],[24] | Aug. 26, 2027 | [1],[11],[12],[25] | Aug. 26, 2027 | [1],[11],[12],[25] | Aug. 26, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 1,711 | [3],[5],[6],[7],[24] | $ 1,711 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 1,456 | [3],[5],[6],[24] | (32) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 1,397 | [3],[5],[6],[24] | $ (34) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | DECA Dental Holdings LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Diligent Corporation | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 8.15% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 8.15% | [3],[5],[6],[22] | 8.15% | [3],[5],[6],[22] | 8.15% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Aug. 04, 2025 | [3],[5],[6] | Aug. 04, 2025 | [1],[11],[12] | Aug. 04, 2025 | [3],[5],[6] | Aug. 04, 2025 | [3],[5],[6] | Aug. 04, 2025 | [3],[5],[6] | Aug. 04, 2025 | [1],[11],[12] | Aug. 04, 2025 | [1],[11],[12] | Aug. 04, 2025 | [1],[11],[12] | ||
Par (++) | € | € 37,675 | [3],[5],[6],[7] | € 38,062 | [1],[11],[12],[13] | ||||||||||||||
Cost | $ 42,831 | [3],[5],[6] | 42,884 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 40,229 | [3],[5],[6] | € 43,658 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Diligent Corporation | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Diligent Corporation | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.63% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 10.63% | [3],[5],[6],[22] | 10.63% | [3],[5],[6],[22] | 10.63% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Aug. 04, 2025 | [3],[5],[6] | Aug. 04, 2025 | [1],[11],[12] | Aug. 04, 2025 | [3],[5],[6] | Aug. 04, 2025 | [3],[5],[6] | Aug. 04, 2025 | [3],[5],[6] | Aug. 04, 2025 | [1],[11],[12] | Aug. 04, 2025 | [1],[11],[12] | Aug. 04, 2025 | [1],[11],[12] | ||
Par (++) | $ 24,352 | [3],[5],[6],[7] | $ 24,602 | [1],[11],[12],[13] | ||||||||||||||
Cost | 23,650 | [3],[5],[6] | 23,661 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 24,291 | [3],[5],[6] | $ 24,786 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Diligent Corporation | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Diligent Corporation | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.63% | 10.63% | 10.63% | 10.63% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Aug. 04, 2025 | [3],[5],[6],[24] | Aug. 04, 2025 | [1],[11],[12],[25] | Aug. 04, 2025 | [3],[5],[6],[24] | Aug. 04, 2025 | [3],[5],[6],[24] | Aug. 04, 2025 | [3],[5],[6],[24] | Aug. 04, 2025 | [1],[11],[12],[25] | Aug. 04, 2025 | [1],[11],[12],[25] | Aug. 04, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 3,100 | [3],[5],[6],[7],[24] | $ 3,100 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 892 | [3],[5],[6],[24] | (52) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 922 | [3],[5],[6],[24] | $ 23 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Diligent Corporation | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [3],[5],[6],[22],[24] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.74% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 10.74% | [3],[5],[6],[22] | 10.74% | [3],[5],[6],[22] | 10.74% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [1],[11],[12] | ||
Par (++) | $ 6,948 | [3],[5],[6],[7] | $ 7,019 | [1],[11],[12],[13] | ||||||||||||||
Cost | 6,624 | [3],[5],[6] | 6,590 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 6,670 | [3],[5],[6] | $ 6,862 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6% | [3],[5],[6],[22] | 5.50% | [1],[11],[12],[23] | 6% | [3],[5],[6],[22] | 6% | [3],[5],[6],[22] | 6% | [3],[5],[6],[22] | 5.50% | [1],[11],[12],[23] | 5.50% | [1],[11],[12],[23] | 5.50% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.58% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 10.58% | [3],[5],[6],[22] | 10.58% | [3],[5],[6],[22] | 10.58% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [1],[11],[12] | ||
Par (++) | $ 1,482 | [3],[5],[6],[7] | $ 1,497 | [1],[11],[12],[13] | ||||||||||||||
Cost | 1,454 | [3],[5],[6] | 1,460 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 1,422 | [3],[5],[6] | $ 1,463 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.68% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 10.68% | [3],[5],[6],[22] | 10.68% | [3],[5],[6],[22] | 10.68% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [1],[11],[12] | ||
Par (++) | $ 1,362 | [3],[5],[6],[7] | $ 1,376 | [1],[11],[12],[13] | ||||||||||||||
Cost | 1,314 | [3],[5],[6] | 1,313 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 1,308 | [3],[5],[6] | $ 1,345 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.51% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 10.51% | [3],[5],[6],[22] | 10.51% | [3],[5],[6],[22] | 10.51% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [1],[11],[12] | Sep. 18, 2025 | [1],[11],[12] | ||
Par (++) | $ 930 | [3],[5],[6],[7] | $ 560 | [1],[11],[12],[13] | ||||||||||||||
Cost | 903 | [3],[5],[6] | 547 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 893 | [3],[5],[6] | $ 548 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.68% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23],[25] | 10.68% | [3],[5],[6],[22] | 10.68% | [3],[5],[6],[22] | 10.68% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [1],[11],[12],[25] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [3],[5],[6] | Sep. 18, 2025 | [1],[11],[12],[25] | Sep. 18, 2025 | [1],[11],[12],[25] | Sep. 18, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 555 | [3],[5],[6],[7] | $ 930 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 545 | [3],[5],[6] | 485 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 532 | [3],[5],[6] | $ 500 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Elemica Parent, Inc. | Chemicals | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.67% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 9.67% | [3],[5],[6],[22] | 9.67% | [3],[5],[6],[22] | 9.67% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [1],[11],[12] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [1],[11],[12] | Dec. 06, 2025 | [1],[11],[12] | Dec. 06, 2025 | [1],[11],[12] | ||
Par (++) | $ 10,369 | [3],[5],[6],[7] | $ 10,476 | [1],[11],[12],[13] | ||||||||||||||
Cost | 10,044 | [3],[5],[6] | 10,054 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 10,032 | [3],[5],[6] | $ 10,371 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.75% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 9.75% | [3],[5],[6],[22] | 9.75% | [3],[5],[6],[22] | 9.75% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [1],[11],[12] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [1],[11],[12] | Dec. 06, 2025 | [1],[11],[12] | Dec. 06, 2025 | [1],[11],[12] | ||
Par (++) | $ 5,682 | [3],[5],[6],[7] | $ 4,928 | [1],[11],[12],[13] | ||||||||||||||
Cost | 5,578 | [3],[5],[6] | 4,852 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 5,569 | [3],[5],[6] | $ 4,878 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.67% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 9.67% | [3],[5],[6],[22] | 9.67% | [3],[5],[6],[22] | 9.67% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [1],[11],[12] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [1],[11],[12] | Dec. 06, 2025 | [1],[11],[12] | Dec. 06, 2025 | [1],[11],[12] | ||
Par (++) | $ 4,878 | [3],[5],[6],[7] | $ 4,514 | [1],[11],[12],[13] | ||||||||||||||
Cost | 4,820 | [3],[5],[6] | 4,418 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 4,720 | [3],[5],[6] | $ 4,469 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.67% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23],[25] | 9.67% | [3],[5],[6],[22] | 9.67% | [3],[5],[6],[22] | 9.67% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [1],[11],[12],[25] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [3],[5],[6] | Dec. 06, 2025 | [1],[11],[12],[25] | Dec. 06, 2025 | [1],[11],[12],[25] | Dec. 06, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 4,469 | [3],[5],[6],[7] | $ 2,269 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 4,395 | [3],[5],[6] | 1,498 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 4,324 | [3],[5],[6] | $ 1,565 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 9.67% | 9.67% | 9.67% | 9.67% | |||||||||||||
Maturity | [3],[5],[6],[24] | Dec. 06, 2025 | Dec. 06, 2025 | Dec. 06, 2025 | Dec. 06, 2025 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,269 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 158 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 153 | ||||||||||||||||
1st Lien/Senior Secured Debt | Eptam Plastics, Ltd. | Health Care Equipment & Supplies | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
1st Lien/Senior Secured Debt | ESO Solutions, Inc | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.59% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 11.59% | [3],[5],[6],[22] | 11.59% | [3],[5],[6],[22] | 11.59% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | May 03, 2027 | [3],[5],[6] | May 03, 2027 | [1],[11],[12] | May 03, 2027 | [3],[5],[6] | May 03, 2027 | [3],[5],[6] | May 03, 2027 | [3],[5],[6] | May 03, 2027 | [1],[11],[12] | May 03, 2027 | [1],[11],[12] | May 03, 2027 | [1],[11],[12] | ||
Par (++) | $ 39,908 | [3],[5],[6],[7] | $ 39,908 | [1],[11],[12],[13] | ||||||||||||||
Cost | 39,288 | [3],[5],[6] | 39,175 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 39,309 | [3],[5],[6] | $ 39,209 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | ESO Solutions, Inc | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | ESO Solutions, Inc | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | ESO Solutions, Inc | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | May 03, 2027 | [3],[5],[6],[24] | May 03, 2027 | [1],[11],[12],[25] | May 03, 2027 | [3],[5],[6],[24] | May 03, 2027 | [3],[5],[6],[24] | May 03, 2027 | [3],[5],[6],[24] | May 03, 2027 | [1],[11],[12],[25] | May 03, 2027 | [1],[11],[12],[25] | May 03, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 3,620 | [3],[5],[6],[7],[24] | $ 3,620 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (53) | [3],[5],[6],[24] | (65) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (54) | [3],[5],[6],[24] | $ (63) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | ESO Solutions, Inc | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | ESO Solutions, Inc | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Everest Clinical Research Corporation | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[8],[22] | 10.65% | 10.65% | 10.65% | 10.65% | |||||||||||||
Maturity | [3],[5],[6],[8] | Nov. 06, 2026 | Nov. 06, 2026 | Nov. 06, 2026 | Nov. 06, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[8] | $ 5,800 | ||||||||||||||||
Cost | [3],[5],[6],[8] | 5,685 | ||||||||||||||||
Fair Value | [3],[5],[6],[8] | $ 5,727 | ||||||||||||||||
1st Lien/Senior Secured Debt | Everest Clinical Research Corporation | Professional Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[8],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Experity, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22],[24] | 6.25% | [1],[11],[12],[23] | 10.48% | [3],[5],[6],[22],[24] | 10.48% | [3],[5],[6],[22],[24] | 10.48% | [3],[5],[6],[22],[24] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Feb. 24, 2028 | [3],[5],[6],[24] | Jul. 22, 2027 | [1],[11],[12] | Feb. 24, 2028 | [3],[5],[6],[24] | Feb. 24, 2028 | [3],[5],[6],[24] | Feb. 24, 2028 | [3],[5],[6],[24] | Jul. 22, 2027 | [1],[11],[12] | Jul. 22, 2027 | [1],[11],[12] | Jul. 22, 2027 | [1],[11],[12] | ||
Par (++) | $ 912 | [3],[5],[6],[7],[24] | $ 37,767 | [1],[11],[12],[13] | ||||||||||||||
Cost | 908 | [3],[5],[6],[24] | 37,594 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 898 | [3],[5],[6],[24] | $ 37,582 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Experity, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22],[24] | 5.50% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.50% | [1],[11],[12],[23] | 5.50% | [1],[11],[12],[23] | 5.50% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Experity, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Feb. 24, 2028 | [3],[5],[6],[24] | Jul. 22, 2027 | [1],[11],[12],[25] | Feb. 24, 2028 | [3],[5],[6],[24] | Feb. 24, 2028 | [3],[5],[6],[24] | Feb. 24, 2028 | [3],[5],[6],[24] | Jul. 22, 2027 | [1],[11],[12],[25] | Jul. 22, 2027 | [1],[11],[12],[25] | Jul. 22, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 81 | [3],[5],[6],[7],[24] | $ 3,332 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | [1],[11],[12],[25] | (15) | ||||||||||||||||
Fair Value | $ (1) | [3],[5],[6],[24] | $ (16) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Experity, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22],[24] | 5.50% | [1],[11],[12],[23],[25] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.50% | [1],[11],[12],[23],[25] | 5.50% | [1],[11],[12],[23],[25] | 5.50% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Four Seasons Heating And Air Conditioning Inc | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
Floor (+) | [1],[12],[23] | 0.75% | ||||||||||||||||
Maturity | [1],[12] | Nov. 17, 2026 | Nov. 17, 2026 | Nov. 17, 2026 | Nov. 17, 2026 | |||||||||||||
Par (++) | [1],[12],[13] | $ 34,330 | ||||||||||||||||
Cost | [1],[12] | 33,826 | ||||||||||||||||
Fair Value | [1],[12] | $ 33,815 | ||||||||||||||||
1st Lien/Senior Secured Debt | Four Seasons Heating And Air Conditioning Inc | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Fullsteam Operations LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.23% | [3],[5],[6],[22] | 9% | [1],[12],[23] | 12.23% | [3],[5],[6],[22] | 12.23% | [3],[5],[6],[22] | 12.23% | [3],[5],[6],[22] | 9% | [1],[12],[23] | 9% | [1],[12],[23] | 9% | [1],[12],[23] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
Floor (+) | [1],[12],[23] | 1.50% | ||||||||||||||||
Maturity | Oct. 04, 2027 | [3],[5],[6] | Oct. 04, 2027 | [1],[12] | Oct. 04, 2027 | [3],[5],[6] | Oct. 04, 2027 | [3],[5],[6] | Oct. 04, 2027 | [3],[5],[6] | Oct. 04, 2027 | [1],[12] | Oct. 04, 2027 | [1],[12] | Oct. 04, 2027 | [1],[12] | ||
Par (++) | $ 59,503 | [3],[5],[6],[7] | $ 55,778 | [1],[12],[13] | ||||||||||||||
Cost | 58,219 | [3],[5],[6] | 54,428 | [1],[12] | ||||||||||||||
Fair Value | $ 58,016 | [3],[5],[6] | $ 54,383 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Fullsteam Operations LLC | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[12],[23] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[12],[23] | 7.50% | [1],[12],[23] | 7.50% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | Fullsteam Operations LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.23% | [3],[5],[6],[22] | 9% | [1],[12],[23],[25] | 12.23% | [3],[5],[6],[22] | 12.23% | [3],[5],[6],[22] | 12.23% | [3],[5],[6],[22] | 9% | [1],[12],[23],[25] | 9% | [1],[12],[23],[25] | 9% | [1],[12],[23],[25] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1.50% | ||||||||||||||||
Maturity | Oct. 04, 2027 | [3],[5],[6] | Oct. 04, 2027 | [1],[12],[25] | Oct. 04, 2027 | [3],[5],[6] | Oct. 04, 2027 | [3],[5],[6] | Oct. 04, 2027 | [3],[5],[6] | Oct. 04, 2027 | [1],[12],[25] | Oct. 04, 2027 | [1],[12],[25] | Oct. 04, 2027 | [1],[12],[25] | ||
Par (++) | $ 23,045 | [3],[5],[6],[7] | $ 21,973 | [1],[12],[13],[25] | ||||||||||||||
Cost | 22,526 | [3],[5],[6] | 7,515 | [1],[12],[25] | ||||||||||||||
Fair Value | $ 22,468 | [3],[5],[6] | $ 7,602 | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Fullsteam Operations LLC | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[12],[23],[25] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[12],[23],[25] | 7.50% | [1],[12],[23],[25] | 7.50% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Fullsteam Operations LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.23% | [3],[5],[6],[22],[24] | 9% | [1],[12],[23],[25] | 12.23% | [3],[5],[6],[22],[24] | 12.23% | [3],[5],[6],[22],[24] | 12.23% | [3],[5],[6],[22],[24] | 9% | [1],[12],[23],[25] | 9% | [1],[12],[23],[25] | 9% | [1],[12],[23],[25] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[24] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1.50% | ||||||||||||||||
Maturity | Oct. 04, 2027 | [3],[5],[6],[24] | Oct. 04, 2027 | [1],[12],[25] | Oct. 04, 2027 | [3],[5],[6],[24] | Oct. 04, 2027 | [3],[5],[6],[24] | Oct. 04, 2027 | [3],[5],[6],[24] | Oct. 04, 2027 | [1],[12],[25] | Oct. 04, 2027 | [1],[12],[25] | Oct. 04, 2027 | [1],[12],[25] | ||
Par (++) | $ 3,380 | [3],[5],[6],[7],[24] | $ 3,380 | [1],[12],[13],[25] | ||||||||||||||
Cost | 1,103 | [3],[5],[6],[24] | 1,098 | [1],[12],[25] | ||||||||||||||
Fair Value | $ 1,094 | [3],[5],[6],[24] | $ 1,094 | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Fullsteam Operations LLC | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.50% | [3],[5],[6],[22],[24] | 7.50% | [1],[12],[23],[25] | 7.50% | [3],[5],[6],[22],[24] | 7.50% | [3],[5],[6],[22],[24] | 7.50% | [3],[5],[6],[22],[24] | 7.50% | [1],[12],[23],[25] | 7.50% | [1],[12],[23],[25] | 7.50% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Fullsteam Operations LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[24] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
Maturity | [3],[5],[6],[24] | Oct. 04, 2027 | Oct. 04, 2027 | Oct. 04, 2027 | Oct. 04, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 440 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (9) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (11) | ||||||||||||||||
1st Lien/Senior Secured Debt | Fullsteam Operations LLC | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
1st Lien/Senior Secured Debt | Gainsight, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.16% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 11.16% | [3],[5],[6],[22] | 11.16% | [3],[5],[6],[22] | 11.16% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Jul. 30, 2027 | [3],[5],[6] | Jul. 30, 2027 | [1],[11],[12] | Jul. 30, 2027 | [3],[5],[6] | Jul. 30, 2027 | [3],[5],[6] | Jul. 30, 2027 | [3],[5],[6] | Jul. 30, 2027 | [1],[11],[12] | Jul. 30, 2027 | [1],[11],[12] | Jul. 30, 2027 | [1],[11],[12] | ||
Par (++) | $ 44,677 | [3],[5],[6],[7] | $ 30,997 | [1],[11],[12],[13] | ||||||||||||||
Cost | 44,096 | [3],[5],[6] | 30,495 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 43,002 | [3],[5],[6] | $ 30,687 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Gainsight, Inc. | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Gainsight, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Jul. 30, 2027 | [3],[5],[6],[24] | Jul. 30, 2027 | [1],[11],[12],[25] | Jul. 30, 2027 | [3],[5],[6],[24] | Jul. 30, 2027 | [3],[5],[6],[24] | Jul. 30, 2027 | [3],[5],[6],[24] | Jul. 30, 2027 | [1],[11],[12],[25] | Jul. 30, 2027 | [1],[11],[12],[25] | Jul. 30, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 5,320 | [3],[5],[6],[7],[24] | $ 5,320 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (71) | [3],[5],[6],[24] | (87) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (200) | [3],[5],[6],[24] | $ (53) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Gainsight, Inc. | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.98% | [3],[5],[6],[22] | 8.50% | [1],[11],[12],[23] | 12.98% | [3],[5],[6],[22] | 12.98% | [3],[5],[6],[22] | 12.98% | [3],[5],[6],[22] | 8.50% | [1],[11],[12],[23] | 8.50% | [1],[11],[12],[23] | 8.50% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 2% | ||||||||||||||||
Maturity | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2025 | [1],[11],[12] | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2025 | [1],[11],[12] | Jun. 24, 2025 | [1],[11],[12] | Jun. 24, 2025 | [1],[11],[12] | ||
Par (++) | $ 14,834 | [3],[5],[6],[7] | $ 14,850 | [1],[11],[12],[13] | ||||||||||||||
Cost | 14,660 | [3],[5],[6] | 14,612 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 13,944 | [3],[5],[6] | $ 14,702 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 8.25% | 8.25% | 8.25% | 8.25% | |||||||||||||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.98% | [3],[5],[6],[22] | 8.50% | [1],[11],[12],[23] | 12.98% | [3],[5],[6],[22] | 12.98% | [3],[5],[6],[22] | 12.98% | [3],[5],[6],[22] | 8.50% | [1],[11],[12],[23] | 8.50% | [1],[11],[12],[23] | 8.50% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 2% | ||||||||||||||||
Maturity | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2025 | [1],[11],[12] | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2025 | [1],[11],[12] | Jun. 24, 2025 | [1],[11],[12] | Jun. 24, 2025 | [1],[11],[12] | ||
Par (++) | $ 2,603 | [3],[5],[6],[7] | $ 2,606 | [1],[11],[12],[13] | ||||||||||||||
Cost | 2,572 | [3],[5],[6] | 2,564 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 2,447 | [3],[5],[6] | $ 2,580 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 8.25% | 8.25% | 8.25% | 8.25% | |||||||||||||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.98% | [3],[5],[6],[22] | 8.50% | [1],[11],[12],[23],[25] | 12.98% | [3],[5],[6],[22] | 12.98% | [3],[5],[6],[22] | 12.98% | [3],[5],[6],[22] | 8.50% | [1],[11],[12],[23],[25] | 8.50% | [1],[11],[12],[23],[25] | 8.50% | [1],[11],[12],[23],[25] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 2% | ||||||||||||||||
Maturity | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2025 | [1],[11],[12],[25] | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2026 | [3],[5],[6] | Jun. 24, 2025 | [1],[11],[12],[25] | Jun. 24, 2025 | [1],[11],[12],[25] | Jun. 24, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 970 | [3],[5],[6],[7] | $ 1,880 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 955 | [3],[5],[6] | 598 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 912 | [3],[5],[6] | $ 608 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 8.25% | 8.25% | 8.25% | 8.25% | |||||||||||||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[24] | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jun. 24, 2026 | Jun. 24, 2026 | Jun. 24, 2026 | Jun. 24, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 1,880 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (21) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (113) | ||||||||||||||||
1st Lien/Senior Secured Debt | GHA Buyer Inc. (dba Cedar Gate) | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 8.25% | 8.25% | 8.25% | 8.25% | |||||||||||||
1st Lien/Senior Secured Debt | GovDelivery Holdings, LLC (dba Granicus, Inc.) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[12],[25] | Jan. 29, 2027 | Jan. 29, 2027 | Jan. 29, 2027 | Jan. 29, 2027 | |||||||||||||
Par (++) | [1],[12],[13],[25] | $ 2,583 | ||||||||||||||||
Cost | [1],[12],[25] | (33) | ||||||||||||||||
Fair Value | [1],[12],[25] | $ (13) | ||||||||||||||||
1st Lien/Senior Secured Debt | GovDelivery Holdings, LLC (dba Granicus, Inc.) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | GovDelivery Holdings, LLC (dba Granicus, Inc.) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.64% | [3],[6],[22] | 7.50% | [1],[12],[23] | 9.64% | [3],[6],[22] | 9.64% | [3],[6],[22] | 9.64% | [3],[6],[22] | 7.50% | [1],[12],[23] | 7.50% | [1],[12],[23] | 7.50% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Jan. 29, 2027 | [3],[6] | Jan. 29, 2027 | [1],[12] | Jan. 29, 2027 | [3],[6] | Jan. 29, 2027 | [3],[6] | Jan. 29, 2027 | [3],[6] | Jan. 29, 2027 | [1],[12] | Jan. 29, 2027 | [1],[12] | Jan. 29, 2027 | [1],[12] | ||
Par (++) | $ 29,145 | [3],[6],[7] | $ 29,367 | [1],[12],[13] | ||||||||||||||
Cost | 28,609 | [3],[6] | 28,720 | [1],[12] | ||||||||||||||
Fair Value | $ 28,417 | [3],[6] | $ 29,220 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | GovDelivery Holdings, LLC (dba Granicus, Inc.) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[6],[22] | 6% | [1],[12],[23],[25] | 5.50% | [3],[6],[22] | 5.50% | [3],[6],[22] | 5.50% | [3],[6],[22] | 6% | [1],[12],[23],[25] | 6% | [1],[12],[23],[25] | 6% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | GovDelivery Holdings, LLC (dba Granicus, Inc.) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.14% | [3],[6],[22] | 7% | [1],[12],[23],[25] | 10.14% | [3],[6],[22] | 10.14% | [3],[6],[22] | 10.14% | [3],[6],[22] | 7% | [1],[12],[23],[25] | 7% | [1],[12],[23],[25] | 7% | [1],[12],[23],[25] | ||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jan. 29, 2027 | [3],[6] | Jan. 29, 2027 | [1],[12],[25] | Jan. 29, 2027 | [3],[6] | Jan. 29, 2027 | [3],[6] | Jan. 29, 2027 | [3],[6] | Jan. 29, 2027 | [1],[12],[25] | Jan. 29, 2027 | [1],[12],[25] | Jan. 29, 2027 | [1],[12],[25] | ||
Par (++) | $ 3,783 | [3],[6],[7] | $ 3,800 | [1],[12],[13],[25] | ||||||||||||||
Cost | 3,722 | [3],[6] | 2,239 | [1],[12],[25] | ||||||||||||||
Fair Value | $ 3,688 | [3],[6] | $ 2,276 | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | GovDelivery Holdings, LLC (dba Granicus, Inc.) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6% | [3],[6],[22] | 6.50% | [1],[12],[23],[25] | 6% | [3],[6],[22] | 6% | [3],[6],[22] | 6% | [3],[6],[22] | 6.50% | [1],[12],[23],[25] | 6.50% | [1],[12],[23],[25] | 6.50% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | GovDelivery Holdings, LLC (dba Granicus, Inc.) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[6],[22],[24] | 10.69% | 10.69% | 10.69% | 10.69% | |||||||||||||
Maturity | [3],[6],[24] | Jan. 29, 2027 | Jan. 29, 2027 | Jan. 29, 2027 | Jan. 29, 2027 | |||||||||||||
Par (++) | [3],[6],[7],[24] | $ 2,583 | ||||||||||||||||
Cost | [3],[6],[24] | 840 | ||||||||||||||||
Fair Value | [3],[6],[24] | $ 802 | ||||||||||||||||
1st Lien/Senior Secured Debt | GovDelivery Holdings, LLC (dba Granicus, Inc.) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[22],[24] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Governmentjobs.com, Inc. (dba NeoGov) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[12],[23] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
Floor (+) | [1],[12],[23] | 0.75% | ||||||||||||||||
Maturity | [1],[12] | Dec. 01, 2028 | Dec. 01, 2028 | Dec. 01, 2028 | Dec. 01, 2028 | |||||||||||||
Par (++) | [1],[12],[13] | $ 42,387 | ||||||||||||||||
Cost | [1],[12] | 42,281 | ||||||||||||||||
Fair Value | [1],[12] | $ 42,281 | ||||||||||||||||
1st Lien/Senior Secured Debt | Governmentjobs.com, Inc. (dba NeoGov) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Governmentjobs.com, Inc. (dba NeoGov) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 9.88% | 9.88% | 9.88% | 9.88% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Dec. 01, 2028 | [3],[5],[6] | Dec. 02, 2027 | [1],[12],[25] | Dec. 01, 2028 | [3],[5],[6] | Dec. 01, 2028 | [3],[5],[6] | Dec. 01, 2028 | [3],[5],[6] | Dec. 02, 2027 | [1],[12],[25] | Dec. 02, 2027 | [1],[12],[25] | Dec. 02, 2027 | [1],[12],[25] | ||
Par (++) | $ 42,069 | [3],[5],[6],[7] | $ 4,710 | [1],[12],[13],[25] | ||||||||||||||
Cost | 41,977 | [3],[5],[6] | (12) | [1],[12],[25] | ||||||||||||||
Fair Value | $ 41,333 | [3],[5],[6] | $ (12) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Governmentjobs.com, Inc. (dba NeoGov) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[5],[6],[22] | 5.50% | [1],[12],[23],[25] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.50% | [1],[12],[23],[25] | 5.50% | [1],[12],[23],[25] | 5.50% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Governmentjobs.com, Inc. (dba NeoGov) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Dec. 02, 2027 | [3],[5],[6],[24] | Dec. 01, 2028 | [1],[12],[25] | Dec. 02, 2027 | [3],[5],[6],[24] | Dec. 02, 2027 | [3],[5],[6],[24] | Dec. 02, 2027 | [3],[5],[6],[24] | Dec. 01, 2028 | [1],[12],[25] | Dec. 01, 2028 | [1],[12],[25] | Dec. 01, 2028 | [1],[12],[25] | ||
Par (++) | $ 4,710 | [3],[5],[6],[7],[24] | $ 14,718 | [1],[12],[13],[25] | ||||||||||||||
Cost | (10) | [3],[5],[6],[24] | (18) | [1],[12],[25] | ||||||||||||||
Fair Value | $ (82) | [3],[5],[6],[24] | $ (18) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Governmentjobs.com, Inc. (dba NeoGov) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [1],[12],[23],[25] | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [1],[12],[23],[25] | 5.50% | [1],[12],[23],[25] | 5.50% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Governmentjobs.com, Inc. (dba NeoGov) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Dec. 01, 2028 | Dec. 01, 2028 | Dec. 01, 2028 | Dec. 01, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 14,718 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (16) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (258) | ||||||||||||||||
1st Lien/Senior Secured Debt | Governmentjobs.com, Inc. (dba NeoGov) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | GS AcquisitionCo, Inc. (dba Insightsoftware) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.92% | [3],[6],[22] | 6.75% | [1],[12],[23] | 9.92% | [3],[6],[22] | 9.92% | [3],[6],[22] | 9.92% | [3],[6],[22] | 6.75% | [1],[12],[23] | 6.75% | [1],[12],[23] | 6.75% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | May 22, 2026 | [3],[6] | May 22, 2026 | [1],[12] | May 22, 2026 | [3],[6] | May 22, 2026 | [3],[6] | May 22, 2026 | [3],[6] | May 22, 2026 | [1],[12] | May 22, 2026 | [1],[12] | May 22, 2026 | [1],[12] | ||
Par (++) | $ 24,566 | [3],[6],[7] | $ 22,452 | [1],[12],[13] | ||||||||||||||
Cost | 24,341 | [3],[6] | 22,178 | [1],[12] | ||||||||||||||
Fair Value | $ 23,707 | [3],[6] | $ 22,340 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | GS AcquisitionCo, Inc. (dba Insightsoftware) | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[6],[22] | 5.75% | [1],[12],[23] | 5.75% | [3],[6],[22] | 5.75% | [3],[6],[22] | 5.75% | [3],[6],[22] | 5.75% | [1],[12],[23] | 5.75% | [1],[12],[23] | 5.75% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | GS AcquisitionCo, Inc. (dba Insightsoftware) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[12],[23],[25] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | May 22, 2026 | [3],[6],[24] | May 22, 2026 | [1],[12],[25] | May 22, 2026 | [3],[6],[24] | May 22, 2026 | [3],[6],[24] | May 22, 2026 | [3],[6],[24] | May 22, 2026 | [1],[12],[25] | May 22, 2026 | [1],[12],[25] | May 22, 2026 | [1],[12],[25] | ||
Par (++) | $ 982 | [3],[6],[7],[24] | $ 982 | [1],[12],[13],[25] | ||||||||||||||
Cost | (10) | [3],[6],[24] | 454 | [1],[12],[25] | ||||||||||||||
Fair Value | $ (34) | [3],[6],[24] | $ 462 | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | GS AcquisitionCo, Inc. (dba Insightsoftware) | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[6],[22],[24] | 5.75% | [1],[12],[23],[25] | 5.75% | [3],[6],[22],[24] | 5.75% | [3],[6],[22],[24] | 5.75% | [3],[6],[22],[24] | 5.75% | [1],[12],[23],[25] | 5.75% | [1],[12],[23],[25] | 5.75% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | GS AcquisitionCo, Inc. (dba Insightsoftware) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[12],[25] | May 22, 2026 | May 22, 2026 | May 22, 2026 | May 22, 2026 | |||||||||||||
Par (++) | [1],[12],[13],[25] | $ 3,664 | ||||||||||||||||
Cost | [1],[12],[25] | (9) | ||||||||||||||||
Fair Value | [1],[12],[25] | $ (18) | ||||||||||||||||
1st Lien/Senior Secured Debt | GS AcquisitionCo, Inc. (dba Insightsoftware) | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Halo Branded Solutions, Inc. | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 8.88% | [6],[22] | 5.50% | [1],[23] | 8.88% | [6],[22] | 8.88% | [6],[22] | 8.88% | [6],[22] | 5.50% | [1],[23] | 5.50% | [1],[23] | 5.50% | [1],[23] | ||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Jun. 30, 2025 | [6] | Jun. 30, 2025 | [1] | Jun. 30, 2025 | [6] | Jun. 30, 2025 | [6] | Jun. 30, 2025 | [6] | Jun. 30, 2025 | [1] | Jun. 30, 2025 | [1] | Jun. 30, 2025 | [1] | ||
Par (++) | $ 6,291 | [6],[7] | $ 6,357 | [1],[13] | ||||||||||||||
Cost | 6,264 | [6] | 6,321 | [1] | ||||||||||||||
Fair Value | $ 5,473 | [6] | $ 5,912 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | Halo Branded Solutions, Inc. | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 4.50% | [6],[22] | 4.50% | [1],[23] | 4.50% | [6],[22] | 4.50% | [6],[22] | 4.50% | [6],[22] | 4.50% | [1],[23] | 4.50% | [1],[23] | 4.50% | [1],[23] | ||
1st Lien/Senior Secured Debt | HealthEdge Software, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.74% | [3],[5],[6],[22] | 7.25% | [1],[12],[23] | 11.74% | [3],[5],[6],[22] | 11.74% | [3],[5],[6],[22] | 11.74% | [3],[5],[6],[22] | 7.25% | [1],[12],[23] | 7.25% | [1],[12],[23] | 7.25% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Apr. 09, 2026 | [3],[5],[6] | Apr. 09, 2026 | [1],[12] | Apr. 09, 2026 | [3],[5],[6] | Apr. 09, 2026 | [3],[5],[6] | Apr. 09, 2026 | [3],[5],[6] | Apr. 09, 2026 | [1],[12] | Apr. 09, 2026 | [1],[12] | Apr. 09, 2026 | [1],[12] | ||
Par (++) | $ 35,400 | [3],[5],[6],[7] | $ 35,400 | [1],[12],[13] | ||||||||||||||
Cost | 34,841 | [3],[5],[6] | 34,698 | [1],[12] | ||||||||||||||
Fair Value | $ 34,603 | [3],[5],[6] | $ 34,692 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | HealthEdge Software, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22] | 6.25% | [1],[12],[23] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 6.25% | [1],[12],[23] | 6.25% | [1],[12],[23] | 6.25% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | HealthEdge Software, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [6],[7],[22] | 11.74% | 11.74% | 11.74% | 11.74% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Apr. 09, 2026 | [6],[7] | Apr. 09, 2026 | [1],[12],[25] | Apr. 09, 2026 | [6],[7] | Apr. 09, 2026 | [6],[7] | Apr. 09, 2026 | [6],[7] | Apr. 09, 2026 | [1],[12],[25] | Apr. 09, 2026 | [1],[12],[25] | Apr. 09, 2026 | [1],[12],[25] | ||
Par (++) | $ 3,299 | [6],[7] | $ 5,030 | [1],[12],[13],[25] | ||||||||||||||
Cost | [6],[7] | 3,299 | ||||||||||||||||
Fair Value | [6],[7] | $ 3,224 | ||||||||||||||||
1st Lien/Senior Secured Debt | HealthEdge Software, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [6],[7],[22] | 6.25% | [1],[12],[23],[25] | 7% | [6],[7],[22] | 7% | [6],[7],[22] | 7% | [6],[7],[22] | 6.25% | [1],[12],[23],[25] | 6.25% | [1],[12],[23],[25] | 6.25% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | HealthEdge Software, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Apr. 09, 2026 | [3],[5],[6],[24] | Apr. 09, 2026 | [1],[12],[25] | Apr. 09, 2026 | [3],[5],[6],[24] | Apr. 09, 2026 | [3],[5],[6],[24] | Apr. 09, 2026 | [3],[5],[6],[24] | Apr. 09, 2026 | [1],[12],[25] | Apr. 09, 2026 | [1],[12],[25] | Apr. 09, 2026 | [1],[12],[25] | ||
Par (++) | $ 3,800 | [3],[5],[6],[7],[24] | $ 3,800 | [1],[12],[13],[25] | ||||||||||||||
Cost | (58) | [3],[5],[6],[24] | (75) | [1],[12],[25] | ||||||||||||||
Fair Value | $ (86) | [3],[5],[6],[24] | $ (76) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | HealthEdge Software, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22],[24] | 6.25% | [1],[12],[23],[25] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 6.25% | [1],[12],[23],[25] | 6.25% | [1],[12],[23],[25] | 6.25% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | HealthEdge Software, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Apr. 09, 2026 | [3],[5],[6],[24] | Apr. 09, 2026 | [1],[12],[25] | Apr. 09, 2026 | [3],[5],[6],[24] | Apr. 09, 2026 | [3],[5],[6],[24] | Apr. 09, 2026 | [3],[5],[6],[24] | Apr. 09, 2026 | [1],[12],[25] | Apr. 09, 2026 | [1],[12],[25] | Apr. 09, 2026 | [1],[12],[25] | ||
Par (++) | $ 9,500 | [3],[5],[6],[7],[24] | $ 9,500 | [1],[12],[13],[25] | ||||||||||||||
Cost | (72) | [3],[5],[6],[24] | (94) | [1],[12],[25] | ||||||||||||||
Fair Value | $ (214) | [3],[5],[6],[24] | $ (95) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | HealthEdge Software, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22],[24] | 6.25% | [1],[12],[23],[25] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 6.25% | [1],[12],[23],[25] | 6.25% | [1],[12],[23],[25] | 6.25% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Heartland Home Services | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23],[25] | 7% | 7% | 7% | 7% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Dec. 15, 2026 | Dec. 15, 2026 | Dec. 15, 2026 | Dec. 15, 2026 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 14,998 | ||||||||||||||||
Cost | [1],[11],[12],[25] | 7,583 | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ 7,540 | ||||||||||||||||
1st Lien/Senior Secured Debt | Heartland Home Services | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Helios Buyer, Inc. (dba Heartland) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.38% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 10.38% | [3],[5],[6],[22] | 10.38% | [3],[5],[6],[22] | 10.38% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [1],[11],[12] | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [1],[11],[12] | Dec. 15, 2026 | [1],[11],[12] | Dec. 15, 2026 | [1],[11],[12] | ||
Par (++) | $ 18,987 | [3],[5],[6],[7] | $ 19,181 | [1],[11],[12],[13] | ||||||||||||||
Cost | 18,748 | [3],[5],[6] | 18,889 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 18,608 | [3],[5],[6] | $ 18,989 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Helios Buyer, Inc. (dba Heartland) | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23] | 6% | [3],[5],[6],[22] | 6% | [3],[5],[6],[22] | 6% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23] | 6% | [1],[11],[12],[23] | 6% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Helios Buyer, Inc. (dba Heartland) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.38% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 10.38% | [3],[5],[6],[22] | 10.38% | [3],[5],[6],[22] | 10.38% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [1],[11],[12] | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [1],[11],[12] | Dec. 15, 2026 | [1],[11],[12] | Dec. 15, 2026 | [1],[11],[12] | ||
Par (++) | $ 14,849 | [3],[5],[6],[7] | $ 7,903 | [1],[11],[12],[13] | ||||||||||||||
Cost | 14,731 | [3],[5],[6] | 7,756 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 14,552 | [3],[5],[6] | $ 7,824 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Helios Buyer, Inc. (dba Heartland) | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23] | 6% | [3],[5],[6],[22] | 6% | [3],[5],[6],[22] | 6% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23] | 6% | [1],[11],[12],[23] | 6% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Helios Buyer, Inc. (dba Heartland) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.38% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23],[25] | 10.38% | [3],[5],[6],[22] | 10.38% | [3],[5],[6],[22] | 10.38% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23],[25] | 7% | [1],[11],[12],[23],[25] | 7% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [1],[11],[12],[25] | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [3],[5],[6] | Dec. 15, 2026 | [1],[11],[12],[25] | Dec. 15, 2026 | [1],[11],[12],[25] | Dec. 15, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 7,824 | [3],[5],[6],[7] | $ 2,482 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 7,703 | [3],[5],[6] | 157 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 7,668 | [3],[5],[6] | $ 174 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Helios Buyer, Inc. (dba Heartland) | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23],[25] | 6% | [3],[5],[6],[22] | 6% | [3],[5],[6],[22] | 6% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23],[25] | 6% | [1],[11],[12],[23],[25] | 6% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Helios Buyer, Inc. (dba Heartland) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Dec. 15, 2026 | Dec. 15, 2026 | Dec. 15, 2026 | Dec. 15, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,363 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (32) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (47) | ||||||||||||||||
1st Lien/Senior Secured Debt | Helios Buyer, Inc. (dba Heartland) | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Hollander Sleep & Décor (dba SureFit) | Household Products | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 10.75% | 10.75% | 10.75% | 10.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Jul. 13, 2023 | Jul. 13, 2023 | Jul. 13, 2023 | Jul. 13, 2023 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 40,045 | ||||||||||||||||
Cost | [1],[11],[12] | 38,015 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 38,644 | ||||||||||||||||
1st Lien/Senior Secured Debt | Hollander Sleep & Décor (dba SureFit) | Household Products | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 9.75% | 9.75% | 9.75% | 9.75% | |||||||||||||
1st Lien/Senior Secured Debt | Hollander Intermediate LLC (dba Bedding Acquisition, LLC | Household Products | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 13.19% | 13.19% | 13.19% | 13.19% | |||||||||||||
Maturity | [3],[5],[6] | Sep. 21, 2026 | Sep. 21, 2026 | Sep. 21, 2026 | Sep. 21, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 39,551 | ||||||||||||||||
Cost | [3],[5],[6] | 38,547 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 37,079 | ||||||||||||||||
1st Lien/Senior Secured Debt | Hollander Intermediate LLC (dba Bedding Acquisition, LLC | Household Products | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 8.75% | 8.75% | 8.75% | 8.75% | |||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 7% | [1],[12],[23] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 7% | [1],[12],[23] | 7% | [1],[12],[23] | 7% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Oct. 15, 2027 | [3],[5],[6] | Oct. 15, 2027 | [1],[12] | Oct. 15, 2027 | [3],[5],[6] | Oct. 15, 2027 | [3],[5],[6] | Oct. 15, 2027 | [3],[5],[6] | Oct. 15, 2027 | [1],[12] | Oct. 15, 2027 | [1],[12] | Oct. 15, 2027 | [1],[12] | ||
Par (++) | $ 24,113 | [3],[5],[6],[7] | $ 24,357 | [1],[12],[13] | ||||||||||||||
Cost | 23,711 | [3],[5],[6] | 23,884 | [1],[12] | ||||||||||||||
Fair Value | $ 23,570 | [3],[5],[6] | $ 23,869 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.48% | 10.48% | 10.48% | 10.48% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Oct. 15, 2027 | [3],[5],[6],[24] | Oct. 15, 2027 | [1],[12],[25] | Oct. 15, 2027 | [3],[5],[6],[24] | Oct. 15, 2027 | [3],[5],[6],[24] | Oct. 15, 2027 | [3],[5],[6],[24] | Oct. 15, 2027 | [1],[12],[25] | Oct. 15, 2027 | [1],[12],[25] | Oct. 15, 2027 | [1],[12],[25] | ||
Par (++) | $ 15,226 | [3],[5],[6],[7],[24] | $ 2,802 | [1],[12],[13],[25] | ||||||||||||||
Cost | 6,842 | [3],[5],[6],[24] | (54) | [1],[12],[25] | ||||||||||||||
Fair Value | $ 6,685 | [3],[5],[6],[24] | $ (56) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23],[25] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Oct. 15, 2027 | [3],[5],[6],[24] | Oct. 15, 2027 | [1],[12],[25] | Oct. 15, 2027 | [3],[5],[6],[24] | Oct. 15, 2027 | [3],[5],[6],[24] | Oct. 15, 2027 | [3],[5],[6],[24] | Oct. 15, 2027 | [1],[12],[25] | Oct. 15, 2027 | [1],[12],[25] | Oct. 15, 2027 | [1],[12],[25] | ||
Par (++) | $ 2,802 | [3],[5],[6],[7],[24] | $ 15,292 | [1],[12],[13],[25] | ||||||||||||||
Cost | (45) | [3],[5],[6],[24] | (148) | [1],[12],[25] | ||||||||||||||
Fair Value | $ (63) | [3],[5],[6],[24] | $ (306) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23],[25] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Oct. 15, 2027 | Oct. 15, 2027 | Oct. 15, 2027 | Oct. 15, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 10,000 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (93) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (225) | ||||||||||||||||
1st Lien/Senior Secured Debt | Honor HN Buyer, Inc | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | HowlCO LLC (dba Lone Wolf) | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.57% | [3],[5],[6],[8],[22] | 7% | [1],[11],[12],[16],[23] | 10.57% | [3],[5],[6],[8],[22] | 10.57% | [3],[5],[6],[8],[22] | 10.57% | [3],[5],[6],[8],[22] | 7% | [1],[11],[12],[16],[23] | 7% | [1],[11],[12],[16],[23] | 7% | [1],[11],[12],[16],[23] | ||
Floor (+) | [1],[11],[12],[16],[23] | 1% | ||||||||||||||||
Maturity | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [1],[11],[12],[16] | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [1],[11],[12],[16] | Oct. 23, 2026 | [1],[11],[12],[16] | Oct. 23, 2026 | [1],[11],[12],[16] | ||
Par (++) | $ 34,957 | [3],[5],[6],[7],[8] | $ 35,313 | [1],[11],[12],[13],[16] | ||||||||||||||
Cost | 34,542 | [3],[5],[6],[8] | 34,803 | [1],[11],[12],[16] | ||||||||||||||
Fair Value | $ 33,209 | [3],[5],[6],[8] | $ 34,960 | [1],[11],[12],[16] | ||||||||||||||
1st Lien/Senior Secured Debt | HowlCO LLC (dba Lone Wolf) | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6% | [3],[5],[6],[8],[22] | 6% | [1],[11],[12],[16],[23] | 6% | [3],[5],[6],[8],[22] | 6% | [3],[5],[6],[8],[22] | 6% | [3],[5],[6],[8],[22] | 6% | [1],[11],[12],[16],[23] | 6% | [1],[11],[12],[16],[23] | 6% | [1],[11],[12],[16],[23] | ||
1st Lien/Senior Secured Debt | HowlCO LLC (dba Lone Wolf) | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.69% | [3],[5],[6],[8],[22] | 7% | [1],[11],[12],[16],[23] | 10.69% | [3],[5],[6],[8],[22] | 10.69% | [3],[5],[6],[8],[22] | 10.69% | [3],[5],[6],[8],[22] | 7% | [1],[11],[12],[16],[23] | 7% | [1],[11],[12],[16],[23] | 7% | [1],[11],[12],[16],[23] | ||
Floor (+) | [1],[11],[12],[16],[23] | 1% | ||||||||||||||||
Maturity | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [1],[11],[12],[16] | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [1],[11],[12],[16] | Oct. 23, 2026 | [1],[11],[12],[16] | Oct. 23, 2026 | [1],[11],[12],[16] | ||
Par (++) | $ 11,313 | [3],[5],[6],[7],[8] | $ 11,428 | [1],[11],[12],[13],[16] | ||||||||||||||
Cost | 11,226 | [3],[5],[6],[8] | 11,320 | [1],[11],[12],[16] | ||||||||||||||
Fair Value | $ 10,747 | [3],[5],[6],[8] | $ 11,314 | [1],[11],[12],[16] | ||||||||||||||
1st Lien/Senior Secured Debt | HowlCO LLC (dba Lone Wolf) | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6% | [3],[5],[6],[8],[22] | 6% | [1],[11],[12],[16],[23] | 6% | [3],[5],[6],[8],[22] | 6% | [3],[5],[6],[8],[22] | 6% | [3],[5],[6],[8],[22] | 6% | [1],[11],[12],[16],[23] | 6% | [1],[11],[12],[16],[23] | 6% | [1],[11],[12],[16],[23] | ||
1st Lien/Senior Secured Debt | HowlCO LLC (dba Lone Wolf) | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.73% | [3],[5],[6],[8],[22] | 7% | [1],[11],[12],[16],[23] | 10.73% | [3],[5],[6],[8],[22] | 10.73% | [3],[5],[6],[8],[22] | 10.73% | [3],[5],[6],[8],[22] | 7% | [1],[11],[12],[16],[23] | 7% | [1],[11],[12],[16],[23] | 7% | [1],[11],[12],[16],[23] | ||
Floor (+) | [1],[11],[12],[16],[23] | 1% | ||||||||||||||||
Maturity | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [1],[11],[12],[16] | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [3],[5],[6],[8] | Oct. 23, 2026 | [1],[11],[12],[16] | Oct. 23, 2026 | [1],[11],[12],[16] | Oct. 23, 2026 | [1],[11],[12],[16] | ||
Par (++) | $ 10,723 | [3],[5],[6],[7],[8] | $ 10,832 | [1],[11],[12],[13],[16] | ||||||||||||||
Cost | 10,643 | [3],[5],[6],[8] | 10,734 | [1],[11],[12],[16] | ||||||||||||||
Fair Value | $ 10,187 | [3],[5],[6],[8] | $ 10,724 | [1],[11],[12],[16] | ||||||||||||||
1st Lien/Senior Secured Debt | HowlCO LLC (dba Lone Wolf) | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6% | [3],[5],[6],[8],[22] | 6% | [1],[11],[12],[16],[23] | 6% | [3],[5],[6],[8],[22] | 6% | [3],[5],[6],[8],[22] | 6% | [3],[5],[6],[8],[22] | 6% | [1],[11],[12],[16],[23] | 6% | [1],[11],[12],[16],[23] | 6% | [1],[11],[12],[16],[23] | ||
1st Lien/Senior Secured Debt | HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth) | Hotels, Restaurants & Leisure | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.14% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 11.14% | [3],[5],[6],[22] | 11.14% | [3],[5],[6],[22] | 11.14% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 09, 2025 | [3],[5],[6] | Jul. 09, 2025 | [1],[11],[12] | Jul. 09, 2025 | [3],[5],[6] | Jul. 09, 2025 | [3],[5],[6] | Jul. 09, 2025 | [3],[5],[6] | Jul. 09, 2025 | [1],[11],[12] | Jul. 09, 2025 | [1],[11],[12] | Jul. 09, 2025 | [1],[11],[12] | ||
Par (++) | $ 56,793 | [3],[5],[6],[7] | $ 57,370 | [1],[11],[12],[13] | ||||||||||||||
Cost | 54,231 | [3],[5],[6] | 53,956 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 55,089 | [3],[5],[6] | $ 55,362 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth) | Hotels, Restaurants & Leisure | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth) | Hotels, Restaurants & Leisure | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 11.14% | 11.14% | 11.14% | 11.14% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jul. 09, 2025 | [3],[5],[6],[24] | Jul. 09, 2025 | [1],[11],[12],[25] | Jul. 09, 2025 | [3],[5],[6],[24] | Jul. 09, 2025 | [3],[5],[6],[24] | Jul. 09, 2025 | [3],[5],[6],[24] | Jul. 09, 2025 | [1],[11],[12],[25] | Jul. 09, 2025 | [1],[11],[12],[25] | Jul. 09, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 4,688 | [3],[5],[6],[7],[24] | $ 4,688 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 2,220 | [3],[5],[6],[24] | (170) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 2,203 | [3],[5],[6],[24] | $ (164) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth) | Hotels, Restaurants & Leisure | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | HumanState Limited (dba PayProp) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[6],[8],[22] | 9.43% | 9.43% | 9.43% | 9.43% | |||||||||||||
Maturity | [3],[6],[8] | Nov. 23, 2028 | Nov. 23, 2028 | Nov. 23, 2028 | Nov. 23, 2028 | |||||||||||||
Par (++) | £ | [3],[6],[7],[8] | £ 17,000 | ||||||||||||||||
Cost | £ | [3],[6],[8] | 20,207 | ||||||||||||||||
Fair Value | £ | [3],[6],[8] | £ 20,244 | ||||||||||||||||
1st Lien/Senior Secured Debt | HumanState Limited (dba PayProp) | Diversified Consumer Services | SONIA | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[8],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | HumanState Limited (dba PayProp) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[6],[8],[24] | Nov. 23, 2028 | Nov. 23, 2028 | Nov. 23, 2028 | Nov. 23, 2028 | |||||||||||||
Par (++) | £ | [3],[6],[7],[8],[24] | £ 2,600 | ||||||||||||||||
Cost | £ | [3],[6],[8],[24] | (94) | ||||||||||||||||
Fair Value | £ | [3],[6],[8],[24] | £ (47) | ||||||||||||||||
1st Lien/Senior Secured Debt | HumanState Limited (dba PayProp) | Diversified Consumer Services | SONIA | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[8],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | HumanState Limited (dba PayProp) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[6],[8],[24] | Nov. 23, 2028 | Nov. 23, 2028 | Nov. 23, 2028 | Nov. 23, 2028 | |||||||||||||
Par (++) | £ | [3],[6],[7],[8],[24] | £ 7,270 | ||||||||||||||||
Cost | £ | [3],[6],[8],[24] | (188) | ||||||||||||||||
Fair Value | £ | [3],[6],[8],[24] | £ (66) | ||||||||||||||||
1st Lien/Senior Secured Debt | HumanState Limited (dba PayProp) | Diversified Consumer Services | SONIA | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[8],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 11.52% | 11.52% | 11.52% | 11.52% | |||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 3.88% | 3.88% | 3.88% | 3.88% | |||||||||||||
Maturity | [3],[5],[6] | Aug. 18, 2028 | Aug. 18, 2028 | Aug. 18, 2028 | Aug. 18, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 44,090 | ||||||||||||||||
Cost | [3],[5],[6] | 43,355 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 43,318 | ||||||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Professional Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Sep. 12, 2024 | Sep. 12, 2024 | Sep. 12, 2024 | Sep. 12, 2024 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 72,489 | ||||||||||||||||
Cost | [1],[11],[12] | 70,139 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 72,489 | ||||||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[24] | 3.88% | 3.88% | 3.88% | 3.88% | |||||||||||||
Maturity | [3],[5],[6],[24] | Aug. 18, 2028 | Aug. 18, 2028 | Aug. 18, 2028 | Aug. 18, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 4,199 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (69) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (73) | ||||||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Professional Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Sep. 12, 2024 | Sep. 12, 2024 | Sep. 12, 2024 | Sep. 12, 2024 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 13,350 | ||||||||||||||||
Cost | [1],[11],[12] | 12,911 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 13,350 | ||||||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Aug. 18, 2028 | Aug. 18, 2028 | Aug. 18, 2028 | Aug. 18, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 11,711 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (205) | ||||||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Professional Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Sep. 12, 2024 | Sep. 12, 2024 | Sep. 12, 2024 | Sep. 12, 2024 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 4,531 | ||||||||||||||||
Cost | [1],[11],[12] | 4,480 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 4,531 | ||||||||||||||||
1st Lien/Senior Secured Debt | iCIMS, Inc. | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Intelligent Medical Objects, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.62% | 10.62% | 10.62% | 10.62% | |||||||||||||
Maturity | [3],[5],[6] | May 11, 2029 | May 11, 2029 | May 11, 2029 | May 11, 2029 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 12,494 | ||||||||||||||||
Cost | [3],[5],[6] | 12,261 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 12,244 | ||||||||||||||||
1st Lien/Senior Secured Debt | Intelligent Medical Objects, Inc. | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Intelligent Medical Objects, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.61% | 10.61% | 10.61% | 10.61% | |||||||||||||
Maturity | [3],[5],[6],[24] | May 11, 2028 | May 11, 2028 | May 11, 2028 | May 11, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 1,490 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 256 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 253 | ||||||||||||||||
1st Lien/Senior Secured Debt | Intelligent Medical Objects, Inc. | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Intelligent Medical Objects, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | May 11, 2029 | May 11, 2029 | May 11, 2029 | May 11, 2029 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,985 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (27) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (60) | ||||||||||||||||
1st Lien/Senior Secured Debt | Intelligent Medical Objects, Inc. | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Internet Truckstop Group, LLC (dba Truckstop) | Transportation Infrastructure | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.23% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.23% | [3],[5],[6],[22] | 10.23% | [3],[5],[6],[22] | 10.23% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Apr. 02, 2025 | [3],[5],[6] | Apr. 02, 2025 | [1],[11],[12] | Apr. 02, 2025 | [3],[5],[6] | Apr. 02, 2025 | [3],[5],[6] | Apr. 02, 2025 | [3],[5],[6] | Apr. 02, 2025 | [1],[11],[12] | Apr. 02, 2025 | [1],[11],[12] | Apr. 02, 2025 | [1],[11],[12] | ||
Par (++) | $ 51,583 | [3],[5],[6],[7] | $ 53,489 | [1],[11],[12],[13] | ||||||||||||||
Cost | 50,126 | [3],[5],[6] | 51,395 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 50,938 | [3],[5],[6] | $ 53,355 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Internet Truckstop Group, LLC (dba Truckstop) | Transportation Infrastructure | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Internet Truckstop Group, LLC (dba Truckstop) | Transportation Infrastructure | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Apr. 02, 2025 | [3],[5],[6],[24] | Apr. 02, 2025 | [1],[11],[12],[25] | Apr. 02, 2025 | [3],[5],[6],[24] | Apr. 02, 2025 | [3],[5],[6],[24] | Apr. 02, 2025 | [3],[5],[6],[24] | Apr. 02, 2025 | [1],[11],[12],[25] | Apr. 02, 2025 | [1],[11],[12],[25] | Apr. 02, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 4,400 | [3],[5],[6],[7],[24] | $ 4,400 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (50) | [3],[5],[6],[24] | (72) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (55) | [3],[5],[6],[24] | $ (11) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Internet Truckstop Group, LLC (dba Truckstop) | Transportation Infrastructure | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23],[25] | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Iracore International Holdings, Inc. | Energy Equipment & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 13.75% | [5],[6],[14],[22] | 10% | [1],[11],[17],[23] | 13.75% | [5],[6],[14],[22] | 13.75% | [5],[6],[14],[22] | 13.75% | [5],[6],[14],[22] | 10% | [1],[11],[17],[23] | 10% | [1],[11],[17],[23] | 10% | [1],[11],[17],[23] | ||
Floor (+) | [1],[11],[17],[23] | 1% | ||||||||||||||||
Maturity | Apr. 12, 2024 | [5],[6],[14] | Apr. 12, 2024 | [1],[11],[17] | Apr. 12, 2024 | [5],[6],[14] | Apr. 12, 2024 | [5],[6],[14] | Apr. 12, 2024 | [5],[6],[14] | Apr. 12, 2024 | [1],[11],[17] | Apr. 12, 2024 | [1],[11],[17] | Apr. 12, 2024 | [1],[11],[17] | ||
Par (++) | $ 2,361 | [5],[6],[7],[14] | $ 2,361 | [1],[11],[13],[17] | ||||||||||||||
Cost | 2,361 | [5],[6],[14] | 2,361 | [1],[11],[17] | ||||||||||||||
Fair Value | $ 2,337 | [5],[6],[14] | $ 2,361 | [1],[11],[17] | ||||||||||||||
1st Lien/Senior Secured Debt | Iracore International Holdings, Inc. | Energy Equipment & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 9% | [5],[6],[14],[22] | 9% | [1],[11],[17],[23] | 9% | [5],[6],[14],[22] | 9% | [5],[6],[14],[22] | 9% | [5],[6],[14],[22] | 9% | [1],[11],[17],[23] | 9% | [1],[11],[17],[23] | 9% | [1],[11],[17],[23] | ||
1st Lien/Senior Secured Debt | iWave Information Systems, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[6],[8],[22] | 11.22% | 11.22% | 11.22% | 11.22% | |||||||||||||
Maturity | [3],[6],[8] | Nov. 23, 2028 | Nov. 23, 2028 | Nov. 23, 2028 | Nov. 23, 2028 | |||||||||||||
Par (++) | [3],[6],[7],[8] | $ 891 | ||||||||||||||||
Cost | [3],[6],[8] | 869 | ||||||||||||||||
Fair Value | [3],[6],[8] | $ 869 | ||||||||||||||||
1st Lien/Senior Secured Debt | iWave Information Systems, Inc. | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[8],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | iWave Information Systems, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[8] | Nov. 23, 2028 | Nov. 23, 2028 | Nov. 23, 2028 | Nov. 23, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[8] | $ 109 | ||||||||||||||||
Cost | [3],[5],[6],[8] | (3) | ||||||||||||||||
Fair Value | [3],[5],[6],[8] | $ (3) | ||||||||||||||||
1st Lien/Senior Secured Debt | iWave Information Systems, Inc. | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[8],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Jill Acquisition LLC (dba J. Jill) | Specialty Retail | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.41% | [6],[22] | 6% | [1],[23] | 9.41% | [6],[22] | 9.41% | [6],[22] | 9.41% | [6],[22] | 6% | [1],[23] | 6% | [1],[23] | 6% | [1],[23] | ||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | May 08, 2024 | [6] | May 08, 2024 | [1] | May 08, 2024 | [6] | May 08, 2024 | [6] | May 08, 2024 | [6] | May 08, 2024 | [1] | May 08, 2024 | [1] | May 08, 2024 | [1] | ||
Par (++) | $ 5,785 | [6],[7] | $ 5,844 | [1],[13] | ||||||||||||||
Cost | 5,640 | [6] | 5,801 | [1] | ||||||||||||||
Fair Value | $ 5,311 | [6] | $ 5,138 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | Jill Acquisition LLC (dba J. Jill) | Specialty Retail | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5% | [6],[22] | 5% | [1],[23] | 5% | [6],[22] | 5% | [6],[22] | 5% | [6],[22] | 5% | [1],[23] | 5% | [1],[23] | 5% | [1],[23] | ||
1st Lien/Senior Secured Debt | Kaseya Inc. | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.33% | 10.33% | 10.33% | 10.33% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jun. 25, 2029 | Jun. 25, 2029 | Jun. 25, 2029 | Jun. 25, 2029 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 18,500 | ||||||||||||||||
Cost | [3],[5],[6] | 18,238 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 18,222 | ||||||||||||||||
1st Lien/Senior Secured Debt | Kaseya Inc. | IT Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Kaseya Inc. | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jun. 25, 2029 | Jun. 25, 2029 | Jun. 25, 2029 | Jun. 25, 2029 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 1,100 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (15) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | (17) | ||||||||||||||||
1st Lien/Senior Secured Debt | Kaseya Inc. | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Par (++) | [3],[5],[6],[7],[24] | 1,100 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (8) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (17) | ||||||||||||||||
1st Lien/Senior Secured Debt | Kawa Solar Holdings Limited | Construction & Engineering | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | Dec. 31, 2023 | [2],[5],[6],[8],[14] | Dec. 31, 2022 | [1],[9],[11],[16],[17] | Dec. 31, 2023 | [2],[5],[6],[8],[14] | Dec. 31, 2023 | [2],[5],[6],[8],[14] | Dec. 31, 2023 | [2],[5],[6],[8],[14] | Dec. 31, 2022 | [1],[9],[11],[16],[17] | Dec. 31, 2022 | [1],[9],[11],[16],[17] | Dec. 31, 2022 | [1],[9],[11],[16],[17] | ||
Par (++) | $ 3,917 | [2],[5],[6],[7],[8],[14] | $ 3,917 | [1],[9],[11],[13],[16],[17] | ||||||||||||||
Cost | 3,603 | [2],[5],[6],[8],[14] | 3,603 | [1],[9],[11],[16],[17] | ||||||||||||||
Fair Value | $ 1,283 | [2],[5],[6],[8],[14] | $ 1,328 | [1],[9],[11],[16],[17] | ||||||||||||||
1st Lien/Senior Secured Debt | Kawa Solar Holdings Limited | Construction & Engineering | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | Dec. 31, 2023 | [2],[5],[6],[8],[14] | Dec. 31, 2022 | [1],[9],[11],[16],[17] | Dec. 31, 2023 | [2],[5],[6],[8],[14] | Dec. 31, 2023 | [2],[5],[6],[8],[14] | Dec. 31, 2023 | [2],[5],[6],[8],[14] | Dec. 31, 2022 | [1],[9],[11],[16],[17] | Dec. 31, 2022 | [1],[9],[11],[16],[17] | Dec. 31, 2022 | [1],[9],[11],[16],[17] | ||
Par (++) | $ 3,318 | [2],[5],[6],[7],[8],[14] | $ 3,318 | [1],[9],[11],[13],[16],[17] | ||||||||||||||
Cost | $ 800 | [2],[5],[6],[8],[14] | $ 800 | [1],[9],[11],[16],[17] | ||||||||||||||
1st Lien/Senior Secured Debt | LCG Vardiman Black, LLC (dba Specialty Dental Brands) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 11.22% | 11.22% | 11.22% | 11.22% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 7% | 7% | 7% | 7% | |||||||||||||
Maturity | [3],[5],[6],[24] | Mar. 18, 2027 | Mar. 18, 2027 | Mar. 18, 2027 | Mar. 18, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 998 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 871 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 870 | ||||||||||||||||
1st Lien/Senior Secured Debt | Lithium Technologies, Inc. | Interactive Media & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.06% | [3],[5],[6],[22] | 9% | [1],[11],[12],[23] | 12.06% | [3],[5],[6],[22] | 12.06% | [3],[5],[6],[22] | 12.06% | [3],[5],[6],[22] | 9% | [1],[11],[12],[23] | 9% | [1],[11],[12],[23] | 9% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 8% | 8% | 8% | 8% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jan. 03, 2024 | [3],[5],[6] | Oct. 03, 2022 | [1],[11],[12] | Jan. 03, 2024 | [3],[5],[6] | Jan. 03, 2024 | [3],[5],[6] | Jan. 03, 2024 | [3],[5],[6] | Oct. 03, 2022 | [1],[11],[12] | Oct. 03, 2022 | [1],[11],[12] | Oct. 03, 2022 | [1],[11],[12] | ||
Par (++) | $ 89,013 | [3],[5],[6],[7] | $ 89,013 | [1],[11],[12],[13] | ||||||||||||||
Cost | 88,464 | [3],[5],[6] | 86,856 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 86,343 | [3],[5],[6] | $ 87,678 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Lithium Technologies, Inc. | Interactive Media & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 8% | 8% | 8% | 8% | |||||||||||||
1st Lien/Senior Secured Debt | Lithium Technologies, Inc. | Interactive Media & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.06% | [3],[5],[6],[22],[24] | 9% | [1],[11],[12],[23],[25] | 12.06% | [3],[5],[6],[22],[24] | 12.06% | [3],[5],[6],[22],[24] | 12.06% | [3],[5],[6],[22],[24] | 9% | [1],[11],[12],[23],[25] | 9% | [1],[11],[12],[23],[25] | 9% | [1],[11],[12],[23],[25] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 8% | 8% | 8% | 8% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jan. 03, 2024 | [3],[5],[6],[24] | Oct. 03, 2022 | [1],[11],[12],[25] | Jan. 03, 2024 | [3],[5],[6],[24] | Jan. 03, 2024 | [3],[5],[6],[24] | Jan. 03, 2024 | [3],[5],[6],[24] | Oct. 03, 2022 | [1],[11],[12],[25] | Oct. 03, 2022 | [1],[11],[12],[25] | Oct. 03, 2022 | [1],[11],[12],[25] | ||
Par (++) | $ 5,110 | [3],[5],[6],[7],[24] | $ 5,110 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 2,023 | [3],[5],[6],[24] | 1,979 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 1,891 | [3],[5],[6],[24] | $ 1,967 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Lithium Technologies, Inc. | Interactive Media & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 8% | 8% | 8% | 8% | |||||||||||||
1st Lien/Senior Secured Debt | LS Clinical Services Holdings, Inc (dba CATO) | Pharmaceuticals | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.48% | [3],[5],[6],[22] | 7.75% | [1],[12],[23] | 11.48% | [3],[5],[6],[22] | 11.48% | [3],[5],[6],[22] | 11.48% | [3],[5],[6],[22] | 7.75% | [1],[12],[23] | 7.75% | [1],[12],[23] | 7.75% | [1],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 16, 2027 | [3],[5],[6] | Dec. 16, 2027 | [1],[12] | Dec. 16, 2027 | [3],[5],[6] | Dec. 16, 2027 | [3],[5],[6] | Dec. 16, 2027 | [3],[5],[6] | Dec. 16, 2027 | [1],[12] | Dec. 16, 2027 | [1],[12] | Dec. 16, 2027 | [1],[12] | ||
Par (++) | $ 15,243 | [3],[5],[6],[7] | $ 15,397 | [1],[12],[13] | ||||||||||||||
Cost | 14,915 | [3],[5],[6] | 15,014 | [1],[12] | ||||||||||||||
Fair Value | $ 14,824 | [3],[5],[6] | $ 15,012 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | LS Clinical Services Holdings, Inc (dba CATO) | Pharmaceuticals | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | LS Clinical Services Holdings, Inc (dba CATO) | Pharmaceuticals | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 11.18% | 11.18% | 11.18% | 11.18% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 16, 2026 | [3],[5],[6] | Dec. 16, 2026 | [1],[12],[25] | Dec. 16, 2026 | [3],[5],[6] | Dec. 16, 2026 | [3],[5],[6] | Dec. 16, 2026 | [3],[5],[6] | Dec. 16, 2026 | [1],[12],[25] | Dec. 16, 2026 | [1],[12],[25] | Dec. 16, 2026 | [1],[12],[25] | ||
Par (++) | $ 2,200 | [3],[5],[6],[7] | $ 2,200 | [1],[12],[13],[25] | ||||||||||||||
Cost | 2,155 | [3],[5],[6] | (55) | [1],[12],[25] | ||||||||||||||
Fair Value | $ 2,139 | [3],[5],[6] | $ (55) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | LS Clinical Services Holdings, Inc (dba CATO) | Pharmaceuticals | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23],[25] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | MedeAnalytics, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[20],[22] | 8% | 8% | 8% | 8% | |||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[20],[22] | 1.50% | 1.50% | 1.50% | 1.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Oct. 09, 2026 | [3],[5],[6],[20] | Oct. 09, 2026 | [1],[11],[12] | Oct. 09, 2026 | [3],[5],[6],[20] | Oct. 09, 2026 | [3],[5],[6],[20] | Oct. 09, 2026 | [3],[5],[6],[20] | Oct. 09, 2026 | [1],[11],[12] | Oct. 09, 2026 | [1],[11],[12] | Oct. 09, 2026 | [1],[11],[12] | ||
Par (++) | $ 1,020 | [3],[5],[6],[7],[20] | $ 948 | [1],[11],[12],[13] | ||||||||||||||
Cost | 953 | [3],[5],[6],[20] | 905 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 806 | [3],[5],[6],[20] | $ 934 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | MedeAnalytics, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | MerchantWise Solutions, LLC (dba HungerRush) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 9.31% | 9.31% | 9.31% | 9.31% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
Maturity | [3],[5],[6] | Jun. 01, 2028 | Jun. 01, 2028 | Jun. 01, 2028 | Jun. 01, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 21,637 | ||||||||||||||||
Cost | [3],[5],[6] | 21,238 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 20,988 | ||||||||||||||||
1st Lien/Senior Secured Debt | MerchantWise Solutions, LLC (dba HungerRush) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.63% | 10.63% | 10.63% | 10.63% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jun. 01, 2028 | Jun. 01, 2028 | Jun. 01, 2028 | Jun. 01, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 5,435 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 3,537 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 3,505 | ||||||||||||||||
1st Lien/Senior Secured Debt | MerchantWise Solutions, LLC (dba HungerRush) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jun. 01, 2028 | Jun. 01, 2028 | Jun. 01, 2028 | Jun. 01, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,718 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (49) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (82) | ||||||||||||||||
1st Lien/Senior Secured Debt | Mervin Manufacturing, Inc. | Leisure Products | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[23] | 8.50% | 8.50% | 8.50% | 8.50% | |||||||||||||
Floor (+) | [1],[11],[23] | 1% | ||||||||||||||||
Maturity | [1],[11] | Sep. 30, 2022 | Sep. 30, 2022 | Sep. 30, 2022 | Sep. 30, 2022 | |||||||||||||
Par (++) | [1],[11],[13] | $ 10,668 | ||||||||||||||||
Cost | [1],[11] | 10,667 | ||||||||||||||||
Fair Value | [1],[11] | $ 10,561 | ||||||||||||||||
1st Lien/Senior Secured Debt | Mervin Manufacturing, Inc. | Leisure Products | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[23] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
1st Lien/Senior Secured Debt | Millstone Medical Outsourcing, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.87% | [3],[5],[6],[22] | 6.50% | [1],[12],[23] | 10.87% | [3],[5],[6],[22] | 10.87% | [3],[5],[6],[22] | 10.87% | [3],[5],[6],[22] | 6.50% | [1],[12],[23] | 6.50% | [1],[12],[23] | 6.50% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 15, 2027 | [3],[5],[6] | Dec. 15, 2027 | [1],[12] | Dec. 15, 2027 | [3],[5],[6] | Dec. 15, 2027 | [3],[5],[6] | Dec. 15, 2027 | [3],[5],[6] | Dec. 15, 2027 | [1],[12] | Dec. 15, 2027 | [1],[12] | Dec. 15, 2027 | [1],[12] | ||
Par (++) | $ 10,245 | [3],[5],[6],[7] | $ 10,348 | [1],[12],[13] | ||||||||||||||
Cost | 10,069 | [3],[5],[6] | 10,143 | [1],[12] | ||||||||||||||
Fair Value | $ 10,040 | [3],[5],[6] | $ 10,141 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Millstone Medical Outsourcing, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Millstone Medical Outsourcing, LLC | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Millstone Medical Outsourcing, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.50% | [3],[5],[6],[22],[24] | 6.50% | [1],[12],[23],[25] | 12.50% | [3],[5],[6],[22],[24] | 12.50% | [3],[5],[6],[22],[24] | 12.50% | [3],[5],[6],[22],[24] | 6.50% | [1],[12],[23],[25] | 6.50% | [1],[12],[23],[25] | 6.50% | [1],[12],[23],[25] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5% | 5% | 5% | 5% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 15, 2027 | [3],[5],[6],[24] | Dec. 15, 2027 | [1],[12],[25] | Dec. 15, 2027 | [3],[5],[6],[24] | Dec. 15, 2027 | [3],[5],[6],[24] | Dec. 15, 2027 | [3],[5],[6],[24] | Dec. 15, 2027 | [1],[12],[25] | Dec. 15, 2027 | [1],[12],[25] | Dec. 15, 2027 | [1],[12],[25] | ||
Par (++) | $ 2,217 | [3],[5],[6],[7],[24] | $ 2,217 | [1],[12],[13],[25] | ||||||||||||||
Cost | 407 | [3],[5],[6],[24] | 30 | [1],[12],[25] | ||||||||||||||
Fair Value | $ 399 | [3],[5],[6],[24] | $ 30 | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Millstone Medical Outsourcing, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23],[25] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | MMIT Holdings, LLC (dba Managed Markets Insight & Technology) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Sep. 15, 2027 | Sep. 15, 2027 | Sep. 15, 2027 | Sep. 15, 2027 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 66,304 | ||||||||||||||||
Cost | [1],[11],[12] | 65,032 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 64,978 | ||||||||||||||||
1st Lien/Senior Secured Debt | MMIT Holdings, LLC (dba Managed Markets Insight & Technology) | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | MMIT Holdings, LLC (dba Managed Markets Insight & Technology) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Sep. 15, 2027 | Sep. 15, 2027 | Sep. 15, 2027 | Sep. 15, 2027 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 6,913 | ||||||||||||||||
Cost | [1],[11],[12] | 6,778 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 6,774 | ||||||||||||||||
1st Lien/Senior Secured Debt | MMIT Holdings, LLC (dba Managed Markets Insight & Technology) | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | MMIT Holdings, LLC (dba Managed Markets Insight & Technology) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23],[25] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Sep. 15, 2027 | Sep. 15, 2027 | Sep. 15, 2027 | Sep. 15, 2027 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 5,923 | ||||||||||||||||
Cost | [1],[11],[12],[25] | 628 | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ 622 | ||||||||||||||||
1st Lien/Senior Secured Debt | MMIT Holdings, LLC (dba Managed Markets Insight & Technology) | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | MRI Software LLC | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.23% | [6],[22] | 6.50% | [1],[23] | 10.23% | [6],[22] | 10.23% | [6],[22] | 10.23% | [6],[22] | 6.50% | [1],[23] | 6.50% | [1],[23] | 6.50% | [1],[23] | ||
Reference Rate and Spread (+) | [6],[22] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [1] | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [1] | Feb. 10, 2026 | [1] | Feb. 10, 2026 | [1] | ||
Par (++) | $ 23,219 | [6],[7] | $ 23,457 | [1],[13] | ||||||||||||||
Cost | 22,424 | [6] | 22,440 | [1] | ||||||||||||||
Fair Value | $ 22,261 | [6] | $ 23,362 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | MRI Software LLC | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | MRI Software LLC | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.23% | [6],[22] | 6.50% | [1],[23] | 10.23% | [6],[22] | 10.23% | [6],[22] | 10.23% | [6],[22] | 6.50% | [1],[23] | 6.50% | [1],[23] | 6.50% | [1],[23] | ||
Reference Rate and Spread (+) | [6],[22] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [1] | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [6] | Feb. 10, 2026 | [1] | Feb. 10, 2026 | [1] | Feb. 10, 2026 | [1] | ||
Par (++) | $ 6,536 | [6],[7] | $ 217 | [1],[13] | ||||||||||||||
Cost | 6,512 | [6] | 217 | [1] | ||||||||||||||
Fair Value | $ 6,266 | [6] | $ 216 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | MRI Software LLC | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | MRI Software LLC | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
Floor (+) | [1],[23],[25] | 1% | ||||||||||||||||
Maturity | Feb. 10, 2026 | [6],[24] | Feb. 10, 2026 | [1],[25] | Feb. 10, 2026 | [6],[24] | Feb. 10, 2026 | [6],[24] | Feb. 10, 2026 | [6],[24] | Feb. 10, 2026 | [1],[25] | Feb. 10, 2026 | [1],[25] | Feb. 10, 2026 | [1],[25] | ||
Par (++) | $ 1,612 | [6],[7],[24] | $ 1,612 | [1],[13],[25] | ||||||||||||||
Cost | (24) | [6],[24] | (31) | [1],[25] | ||||||||||||||
Fair Value | $ (66) | [6],[24] | $ (7) | [1],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | MRI Software LLC | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[23],[25] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | MRI Software LLC | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[25] | Feb. 10, 2026 | Feb. 10, 2026 | Feb. 10, 2026 | Feb. 10, 2026 | |||||||||||||
Par (++) | [1],[13],[25] | $ 6,382 | ||||||||||||||||
Cost | [1],[25] | (14) | ||||||||||||||||
Fair Value | [1],[25] | $ (26) | ||||||||||||||||
1st Lien/Senior Secured Debt | MRI Software LLC | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[23],[25] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | NFM & J, L.P. (dba the Facilities Group) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.13% | [3],[5],[6],[22] | 6.75% | [1],[12],[23] | 10.13% | [3],[5],[6],[22] | 10.13% | [3],[5],[6],[22] | 10.13% | [3],[5],[6],[22] | 6.75% | [1],[12],[23] | 6.75% | [1],[12],[23] | 6.75% | [1],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 30, 2027 | [5],[6] | Nov. 30, 2027 | [1],[12] | Nov. 30, 2027 | [5],[6] | Nov. 30, 2027 | [5],[6] | Nov. 30, 2027 | [5],[6] | Nov. 30, 2027 | [1],[12] | Nov. 30, 2027 | [1],[12] | Nov. 30, 2027 | [1],[12] | ||
Par (++) | $ 17,080 | [5],[6],[7] | $ 17,253 | [1],[12],[13] | ||||||||||||||
Cost | 16,791 | [5],[6] | 16,913 | [1],[12] | ||||||||||||||
Fair Value | $ 16,568 | [5],[6] | $ 16,908 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | NFM & J, L.P. (dba the Facilities Group) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | NFM & J, L.P. (dba the Facilities Group) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.27% | [3],[5],[6],[22],[24] | 6.75% | [1],[12],[23],[25] | 10.27% | [3],[5],[6],[22],[24] | 10.27% | [3],[5],[6],[22],[24] | 10.27% | [3],[5],[6],[22],[24] | 6.75% | [1],[12],[23],[25] | 6.75% | [1],[12],[23],[25] | 6.75% | [1],[12],[23],[25] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Nov. 30, 2027 | [3],[5],[6],[24] | Nov. 30, 2027 | [1],[12],[25] | Nov. 30, 2027 | [3],[5],[6],[24] | Nov. 30, 2027 | [3],[5],[6],[24] | Nov. 30, 2027 | [3],[5],[6],[24] | Nov. 30, 2027 | [1],[12],[25] | Nov. 30, 2027 | [1],[12],[25] | Nov. 30, 2027 | [1],[12],[25] | ||
Par (++) | $ 17,340 | [3],[5],[6],[7],[24] | $ 17,452 | [1],[12],[13],[25] | ||||||||||||||
Cost | 14,005 | [3],[5],[6],[24] | 8,467 | [1],[12],[25] | ||||||||||||||
Fair Value | $ 13,758 | [3],[5],[6],[24] | $ 8,552 | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | NFM & J, L.P. (dba the Facilities Group) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | NFM & J, L.P. (dba the Facilities Group) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[12],[23],[25] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Nov. 30, 2027 | [3],[5],[6],[24] | Nov. 30, 2027 | [1],[12],[25] | Nov. 30, 2027 | [3],[5],[6],[24] | Nov. 30, 2027 | [3],[5],[6],[24] | Nov. 30, 2027 | [3],[5],[6],[24] | Nov. 30, 2027 | [1],[12],[25] | Nov. 30, 2027 | [1],[12],[25] | Nov. 30, 2027 | [1],[12],[25] | ||
Par (++) | $ 2,992 | [3],[5],[6],[7],[24] | $ 2,992 | [1],[12],[13],[25] | ||||||||||||||
Cost | (49) | [3],[5],[6],[24] | 440 | [1],[12],[25] | ||||||||||||||
Fair Value | $ (90) | [3],[5],[6],[24] | $ 439 | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | NFM & J, L.P. (dba the Facilities Group) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.13% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 11.13% | [3],[5],[6],[22] | 11.13% | [3],[5],[6],[22] | 11.13% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [1],[11],[12] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [1],[11],[12] | Dec. 22, 2025 | [1],[11],[12] | Dec. 22, 2025 | [1],[11],[12] | ||
Par (++) | $ 22,644 | [3],[5],[6],[7] | $ 22,875 | [1],[11],[12],[13] | ||||||||||||||
Cost | 22,349 | [3],[5],[6] | 22,492 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 21,512 | [3],[5],[6] | $ 22,418 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.13% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 11.13% | [3],[5],[6],[22] | 11.13% | [3],[5],[6],[22] | 11.13% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [1],[11],[12] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [1],[11],[12] | Dec. 22, 2025 | [1],[11],[12] | Dec. 22, 2025 | [1],[11],[12] | ||
Par (++) | $ 12,086 | [3],[5],[6],[7] | $ 9,405 | [1],[11],[12],[13] | ||||||||||||||
Cost | 11,899 | [3],[5],[6] | 9,249 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 11,482 | [3],[5],[6] | $ 9,217 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.13% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23],[25] | 11.13% | [3],[5],[6],[22] | 11.13% | [3],[5],[6],[22] | 11.13% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23],[25] | 7.75% | [1],[11],[12],[23],[25] | 7.75% | [1],[11],[12],[23],[25] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [1],[11],[12],[25] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [1],[11],[12],[25] | Dec. 22, 2025 | [1],[11],[12],[25] | Dec. 22, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 9,310 | [3],[5],[6],[7] | $ 12,208 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 9,190 | [3],[5],[6] | 8,670 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 8,844 | [3],[5],[6] | $ 8,635 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 11.07% | 11.07% | 11.07% | 11.07% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Maturity | [3],[5],[6],[24] | Dec. 22, 2025 | Dec. 22, 2025 | Dec. 22, 2025 | Dec. 22, 2025 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 6,659 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 6,500 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 6,282 | ||||||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Dec. 22, 2025 | Dec. 22, 2025 | Dec. 22, 2025 | Dec. 22, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 3,610 | ||||||||||||||||
Cost | [1],[11],[12],[25] | (62) | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ (72) | ||||||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 22, 2025 | [3],[5],[6],[24] | Dec. 22, 2025 | [1],[11],[12],[25] | Dec. 22, 2025 | [3],[5],[6],[24] | Dec. 22, 2025 | [3],[5],[6],[24] | Dec. 22, 2025 | [3],[5],[6],[24] | Dec. 22, 2025 | [1],[11],[12],[25] | Dec. 22, 2025 | [1],[11],[12],[25] | Dec. 22, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 3,610 | [3],[5],[6],[7],[24] | $ 6,659 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (46) | [3],[5],[6],[24] | (66) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (180) | [3],[5],[6],[24] | $ (133) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | One GI LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Output Services Group, Inc. | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.80% | [3],[5],[6],[22] | 5.50% | [1],[23] | 9.80% | [3],[5],[6],[22] | 9.80% | [3],[5],[6],[22] | 9.80% | [3],[5],[6],[22] | 5.50% | [1],[23] | 5.50% | [1],[23] | 5.50% | [1],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 1.50% | 1.50% | 1.50% | 1.50% | |||||||||||||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Jun. 29, 2026 | [3],[5],[6] | Mar. 27, 2024 | [1] | Jun. 29, 2026 | [3],[5],[6] | Jun. 29, 2026 | [3],[5],[6] | Jun. 29, 2026 | [3],[5],[6] | Mar. 27, 2024 | [1] | Mar. 27, 2024 | [1] | Mar. 27, 2024 | [1] | ||
Par (++) | $ 3,855 | [3],[5],[6],[7] | $ 3,862 | [1],[13] | ||||||||||||||
Cost | 3,847 | [3],[5],[6] | 3,854 | [1] | ||||||||||||||
Fair Value | $ 2,593 | [3],[5],[6] | $ 3,282 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | Output Services Group, Inc. | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[23] | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||||||
1st Lien/Senior Secured Debt | PDDS Holdco, Inc. (dba Planet DDS) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 12.54% | 12.54% | 12.54% | 12.54% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Maturity | [3],[5],[6] | Jul. 18, 2028 | Jul. 18, 2028 | Jul. 18, 2028 | Jul. 18, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 24,090 | ||||||||||||||||
Cost | [3],[5],[6] | 23,636 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 23,608 | ||||||||||||||||
1st Lien/Senior Secured Debt | PDDS Holdco, Inc. (dba Planet DDS) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 12.54% | 12.54% | 12.54% | 12.54% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Maturity | [3],[5],[6] | Jul. 18, 2028 | Jul. 18, 2028 | Jul. 18, 2028 | Jul. 18, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 2,255 | ||||||||||||||||
Cost | [3],[5],[6] | 2,234 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 2,210 | ||||||||||||||||
1st Lien/Senior Secured Debt | PDDS Holdco, Inc. (dba Planet DDS) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 12.53% | 12.53% | 12.53% | 12.53% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jul. 18, 2028 | Jul. 18, 2028 | Jul. 18, 2028 | Jul. 18, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,805 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 1,297 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 1,241 | ||||||||||||||||
1st Lien/Senior Secured Debt | PDDS Holdco, Inc. (dba Planet DDS) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jul. 18, 2028 | Jul. 18, 2028 | Jul. 18, 2028 | Jul. 18, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 1,815 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (34) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (36) | ||||||||||||||||
1st Lien/Senior Secured Debt | PDDS Holdco, Inc. (dba Planet DDS) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jul. 18, 2028 | Jul. 18, 2028 | Jul. 18, 2028 | Jul. 18, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,805 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (26) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (56) | ||||||||||||||||
1st Lien/Senior Secured Debt | Picture Head Midco LLC | Entertainment | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.11% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 11.11% | [3],[5],[6],[22] | 11.11% | [3],[5],[6],[22] | 11.11% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Aug. 31, 2023 | [3],[5],[6] | Aug. 31, 2023 | [1],[11],[12] | Aug. 31, 2023 | [3],[5],[6] | Aug. 31, 2023 | [3],[5],[6] | Aug. 31, 2023 | [3],[5],[6] | Aug. 31, 2023 | [1],[11],[12] | Aug. 31, 2023 | [1],[11],[12] | Aug. 31, 2023 | [1],[11],[12] | ||
Par (++) | $ 45,307 | [3],[5],[6],[7] | $ 45,766 | [1],[11],[12],[13] | ||||||||||||||
Cost | 44,272 | [3],[5],[6] | 43,318 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 44,401 | [3],[5],[6] | $ 44,850 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Picture Head Midco LLC | Entertainment | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Pioneer Buyer I, LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.72% | [3],[5],[6],[22] | 7.75% | [1],[12],[23] | 11.72% | [3],[5],[6],[22] | 11.72% | [3],[5],[6],[22] | 11.72% | [3],[5],[6],[22] | 7.75% | [1],[12],[23] | 7.75% | [1],[12],[23] | 7.75% | [1],[12],[23] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 7% | 7% | 7% | 7% | |||||||||||||
Floor (+) | [1],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Nov. 01, 2028 | [3],[5],[6] | Nov. 01, 2028 | [1],[12] | Nov. 01, 2028 | [3],[5],[6] | Nov. 01, 2028 | [3],[5],[6] | Nov. 01, 2028 | [3],[5],[6] | Nov. 01, 2028 | [1],[12] | Nov. 01, 2028 | [1],[12] | Nov. 01, 2028 | [1],[12] | ||
Par (++) | $ 26,257 | [3],[5],[6],[7] | $ 24,016 | [1],[12],[13] | ||||||||||||||
Cost | 25,850 | [3],[5],[6] | 23,551 | [1],[12] | ||||||||||||||
Fair Value | $ 25,732 | [3],[5],[6] | $ 23,536 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Pioneer Buyer I, LLC | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [1],[12],[23] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Pioneer Buyer I, LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 7% | 7% | 7% | 7% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Nov. 01, 2027 | [3],[5],[6],[24] | Nov. 01, 2027 | [1],[12],[25] | Nov. 01, 2027 | [3],[5],[6],[24] | Nov. 01, 2027 | [3],[5],[6],[24] | Nov. 01, 2027 | [3],[5],[6],[24] | Nov. 01, 2027 | [1],[12],[25] | Nov. 01, 2027 | [1],[12],[25] | Nov. 01, 2027 | [1],[12],[25] | ||
Par (++) | $ 4,300 | [3],[5],[6],[7],[24] | $ 4,300 | [1],[12],[13],[25] | ||||||||||||||
Cost | (70) | [3],[5],[6],[24] | (84) | [1],[12],[25] | ||||||||||||||
Fair Value | $ (86) | [3],[5],[6],[24] | $ (86) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Pioneer Buyer I, LLC | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23],[25] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | PlanSource Holdings, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.55% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 9.55% | [3],[5],[6],[22] | 9.55% | [3],[5],[6],[22] | 9.55% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Apr. 22, 2025 | [3],[5],[6] | Apr. 22, 2025 | [1],[11],[12] | Apr. 22, 2025 | [3],[5],[6] | Apr. 22, 2025 | [3],[5],[6] | Apr. 22, 2025 | [3],[5],[6] | Apr. 22, 2025 | [1],[11],[12] | Apr. 22, 2025 | [1],[11],[12] | Apr. 22, 2025 | [1],[11],[12] | ||
Par (++) | $ 56,720 | [3],[5],[6],[7] | $ 56,720 | [1],[11],[12],[13] | ||||||||||||||
Cost | 54,845 | [3],[5],[6] | 54,142 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 56,011 | [3],[5],[6] | $ 55,586 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | PlanSource Holdings, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | PlanSource Holdings, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Apr. 22, 2025 | Apr. 22, 2025 | Apr. 22, 2025 | Apr. 22, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 905 | ||||||||||||||||
Cost | [1],[11],[12] | 891 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 887 | ||||||||||||||||
1st Lien/Senior Secured Debt | PlanSource Holdings, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | PlanSource Holdings, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 9.55% | 9.55% | 9.55% | 9.55% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Apr. 22, 2025 | [3],[5],[6] | Apr. 22, 2025 | [1],[11],[12],[25] | Apr. 22, 2025 | [3],[5],[6] | Apr. 22, 2025 | [3],[5],[6] | Apr. 22, 2025 | [3],[5],[6] | Apr. 22, 2025 | [1],[11],[12],[25] | Apr. 22, 2025 | [1],[11],[12],[25] | Apr. 22, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 905 | [3],[5],[6],[7] | $ 905 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 895 | [3],[5],[6] | (7) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 893 | [3],[5],[6] | $ (18) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | PlanSource Holdings, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | PlanSource Holdings, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Apr. 22, 2025 | [3],[5],[6],[24] | Apr. 22, 2025 | [1],[11],[12],[25] | Apr. 22, 2025 | [3],[5],[6],[24] | Apr. 22, 2025 | [3],[5],[6],[24] | Apr. 22, 2025 | [3],[5],[6],[24] | Apr. 22, 2025 | [1],[11],[12],[25] | Apr. 22, 2025 | [1],[11],[12],[25] | Apr. 22, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 7,824 | [3],[5],[6],[7],[24] | $ 7,824 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (124) | [3],[5],[6],[24] | (176) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (98) | [3],[5],[6],[24] | $ (156) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | PlanSource Holdings, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | Pluralsight, Inc | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.83% | [3],[5],[6],[22] | 9% | [1],[11],[12],[23] | 11.83% | [3],[5],[6],[22] | 11.83% | [3],[5],[6],[22] | 11.83% | [3],[5],[6],[22] | 9% | [1],[11],[12],[23] | 9% | [1],[11],[12],[23] | 9% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 8% | 8% | 8% | 8% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Apr. 06, 2027 | [3],[5],[6] | Apr. 06, 2027 | [1],[11],[12] | Apr. 06, 2027 | [3],[5],[6] | Apr. 06, 2027 | [3],[5],[6] | Apr. 06, 2027 | [3],[5],[6] | Apr. 06, 2027 | [1],[11],[12] | Apr. 06, 2027 | [1],[11],[12] | Apr. 06, 2027 | [1],[11],[12] | ||
Par (++) | $ 75,915 | [3],[5],[6],[7] | $ 75,915 | [1],[11],[12],[13] | ||||||||||||||
Cost | 74,744 | [3],[5],[6] | 74,532 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 74,207 | [3],[5],[6] | $ 74,396 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Pluralsight, Inc | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 8% | 8% | 8% | 8% | |||||||||||||
1st Lien/Senior Secured Debt | Pluralsight, Inc | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 12.36% | 12.36% | 12.36% | 12.36% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 8% | 8% | 8% | 8% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Apr. 06, 2027 | [3],[5],[6],[24] | Apr. 06, 2027 | [1],[11],[12],[25] | Apr. 06, 2027 | [3],[5],[6],[24] | Apr. 06, 2027 | [3],[5],[6],[24] | Apr. 06, 2027 | [3],[5],[6],[24] | Apr. 06, 2027 | [1],[11],[12],[25] | Apr. 06, 2027 | [1],[11],[12],[25] | Apr. 06, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 5,100 | [3],[5],[6],[7],[24] | $ 5,100 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 2,477 | [3],[5],[6],[24] | (90) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 2,435 | [3],[5],[6],[24] | $ (102) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Pluralsight, Inc | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 8% | 8% | 8% | 8% | |||||||||||||
1st Lien/Senior Secured Debt | Power Stop, LLC | Auto Components | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[12],[23] | 4.60% | 4.60% | 4.60% | 4.60% | |||||||||||||
Maturity | [1],[12] | Oct. 19, 2025 | Oct. 19, 2025 | Oct. 19, 2025 | Oct. 19, 2025 | |||||||||||||
Par (++) | [1],[12],[13] | $ 17,945 | ||||||||||||||||
Cost | [1],[12] | 17,129 | ||||||||||||||||
Fair Value | [1],[12] | $ 17,810 | ||||||||||||||||
1st Lien/Senior Secured Debt | Power Stop, LLC | Auto Components | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[12],[23] | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||||||
1st Lien/Senior Secured Debt | Premier Care Dental Management, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.88% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 9.88% | [3],[5],[6],[22] | 9.88% | [3],[5],[6],[22] | 9.88% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Aug. 05, 2028 | [3],[5],[6] | Aug. 05, 2028 | [1],[11],[12] | Aug. 05, 2028 | [3],[5],[6] | Aug. 05, 2028 | [3],[5],[6] | Aug. 05, 2028 | [3],[5],[6] | Aug. 05, 2028 | [1],[11],[12] | Aug. 05, 2028 | [1],[11],[12] | Aug. 05, 2028 | [1],[11],[12] | ||
Par (++) | $ 18,635 | [3],[5],[6],[7] | $ 18,823 | [1],[11],[12],[13] | ||||||||||||||
Cost | 18,323 | [3],[5],[6] | 18,464 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 18,076 | [3],[5],[6] | $ 18,447 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Premier Care Dental Management, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Premier Care Dental Management, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.88% | [3],[5],[6],[22],[24] | 6.50% | [1],[11],[12],[23],[25] | 9.88% | [3],[5],[6],[22],[24] | 9.88% | [3],[5],[6],[22],[24] | 9.88% | [3],[5],[6],[22],[24] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Aug. 05, 2028 | [3],[5],[6],[24] | Aug. 05, 2028 | [1],[11],[12],[25] | Aug. 05, 2028 | [3],[5],[6],[24] | Aug. 05, 2028 | [3],[5],[6],[24] | Aug. 05, 2028 | [3],[5],[6],[24] | Aug. 05, 2028 | [1],[11],[12],[25] | Aug. 05, 2028 | [1],[11],[12],[25] | Aug. 05, 2028 | [1],[11],[12],[25] | ||
Par (++) | $ 10,110 | [3],[5],[6],[7],[24] | $ 10,175 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 8,384 | [3],[5],[6],[24] | 2,608 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 8,240 | [3],[5],[6],[24] | $ 2,493 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Premier Care Dental Management, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Premier Care Dental Management, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.73% | [3],[5],[6],[22],[24] | 6.50% | [1],[11],[12],[23],[25] | 9.73% | [3],[5],[6],[22],[24] | 9.73% | [3],[5],[6],[22],[24] | 9.73% | [3],[5],[6],[22],[24] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Aug. 05, 2027 | [3],[5],[6],[24] | Aug. 05, 2027 | [1],[11],[12],[25] | Aug. 05, 2027 | [3],[5],[6],[24] | Aug. 05, 2027 | [3],[5],[6],[24] | Aug. 05, 2027 | [3],[5],[6],[24] | Aug. 05, 2027 | [1],[11],[12],[25] | Aug. 05, 2027 | [1],[11],[12],[25] | Aug. 05, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 3,052 | [3],[5],[6],[7],[24] | $ 3,052 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 970 | [3],[5],[6],[24] | 492 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 926 | [3],[5],[6],[24] | $ 488 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Premier Care Dental Management, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Premier Imaging, LLC (dba Lucid Health) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.13% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 10.13% | [3],[5],[6],[22] | 10.13% | [3],[5],[6],[22] | 10.13% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [1],[11],[12] | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [1],[11],[12] | Jan. 02, 2025 | [1],[11],[12] | Jan. 02, 2025 | [1],[11],[12] | ||
Par (++) | $ 27,277 | [3],[5],[6],[7] | $ 27,277 | [1],[11],[12],[13] | ||||||||||||||
Cost | 26,383 | [3],[5],[6] | 25,990 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 26,596 | [3],[5],[6] | $ 26,868 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Premier Imaging, LLC (dba Lucid Health) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Premier Imaging, LLC (dba Lucid Health) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.13% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 10.13% | [3],[5],[6],[22] | 10.13% | [3],[5],[6],[22] | 10.13% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [1],[11],[12] | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [1],[11],[12] | Jan. 02, 2025 | [1],[11],[12] | Jan. 02, 2025 | [1],[11],[12] | ||
Par (++) | $ 7,616 | [3],[5],[6],[7] | $ 7,616 | [1],[11],[12],[13] | ||||||||||||||
Cost | 7,538 | [3],[5],[6] | 7,504 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 7,425 | [3],[5],[6] | $ 7,502 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Premier Imaging, LLC (dba Lucid Health) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Premier Imaging, LLC (dba Lucid Health) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.13% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 10.13% | [3],[5],[6],[22] | 10.13% | [3],[5],[6],[22] | 10.13% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [1],[11],[12] | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [3],[5],[6] | Jan. 02, 2025 | [1],[11],[12] | Jan. 02, 2025 | [1],[11],[12] | Jan. 02, 2025 | [1],[11],[12] | ||
Par (++) | $ 6,093 | [3],[5],[6],[7] | $ 6,155 | [1],[11],[12],[13] | ||||||||||||||
Cost | 6,030 | [3],[5],[6] | 6,062 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 5,941 | [3],[5],[6] | $ 6,062 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Premier Imaging, LLC (dba Lucid Health) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Premier Imaging, LLC (dba Lucid Health) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.13% | 10.13% | 10.13% | 10.13% | |||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jan. 02, 2025 | [3],[5],[6],[24] | Jan. 02, 2025 | [1],[11],[12],[25] | Jan. 02, 2025 | [3],[5],[6],[24] | Jan. 02, 2025 | [3],[5],[6],[24] | Jan. 02, 2025 | [3],[5],[6],[24] | Jan. 02, 2025 | [1],[11],[12],[25] | Jan. 02, 2025 | [1],[11],[12],[25] | Jan. 02, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 5,762 | [3],[5],[6],[7],[24] | $ 5,778 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 1,594 | [3],[5],[6],[24] | (87) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 1,508 | [3],[5],[6],[24] | $ (87) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Premier Imaging, LLC (dba Lucid Health) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Professional Physical Therapy | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[23] | 9% | 9% | 9% | 9% | |||||||||||||
Reference Rate and Spread (+), PIK | [1],[11],[23] | 2% | 2% | 2% | 2% | |||||||||||||
Floor (+) | [1],[11],[23] | 1% | ||||||||||||||||
Maturity | [1],[11] | Dec. 16, 2022 | Dec. 16, 2022 | Dec. 16, 2022 | Dec. 16, 2022 | |||||||||||||
Par (++) | [1],[11],[13] | $ 5,957 | ||||||||||||||||
Cost | [1],[11] | 5,726 | ||||||||||||||||
Fair Value | [1],[11] | $ 5,302 | ||||||||||||||||
1st Lien/Senior Secured Debt | Professional Physical Therapy | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[23] | 8% | 8% | 8% | 8% | |||||||||||||
1st Lien/Senior Secured Debt | Project Eagle Holdings, LLC (dba Exostar) | Aerospace & Defense | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.64% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 10.64% | [3],[5],[6],[22] | 10.64% | [3],[5],[6],[22] | 10.64% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 06, 2002 | [3],[5],[6] | Jul. 06, 2026 | [1],[11],[12] | Jul. 06, 2002 | [3],[5],[6] | Jul. 06, 2002 | [3],[5],[6] | Jul. 06, 2002 | [3],[5],[6] | Jul. 06, 2026 | [1],[11],[12] | Jul. 06, 2026 | [1],[11],[12] | Jul. 06, 2026 | [1],[11],[12] | ||
Par (++) | $ 35,359 | [3],[5],[6],[7] | $ 35,718 | [1],[11],[12],[13] | ||||||||||||||
Cost | 34,809 | [3],[5],[6] | 35,031 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 34,652 | [3],[5],[6] | $ 35,004 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Project Eagle Holdings, LLC (dba Exostar) | Aerospace & Defense | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Project Eagle Holdings, LLC (dba Exostar) | Aerospace & Defense | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jul. 06, 2026 | [3],[5],[6],[24] | Jul. 06, 2026 | [1],[11],[12],[25] | Jul. 06, 2026 | [3],[5],[6],[24] | Jul. 06, 2026 | [3],[5],[6],[24] | Jul. 06, 2026 | [3],[5],[6],[24] | Jul. 06, 2026 | [1],[11],[12],[25] | Jul. 06, 2026 | [1],[11],[12],[25] | Jul. 06, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 75 | [3],[5],[6],[7],[24] | $ 75 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (1) | [3],[5],[6],[24] | (1) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (2) | [3],[5],[6],[24] | $ (1) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Project Eagle Holdings, LLC (dba Exostar) | Aerospace & Defense | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[12],[23],[25] | 6.50% | [3],[5],[6],[22],[24] | 6.50% | [3],[5],[6],[22],[24] | 6.50% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Prophix Software Inc. (dba Pound Bidco) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.67% | [3],[5],[6],[8],[22] | 7.50% | [1],[11],[12],[16],[23] | 10.67% | [3],[5],[6],[8],[22] | 10.67% | [3],[5],[6],[8],[22] | 10.67% | [3],[5],[6],[8],[22] | 7.50% | [1],[11],[12],[16],[23] | 7.50% | [1],[11],[12],[16],[23] | 7.50% | [1],[11],[12],[16],[23] | ||
Floor (+) | [1],[11],[12],[16],[23] | 1% | ||||||||||||||||
Maturity | Jan. 30, 2026 | [3],[5],[6],[8] | Jan. 30, 2026 | [1],[11],[12],[16] | Jan. 30, 2026 | [3],[5],[6],[8] | Jan. 30, 2026 | [3],[5],[6],[8] | Jan. 30, 2026 | [3],[5],[6],[8] | Jan. 30, 2026 | [1],[11],[12],[16] | Jan. 30, 2026 | [1],[11],[12],[16] | Jan. 30, 2026 | [1],[11],[12],[16] | ||
Par (++) | $ 18,948 | [3],[5],[6],[7],[8] | $ 18,948 | [1],[11],[12],[13],[16] | ||||||||||||||
Cost | 18,697 | [3],[5],[6],[8] | 18,628 | [1],[11],[12],[16] | ||||||||||||||
Fair Value | $ 18,711 | [3],[5],[6],[8] | $ 18,948 | [1],[11],[12],[16] | ||||||||||||||
1st Lien/Senior Secured Debt | Prophix Software Inc. (dba Pound Bidco) | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [3],[5],[6],[8],[22] | 6.50% | [1],[11],[12],[16],[23] | 6.50% | [3],[5],[6],[8],[22] | 6.50% | [3],[5],[6],[8],[22] | 6.50% | [3],[5],[6],[8],[22] | 6.50% | [1],[11],[12],[16],[23] | 6.50% | [1],[11],[12],[16],[23] | 6.50% | [1],[11],[12],[16],[23] | ||
1st Lien/Senior Secured Debt | Prophix Software Inc. (dba Pound Bidco) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.67% | [3],[5],[6],[8],[22] | 7.50% | [1],[11],[12],[16],[23] | 10.67% | [3],[5],[6],[8],[22] | 10.67% | [3],[5],[6],[8],[22] | 10.67% | [3],[5],[6],[8],[22] | 7.50% | [1],[11],[12],[16],[23] | 7.50% | [1],[11],[12],[16],[23] | 7.50% | [1],[11],[12],[16],[23] | ||
Floor (+) | [1],[11],[12],[16],[23] | 1% | ||||||||||||||||
Maturity | Jan. 30, 2026 | [3],[5],[6],[8] | Jan. 30, 2026 | [1],[11],[12],[16] | Jan. 30, 2026 | [3],[5],[6],[8] | Jan. 30, 2026 | [3],[5],[6],[8] | Jan. 30, 2026 | [3],[5],[6],[8] | Jan. 30, 2026 | [1],[11],[12],[16] | Jan. 30, 2026 | [1],[11],[12],[16] | Jan. 30, 2026 | [1],[11],[12],[16] | ||
Par (++) | $ 7,752 | [3],[5],[6],[7],[8] | $ 7,752 | [1],[11],[12],[13],[16] | ||||||||||||||
Cost | 7,635 | [3],[5],[6],[8] | 7,603 | [1],[11],[12],[16] | ||||||||||||||
Fair Value | $ 7,655 | [3],[5],[6],[8] | $ 7,752 | [1],[11],[12],[16] | ||||||||||||||
1st Lien/Senior Secured Debt | Prophix Software Inc. (dba Pound Bidco) | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [3],[5],[6],[8],[22] | 6.50% | [1],[11],[12],[16],[23] | 6.50% | [3],[5],[6],[8],[22] | 6.50% | [3],[5],[6],[8],[22] | 6.50% | [3],[5],[6],[8],[22] | 6.50% | [1],[11],[12],[16],[23] | 6.50% | [1],[11],[12],[16],[23] | 6.50% | [1],[11],[12],[16],[23] | ||
1st Lien/Senior Secured Debt | Prophix Software Inc. (dba Pound Bidco) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[16],[23],[25] | 1% | ||||||||||||||||
Maturity | Jan. 30, 2026 | [3],[5],[6],[8],[24] | Jan. 30, 2026 | [1],[11],[12],[16],[25] | Jan. 30, 2026 | [3],[5],[6],[8],[24] | Jan. 30, 2026 | [3],[5],[6],[8],[24] | Jan. 30, 2026 | [3],[5],[6],[8],[24] | Jan. 30, 2026 | [1],[11],[12],[16],[25] | Jan. 30, 2026 | [1],[11],[12],[16],[25] | Jan. 30, 2026 | [1],[11],[12],[16],[25] | ||
Par (++) | $ 3,445 | [3],[5],[6],[7],[8],[24] | $ 3,445 | [1],[11],[12],[13],[16],[25] | ||||||||||||||
Cost | (43) | [3],[5],[6],[8],[24] | $ (57) | [1],[11],[12],[16],[25] | ||||||||||||||
Fair Value | [3],[5],[6],[8],[24] | $ (43) | ||||||||||||||||
1st Lien/Senior Secured Debt | Prophix Software Inc. (dba Pound Bidco) | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.50% | [3],[5],[6],[8],[22],[24] | 6.50% | [1],[11],[12],[16],[23],[25] | 6.50% | [3],[5],[6],[8],[22],[24] | 6.50% | [3],[5],[6],[8],[22],[24] | 6.50% | [3],[5],[6],[8],[22],[24] | 6.50% | [1],[11],[12],[16],[23],[25] | 6.50% | [1],[11],[12],[16],[23],[25] | 6.50% | [1],[11],[12],[16],[23],[25] | ||
1st Lien/Senior Secured Debt | PT Intermediate Holdings III, LLC (dba Parts Town) | Trading Companies & Distributors | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.23% | [3],[6],[22] | 6.25% | [1],[12],[23] | 10.23% | [3],[6],[22] | 10.23% | [3],[6],[22] | 10.23% | [3],[6],[22] | 6.25% | [1],[12],[23] | 6.25% | [1],[12],[23] | 6.25% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [1],[12] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [1],[12] | Nov. 01, 2028 | [1],[12] | Nov. 01, 2028 | [1],[12] | ||
Par (++) | $ 22,790 | [3],[6],[7] | $ 23,020 | [1],[12],[13] | ||||||||||||||
Cost | 22,592 | [3],[6] | 22,793 | [1],[12] | ||||||||||||||
Fair Value | $ 21,992 | [3],[6] | $ 22,790 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | PT Intermediate Holdings III, LLC (dba Parts Town) | Trading Companies & Distributors | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[6],[22] | 5.50% | [1],[12],[23] | 5.50% | [3],[6],[22] | 5.50% | [3],[6],[22] | 5.50% | [3],[6],[22] | 5.50% | [1],[12],[23] | 5.50% | [1],[12],[23] | 5.50% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | PT Intermediate Holdings III, LLC (dba Parts Town) | Trading Companies & Distributors | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.23% | [3],[6],[22] | 6.25% | [1],[12],[23] | 10.23% | [3],[6],[22] | 10.23% | [3],[6],[22] | 10.23% | [3],[6],[22] | 6.25% | [1],[12],[23] | 6.25% | [1],[12],[23] | 6.25% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [1],[12] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [1],[12] | Nov. 01, 2028 | [1],[12] | Nov. 01, 2028 | [1],[12] | ||
Par (++) | $ 2,025 | [3],[6],[7] | $ 1,414 | [1],[12],[13] | ||||||||||||||
Cost | 2,006 | [3],[6] | 1,401 | [1],[12] | ||||||||||||||
Fair Value | $ 1,954 | [3],[6] | $ 1,400 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | PT Intermediate Holdings III, LLC (dba Parts Town) | Trading Companies & Distributors | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[6],[22] | 5.50% | [1],[12],[23] | 5.50% | [3],[6],[22] | 5.50% | [3],[6],[22] | 5.50% | [3],[6],[22] | 5.50% | [1],[12],[23] | 5.50% | [1],[12],[23] | 5.50% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | PT Intermediate Holdings III, LLC (dba Parts Town) | Trading Companies & Distributors | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[6],[22] | 10.23% | 10.23% | 10.23% | 10.23% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [1],[12],[25] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [3],[6] | Nov. 01, 2028 | [1],[12],[25] | Nov. 01, 2028 | [1],[12],[25] | Nov. 01, 2028 | [1],[12],[25] | ||
Par (++) | $ 1,960 | [3],[6],[7] | $ 1,980 | [1],[12],[13],[25] | ||||||||||||||
Cost | [3],[6] | 1,943 | ||||||||||||||||
Fair Value | $ 1,892 | [3],[6] | $ (20) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | PT Intermediate Holdings III, LLC (dba Parts Town) | Trading Companies & Distributors | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[6],[22] | 5.50% | [1],[12],[23],[25] | 5.50% | [3],[6],[22] | 5.50% | [3],[6],[22] | 5.50% | [3],[6],[22] | 5.50% | [1],[12],[23],[25] | 5.50% | [1],[12],[23],[25] | 5.50% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | PT Intermediate Holdings III, LLC (dba Parts Town) | Trading Companies & Distributors | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[6],[22] | 10.23% | 10.23% | 10.23% | 10.23% | |||||||||||||
Maturity | [3],[6] | Nov. 01, 2028 | Nov. 01, 2028 | Nov. 01, 2028 | Nov. 01, 2028 | |||||||||||||
Par (++) | [3],[6],[7] | $ 1,400 | ||||||||||||||||
Cost | [3],[6] | 1,388 | ||||||||||||||||
Fair Value | [3],[6] | $ 1,351 | ||||||||||||||||
1st Lien/Senior Secured Debt | PT Intermediate Holdings III, LLC (dba Parts Town) | Trading Companies & Distributors | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[22] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Purfoods, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.90% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 10.90% | [3],[5],[6],[22] | 10.90% | [3],[5],[6],[22] | 10.90% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Aug. 12, 2026 | [3],[5],[6] | Aug. 12, 2026 | [1],[11],[12] | Aug. 12, 2026 | [3],[5],[6] | Aug. 12, 2026 | [3],[5],[6] | Aug. 12, 2026 | [3],[5],[6] | Aug. 12, 2026 | [1],[11],[12] | Aug. 12, 2026 | [1],[11],[12] | Aug. 12, 2026 | [1],[11],[12] | ||
Par (++) | $ 587 | [3],[5],[6],[7] | $ 593 | [1],[11],[12],[13] | ||||||||||||||
Cost | 568 | [3],[5],[6] | 570 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 573 | [3],[5],[6] | $ 591 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Purfoods, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23] | 6% | [1],[11],[12],[23] | 6% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Purfoods, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.88% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23],[25] | 10.88% | [3],[5],[6],[22] | 10.88% | [3],[5],[6],[22] | 10.88% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23],[25] | 7% | [1],[11],[12],[23],[25] | 7% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Aug. 12, 2026 | [3],[5],[6] | Aug. 12, 2026 | [1],[11],[12],[25] | Aug. 12, 2026 | [3],[5],[6] | Aug. 12, 2026 | [3],[5],[6] | Aug. 12, 2026 | [3],[5],[6] | Aug. 12, 2026 | [1],[11],[12],[25] | Aug. 12, 2026 | [1],[11],[12],[25] | Aug. 12, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 396 | [3],[5],[6],[7] | $ 399 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 390 | [3],[5],[6] | 243 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 387 | [3],[5],[6] | $ 248 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Purfoods, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23],[25] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6.25% | [3],[5],[6],[22] | 6% | [1],[11],[12],[23],[25] | 6% | [1],[11],[12],[23],[25] | 6% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Qualawash Holdings, LLC | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 9.44% | 9.44% | 9.44% | 9.44% | |||||||||||||
Maturity | [3],[5],[6] | Aug. 31, 2026 | Aug. 31, 2026 | Aug. 31, 2026 | Aug. 31, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 11,317 | ||||||||||||||||
Cost | [3],[5],[6] | 11,170 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 11,091 | ||||||||||||||||
1st Lien/Senior Secured Debt | Qualawash Holdings, LLC | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Qualawash Holdings, LLC | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 9.89% | 9.89% | 9.89% | 9.89% | |||||||||||||
Maturity | [3],[5],[6],[24] | Aug. 31, 2026 | Aug. 31, 2026 | Aug. 31, 2026 | Aug. 31, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,852 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 2,323 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 2,295 | ||||||||||||||||
1st Lien/Senior Secured Debt | Qualawash Holdings, LLC | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Qualawash Holdings, LLC | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Aug. 31, 2026 | Aug. 31, 2026 | Aug. 31, 2026 | Aug. 31, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,859 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (36) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (57) | ||||||||||||||||
1st Lien/Senior Secured Debt | Qualawash Holdings, LLC | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 21,953 | ||||||||||||||||
Cost | [1],[11],[12] | 21,013 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 21,788 | ||||||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Equipment & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 9.73% | 9.73% | 9.73% | 9.73% | |||||||||||||
Maturity | [3],[5],[6] | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 21,643 | ||||||||||||||||
Cost | [3],[5],[6] | 20,957 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 21,156 | ||||||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Equipment & Supplies | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5% | 5% | 5% | 5% | |||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 1,663 | ||||||||||||||||
Cost | [1],[11],[12] | 1,643 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 1,650 | ||||||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Equipment & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 9.73% | 9.73% | 9.73% | 9.73% | |||||||||||||
Maturity | [3],[5],[6] | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 1,639 | ||||||||||||||||
Cost | [3],[5],[6] | 1,625 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 1,602 | ||||||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Equipment & Supplies | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5% | 5% | 5% | 5% | |||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 4,094 | ||||||||||||||||
Cost | [1],[11],[12],[25] | (73) | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ (31) | ||||||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Equipment & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | Jun. 21, 2025 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 4,094 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (52) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (92) | ||||||||||||||||
1st Lien/Senior Secured Debt | Riverpoint Medical, LLC | Health Care Equipment & Supplies | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5% | 5% | 5% | 5% | |||||||||||||
1st Lien/Senior Secured Debt | Rodeo Buyer Company (dba Absorb Software) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.63% | [3],[5],[6],[8],[22] | 7.25% | [1],[11],[12],[16],[23] | 10.63% | [3],[5],[6],[8],[22] | 10.63% | [3],[5],[6],[8],[22] | 10.63% | [3],[5],[6],[8],[22] | 7.25% | [1],[11],[12],[16],[23] | 7.25% | [1],[11],[12],[16],[23] | 7.25% | [1],[11],[12],[16],[23] | ||
Floor (+) | [1],[11],[12],[16],[23] | 1% | ||||||||||||||||
Maturity | May 25, 2027 | [3],[5],[6],[8] | May 25, 2027 | [1],[11],[12],[16] | May 25, 2027 | [3],[5],[6],[8] | May 25, 2027 | [3],[5],[6],[8] | May 25, 2027 | [3],[5],[6],[8] | May 25, 2027 | [1],[11],[12],[16] | May 25, 2027 | [1],[11],[12],[16] | May 25, 2027 | [1],[11],[12],[16] | ||
Par (++) | $ 21,167 | [3],[5],[6],[7],[8] | $ 21,167 | [1],[11],[12],[13],[16] | ||||||||||||||
Cost | 20,838 | [3],[5],[6],[8] | 20,778 | [1],[11],[12],[16] | ||||||||||||||
Fair Value | $ 20,796 | [3],[5],[6],[8] | $ 20,796 | [1],[11],[12],[16] | ||||||||||||||
1st Lien/Senior Secured Debt | Rodeo Buyer Company (dba Absorb Software) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[8],[22] | 6.25% | [1],[11],[12],[16],[23] | 6.25% | [3],[5],[6],[8],[22] | 6.25% | [3],[5],[6],[8],[22] | 6.25% | [3],[5],[6],[8],[22] | 6.25% | [1],[11],[12],[16],[23] | 6.25% | [1],[11],[12],[16],[23] | 6.25% | [1],[11],[12],[16],[23] | ||
1st Lien/Senior Secured Debt | Rodeo Buyer Company (dba Absorb Software) | Professional Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[8],[22],[24] | 10.49% | 10.49% | 10.49% | 10.49% | |||||||||||||
Floor (+) | [1],[11],[12],[16],[23],[25] | 1% | ||||||||||||||||
Maturity | May 25, 2027 | [3],[5],[6],[8],[24] | May 25, 2027 | [1],[11],[12],[16],[25] | May 25, 2027 | [3],[5],[6],[8],[24] | May 25, 2027 | [3],[5],[6],[8],[24] | May 25, 2027 | [3],[5],[6],[8],[24] | May 25, 2027 | [1],[11],[12],[16],[25] | May 25, 2027 | [1],[11],[12],[16],[25] | May 25, 2027 | [1],[11],[12],[16],[25] | ||
Par (++) | $ 3,387 | [3],[5],[6],[7],[8],[24] | $ 3,387 | [1],[11],[12],[13],[16],[25] | ||||||||||||||
Cost | 289 | [3],[5],[6],[8],[24] | (61) | [1],[11],[12],[16],[25] | ||||||||||||||
Fair Value | $ 279 | [3],[5],[6],[8],[24] | $ (59) | [1],[11],[12],[16],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Rodeo Buyer Company (dba Absorb Software) | Professional Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[5],[6],[8],[22],[24] | 6.25% | [1],[11],[12],[16],[23],[25] | 6.25% | [3],[5],[6],[8],[22],[24] | 6.25% | [3],[5],[6],[8],[22],[24] | 6.25% | [3],[5],[6],[8],[22],[24] | 6.25% | [1],[11],[12],[16],[23],[25] | 6.25% | [1],[11],[12],[16],[23],[25] | 6.25% | [1],[11],[12],[16],[23],[25] | ||
1st Lien/Senior Secured Debt | Rubrik,Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.75% | 10.75% | 10.75% | 10.75% | |||||||||||||
Maturity | [3],[5],[6] | Jun. 10, 2027 | Jun. 10, 2027 | Jun. 10, 2027 | Jun. 10, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 35,173 | ||||||||||||||||
Cost | [3],[5],[6] | 34,533 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 34,470 | ||||||||||||||||
1st Lien/Senior Secured Debt | Rubrik,Inc. | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Rubrik,Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 11.45% | 11.45% | 11.45% | 11.45% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jun. 10, 2027 | Jun. 10, 2027 | Jun. 10, 2027 | Jun. 10, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 4,020 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 1,709 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 1,629 | ||||||||||||||||
1st Lien/Senior Secured Debt | Rubrik,Inc. | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Smarsh, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [5],[6],[22] | 11.29% | 11.29% | 11.29% | 11.29% | |||||||||||||
Maturity | [5],[6] | Feb. 16, 2029 | Feb. 16, 2029 | Feb. 16, 2029 | Feb. 16, 2029 | |||||||||||||
Par (++) | [5],[6],[7] | $ 26,667 | ||||||||||||||||
Cost | [5],[6] | 26,426 | ||||||||||||||||
Fair Value | [5],[6] | $ 26,400 | ||||||||||||||||
1st Lien/Senior Secured Debt | Smarsh, Inc. | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [5],[6],[22] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Smarsh, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [5],[6],[22],[24] | 11.29% | 11.29% | 11.29% | 11.29% | |||||||||||||
Maturity | [5],[6],[24] | Feb. 16, 2029 | Feb. 16, 2029 | Feb. 16, 2029 | Feb. 16, 2029 | |||||||||||||
Par (++) | [5],[6],[7],[24] | $ 6,667 | ||||||||||||||||
Cost | [5],[6],[24] | 3,287 | ||||||||||||||||
Fair Value | [5],[6],[24] | $ 3,267 | ||||||||||||||||
1st Lien/Senior Secured Debt | Smarsh, Inc. | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [5],[6],[22],[24] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Smarsh, Inc. | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [5],[6],[24] | Feb. 16, 2029 | Feb. 16, 2029 | Feb. 16, 2029 | Feb. 16, 2029 | |||||||||||||
Par (++) | [5],[6],[7],[24] | $ 1,667 | ||||||||||||||||
Cost | [5],[6],[24] | (15) | ||||||||||||||||
Fair Value | [5],[6],[24] | $ (17) | ||||||||||||||||
1st Lien/Senior Secured Debt | Smarsh, Inc. | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [5],[6],[22],[24] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Southeast Mechanical, LLC (dba. SEM Holdings, LLC) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[14],[22] | 10.44% | 10.44% | 10.44% | 10.44% | |||||||||||||
Maturity | [3],[5],[6],[14] | Jul. 06, 2027 | Jul. 06, 2027 | Jul. 06, 2027 | Jul. 06, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7],[14] | $ 10,746 | ||||||||||||||||
Cost | [3],[5],[6],[14] | 10,548 | ||||||||||||||||
Fair Value | [3],[5],[6],[14] | $ 10,531 | ||||||||||||||||
1st Lien/Senior Secured Debt | Southeast Mechanical, LLC (dba. SEM Holdings, LLC) | Diversified Consumer Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[14],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Southeast Mechanical, LLC (dba. SEM Holdings, LLC) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[14],[24] | Jul. 06, 2027 | Jul. 06, 2027 | Jul. 06, 2027 | Jul. 06, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7],[14],[24] | $ 1,900 | ||||||||||||||||
Cost | [3],[5],[6],[14],[24] | (34) | ||||||||||||||||
Fair Value | [3],[5],[6],[14],[24] | $ (38) | ||||||||||||||||
1st Lien/Senior Secured Debt | Southeast Mechanical, LLC (dba. SEM Holdings, LLC) | Diversified Consumer Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[14],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Southeast Mechanical, LLC (dba. SEM Holdings, LLC) | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[14],[24] | Jul. 06, 2027 | Jul. 06, 2027 | Jul. 06, 2027 | Jul. 06, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7],[14],[24] | $ 7,400 | ||||||||||||||||
Cost | [3],[5],[6],[14],[24] | (67) | ||||||||||||||||
Fair Value | [3],[5],[6],[14],[24] | $ (148) | ||||||||||||||||
1st Lien/Senior Secured Debt | Southeast Mechanical, LLC (dba. SEM Holdings, LLC) | Diversified Consumer Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[14],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | SPay, Inc. (dba Stack Sports) | Interactive Media & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 13.66% | [3],[5],[6],[22] | 10.25% | [1],[23] | 13.66% | [3],[5],[6],[22] | 13.66% | [3],[5],[6],[22] | 13.66% | [3],[5],[6],[22] | 10.25% | [1],[23] | 10.25% | [1],[23] | 10.25% | [1],[23] | ||
Reference Rate and Spread (+), PIK | 3.50% | [3],[5],[6],[22] | 3.50% | [1],[23] | 3.50% | [3],[5],[6],[22] | 3.50% | [3],[5],[6],[22] | 3.50% | [3],[5],[6],[22] | 3.50% | [1],[23] | 3.50% | [1],[23] | 3.50% | [1],[23] | ||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [1] | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [1] | Jun. 17, 2024 | [1] | Jun. 17, 2024 | [1] | ||
Par (++) | $ 29,750 | [3],[5],[6],[7] | $ 28,204 | [1],[13] | ||||||||||||||
Cost | 28,546 | [3],[5],[6] | 26,355 | [1] | ||||||||||||||
Fair Value | $ 28,263 | [3],[5],[6] | $ 26,653 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | SPay, Inc. (dba Stack Sports) | Interactive Media & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 9.25% | [3],[5],[6],[22] | 9.25% | [1],[23] | 9.25% | [3],[5],[6],[22] | 9.25% | [3],[5],[6],[22] | 9.25% | [3],[5],[6],[22] | 9.25% | [1],[23] | 9.25% | [1],[23] | 9.25% | [1],[23] | ||
1st Lien/Senior Secured Debt | SPay, Inc. (dba Stack Sports) | Interactive Media & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 13.66% | [3],[5],[6],[22] | 10.25% | [1],[23] | 13.66% | [3],[5],[6],[22] | 13.66% | [3],[5],[6],[22] | 13.66% | [3],[5],[6],[22] | 10.25% | [1],[23] | 10.25% | [1],[23] | 10.25% | [1],[23] | ||
Reference Rate and Spread (+), PIK | 3.50% | [3],[5],[6],[22] | 3.50% | [1],[23] | 3.50% | [3],[5],[6],[22] | 3.50% | [3],[5],[6],[22] | 3.50% | [3],[5],[6],[22] | 3.50% | [1],[23] | 3.50% | [1],[23] | 3.50% | [1],[23] | ||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [1] | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [1] | Jun. 17, 2024 | [1] | Jun. 17, 2024 | [1] | ||
Par (++) | $ 2,157 | [3],[5],[6],[7] | $ 2,019 | [1],[13] | ||||||||||||||
Cost | 2,062 | [3],[5],[6] | 1,883 | [1] | ||||||||||||||
Fair Value | $ 2,049 | [3],[5],[6] | $ 1,908 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | SPay, Inc. (dba Stack Sports) | Interactive Media & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 9.25% | [3],[5],[6],[22] | 9.25% | [1],[23] | 9.25% | [3],[5],[6],[22] | 9.25% | [3],[5],[6],[22] | 9.25% | [3],[5],[6],[22] | 9.25% | [1],[23] | 9.25% | [1],[23] | 9.25% | [1],[23] | ||
1st Lien/Senior Secured Debt | SPay, Inc. (dba Stack Sports) | Interactive Media & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 13.68% | [3],[5],[6],[22] | 10.25% | [1],[23] | 13.68% | [3],[5],[6],[22] | 13.68% | [3],[5],[6],[22] | 13.68% | [3],[5],[6],[22] | 10.25% | [1],[23] | 10.25% | [1],[23] | 10.25% | [1],[23] | ||
Reference Rate and Spread (+), PIK | 3.50% | [3],[5],[6],[22] | 3.50% | [1],[23] | 3.50% | [3],[5],[6],[22] | 3.50% | [3],[5],[6],[22] | 3.50% | [3],[5],[6],[22] | 3.50% | [1],[23] | 3.50% | [1],[23] | 3.50% | [1],[23] | ||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [1] | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [3],[5],[6] | Jun. 17, 2024 | [1] | Jun. 17, 2024 | [1] | Jun. 17, 2024 | [1] | ||
Par (++) | $ 1,074 | [3],[5],[6],[7] | $ 1,011 | [1],[13] | ||||||||||||||
Cost | 1,032 | [3],[5],[6] | 943 | [1] | ||||||||||||||
Fair Value | $ 1,021 | [3],[5],[6] | $ 955 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | SPay, Inc. (dba Stack Sports) | Interactive Media & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 9.25% | [3],[5],[6],[22] | 9.25% | [1],[23] | 9.25% | [3],[5],[6],[22] | 9.25% | [3],[5],[6],[22] | 9.25% | [3],[5],[6],[22] | 9.25% | [1],[23] | 9.25% | [1],[23] | 9.25% | [1],[23] | ||
1st Lien/Senior Secured Debt | SpendMend, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.17% | 10.17% | 10.17% | 10.17% | |||||||||||||
Maturity | [3],[5],[6] | Mar. 01, 2028 | Mar. 01, 2028 | Mar. 01, 2028 | Mar. 01, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 634 | ||||||||||||||||
Cost | [3],[5],[6] | 624 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 618 | ||||||||||||||||
1st Lien/Senior Secured Debt | SpendMend, LLC | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | SpendMend, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.17% | 10.17% | 10.17% | 10.17% | |||||||||||||
Maturity | [3],[5],[6],[24] | Mar. 01, 2028 | Mar. 01, 2028 | Mar. 01, 2028 | Mar. 01, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 277 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 109 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 105 | ||||||||||||||||
1st Lien/Senior Secured Debt | SpendMend, LLC | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | SpendMend, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.17% | 10.17% | 10.17% | 10.17% | |||||||||||||
Maturity | [3],[5],[6],[24] | Mar. 01, 2028 | Mar. 01, 2028 | Mar. 01, 2028 | Mar. 01, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 83 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 10 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 9 | ||||||||||||||||
1st Lien/Senior Secured Debt | SpendMend, LLC | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Spotless Brands, LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[6],[22] | 10.92% | 10.92% | 10.92% | 10.92% | |||||||||||||
Maturity | [3],[6] | Jul. 25, 2028 | Jul. 25, 2028 | Jul. 25, 2028 | Jul. 25, 2028 | |||||||||||||
Par (++) | [3],[6],[7] | $ 217 | ||||||||||||||||
Cost | [3],[6] | 210 | ||||||||||||||||
Fair Value | [3],[6] | $ 210 | ||||||||||||||||
1st Lien/Senior Secured Debt | Spotless Brands, LLC | Diversified Consumer Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[22] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Spotless Brands, LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[6],[24] | Jul. 25, 2028 | Jul. 25, 2028 | Jul. 25, 2028 | Jul. 25, 2028 | |||||||||||||
Par (++) | [3],[6],[7],[24] | $ 33 | ||||||||||||||||
Fair Value | [3],[6],[24] | $ (1) | ||||||||||||||||
1st Lien/Senior Secured Debt | Spotless Brands, LLC | Diversified Consumer Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[22],[24] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | StarCompliance Intermediate, LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.48% | [3],[5],[6],[22] | 7.75% | [1],[23] | 11.48% | [3],[5],[6],[22] | 11.48% | [3],[5],[6],[22] | 11.48% | [3],[5],[6],[22] | 7.75% | [1],[23] | 7.75% | [1],[23] | 7.75% | [1],[23] | ||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Jan. 12, 2027 | [3],[5],[6] | Jan. 12, 2027 | [1] | Jan. 12, 2027 | [3],[5],[6] | Jan. 12, 2027 | [3],[5],[6] | Jan. 12, 2027 | [3],[5],[6] | Jan. 12, 2027 | [1] | Jan. 12, 2027 | [1] | Jan. 12, 2027 | [1] | ||
Par (++) | $ 15,600 | [3],[5],[6],[7] | $ 15,600 | [1],[13] | ||||||||||||||
Cost | 15,374 | [3],[5],[6] | 15,329 | [1] | ||||||||||||||
Fair Value | $ 15,366 | [3],[5],[6] | $ 15,366 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | StarCompliance Intermediate, LLC | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[23] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[23] | 6.75% | [1],[23] | 6.75% | [1],[23] | ||
1st Lien/Senior Secured Debt | StarCompliance Intermediate, LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.48% | [3],[5],[6],[22] | 7.75% | [1],[23] | 11.48% | [3],[5],[6],[22] | 11.48% | [3],[5],[6],[22] | 11.48% | [3],[5],[6],[22] | 7.75% | [1],[23] | 7.75% | [1],[23] | 7.75% | [1],[23] | ||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Jan. 12, 2027 | [3],[5],[6] | Jan. 12, 2027 | [1] | Jan. 12, 2027 | [3],[5],[6] | Jan. 12, 2027 | [3],[5],[6] | Jan. 12, 2027 | [3],[5],[6] | Jan. 12, 2027 | [1] | Jan. 12, 2027 | [1] | Jan. 12, 2027 | [1] | ||
Par (++) | $ 2,514 | [3],[5],[6],[7] | $ 2,514 | [1],[13] | ||||||||||||||
Cost | 2,473 | [3],[5],[6] | 2,465 | [1] | ||||||||||||||
Fair Value | $ 2,476 | [3],[5],[6] | $ 2,476 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | StarCompliance Intermediate, LLC | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[23] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[23] | 6.75% | [1],[23] | 6.75% | [1],[23] | ||
1st Lien/Senior Secured Debt | StarCompliance Intermediate, LLC | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 11.14% | 11.14% | 11.14% | 11.14% | |||||||||||||
Floor (+) | [1],[11],[23],[25] | 1% | ||||||||||||||||
Maturity | Jan. 12, 2027 | [3],[5],[6],[24] | Jan. 12, 2027 | [1],[11],[25] | Jan. 12, 2027 | [3],[5],[6],[24] | Jan. 12, 2027 | [3],[5],[6],[24] | Jan. 12, 2027 | [3],[5],[6],[24] | Jan. 12, 2027 | [1],[11],[25] | Jan. 12, 2027 | [1],[11],[25] | Jan. 12, 2027 | [1],[11],[25] | ||
Par (++) | $ 2,500 | [3],[5],[6],[7],[24] | $ 2,500 | [1],[11],[13],[25] | ||||||||||||||
Cost | 591 | [3],[5],[6],[24] | (42) | [1],[11],[25] | ||||||||||||||
Fair Value | $ 587 | [3],[5],[6],[24] | $ (37) | [1],[11],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | StarCompliance Intermediate, LLC | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[23],[25] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[23],[25] | 6.75% | [1],[11],[23],[25] | 6.75% | [1],[11],[23],[25] | ||
1st Lien/Senior Secured Debt | Sundance Group Holdings, Inc. (dba NetDocuments) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.75% | [3],[5],[6],[22] | 7.75% | [1],[11],[23] | 10.75% | [3],[5],[6],[22] | 10.75% | [3],[5],[6],[22] | 10.75% | [3],[5],[6],[22] | 7.75% | [1],[11],[23] | 7.75% | [1],[11],[23] | 7.75% | [1],[11],[23] | ||
Floor (+) | [1],[11],[23] | 1% | ||||||||||||||||
Maturity | Jul. 02, 2027 | [3],[5],[6] | Jul. 02, 2027 | [1],[11] | Jul. 02, 2027 | [3],[5],[6] | Jul. 02, 2027 | [3],[5],[6] | Jul. 02, 2027 | [3],[5],[6] | Jul. 02, 2027 | [1],[11] | Jul. 02, 2027 | [1],[11] | Jul. 02, 2027 | [1],[11] | ||
Par (++) | $ 41,043 | [3],[5],[6],[7] | $ 41,043 | [1],[11],[13] | ||||||||||||||
Cost | 40,538 | [3],[5],[6] | 40,449 | [1],[11] | ||||||||||||||
Fair Value | $ 40,017 | [3],[5],[6] | $ 40,530 | [1],[11] | ||||||||||||||
1st Lien/Senior Secured Debt | Sundance Group Holdings, Inc. (dba NetDocuments) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[23] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Sundance Group Holdings, Inc. (dba NetDocuments) | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | Sundance Group Holdings, Inc. (dba NetDocuments) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.75% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23],[25] | 10.75% | [3],[5],[6],[22] | 10.75% | [3],[5],[6],[22] | 10.75% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23],[25] | 7.75% | [1],[11],[12],[23],[25] | 7.75% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jul. 02, 2027 | [3],[5],[6] | Jul. 02, 2027 | [1],[11],[12],[25] | Jul. 02, 2027 | [3],[5],[6] | Jul. 02, 2027 | [3],[5],[6] | Jul. 02, 2027 | [3],[5],[6] | Jul. 02, 2027 | [1],[11],[12],[25] | Jul. 02, 2027 | [1],[11],[12],[25] | Jul. 02, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 12,313 | [3],[5],[6],[7] | $ 4,925 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 12,121 | [3],[5],[6] | 1,407 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 12,005 | [3],[5],[6] | $ 1,416 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Sundance Group Holdings, Inc. (dba NetDocuments) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Sundance Group Holdings, Inc. (dba NetDocuments) | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | Sundance Group Holdings, Inc. (dba NetDocuments) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jul. 02, 2027 | [3],[5],[6],[24] | Jul. 02, 2027 | [1],[11],[12],[25] | Jul. 02, 2027 | [3],[5],[6],[24] | Jul. 02, 2027 | [3],[5],[6],[24] | Jul. 02, 2027 | [3],[5],[6],[24] | Jul. 02, 2027 | [1],[11],[12],[25] | Jul. 02, 2027 | [1],[11],[12],[25] | Jul. 02, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 4,925 | [3],[5],[6],[7],[24] | $ 12,313 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (58) | [3],[5],[6],[24] | (88) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (123) | [3],[5],[6],[24] | $ (154) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Sundance Group Holdings, Inc. (dba NetDocuments) | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Sundance Group Holdings, Inc. (dba NetDocuments) | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.73% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[12],[23],[25] | 10.73% | [3],[5],[6],[22],[24] | 10.73% | [3],[5],[6],[22],[24] | 10.73% | [3],[5],[6],[22],[24] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Oct. 09, 2026 | [3],[5],[6],[24] | Oct. 09, 2026 | [1],[11],[12],[25] | Oct. 09, 2026 | [3],[5],[6],[24] | Oct. 09, 2026 | [3],[5],[6],[24] | Oct. 09, 2026 | [3],[5],[6],[24] | Oct. 09, 2026 | [1],[11],[12],[25] | Oct. 09, 2026 | [1],[11],[12],[25] | Oct. 09, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 20,533 | [3],[5],[6],[7],[24] | $ 20,622 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 17,480 | [3],[5],[6],[24] | 8,501 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 17,237 | [3],[5],[6],[24] | $ 8,474 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.73% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.73% | [3],[5],[6],[22] | 10.73% | [3],[5],[6],[22] | 10.73% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Oct. 09, 2026 | [3],[5],[6] | Oct. 09, 2026 | [1],[11],[12] | Oct. 09, 2026 | [3],[5],[6] | Oct. 09, 2026 | [3],[5],[6] | Oct. 09, 2026 | [3],[5],[6] | Oct. 09, 2026 | [1],[11],[12] | Oct. 09, 2026 | [1],[11],[12] | Oct. 09, 2026 | [1],[11],[12] | ||
Par (++) | $ 4,034 | [3],[5],[6],[7] | $ 4,076 | [1],[11],[12],[13] | ||||||||||||||
Cost | 3,988 | [3],[5],[6] | 4,025 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 3,953 | [3],[5],[6] | $ 4,035 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.73% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.73% | [3],[5],[6],[22] | 10.73% | [3],[5],[6],[22] | 10.73% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Oct. 09, 2026 | [3],[5],[6] | Oct. 09, 2026 | [1],[11],[12] | Oct. 09, 2026 | [3],[5],[6] | Oct. 09, 2026 | [3],[5],[6] | Oct. 09, 2026 | [3],[5],[6] | Oct. 09, 2026 | [1],[11],[12] | Oct. 09, 2026 | [1],[11],[12] | Oct. 09, 2026 | [1],[11],[12] | ||
Par (++) | $ 339 | [3],[5],[6],[7] | $ 342 | [1],[11],[12],[13] | ||||||||||||||
Cost | 334 | [3],[5],[6] | 336 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 332 | [3],[5],[6] | $ 339 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Oct. 09, 2026 | [3],[5],[6],[24] | Oct. 09, 2026 | [1],[11],[12],[25] | Oct. 09, 2026 | [3],[5],[6],[24] | Oct. 09, 2026 | [3],[5],[6],[24] | Oct. 09, 2026 | [3],[5],[6],[24] | Oct. 09, 2026 | [1],[11],[12],[25] | Oct. 09, 2026 | [1],[11],[12],[25] | Oct. 09, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 374 | [3],[5],[6],[7],[24] | $ 111 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (6) | [3],[5],[6],[24] | (2) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (7) | [3],[5],[6],[24] | $ (1) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Oct. 09, 2026 | Oct. 09, 2026 | Oct. 09, 2026 | Oct. 09, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 4,737 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (85) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (95) | ||||||||||||||||
1st Lien/Senior Secured Debt | Sunstar Insurance Group, LLC | Insurance | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Superman Holdings, LLC (dba Foundation Software) | Construction & Engineering | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.85% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 10.85% | [3],[5],[6],[22] | 10.85% | [3],[5],[6],[22] | 10.85% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Aug. 31, 2027 | [3],[5],[6] | Aug. 31, 2027 | [1],[11],[12] | Aug. 31, 2027 | [3],[5],[6] | Aug. 31, 2027 | [3],[5],[6] | Aug. 31, 2027 | [3],[5],[6] | Aug. 31, 2027 | [1],[11],[12] | Aug. 31, 2027 | [1],[11],[12] | Aug. 31, 2027 | [1],[11],[12] | ||
Par (++) | $ 31,476 | [3],[5],[6],[7] | $ 31,795 | [1],[11],[12],[13] | ||||||||||||||
Cost | 30,938 | [3],[5],[6] | 31,160 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 30,846 | [3],[5],[6] | $ 31,080 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Superman Holdings, LLC (dba Foundation Software) | Construction & Engineering | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.13% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.13% | [3],[5],[6],[22] | 6.13% | [3],[5],[6],[22] | 6.13% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Superman Holdings, LLC (dba Foundation Software) | Construction & Engineering | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.85% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 10.85% | [3],[5],[6],[22] | 10.85% | [3],[5],[6],[22] | 10.85% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Aug. 31, 2027 | [3],[5],[6] | Aug. 31, 2027 | [1],[11],[12] | Aug. 31, 2027 | [3],[5],[6] | Aug. 31, 2027 | [3],[5],[6] | Aug. 31, 2027 | [3],[5],[6] | Aug. 31, 2027 | [1],[11],[12] | Aug. 31, 2027 | [1],[11],[12] | Aug. 31, 2027 | [1],[11],[12] | ||
Par (++) | $ 952 | [3],[5],[6],[7] | $ 962 | [1],[11],[12],[13] | ||||||||||||||
Cost | 920 | [3],[5],[6] | 924 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 933 | [3],[5],[6] | $ 940 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Superman Holdings, LLC (dba Foundation Software) | Construction & Engineering | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.13% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.13% | [3],[5],[6],[22] | 6.13% | [3],[5],[6],[22] | 6.13% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Superman Holdings, LLC (dba Foundation Software) | Construction & Engineering | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Aug. 31, 2026 | [3],[5],[6],[24] | Aug. 31, 2026 | [1],[11],[12],[25] | Aug. 31, 2026 | [3],[5],[6],[24] | Aug. 31, 2026 | [3],[5],[6],[24] | Aug. 31, 2026 | [3],[5],[6],[24] | Aug. 31, 2026 | [1],[11],[12],[25] | Aug. 31, 2026 | [1],[11],[12],[25] | Aug. 31, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 122 | [3],[5],[6],[7],[24] | $ 122 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (2) | [3],[5],[6],[24] | (2) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (2) | [3],[5],[6],[24] | $ (3) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Superman Holdings, LLC (dba Foundation Software) | Construction & Engineering | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 8% | [3],[5],[6],[22],[24] | 6.50% | [1],[11],[12],[23],[25] | 8% | [3],[5],[6],[22],[24] | 8% | [3],[5],[6],[22],[24] | 8% | [3],[5],[6],[22],[24] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | 6.50% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Sweep Purchaser LLC | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [1],[11],[12] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [1],[11],[12] | Nov. 30, 2026 | [1],[11],[12] | Nov. 30, 2026 | [1],[11],[12] | ||
Par (++) | $ 28,107 | [3],[5],[6],[7] | $ 28,393 | [1],[11],[12],[13] | ||||||||||||||
Cost | 27,714 | [3],[5],[6] | 27,911 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 27,615 | [3],[5],[6] | $ 28,109 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Sweep Purchaser LLC | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Sweep Purchaser LLC | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.35% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.35% | [3],[5],[6],[22] | 10.35% | [3],[5],[6],[22] | 10.35% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [1],[11],[12] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [1],[11],[12] | Nov. 30, 2026 | [1],[11],[12] | Nov. 30, 2026 | [1],[11],[12] | ||
Par (++) | $ 8,923 | [3],[5],[6],[7] | $ 9,014 | [1],[11],[12],[13] | ||||||||||||||
Cost | 8,796 | [3],[5],[6] | 8,859 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 8,767 | [3],[5],[6] | $ 8,924 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Sweep Purchaser LLC | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Sweep Purchaser LLC | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.20% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.20% | [3],[5],[6],[22] | 10.20% | [3],[5],[6],[22] | 10.20% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [1],[11],[12] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [1],[11],[12] | Nov. 30, 2026 | [1],[11],[12] | Nov. 30, 2026 | [1],[11],[12] | ||
Par (++) | $ 7,155 | [3],[5],[6],[7] | $ 7,227 | [1],[11],[12],[13] | ||||||||||||||
Cost | 7,049 | [3],[5],[6] | 7,098 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 7,029 | [3],[5],[6] | $ 7,155 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Sweep Purchaser LLC | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | 5.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Sweep Purchaser LLC | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.35% | [3],[5],[6],[22] | 7.61% | [1],[11],[12],[23],[25] | 10.35% | [3],[5],[6],[22] | 10.35% | [3],[5],[6],[22] | 10.35% | [3],[5],[6],[22] | 7.61% | [1],[11],[12],[23],[25] | 7.61% | [1],[11],[12],[23],[25] | 7.61% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [1],[11],[12],[25] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [3],[5],[6] | Nov. 30, 2026 | [1],[11],[12],[25] | Nov. 30, 2026 | [1],[11],[12],[25] | Nov. 30, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 4,970 | [3],[5],[6],[7] | $ 4,541 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 4,887 | [3],[5],[6] | 1,378 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 4,883 | [3],[5],[6] | $ 1,408 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Sweep Purchaser LLC | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Sweep Purchaser LLC | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.14% | 10.14% | 10.14% | 10.14% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Nov. 30, 2026 | [3],[5],[6],[24] | Nov. 30, 2026 | [1],[11],[12],[25] | Nov. 30, 2026 | [3],[5],[6],[24] | Nov. 30, 2026 | [3],[5],[6],[24] | Nov. 30, 2026 | [3],[5],[6],[24] | Nov. 30, 2026 | [1],[11],[12],[25] | Nov. 30, 2026 | [1],[11],[12],[25] | Nov. 30, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 4,541 | [3],[5],[6],[7],[24] | $ 5,018 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 757 | [3],[5],[6],[24] | (50) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 738 | [3],[5],[6],[24] | $ (50) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Sweep Purchaser LLC | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | 5.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Syntellis Performance Solutions L L C Dba Axiom | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.82% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 10.82% | [3],[5],[6],[22] | 10.82% | [3],[5],[6],[22] | 10.82% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Aug. 02, 2027 | [3],[5],[6] | Aug. 02, 2027 | [1],[11],[12] | Aug. 02, 2027 | [3],[5],[6] | Aug. 02, 2027 | [3],[5],[6] | Aug. 02, 2027 | [3],[5],[6] | Aug. 02, 2027 | [1],[11],[12] | Aug. 02, 2027 | [1],[11],[12] | Aug. 02, 2027 | [1],[11],[12] | ||
Par (++) | $ 16,367 | [3],[5],[6],[7] | $ 828 | [1],[11],[12],[13] | ||||||||||||||
Cost | 16,062 | [3],[5],[6] | 790 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 16,040 | [3],[5],[6] | $ 806 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Syntellis Performance Solutions L L C Dba Axiom | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Syntellis Performance Solutions L L C Dba Axiom | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Syntellis Performance Solutions, LLC (dba Axiom) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.82% | 10.82% | 10.82% | 10.82% | |||||||||||||
Maturity | [3],[5],[6] | Aug. 02, 2027 | Aug. 02, 2027 | Aug. 02, 2027 | Aug. 02, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 820 | ||||||||||||||||
Cost | [3],[5],[6] | 787 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 804 | ||||||||||||||||
1st Lien/Senior Secured Debt | Syntellis Performance Solutions, LLC (dba Axiom) | Health Care Technology | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.24% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 10.24% | [3],[5],[6],[22] | 10.24% | [3],[5],[6],[22] | 10.24% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [1],[11],[12] | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [1],[11],[12] | Aug. 15, 2025 | [1],[11],[12] | Aug. 15, 2025 | [1],[11],[12] | ||
Par (++) | $ 26,058 | [3],[5],[6],[7] | $ 26,327 | [1],[11],[12],[13] | ||||||||||||||
Cost | 25,101 | [3],[5],[6] | 25,116 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 25,602 | [3],[5],[6] | $ 25,932 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.91% | [3],[5],[6],[22] | 7.31% | [1],[11],[12],[23],[25] | 9.91% | [3],[5],[6],[22] | 9.91% | [3],[5],[6],[22] | 9.91% | [3],[5],[6],[22] | 7.31% | [1],[11],[12],[23],[25] | 7.31% | [1],[11],[12],[23],[25] | 7.31% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [1],[11],[12],[25] | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [1],[11],[12],[25] | Aug. 15, 2025 | [1],[11],[12],[25] | Aug. 15, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 7,897 | [3],[5],[6],[7] | $ 4,565 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 7,773 | [3],[5],[6] | 1,951 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 7,759 | [3],[5],[6] | $ 1,986 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.41% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23],[25] | 10.41% | [3],[5],[6],[22] | 10.41% | [3],[5],[6],[22] | 10.41% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [1],[11],[12],[25] | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [3],[5],[6] | Aug. 15, 2025 | [1],[11],[12],[25] | Aug. 15, 2025 | [1],[11],[12],[25] | Aug. 15, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 4,689 | [3],[5],[6],[7] | $ 7,921 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 4,621 | [3],[5],[6] | 1,286 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 4,607 | [3],[5],[6] | $ 1,244 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.05% | 10.05% | 10.05% | 10.05% | |||||||||||||
Maturity | [3],[5],[6],[24] | Aug. 15, 2025 | Aug. 15, 2025 | Aug. 15, 2025 | Aug. 15, 2025 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 4,565 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 3,565 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 3,572 | ||||||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.20% | 10.20% | 10.20% | 10.20% | |||||||||||||
Maturity | [3],[5],[6],[24] | Aug. 15, 2025 | Aug. 15, 2025 | Aug. 15, 2025 | Aug. 15, 2025 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 2,120 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 547 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 529 | ||||||||||||||||
1st Lien/Senior Secured Debt | The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Thrasio, LLC | Internet & Direct Marketing Retail | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.17% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 11.17% | [3],[5],[6],[22] | 11.17% | [3],[5],[6],[22] | 11.17% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 18, 2026 | [3],[5],[6] | Dec. 18, 2026 | [1],[11],[12] | Dec. 18, 2026 | [3],[5],[6] | Dec. 18, 2026 | [3],[5],[6] | Dec. 18, 2026 | [3],[5],[6] | Dec. 18, 2026 | [1],[11],[12] | Dec. 18, 2026 | [1],[11],[12] | Dec. 18, 2026 | [1],[11],[12] | ||
Par (++) | $ 39,131 | [3],[5],[6],[7] | $ 39,531 | [1],[11],[12],[13] | ||||||||||||||
Cost | 38,625 | [3],[5],[6] | 38,918 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 36,392 | [3],[5],[6] | $ 39,531 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Thrasio, LLC | Internet & Direct Marketing Retail | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Thrasio, LLC | Internet & Direct Marketing Retail | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 18, 2026 | [3],[5],[6],[24] | Dec. 18, 2026 | [1],[11],[12],[25] | Dec. 18, 2026 | [3],[5],[6],[24] | Dec. 18, 2026 | [3],[5],[6],[24] | Dec. 18, 2026 | [3],[5],[6],[24] | Dec. 18, 2026 | [1],[11],[12],[25] | Dec. 18, 2026 | [1],[11],[12],[25] | Dec. 18, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 14,686 | [3],[5],[6],[7],[24] | $ 14,686 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (56) | [3],[5],[6],[24] | $ (70) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (1,028) | ||||||||||||||||
1st Lien/Senior Secured Debt | Thrasio, LLC | Internet & Direct Marketing Retail | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22],[24] | 7% | [1],[11],[12],[23],[25] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 7% | [3],[5],[6],[22],[24] | 7% | [1],[11],[12],[23],[25] | 7% | [1],[11],[12],[23],[25] | 7% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.32% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 10.32% | [3],[5],[6],[22] | 10.32% | [3],[5],[6],[22] | 10.32% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [1],[11],[12] | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [1],[11],[12] | Jul. 15, 2026 | [1],[11],[12] | Jul. 15, 2026 | [1],[11],[12] | ||
Par (++) | $ 17,015 | [3],[5],[6],[7] | $ 5,057 | [1],[11],[12],[13] | ||||||||||||||
Cost | 16,722 | [3],[5],[6] | 4,963 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 16,674 | [3],[5],[6] | $ 4,956 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.60% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 10.60% | [3],[5],[6],[22] | 10.60% | [3],[5],[6],[22] | 10.60% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [1],[11],[12] | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [1],[11],[12] | Jul. 15, 2026 | [1],[11],[12] | Jul. 15, 2026 | [1],[11],[12] | ||
Par (++) | $ 5,007 | [3],[5],[6],[7] | $ 2,517 | [1],[11],[12],[13] | ||||||||||||||
Cost | 4,931 | [3],[5],[6] | 2,471 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 4,906 | [3],[5],[6] | $ 2,467 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.22% | 10.22% | 10.22% | 10.22% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [1],[11],[12],[25] | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [3],[5],[6] | Jul. 15, 2026 | [1],[11],[12],[25] | Jul. 15, 2026 | [1],[11],[12],[25] | Jul. 15, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 2,492 | [3],[5],[6],[7] | $ 1,270 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 2,455 | [3],[5],[6] | (23) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 2,442 | [3],[5],[6] | $ (25) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.42% | 10.42% | 10.42% | 10.42% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jul. 15, 2026 | Jul. 15, 2026 | Jul. 15, 2026 | Jul. 15, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 10,394 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 1,104 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 992 | ||||||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Jul. 15, 2026 | Jul. 15, 2026 | Jul. 15, 2026 | Jul. 15, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 1,270 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (18) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (25) | ||||||||||||||||
1st Lien/Senior Secured Debt | Total Vision LLC | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Senior Secured Debt | Trader Corporation | Automobiles | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[6],[22] | 11.40% | 11.40% | 11.40% | 11.40% | |||||||||||||
Maturity | [3],[6] | Dec. 21, 2029 | Dec. 21, 2029 | Dec. 21, 2029 | Dec. 21, 2029 | |||||||||||||
Par (++) | [3],[6],[7] | $ 317 | ||||||||||||||||
Cost | [3],[6] | 229 | ||||||||||||||||
Fair Value | [3],[6] | $ 228 | ||||||||||||||||
1st Lien/Senior Secured Debt | Trader Corporation | Automobiles | C | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[22] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Trader Corporation | Automobiles | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[6],[24] | Dec. 22, 2028 | Dec. 22, 2028 | Dec. 22, 2028 | Dec. 22, 2028 | |||||||||||||
Par (++) | [3],[6],[7],[24] | $ 24 | ||||||||||||||||
1st Lien/Senior Secured Debt | Trader Corporation | Automobiles | C | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[6],[22],[24] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Senior Secured Debt | Tronair Parent Inc. | Air Freight & Logistics | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.84% | [3],[6],[22] | 7.25% | [1],[23] | 10.84% | [3],[6],[22] | 10.84% | [3],[6],[22] | 10.84% | [3],[6],[22] | 7.25% | [1],[23] | 7.25% | [1],[23] | 7.25% | [1],[23] | ||
Reference Rate and Spread (+), PIK | 0.50% | [3],[6],[22] | 0.50% | [1],[23] | 0.50% | [3],[6],[22] | 0.50% | [3],[6],[22] | 0.50% | [3],[6],[22] | 0.50% | [1],[23] | 0.50% | [1],[23] | 0.50% | [1],[23] | ||
Floor (+) | [1],[23] | 1% | ||||||||||||||||
Maturity | Sep. 08, 2023 | [3],[6] | Sep. 08, 2023 | [1] | Sep. 08, 2023 | [3],[6] | Sep. 08, 2023 | [3],[6] | Sep. 08, 2023 | [3],[6] | Sep. 08, 2023 | [1] | Sep. 08, 2023 | [1] | Sep. 08, 2023 | [1] | ||
Par (++) | $ 6,255 | [3],[6],[7] | $ 6,382 | [1],[13] | ||||||||||||||
Cost | 6,237 | [3],[6] | 6,338 | [1] | ||||||||||||||
Fair Value | $ 5,874 | [3],[6] | $ 5,651 | [1] | ||||||||||||||
1st Lien/Senior Secured Debt | Tronair Parent Inc. | Air Freight & Logistics | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[6],[22] | 6.25% | [1],[23] | 6.25% | [3],[6],[22] | 6.25% | [3],[6],[22] | 6.25% | [3],[6],[22] | 6.25% | [1],[23] | 6.25% | [1],[23] | 6.25% | [1],[23] | ||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [1],[11],[12] | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [1],[11],[12] | Dec. 21, 2026 | [1],[11],[12] | Dec. 21, 2026 | [1],[11],[12] | ||
Par (++) | $ 21,652 | [3],[5],[6],[7] | $ 21,873 | [1],[11],[12],[13] | ||||||||||||||
Cost | 21,346 | [3],[5],[6] | 21,499 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 21,003 | [3],[5],[6] | $ 21,654 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23],[25] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [1],[11],[12],[23],[25] | 6.25% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [1],[11],[12],[25] | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [1],[11],[12],[25] | Dec. 21, 2026 | [1],[11],[12],[25] | Dec. 21, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 7,526 | [3],[5],[6],[7] | $ 7,596 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 7,413 | [3],[5],[6] | 6,933 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 7,300 | [3],[5],[6] | $ 6,950 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.45% | 10.45% | 10.45% | 10.45% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 21, 2026 | [3],[5],[6],[24] | Dec. 21, 2026 | [1],[11],[12],[25] | Dec. 21, 2026 | [3],[5],[6],[24] | Dec. 21, 2026 | [3],[5],[6],[24] | Dec. 21, 2026 | [3],[5],[6],[24] | Dec. 21, 2026 | [1],[11],[12],[25] | Dec. 21, 2026 | [1],[11],[12],[25] | Dec. 21, 2026 | [1],[11],[12],[25] | ||
Par (++) | $ 9,666 | [3],[5],[6],[7],[24] | $ 3,023 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 4,771 | [3],[5],[6],[24] | (50) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 4,579 | [3],[5],[6],[24] | $ (30) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||||||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.48% | 10.48% | 10.48% | 10.48% | |||||||||||||
Maturity | [3],[5],[6],[24] | Dec. 21, 2026 | Dec. 21, 2026 | Dec. 21, 2026 | Dec. 21, 2026 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 3,023 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 1,900 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 1,850 | ||||||||||||||||
1st Lien/Senior Secured Debt | USN Opco LLC (dba Global Nephrology Solutions) | Health Care Providers & Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | Viant Medical Holdings, Inc. | Health Care Equipment & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.63% | [3],[6],[22] | 7.25% | [1],[12],[23] | 10.63% | [3],[6],[22] | 10.63% | [3],[6],[22] | 10.63% | [3],[6],[22] | 7.25% | [1],[12],[23] | 7.25% | [1],[12],[23] | 7.25% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 02, 2025 | [3],[6] | Jul. 02, 2025 | [1],[12] | Jul. 02, 2025 | [3],[6] | Jul. 02, 2025 | [3],[6] | Jul. 02, 2025 | [3],[6] | Jul. 02, 2025 | [1],[12] | Jul. 02, 2025 | [1],[12] | Jul. 02, 2025 | [1],[12] | ||
Par (++) | $ 31,141 | [3],[6],[7] | $ 31,463 | [1],[12],[13] | ||||||||||||||
Cost | 29,978 | [3],[6] | 29,897 | [1],[12] | ||||||||||||||
Fair Value | $ 29,973 | [3],[6] | $ 31,305 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Viant Medical Holdings, Inc. | Health Care Equipment & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.25% | [3],[6],[22] | 6.25% | [1],[12],[23] | 6.25% | [3],[6],[22] | 6.25% | [3],[6],[22] | 6.25% | [3],[6],[22] | 6.25% | [1],[12],[23] | 6.25% | [1],[12],[23] | 6.25% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | Volt Bidco, Inc. (dba Power Factors) | Independent Power & Renewable Electricity Producers | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.08% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 11.08% | [3],[5],[6],[22] | 11.08% | [3],[5],[6],[22] | 11.08% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Aug. 11, 2027 | [3],[5],[6] | Aug. 11, 2027 | [1],[11],[12] | Aug. 11, 2027 | [3],[5],[6] | Aug. 11, 2027 | [3],[5],[6] | Aug. 11, 2027 | [3],[5],[6] | Aug. 11, 2027 | [1],[11],[12] | Aug. 11, 2027 | [1],[11],[12] | Aug. 11, 2027 | [1],[11],[12] | ||
Par (++) | $ 34,826 | [3],[5],[6],[7] | $ 22,800 | [1],[11],[12],[13] | ||||||||||||||
Cost | 34,236 | [3],[5],[6] | 22,368 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 34,217 | [3],[5],[6] | $ 22,344 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Volt Bidco, Inc. (dba Power Factors) | Independent Power & Renewable Electricity Producers | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Volt Bidco, Inc. (dba Power Factors) | Independent Power & Renewable Electricity Producers | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Volt Bidco, Inc. (dba Power Factors) | Independent Power & Renewable Electricity Producers | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.07% | [3],[5],[6],[22],[24] | 7.50% | [1],[11],[12],[23],[25] | 11.07% | [3],[5],[6],[22],[24] | 11.07% | [3],[5],[6],[22],[24] | 11.07% | [3],[5],[6],[22],[24] | 7.50% | [1],[11],[12],[23],[25] | 7.50% | [1],[11],[12],[23],[25] | 7.50% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Aug. 11, 2027 | [3],[5],[6],[24] | Aug. 11, 2027 | [1],[11],[12],[25] | Aug. 11, 2027 | [3],[5],[6],[24] | Aug. 11, 2027 | [3],[5],[6],[24] | Aug. 11, 2027 | [3],[5],[6],[24] | Aug. 11, 2027 | [1],[11],[12],[25] | Aug. 11, 2027 | [1],[11],[12],[25] | Aug. 11, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 6,297 | [3],[5],[6],[7],[24] | $ 2,618 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 3,370 | [3],[5],[6],[24] | 442 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 3,260 | [3],[5],[6],[24] | $ 390 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Volt Bidco, Inc. (dba Power Factors) | Independent Power & Renewable Electricity Producers | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Volt Bidco, Inc. (dba Power Factors) | Independent Power & Renewable Electricity Producers | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[24] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Volt Bidco, Inc. (dba Power Factors) | Independent Power & Renewable Electricity Producers | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Aug. 11, 2027 | [3],[5],[6],[24] | Aug. 11, 2027 | [1],[11],[12],[25] | Aug. 11, 2027 | [3],[5],[6],[24] | Aug. 11, 2027 | [3],[5],[6],[24] | Aug. 11, 2027 | [3],[5],[6],[24] | Aug. 11, 2027 | [1],[11],[12],[25] | Aug. 11, 2027 | [1],[11],[12],[25] | Aug. 11, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 3,685 | [3],[5],[6],[7],[24] | $ 2,181 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (61) | [3],[5],[6],[24] | (41) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (64) | [3],[5],[6],[24] | $ (44) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Volt Bidco, Inc. (dba Power Factors) | Independent Power & Renewable Electricity Producers | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Volt Bidco, Inc. (dba Power Factors) | Independent Power & Renewable Electricity Producers | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | VRC Companies, LLC (dba Vital Records Control) | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.65% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23] | 10.65% | [3],[5],[6],[22] | 10.65% | [3],[5],[6],[22] | 10.65% | [3],[5],[6],[22] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | 6.25% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Jun. 29, 2027 | [3],[5],[6] | Jun. 29, 2027 | [1],[11],[12] | Jun. 29, 2027 | [3],[5],[6] | Jun. 29, 2027 | [3],[5],[6] | Jun. 29, 2027 | [3],[5],[6] | Jun. 29, 2027 | [1],[11],[12] | Jun. 29, 2027 | [1],[11],[12] | Jun. 29, 2027 | [1],[11],[12] | ||
Par (++) | $ 32,582 | [3],[5],[6],[7] | $ 28,174 | [1],[11],[12],[13] | ||||||||||||||
Cost | 32,197 | [3],[5],[6] | 27,780 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 31,523 | [3],[5],[6] | $ 27,751 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | VRC Companies, LLC (dba Vital Records Control) | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[5],[6],[22] | 5.50% | [1],[11],[12],[23] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.50% | [1],[11],[12],[23] | 5.50% | [1],[11],[12],[23] | 5.50% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | VRC Companies, LLC (dba Vital Records Control) | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23],[25] | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Jun. 29, 2027 | [3],[5],[6],[24] | Jun. 29, 2027 | [1],[11],[12],[25] | Jun. 29, 2027 | [3],[5],[6],[24] | Jun. 29, 2027 | [3],[5],[6],[24] | Jun. 29, 2027 | [3],[5],[6],[24] | Jun. 29, 2027 | [1],[11],[12],[25] | Jun. 29, 2027 | [1],[11],[12],[25] | Jun. 29, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 944 | [3],[5],[6],[7],[24] | $ 4,718 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (11) | [3],[5],[6],[24] | 1,798 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ (31) | [3],[5],[6],[24] | $ 1,792 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | VRC Companies, LLC (dba Vital Records Control) | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | VRC Companies, LLC (dba Vital Records Control) | Commercial Services & Supplies | U.S. Prime Rate | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||||||
1st Lien/Senior Secured Debt | VRC Companies, LLC (dba Vital Records Control) | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Jun. 29, 2027 | Jun. 29, 2027 | Jun. 29, 2027 | Jun. 29, 2027 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 944 | ||||||||||||||||
Cost | [1],[11],[12],[25] | (13) | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ (14) | ||||||||||||||||
1st Lien/Senior Secured Debt | VRC Companies, LLC (dba Vital Records Control) | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | WebPT, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.48% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 11.48% | [3],[5],[6],[22] | 11.48% | [3],[5],[6],[22] | 11.48% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jan. 18, 2028 | [3],[5],[6] | Aug. 28, 2024 | [1],[11],[12] | Jan. 18, 2028 | [3],[5],[6] | Jan. 18, 2028 | [3],[5],[6] | Jan. 18, 2028 | [3],[5],[6] | Aug. 28, 2024 | [1],[11],[12] | Aug. 28, 2024 | [1],[11],[12] | Aug. 28, 2024 | [1],[11],[12] | ||
Par (++) | $ 25,126 | [3],[5],[6],[7] | $ 25,126 | [1],[11],[12],[13] | ||||||||||||||
Cost | 23,621 | [3],[5],[6] | 24,060 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 24,372 | [3],[5],[6] | $ 24,874 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | WebPT, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | 6.75% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | WebPT, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.98% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23],[25] | 10.98% | [3],[5],[6],[22] | 10.98% | [3],[5],[6],[22] | 10.98% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23],[25] | 7.75% | [1],[11],[12],[23],[25] | 7.75% | [1],[11],[12],[23],[25] | ||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jan. 18, 2028 | [3],[5],[6] | Aug. 28, 2024 | [1],[11],[12],[25] | Jan. 18, 2028 | [3],[5],[6] | Jan. 18, 2028 | [3],[5],[6] | Jan. 18, 2028 | [3],[5],[6] | Aug. 28, 2024 | [1],[11],[12],[25] | Aug. 28, 2024 | [1],[11],[12],[25] | Aug. 28, 2024 | [1],[11],[12],[25] | ||
Par (++) | $ 5,534 | [3],[5],[6],[7] | $ 2,617 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 5,461 | [3],[5],[6] | 730 | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 5,368 | [3],[5],[6] | $ 759 | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | WebPT, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [3],[5],[6],[22] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | 6.75% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | WebPT, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 11.26% | 11.26% | 11.26% | 11.26% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jan. 18, 2028 | [3],[5],[6],[24] | Aug. 28, 2024 | [1],[12],[25] | Jan. 18, 2028 | [3],[5],[6],[24] | Jan. 18, 2028 | [3],[5],[6],[24] | Jan. 18, 2028 | [3],[5],[6],[24] | Aug. 28, 2024 | [1],[12],[25] | Aug. 28, 2024 | [1],[12],[25] | Aug. 28, 2024 | [1],[12],[25] | ||
Par (++) | $ 2,617 | [3],[5],[6],[7],[24] | $ 5,534 | [1],[12],[13],[25] | ||||||||||||||
Cost | [3],[5],[6],[24] | 951 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 931 | ||||||||||||||||
1st Lien/Senior Secured Debt | WebPT, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [1],[12],[23],[25] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [1],[12],[23],[25] | 6.75% | [1],[12],[23],[25] | 6.75% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | WebPT, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jan. 18, 2028 | [3],[5],[6],[24] | Aug. 28, 2024 | [1],[12],[25] | Jan. 18, 2028 | [3],[5],[6],[24] | Jan. 18, 2028 | [3],[5],[6],[24] | Jan. 18, 2028 | [3],[5],[6],[24] | Aug. 28, 2024 | [1],[12],[25] | Aug. 28, 2024 | [1],[12],[25] | Aug. 28, 2024 | [1],[12],[25] | ||
Par (++) | $ 2,617 | [3],[5],[6],[7],[24] | $ 2,617 | [1],[12],[13],[25] | ||||||||||||||
Cost | [3],[5],[6],[24] | (17) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (79) | ||||||||||||||||
1st Lien/Senior Secured Debt | WebPT, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [1],[12],[23],[25] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [3],[5],[6],[22],[24] | 6.75% | [1],[12],[23],[25] | 6.75% | [1],[12],[23],[25] | 6.75% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Wellness AcquisitionCo, Inc. (dba SPINS) | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 9.91% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 9.91% | [3],[5],[6],[22] | 9.91% | [3],[5],[6],[22] | 9.91% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jan. 20, 2027 | [3],[5],[6] | Jan. 20, 2027 | [1],[11],[12] | Jan. 20, 2027 | [3],[5],[6] | Jan. 20, 2027 | [3],[5],[6] | Jan. 20, 2027 | [3],[5],[6] | Jan. 20, 2027 | [1],[11],[12] | Jan. 20, 2027 | [1],[11],[12] | Jan. 20, 2027 | [1],[11],[12] | ||
Par (++) | $ 21,778 | [3],[5],[6],[7] | $ 20,000 | [1],[11],[12],[13] | ||||||||||||||
Cost | 21,460 | [3],[5],[6] | 19,653 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 21,452 | [3],[5],[6] | $ 20,000 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Wellness AcquisitionCo, Inc. (dba SPINS) | IT Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[5],[6],[22] | 5.50% | [1],[11],[12],[23] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.50% | [3],[5],[6],[22] | 5.50% | [1],[11],[12],[23] | 5.50% | [1],[11],[12],[23] | 5.50% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Wellness AcquisitionCo, Inc. (dba SPINS) | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jan. 20, 2027 | [3],[5],[6],[24] | Jan. 20, 2027 | [1],[11],[12],[25] | Jan. 20, 2027 | [3],[5],[6],[24] | Jan. 20, 2027 | [3],[5],[6],[24] | Jan. 20, 2027 | [3],[5],[6],[24] | Jan. 20, 2027 | [1],[11],[12],[25] | Jan. 20, 2027 | [1],[11],[12],[25] | Jan. 20, 2027 | [1],[11],[12],[25] | ||
Par (++) | $ 2,600 | [3],[5],[6],[7],[24] | $ 2,600 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | (35) | [3],[5],[6],[24] | $ (44) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (39) | ||||||||||||||||
1st Lien/Senior Secured Debt | Wellness AcquisitionCo, Inc. (dba SPINS) | IT Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [1],[11],[12],[23],[25] | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [3],[5],[6],[22],[24] | 5.50% | [1],[11],[12],[23],[25] | 5.50% | [1],[11],[12],[23],[25] | 5.50% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Wellness AcquisitionCo, Inc. (dba SPINS) | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | [3],[5],[6],[24] | Jan. 20, 2027 | Jan. 20, 2027 | Jan. 20, 2027 | Jan. 20, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 4,000 | ||||||||||||||||
Cost | [3],[5],[6],[24] | (33) | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ (60) | ||||||||||||||||
1st Lien/Senior Secured Debt | Wellness AcquisitionCo, Inc. (dba SPINS) | IT Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
1st Lien/Senior Secured Debt | WhiteWater Holding Company LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 10.48% | 10.48% | 10.48% | 10.48% | |||||||||||||
Maturity | [3],[5],[6] | Dec. 21, 2027 | Dec. 21, 2027 | Dec. 21, 2027 | Dec. 21, 2027 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 17,344 | ||||||||||||||||
Cost | [3],[5],[6] | 17,046 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 16,867 | ||||||||||||||||
1st Lien/Senior Secured Debt | WhiteWater Holding Company LLC | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||||||
1st Lien/Senior Secured Debt | WhiteWater Holding Company LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.50% | [1],[12],[23] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.50% | [1],[12],[23] | 6.50% | [1],[12],[23] | 6.50% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Dec. 21, 2027 | [3],[5],[6] | Dec. 21, 2027 | [1],[12] | Dec. 21, 2027 | [3],[5],[6] | Dec. 21, 2027 | [3],[5],[6] | Dec. 21, 2027 | [3],[5],[6] | Dec. 21, 2027 | [1],[12] | Dec. 21, 2027 | [1],[12] | Dec. 21, 2027 | [1],[12] | ||
Par (++) | $ 5,822 | [3],[5],[6],[7] | $ 17,519 | [1],[12],[13] | ||||||||||||||
Cost | 5,718 | [3],[5],[6] | 17,170 | [1],[12] | ||||||||||||||
Fair Value | $ 5,661 | [3],[5],[6] | $ 17,169 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | WhiteWater Holding Company LLC | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[12],[23] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[12],[23] | 5.75% | [1],[12],[23] | 5.75% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | WhiteWater Holding Company LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.48% | [3],[5],[6],[22] | 6.50% | [1],[12],[23],[25] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 10.48% | [3],[5],[6],[22] | 6.50% | [1],[12],[23],[25] | 6.50% | [1],[12],[23],[25] | 6.50% | [1],[12],[23],[25] | ||
Floor (+) | [1],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Dec. 21, 2027 | [3],[5],[6] | Dec. 21, 2027 | [1],[12],[25] | Dec. 21, 2027 | [3],[5],[6] | Dec. 21, 2027 | [3],[5],[6] | Dec. 21, 2027 | [3],[5],[6] | Dec. 21, 2027 | [1],[12],[25] | Dec. 21, 2027 | [1],[12],[25] | Dec. 21, 2027 | [1],[12],[25] | ||
Par (++) | $ 5,785 | [3],[5],[6],[7] | $ 5,840 | [1],[12],[13],[25] | ||||||||||||||
Cost | 5,686 | [3],[5],[6] | 4,266 | [1],[12],[25] | ||||||||||||||
Fair Value | $ 5,626 | [3],[5],[6] | $ 4,251 | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | WhiteWater Holding Company LLC | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[12],[23],[25] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [3],[5],[6],[22] | 5.75% | [1],[12],[23],[25] | 5.75% | [1],[12],[23],[25] | 5.75% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | WhiteWater Holding Company LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.50% | 10.50% | 10.50% | 10.50% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Dec. 21, 2027 | [3],[5],[6],[24] | Dec. 21, 2027 | [1],[12],[25] | Dec. 21, 2027 | [3],[5],[6],[24] | Dec. 21, 2027 | [3],[5],[6],[24] | Dec. 21, 2027 | [3],[5],[6],[24] | Dec. 21, 2027 | [1],[12],[25] | Dec. 21, 2027 | [1],[12],[25] | Dec. 21, 2027 | [1],[12],[25] | ||
Par (++) | $ 2,340 | [3],[5],[6],[7],[24] | $ 2,340 | [1],[12],[13],[25] | ||||||||||||||
Cost | 780 | [3],[5],[6],[24] | (47) | [1],[12],[25] | ||||||||||||||
Fair Value | $ 755 | [3],[5],[6],[24] | $ (47) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | WhiteWater Holding Company LLC | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[12],[23],[25] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [3],[5],[6],[22],[24] | 5.75% | [1],[12],[23],[25] | 5.75% | [1],[12],[23],[25] | 5.75% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | WhiteWater Holding Company LLC | Diversified Consumer Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 10.54% | 10.54% | 10.54% | 10.54% | |||||||||||||
Floor (+) | [1],[12],[23],[25] | 0.75% | ||||||||||||||||
Maturity | Dec. 21, 2027 | [3],[5],[6],[24] | Dec. 21, 2027 | [1],[12],[25] | Dec. 21, 2027 | [3],[5],[6],[24] | Dec. 21, 2027 | [3],[5],[6],[24] | Dec. 21, 2027 | [3],[5],[6],[24] | Dec. 21, 2027 | [1],[12],[25] | Dec. 21, 2027 | [1],[12],[25] | Dec. 21, 2027 | [1],[12],[25] | ||
Par (++) | $ 2,700 | [3],[5],[6],[7],[24] | $ 5,840 | [1],[12],[13],[25] | ||||||||||||||
Cost | 249 | [3],[5],[6],[24] | (58) | [1],[12],[25] | ||||||||||||||
Fair Value | $ 223 | [3],[5],[6],[24] | $ (117) | [1],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | WhiteWater Holding Company LLC | Diversified Consumer Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 6% | [3],[5],[6],[22],[24] | 5.75% | [1],[12],[23],[25] | 6% | [3],[5],[6],[22],[24] | 6% | [3],[5],[6],[22],[24] | 6% | [3],[5],[6],[22],[24] | 5.75% | [1],[12],[23],[25] | 5.75% | [1],[12],[23],[25] | 5.75% | [1],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Wine.com, LLC | Beverages | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.65% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 11.65% | [3],[5],[6],[22] | 11.65% | [3],[5],[6],[22] | 11.65% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 14, 2024 | [3],[5],[6] | Nov. 14, 2024 | [1],[11],[12] | Nov. 14, 2024 | [3],[5],[6] | Nov. 14, 2024 | [3],[5],[6] | Nov. 14, 2024 | [3],[5],[6] | Nov. 14, 2024 | [1],[11],[12] | Nov. 14, 2024 | [1],[11],[12] | Nov. 14, 2024 | [1],[11],[12] | ||
Par (++) | $ 15,400 | [3],[5],[6],[7] | $ 15,400 | [1],[11],[12],[13] | ||||||||||||||
Cost | 15,419 | [3],[5],[6] | 14,983 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 15,400 | [3],[5],[6] | $ 15,400 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Wine.com, LLC | Beverages | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [3],[5],[6],[22] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | 7% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Wine.com, LLC | Beverages | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12% | [3],[5],[6],[22],[26] | 8% | [1],[11],[12],[23] | 12% | [3],[5],[6],[22],[26] | 12% | [3],[5],[6],[22],[26] | 12% | [3],[5],[6],[22],[26] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[26] | 12% | 12% | 12% | 12% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 14, 2024 | [3],[5],[6],[26] | Nov. 14, 2024 | [1],[11],[12] | Nov. 14, 2024 | [3],[5],[6],[26] | Nov. 14, 2024 | [3],[5],[6],[26] | Nov. 14, 2024 | [3],[5],[6],[26] | Nov. 14, 2024 | [1],[11],[12] | Nov. 14, 2024 | [1],[11],[12] | Nov. 14, 2024 | [1],[11],[12] | ||
Par (++) | $ 5,373 | [3],[5],[6],[7],[26] | $ 3,700 | [1],[11],[12],[13] | ||||||||||||||
Cost | 6,228 | [3],[5],[6],[26] | 3,641 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 8,900 | [3],[5],[6],[26] | $ 3,700 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Wine.com, LLC | Beverages | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Wine.com, LLC | Beverages | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 11.65% | 11.65% | 11.65% | 11.65% | |||||||||||||
Maturity | [3],[5],[6] | Nov. 14, 2024 | Nov. 14, 2024 | Nov. 14, 2024 | Nov. 14, 2024 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 3,700 | ||||||||||||||||
Cost | [3],[5],[6] | 3,703 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 3,700 | ||||||||||||||||
1st Lien/Senior Secured Debt | Wine.com, LLC | Beverages | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Senior Secured Debt | Wine.com, LLC | Beverages | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24],[26] | 12% | 12% | 12% | 12% | |||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[24],[26] | 12% | 12% | 12% | 12% | |||||||||||||
Maturity | [3],[5],[6],[24],[26] | Nov. 14, 2024 | Nov. 14, 2024 | Nov. 14, 2024 | Nov. 14, 2024 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24],[26] | $ 1,541 | ||||||||||||||||
Cost | [3],[5],[6],[24],[26] | 308 | ||||||||||||||||
Fair Value | [3],[5],[6],[24],[26] | $ 1,012 | ||||||||||||||||
1st Lien/Senior Secured Debt | WorkForce Software, LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.46% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 12.46% | [3],[5],[6],[22] | 12.46% | [3],[5],[6],[22] | 12.46% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+), PIK | 3% | [3],[5],[6],[22] | 1% | [1],[11],[12],[23] | 3% | [3],[5],[6],[22] | 3% | [3],[5],[6],[22] | 3% | [3],[5],[6],[22] | 1% | [1],[11],[12],[23] | 1% | [1],[11],[12],[23] | 1% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | ||
Par (++) | $ 22,524 | [3],[5],[6],[7] | $ 21,740 | [1],[11],[12],[13] | ||||||||||||||
Cost | 21,887 | [3],[5],[6] | 20,891 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 22,074 | [3],[5],[6] | $ 21,305 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | WorkForce Software, LLC | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.25% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 7.25% | [3],[5],[6],[22] | 7.25% | [3],[5],[6],[22] | 7.25% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | WorkForce Software, LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.46% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 12.46% | [3],[5],[6],[22] | 12.46% | [3],[5],[6],[22] | 12.46% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
Reference Rate and Spread (+), PIK | 3% | [3],[5],[6],[22] | 1% | [1],[11],[12],[23] | 3% | [3],[5],[6],[22] | 3% | [3],[5],[6],[22] | 3% | [3],[5],[6],[22] | 1% | [1],[11],[12],[23] | 1% | [1],[11],[12],[23] | 1% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | ||
Par (++) | $ 3,177 | [3],[5],[6],[7] | $ 1,894 | [1],[11],[12],[13] | ||||||||||||||
Cost | 3,130 | [3],[5],[6] | 1,864 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 3,113 | [3],[5],[6] | $ 1,856 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | WorkForce Software, LLC | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.25% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 7.25% | [3],[5],[6],[22] | 7.25% | [3],[5],[6],[22] | 7.25% | [3],[5],[6],[22] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | 6.50% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | WorkForce Software, LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 12.46% | 12.46% | 12.46% | 12.46% | |||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22],[27] | 3% | 3% | 3% | 3% | |||||||||||||
Maturity | [3],[5],[6] | Jul. 31, 2025 | Jul. 31, 2025 | Jul. 31, 2025 | Jul. 31, 2025 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 2,335 | ||||||||||||||||
Cost | [3],[5],[6] | 2,295 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 2,288 | ||||||||||||||||
1st Lien/Senior Secured Debt | WorkForce Software, LLC | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||||||
1st Lien/Senior Secured Debt | WorkForce Software, LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24] | 11.71% | 11.71% | 11.71% | 11.71% | |||||||||||||
Maturity | [3],[5],[6],[24] | Jul. 31, 2025 | Jul. 31, 2025 | Jul. 31, 2025 | Jul. 31, 2025 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24] | $ 1,894 | ||||||||||||||||
Cost | [3],[5],[6],[24] | 1,240 | ||||||||||||||||
Fair Value | [3],[5],[6],[24] | $ 1,225 | ||||||||||||||||
1st Lien/Senior Secured Debt | WorkForce Software, LLC | Software | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | WSO2, Inc. | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.80% | [3],[5],[6],[22] | 8.50% | [1],[12],[23] | 11.80% | [3],[5],[6],[22] | 11.80% | [3],[5],[6],[22] | 11.80% | [3],[5],[6],[22] | 8.50% | [1],[12],[23] | 8.50% | [1],[12],[23] | 8.50% | [1],[12],[23] | ||
Reference Rate and Spread (+), PIK | 3% | [3],[5],[6],[22] | 3% | [1],[12],[23] | 3% | [3],[5],[6],[22] | 3% | [3],[5],[6],[22] | 3% | [3],[5],[6],[22] | 3% | [1],[12],[23] | 3% | [1],[12],[23] | 3% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 04, 2026 | [3],[5],[6] | Nov. 04, 2026 | [1],[12] | Nov. 04, 2026 | [3],[5],[6] | Nov. 04, 2026 | [3],[5],[6] | Nov. 04, 2026 | [3],[5],[6] | Nov. 04, 2026 | [1],[12] | Nov. 04, 2026 | [1],[12] | Nov. 04, 2026 | [1],[12] | ||
Par (++) | $ 32,129 | [3],[5],[6],[7] | $ 31,065 | [1],[12],[13] | ||||||||||||||
Cost | 31,634 | [3],[5],[6] | 30,461 | [1],[12] | ||||||||||||||
Fair Value | $ 31,808 | [3],[5],[6] | $ 30,443 | [1],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | WSO2, Inc. | IT Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[12],[23] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[12],[23] | 7.50% | [1],[12],[23] | 7.50% | [1],[12],[23] | ||
1st Lien/Senior Secured Debt | Xactly Corporation | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.99% | [3],[5],[6],[22] | 8.25% | [1],[11],[12],[23] | 11.99% | [3],[5],[6],[22] | 11.99% | [3],[5],[6],[22] | 11.99% | [3],[5],[6],[22] | 8.25% | [1],[11],[12],[23] | 8.25% | [1],[11],[12],[23] | 8.25% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 31, 2023 | [3],[5],[6] | Jul. 31, 2023 | [1],[11],[12] | Jul. 31, 2023 | [3],[5],[6] | Jul. 31, 2023 | [3],[5],[6] | Jul. 31, 2023 | [3],[5],[6] | Jul. 31, 2023 | [1],[11],[12] | Jul. 31, 2023 | [1],[11],[12] | Jul. 31, 2023 | [1],[11],[12] | ||
Par (++) | $ 62,025 | [3],[5],[6],[7] | $ 62,025 | [1],[11],[12],[13] | ||||||||||||||
Cost | 61,459 | [3],[5],[6] | 60,548 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 61,250 | [3],[5],[6] | $ 62,025 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Xactly Corporation | IT Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.25% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 7.25% | [3],[5],[6],[22] | 7.25% | [3],[5],[6],[22] | 7.25% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | 7.25% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Xactly Corporation | IT Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 11.70% | 11.70% | 11.70% | 11.70% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Jul. 31, 2023 | [3],[5],[6] | Jul. 31, 2023 | [1],[11],[12],[25] | Jul. 31, 2023 | [3],[5],[6] | Jul. 31, 2023 | [3],[5],[6] | Jul. 31, 2023 | [3],[5],[6] | Jul. 31, 2023 | [1],[11],[12],[25] | Jul. 31, 2023 | [1],[11],[12],[25] | Jul. 31, 2023 | [1],[11],[12],[25] | ||
Par (++) | $ 3,874 | [3],[5],[6],[7] | $ 3,874 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 3,860 | [3],[5],[6] | $ (38) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | [3],[5],[6] | $ 3,826 | ||||||||||||||||
1st Lien/Senior Secured Debt | Xactly Corporation | IT Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.25% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23],[25] | 7.25% | [3],[5],[6],[22] | 7.25% | [3],[5],[6],[22] | 7.25% | [3],[5],[6],[22] | 7.25% | [1],[11],[12],[23],[25] | 7.25% | [1],[11],[12],[23],[25] | 7.25% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | Zarya Intermediate, LLC (dba iOFFICE) | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.90% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 10.90% | [3],[5],[6],[22] | 10.90% | [3],[5],[6],[22] | 10.90% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 01, 2027 | [3],[5],[6] | Jul. 01, 2027 | [1],[11],[12] | Jul. 01, 2027 | [3],[5],[6] | Jul. 01, 2027 | [3],[5],[6] | Jul. 01, 2027 | [3],[5],[6] | Jul. 01, 2027 | [1],[11],[12] | Jul. 01, 2027 | [1],[11],[12] | Jul. 01, 2027 | [1],[11],[12] | ||
Par (++) | $ 76,666 | [3],[5],[6],[7] | $ 35,480 | [1],[11],[12],[13] | ||||||||||||||
Cost | 76,666 | [3],[5],[6] | 34,818 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 75,899 | [3],[5],[6] | $ 34,859 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Zarya Intermediate, LLC (dba iOFFICE) | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Zarya Intermediate, LLC (dba iOFFICE) | Real Estate Mgmt. & Development | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Zarya Intermediate, LLC (dba iOFFICE) | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Jul. 01, 2027 | [3],[5],[6],[24] | Jul. 01, 2027 | [1],[11],[12] | Jul. 01, 2027 | [3],[5],[6],[24] | Jul. 01, 2027 | [3],[5],[6],[24] | Jul. 01, 2027 | [3],[5],[6],[24] | Jul. 01, 2027 | [1],[11],[12] | Jul. 01, 2027 | [1],[11],[12] | Jul. 01, 2027 | [1],[11],[12] | ||
Par (++) | $ 7,987 | [3],[5],[6],[7],[24] | $ 27,870 | [1],[11],[12],[13] | ||||||||||||||
Cost | [1],[11],[12] | 27,340 | ||||||||||||||||
Fair Value | $ (80) | [3],[5],[6],[24] | $ 27,382 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Zarya Intermediate, LLC (dba iOFFICE) | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Zarya Intermediate, LLC (dba iOFFICE) | Real Estate Mgmt. & Development | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Zarya Intermediate, LLC (dba iOFFICE) | Real Estate Mgmt. & Development | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[25] | Jul. 01, 2027 | Jul. 01, 2027 | Jul. 01, 2027 | Jul. 01, 2027 | |||||||||||||
Par (++) | [1],[11],[12],[13],[25] | $ 6,757 | ||||||||||||||||
Cost | [1],[11],[12],[25] | (125) | ||||||||||||||||
Fair Value | [1],[11],[12],[25] | $ (118) | ||||||||||||||||
1st Lien/Senior Secured Debt | Zarya Intermediate, LLC (dba iOFFICE) | Real Estate Mgmt. & Development | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[25] | 6.50% | 6.50% | 6.50% | 6.50% | |||||||||||||
1st Lien/Senior Secured Debt | Zodiac Intermediate, LLC (dba Zipari) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.42% | [3],[5],[6],[22] | 9% | [1],[11],[12],[23] | 12.42% | [3],[5],[6],[22] | 12.42% | [3],[5],[6],[22] | 12.42% | [3],[5],[6],[22] | 9% | [1],[11],[12],[23] | 9% | [1],[11],[12],[23] | 9% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [1],[11],[12] | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [3],[5],[6] | Dec. 21, 2026 | [1],[11],[12] | Dec. 21, 2026 | [1],[11],[12] | Dec. 21, 2026 | [1],[11],[12] | ||
Par (++) | $ 50,230 | [3],[5],[6],[7] | $ 50,230 | [1],[11],[12],[13] | ||||||||||||||
Cost | 49,161 | [3],[5],[6] | 48,951 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 45,333 | [3],[5],[6] | $ 49,100 | [1],[11],[12] | ||||||||||||||
1st Lien/Senior Secured Debt | Zodiac Intermediate, LLC (dba Zipari) | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 8% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 8% | [3],[5],[6],[22] | 8% | [3],[5],[6],[22] | 8% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | 8% | [1],[11],[12],[23] | ||
1st Lien/Senior Secured Debt | Zodiac Intermediate, LLC (dba Zipari) | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 12.30% | 12.30% | 12.30% | 12.30% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[25] | 1% | ||||||||||||||||
Maturity | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [1],[11],[12],[25] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [3],[5],[6] | Dec. 22, 2025 | [1],[11],[12],[25] | Dec. 22, 2025 | [1],[11],[12],[25] | Dec. 22, 2025 | [1],[11],[12],[25] | ||
Par (++) | $ 7,500 | [3],[5],[6],[7] | $ 7,500 | [1],[11],[12],[13],[25] | ||||||||||||||
Cost | 7,364 | [3],[5],[6] | (179) | [1],[11],[12],[25] | ||||||||||||||
Fair Value | $ 6,769 | [3],[5],[6] | $ (169) | [1],[11],[12],[25] | ||||||||||||||
1st Lien/Senior Secured Debt | Zodiac Intermediate, LLC (dba Zipari) | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 8% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23],[25] | 8% | [3],[5],[6],[22] | 8% | [3],[5],[6],[22] | 8% | [3],[5],[6],[22] | 8% | [1],[11],[12],[23],[25] | 8% | [1],[11],[12],[23],[25] | 8% | [1],[11],[12],[23],[25] | ||
1st Lien/Senior Secured Debt | PPT Management Holdings, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [5],[6],[20],[22] | 8.50% | 8.50% | 8.50% | 8.50% | |||||||||||||
Reference Rate and Spread (+), PIK | [5],[6],[20],[22] | 2.50% | 2.50% | 2.50% | 2.50% | |||||||||||||
Maturity | [5],[6],[20] | Jan. 30, 2023 | Jan. 30, 2023 | Jan. 30, 2023 | Jan. 30, 2023 | |||||||||||||
Par (++) | [5],[6],[7],[20] | $ 6,345 | ||||||||||||||||
Cost | [5],[6],[20] | 5,908 | ||||||||||||||||
Fair Value | [5],[6],[20] | $ 4,521 | ||||||||||||||||
1st Lien/Senior Secured Debt | PPT Management Holdings, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [5],[6],[22],[24] | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||||||
Maturity | [5],[6],[24] | Jan. 30, 2023 | Jan. 30, 2023 | Jan. 30, 2023 | Jan. 30, 2023 | |||||||||||||
Par (++) | [5],[6],[7],[24] | $ 123 | ||||||||||||||||
Fair Value | [5],[6],[24] | (35) | ||||||||||||||||
1st Lien/Last-Out Unitranche | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | 120,253 | [28] | $ 157,768 | [1] | ||||||||||||||
Fair Value | $ 116,230 | [28] | $ 162,532 | [1] | ||||||||||||||
1st Lien/Last-Out Unitranche | EDB Parent, LLC (dba Enterprise DB) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[28] | 11.58% | 11.58% | 11.58% | 11.58% | |||||||||||||
Maturity | [3],[5],[6],[28] | Jul. 07, 2028 | Jul. 07, 2028 | Jul. 07, 2028 | Jul. 07, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[28] | $ 19,504 | ||||||||||||||||
Cost | [3],[5],[6],[28] | 19,008 | ||||||||||||||||
Fair Value | [3],[5],[6],[28] | $ 19,016 | ||||||||||||||||
1st Lien/Last-Out Unitranche | EDB Parent, LLC (dba Enterprise DB) | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[28] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Last-Out Unitranche | EDB Parent, LLC (dba Enterprise DB) | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22],[24],[28] | 11.58% | 11.58% | 11.58% | 11.58% | |||||||||||||
Maturity | [3],[5],[6],[24],[28] | Jul. 07, 2028 | Jul. 07, 2028 | Jul. 07, 2028 | Jul. 07, 2028 | |||||||||||||
Par (++) | [3],[5],[6],[7],[24],[28] | $ 7,591 | ||||||||||||||||
Cost | [3],[5],[6],[24],[28] | 1,075 | ||||||||||||||||
Fair Value | [3],[5],[6],[24],[28] | $ 885 | ||||||||||||||||
1st Lien/Last-Out Unitranche | EDB Parent, LLC (dba Enterprise DB) | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[24],[28] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.84% | [3],[5],[6],[22],[28] | 7% | [1],[11],[12],[23],[29] | 10.84% | [3],[5],[6],[22],[28] | 10.84% | [3],[5],[6],[22],[28] | 10.84% | [3],[5],[6],[22],[28] | 7% | [1],[11],[12],[23],[29] | 7% | [1],[11],[12],[23],[29] | 7% | [1],[11],[12],[23],[29] | ||
Floor (+) | [1],[11],[12],[23],[29] | 1% | ||||||||||||||||
Maturity | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | ||
Par (++) | $ 38,967 | [3],[5],[6],[7],[28] | $ 38,967 | [1],[11],[12],[13],[29] | ||||||||||||||
Cost | 38,028 | [3],[5],[6],[28] | 37,468 | [1],[11],[12],[29] | ||||||||||||||
Fair Value | $ 36,726 | [3],[5],[6],[28] | $ 38,870 | [1],[11],[12],[29] | ||||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[29] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[28] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.19% | [3],[5],[6],[22],[28] | 7.75% | [1],[11],[12],[23],[29] | 11.19% | [3],[5],[6],[22],[28] | 11.19% | [3],[5],[6],[22],[28] | 11.19% | [3],[5],[6],[22],[28] | 7.75% | [1],[11],[12],[23],[29] | 7.75% | [1],[11],[12],[23],[29] | 7.75% | [1],[11],[12],[23],[29] | ||
Floor (+) | [1],[11],[12],[23],[29] | 1% | ||||||||||||||||
Maturity | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | ||
Par (++) | $ 24,750 | [3],[5],[6],[7],[28] | $ 25,000 | [1],[11],[12],[13],[29] | ||||||||||||||
Cost | 24,444 | [3],[5],[6],[28] | 24,554 | [1],[11],[12],[29] | ||||||||||||||
Fair Value | $ 23,141 | [3],[5],[6],[28] | $ 24,563 | [1],[11],[12],[29] | ||||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[29] | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[28] | 7% | 7% | 7% | 7% | |||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10.84% | [3],[5],[6],[22],[28] | 7% | [1],[11],[12],[23],[29] | 10.84% | [3],[5],[6],[22],[28] | 10.84% | [3],[5],[6],[22],[28] | 10.84% | [3],[5],[6],[22],[28] | 7% | [1],[11],[12],[23],[29] | 7% | [1],[11],[12],[23],[29] | 7% | [1],[11],[12],[23],[29] | ||
Floor (+) | [1],[11],[12],[23],[29] | 1% | ||||||||||||||||
Maturity | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | ||
Par (++) | $ 22,863 | [3],[5],[6],[7],[28] | $ 22,863 | [1],[11],[12],[13],[29] | ||||||||||||||
Cost | 22,184 | [3],[5],[6],[28] | 21,758 | [1],[11],[12],[29] | ||||||||||||||
Fair Value | $ 21,549 | [3],[5],[6],[28] | $ 22,806 | [1],[11],[12],[29] | ||||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[29] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [3],[5],[6],[22],[28] | 6% | 6% | 6% | 6% | |||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.39% | [3],[5],[6],[22],[28] | 8% | [1],[11],[12],[23],[29] | 11.39% | [3],[5],[6],[22],[28] | 11.39% | [3],[5],[6],[22],[28] | 11.39% | [3],[5],[6],[22],[28] | 8% | [1],[11],[12],[23],[29] | 8% | [1],[11],[12],[23],[29] | 8% | [1],[11],[12],[23],[29] | ||
Floor (+) | [1],[11],[12],[23],[29] | 1% | ||||||||||||||||
Maturity | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | ||
Par (++) | $ 6,666 | [3],[5],[6],[7],[28] | $ 6,734 | [1],[11],[12],[13],[29] | ||||||||||||||
Cost | 6,580 | [3],[5],[6],[28] | 6,607 | [1],[11],[12],[29] | ||||||||||||||
Fair Value | $ 6,266 | [3],[5],[6],[28] | $ 6,649 | [1],[11],[12],[29] | ||||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[5],[6],[22],[28] | 7% | [1],[11],[12],[23],[29] | 7% | [3],[5],[6],[22],[28] | 7% | [3],[5],[6],[22],[28] | 7% | [3],[5],[6],[22],[28] | 7% | [1],[11],[12],[23],[29] | 7% | [1],[11],[12],[23],[29] | 7% | [1],[11],[12],[23],[29] | ||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.44% | [3],[5],[6],[22],[28] | 9% | [1],[11],[12],[23],[29] | 12.44% | [3],[5],[6],[22],[28] | 12.44% | [3],[5],[6],[22],[28] | 12.44% | [3],[5],[6],[22],[28] | 9% | [1],[11],[12],[23],[29] | 9% | [1],[11],[12],[23],[29] | 9% | [1],[11],[12],[23],[29] | ||
Floor (+) | [1],[11],[12],[23],[29] | 1% | ||||||||||||||||
Maturity | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | ||
Par (++) | $ 5,176 | [3],[5],[6],[7],[28] | $ 5,229 | [1],[11],[12],[13],[29] | ||||||||||||||
Cost | 5,104 | [3],[5],[6],[28] | 5,122 | [1],[11],[12],[29] | ||||||||||||||
Fair Value | $ 4,943 | [3],[5],[6],[28] | $ 5,268 | [1],[11],[12],[29] | ||||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 8% | [3],[5],[6],[22],[28] | 8% | [1],[11],[12],[23],[29] | 8% | [3],[5],[6],[22],[28] | 8% | [3],[5],[6],[22],[28] | 8% | [3],[5],[6],[22],[28] | 8% | [1],[11],[12],[23],[29] | 8% | [1],[11],[12],[23],[29] | 8% | [1],[11],[12],[23],[29] | ||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.44% | [3],[5],[6],[22],[28] | 9% | [1],[11],[12],[23],[29] | 12.44% | [3],[5],[6],[22],[28] | 12.44% | [3],[5],[6],[22],[28] | 12.44% | [3],[5],[6],[22],[28] | 9% | [1],[11],[12],[23],[29] | 9% | [1],[11],[12],[23],[29] | 9% | [1],[11],[12],[23],[29] | ||
Floor (+) | [1],[11],[12],[23],[29] | 1% | ||||||||||||||||
Maturity | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Aug. 31, 2024 | [3],[5],[6],[28] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | Feb. 28, 2024 | [1],[11],[12],[29] | ||
Par (++) | $ 3,878 | [3],[5],[6],[7],[28] | $ 3,918 | [1],[11],[12],[13],[29] | ||||||||||||||
Cost | 3,830 | [3],[5],[6],[28] | 3,849 | [1],[11],[12],[29] | ||||||||||||||
Fair Value | $ 3,704 | [3],[5],[6],[28] | $ 3,947 | [1],[11],[12],[29] | ||||||||||||||
1st Lien/Last-Out Unitranche | Doxim, Inc. | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 8% | [3],[5],[6],[22],[28] | 8% | [1],[11],[12],[23],[29] | 8% | [3],[5],[6],[22],[28] | 8% | [3],[5],[6],[22],[28] | 8% | [3],[5],[6],[22],[28] | 8% | [1],[11],[12],[23],[29] | 8% | [1],[11],[12],[23],[29] | 8% | [1],[11],[12],[23],[29] | ||
1st Lien/Last-Out Unitranche | Smarsh, Inc. | Interactive Media & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23],[29] | 9.25% | 9.25% | 9.25% | 9.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23],[29] | 1% | ||||||||||||||||
Maturity | [1],[11],[12],[29] | Nov. 20, 2025 | Nov. 20, 2025 | Nov. 20, 2025 | Nov. 20, 2025 | |||||||||||||
Par (++) | [1],[11],[12],[13],[29] | $ 60,886 | ||||||||||||||||
Cost | [1],[11],[12],[29] | 58,410 | ||||||||||||||||
Fair Value | [1],[11],[12],[29] | $ 60,429 | ||||||||||||||||
1st Lien/Last-Out Unitranche | Smarsh, Inc. | Interactive Media & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23],[29] | 8.25% | 8.25% | 8.25% | 8.25% | |||||||||||||
2nd Lien/Senior Secured Debt | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | $ 255,354 | $ 295,533 | [1] | |||||||||||||||
Fair Value | $ 174,326 | $ 283,521 | [1] | |||||||||||||||
2nd Lien/Senior Secured Debt | Intelligent Medical Objects, Inc. | Health Care Technology | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 9.50% | 9.50% | 9.50% | 9.50% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | [1],[11],[12] | Dec. 22, 2024 | Dec. 22, 2024 | Dec. 22, 2024 | Dec. 22, 2024 | |||||||||||||
Par (++) | [1],[11],[12],[13] | $ 29,200 | ||||||||||||||||
Cost | [1],[11],[12] | 27,881 | ||||||||||||||||
Fair Value | [1],[11],[12] | $ 28,908 | ||||||||||||||||
2nd Lien/Senior Secured Debt | Intelligent Medical Objects, Inc. | Health Care Technology | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | [1],[11],[12],[23] | 8.50% | 8.50% | 8.50% | 8.50% | |||||||||||||
2nd Lien/Senior Secured Debt | Animal Supply Intermediate, LLC | Distributors | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[17],[23] | 7% | 7% | 7% | 7% | |||||||||||||
Reference Rate and Spread (+), PIK | 7% | [6],[14],[18],[22] | 7% | [1],[11],[17],[23] | 7% | [6],[14],[18],[22] | 7% | [6],[14],[18],[22] | 7% | [6],[14],[18],[22] | 7% | [1],[11],[17],[23] | 7% | [1],[11],[17],[23] | 7% | [1],[11],[17],[23] | ||
Maturity | Nov. 14, 2025 | [5],[6],[14],[20] | Nov. 14, 2025 | [1],[11],[17] | Nov. 14, 2025 | [5],[6],[14],[20] | Nov. 14, 2025 | [5],[6],[14],[20] | Nov. 14, 2025 | [5],[6],[14],[20] | Nov. 14, 2025 | [1],[11],[17] | Nov. 14, 2025 | [1],[11],[17] | Nov. 14, 2025 | [1],[11],[17] | ||
Par (++) | $ 9,756 | [5],[6],[7],[14],[20] | $ 9,092 | [1],[11],[13],[17] | ||||||||||||||
Cost | $ 9,031 | [5],[6],[14],[20] | 8,649 | [1],[11],[17] | ||||||||||||||
Fair Value | [1],[11],[17] | $ 6,569 | ||||||||||||||||
2nd Lien/Senior Secured Debt | Bolttech Mannings, Inc. | Commercial Services & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[19],[23] | 8.17% | 8.17% | 8.17% | 8.17% | |||||||||||||
Maturity | [1],[11],[19] | Nov. 20, 2022 | Nov. 20, 2022 | Nov. 20, 2022 | Nov. 20, 2022 | |||||||||||||
Par (++) | [1],[11],[13],[19] | $ 18,577 | ||||||||||||||||
Cost | [1],[11],[19] | 18,489 | ||||||||||||||||
Fair Value | [1],[11],[19] | $ 17,648 | ||||||||||||||||
2nd Lien/Senior Secured Debt | Bolttech Mannings, Inc. | Commercial Services & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [1],[11],[19],[23] | 8% | 8% | 8% | 8% | |||||||||||||
2nd Lien/Senior Secured Debt | Chase Industries, Inc. (dba Senneca Holdings) | Building Products | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | 10% | [3],[5],[6],[20],[22] | 10% | [1],[11],[12],[21],[23] | 10% | [3],[5],[6],[20],[22] | 10% | [3],[5],[6],[20],[22] | 10% | [3],[5],[6],[20],[22] | 10% | [1],[11],[12],[21],[23] | 10% | [1],[11],[12],[21],[23] | 10% | [1],[11],[12],[21],[23] | ||
Maturity | Nov. 11, 2025 | [3],[5],[6],[20] | Nov. 11, 2025 | [1],[11],[12],[21] | Nov. 11, 2025 | [3],[5],[6],[20] | Nov. 11, 2025 | [3],[5],[6],[20] | Nov. 11, 2025 | [3],[5],[6],[20] | Nov. 11, 2025 | [1],[11],[12],[21] | Nov. 11, 2025 | [1],[11],[12],[21] | Nov. 11, 2025 | [1],[11],[12],[21] | ||
Par (++) | $ 12,150 | [3],[5],[6],[7],[20] | $ 12,150 | [1],[11],[12],[13],[21] | ||||||||||||||
Cost | 9,714 | [3],[5],[6],[20] | 9,714 | [1],[11],[12],[21] | ||||||||||||||
Fair Value | $ 1,701 | [3],[5],[6],[20] | $ 1,701 | [1],[11],[12],[21] | ||||||||||||||
2nd Lien/Senior Secured Debt | Chase Industries, Inc. (dba Senneca Holdings) | Building Products | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [1],[11],[12],[21],[23] | 11% | 11% | 11% | 11% | |||||||||||||
Maturity | May 11, 2026 | [2],[3],[5],[6] | May 11, 2026 | [1],[11],[12],[21] | May 11, 2026 | [2],[3],[5],[6] | May 11, 2026 | [2],[3],[5],[6] | May 11, 2026 | [2],[3],[5],[6] | May 11, 2026 | [1],[11],[12],[21] | May 11, 2026 | [1],[11],[12],[21] | May 11, 2026 | [1],[11],[12],[21] | ||
Par (++) | $ 15,511 | [2],[3],[5],[6],[7] | $ 12,150 | [1],[11],[12],[13],[21] | ||||||||||||||
2nd Lien/Senior Secured Debt | Genesis Acquisition Co. (dba ProCare Software) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.24% | [3],[5],[6],[22] | 7.63% | [1],[11],[12],[23] | 11.24% | [3],[5],[6],[22] | 11.24% | [3],[5],[6],[22] | 11.24% | [3],[5],[6],[22] | 7.63% | [1],[11],[12],[23] | 7.63% | [1],[11],[12],[23] | 7.63% | [1],[11],[12],[23] | ||
Maturity | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | ||
Par (++) | $ 17,000 | [3],[5],[6],[7] | $ 17,000 | [1],[11],[12],[13] | ||||||||||||||
Cost | 16,079 | [3],[5],[6] | 15,796 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 16,448 | [3],[5],[6] | $ 16,660 | [1],[11],[12] | ||||||||||||||
2nd Lien/Senior Secured Debt | Genesis Acquisition Co. (dba ProCare Software) | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
2nd Lien/Senior Secured Debt | Genesis Acquisition Co. (dba ProCare Software) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.24% | [3],[5],[6],[22] | 8.25% | [1],[11],[12],[23] | 11.24% | [3],[5],[6],[22] | 11.24% | [3],[5],[6],[22] | 11.24% | [3],[5],[6],[22] | 8.25% | [1],[11],[12],[23] | 8.25% | [1],[11],[12],[23] | 8.25% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 0.75% | ||||||||||||||||
Maturity | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | ||
Par (++) | $ 13,890 | [3],[5],[6],[7] | $ 13,890 | [1],[11],[12],[13] | ||||||||||||||
Cost | 13,687 | [3],[5],[6] | 13,620 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 13,439 | [3],[5],[6] | $ 13,612 | [1],[11],[12] | ||||||||||||||
2nd Lien/Senior Secured Debt | Genesis Acquisition Co. (dba ProCare Software) | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
2nd Lien/Senior Secured Debt | Genesis Acquisition Co. (dba ProCare Software) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.24% | [3],[5],[6],[22] | 7.70% | [1],[11],[12],[23] | 11.24% | [3],[5],[6],[22] | 11.24% | [3],[5],[6],[22] | 11.24% | [3],[5],[6],[22] | 7.70% | [1],[11],[12],[23] | 7.70% | [1],[11],[12],[23] | 7.70% | [1],[11],[12],[23] | ||
Maturity | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | ||
Par (++) | $ 4,939 | [3],[5],[6],[7] | $ 4,939 | [1],[11],[12],[13] | ||||||||||||||
Cost | 4,824 | [3],[5],[6] | 4,787 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 4,779 | [3],[5],[6] | $ 4,840 | [1],[11],[12] | ||||||||||||||
2nd Lien/Senior Secured Debt | Genesis Acquisition Co. (dba ProCare Software) | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
2nd Lien/Senior Secured Debt | Genesis Acquisition Co. (dba ProCare Software) | Diversified Financial Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.24% | [3],[5],[6],[22] | 7.63% | [1],[11],[12],[23] | 11.24% | [3],[5],[6],[22] | 11.24% | [3],[5],[6],[22] | 11.24% | [3],[5],[6],[22] | 7.63% | [1],[11],[12],[23] | 7.63% | [1],[11],[12],[23] | 7.63% | [1],[11],[12],[23] | ||
Maturity | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [3],[5],[6] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | Jul. 31, 2025 | [1],[11],[12] | ||
Par (++) | $ 4,300 | [3],[5],[6],[7] | $ 4,300 | [1],[11],[12],[13] | ||||||||||||||
Cost | 4,067 | [3],[5],[6] | 3,996 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 4,160 | [3],[5],[6] | $ 4,214 | [1],[11],[12] | ||||||||||||||
2nd Lien/Senior Secured Debt | Genesis Acquisition Co. (dba ProCare Software) | Diversified Financial Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [3],[5],[6],[22] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | 7.50% | [1],[11],[12],[23] | ||
2nd Lien/Senior Secured Debt | IHS Intermediate Inc. (dba Interactive Health Solutions) | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Floor (+) | [1],[11],[21],[23] | 1% | ||||||||||||||||
Maturity | Jul. 20, 2022 | [5],[6],[20],[30] | Jul. 20, 2022 | [1],[11],[21] | Jul. 20, 2022 | [5],[6],[20],[30] | Jul. 20, 2022 | [5],[6],[20],[30] | Jul. 20, 2022 | [5],[6],[20],[30] | Jul. 20, 2022 | [1],[11],[21] | Jul. 20, 2022 | [1],[11],[21] | Jul. 20, 2022 | [1],[11],[21] | ||
Par (++) | $ 10,000 | [5],[6],[7],[20],[30] | $ 10,000 | [1],[11],[13],[21] | ||||||||||||||
Cost | $ 9,902 | [5],[6],[20],[30] | $ 9,902 | [1],[11],[21] | ||||||||||||||
2nd Lien/Senior Secured Debt | IHS Intermediate Inc. (dba Interactive Health Solutions) | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 8.25% | [5],[6],[20],[22],[30] | 8.25% | [1],[11],[21],[23] | 8.25% | [5],[6],[20],[22],[30] | 8.25% | [5],[6],[20],[22],[30] | 8.25% | [5],[6],[20],[22],[30] | 8.25% | [1],[11],[21],[23] | 8.25% | [1],[11],[21],[23] | 8.25% | [1],[11],[21],[23] | ||
2nd Lien/Senior Secured Debt | MPI Engineered Technologies, LLC | Auto Components | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12% | [5],[6],[22] | 12% | [1],[11],[23] | 12% | [5],[6],[22] | 12% | [5],[6],[22] | 12% | [5],[6],[22] | 12% | [1],[11],[23] | 12% | [1],[11],[23] | 12% | [1],[11],[23] | ||
Reference Rate and Spread (+), PIK | [5],[6],[22] | 12% | 12% | 12% | 12% | |||||||||||||
Maturity | Jul. 15, 2025 | [5],[6] | Jul. 15, 2025 | [1],[11] | Jul. 15, 2025 | [5],[6] | Jul. 15, 2025 | [5],[6] | Jul. 15, 2025 | [5],[6] | Jul. 15, 2025 | [1],[11] | Jul. 15, 2025 | [1],[11] | Jul. 15, 2025 | [1],[11] | ||
Par (++) | $ 16,250 | [5],[6],[7] | $ 14,428 | [1],[11],[23] | ||||||||||||||
Cost | 16,250 | [5],[6] | 14,428 | [1],[11] | ||||||||||||||
Fair Value | $ 14,137 | [5],[6] | $ 12,841 | [1],[11] | ||||||||||||||
2nd Lien/Senior Secured Debt | MPI Products LLC | Auto Components | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | Jul. 15, 2025 | [2],[5],[6] | Jul. 15, 2025 | [1],[9],[11] | Jul. 15, 2025 | [2],[5],[6] | Jul. 15, 2025 | [2],[5],[6] | Jul. 15, 2025 | [2],[5],[6] | Jul. 15, 2025 | [1],[9],[11] | Jul. 15, 2025 | [1],[9],[11] | Jul. 15, 2025 | [1],[9],[11] | ||
Par (++) | $ 7,412 | [2],[5],[6],[7] | $ 7,412 | [1],[9],[11],[23] | ||||||||||||||
2nd Lien/Senior Secured Debt | National Spine and Pain Centers, LLC | Health Care Providers & Services | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [1],[11],[12],[23] | 9.25% | 9.25% | 9.25% | 9.25% | |||||||||||||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Dec. 02, 2024 | [3],[5],[6],[20] | Dec. 02, 2024 | [1],[11],[12] | Dec. 02, 2024 | [3],[5],[6],[20] | Dec. 02, 2024 | [3],[5],[6],[20] | Dec. 02, 2024 | [3],[5],[6],[20] | Dec. 02, 2024 | [1],[11],[12] | Dec. 02, 2024 | [1],[11],[12] | Dec. 02, 2024 | [1],[11],[12] | ||
Par (++) | $ 36,589 | [3],[5],[6],[7],[20] | $ 36,500 | [1],[11],[12],[13] | ||||||||||||||
Cost | $ 35,382 | [3],[5],[6],[20] | 35,051 | [1],[11],[12] | ||||||||||||||
Fair Value | [1],[11],[12] | $ 35,588 | ||||||||||||||||
2nd Lien/Senior Secured Debt | National Spine and Pain Centers, LLC | Health Care Providers & Services | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 8.25% | [3],[5],[6],[20],[22] | 8.25% | [1],[11],[12],[23] | 8.25% | [3],[5],[6],[20],[22] | 8.25% | [3],[5],[6],[20],[22] | 8.25% | [3],[5],[6],[20],[22] | 8.25% | [1],[11],[12],[23] | 8.25% | [1],[11],[12],[23] | 8.25% | [1],[11],[12],[23] | ||
2nd Lien/Senior Secured Debt | Odyssey Logistics & Technology Corporation | Road & Rail | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.38% | [3],[6],[22] | 9% | [1],[12],[23] | 12.38% | [3],[6],[22] | 12.38% | [3],[6],[22] | 12.38% | [3],[6],[22] | 9% | [1],[12],[23] | 9% | [1],[12],[23] | 9% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Oct. 12, 2025 | [3],[6] | Oct. 12, 2025 | [1],[12] | Oct. 12, 2025 | [3],[6] | Oct. 12, 2025 | [3],[6] | Oct. 12, 2025 | [3],[6] | Oct. 12, 2025 | [1],[12] | Oct. 12, 2025 | [1],[12] | Oct. 12, 2025 | [1],[12] | ||
Par (++) | $ 45,348 | [3],[6],[7] | $ 45,348 | [1],[12],[13] | ||||||||||||||
Cost | 41,502 | [3],[6] | 40,432 | [1],[12] | ||||||||||||||
Fair Value | $ 41,663 | [3],[6] | $ 43,081 | [1],[12] | ||||||||||||||
2nd Lien/Senior Secured Debt | Odyssey Logistics & Technology Corporation | Road & Rail | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 8% | [3],[6],[22] | 8% | [1],[12],[23] | 8% | [3],[6],[22] | 8% | [3],[6],[22] | 8% | [3],[6],[22] | 8% | [1],[12],[23] | 8% | [1],[12],[23] | 8% | [1],[12],[23] | ||
2nd Lien/Senior Secured Debt | Spectrum Plastics Group, Inc. | Containers & Packaging | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 11.38% | [3],[6],[22] | 8% | [1],[12],[23] | 11.38% | [3],[6],[22] | 11.38% | [3],[6],[22] | 11.38% | [3],[6],[22] | 8% | [1],[12],[23] | 8% | [1],[12],[23] | 8% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Jan. 31, 2026 | [3],[6] | Jan. 31, 2026 | [1],[12] | Jan. 31, 2026 | [3],[6] | Jan. 31, 2026 | [3],[6] | Jan. 31, 2026 | [3],[6] | Jan. 31, 2026 | [1],[12] | Jan. 31, 2026 | [1],[12] | Jan. 31, 2026 | [1],[12] | ||
Par (++) | $ 12,525 | [3],[6],[7] | $ 12,525 | [1],[12],[13] | ||||||||||||||
Cost | 11,602 | [3],[6] | 11,382 | [1],[12] | ||||||||||||||
Fair Value | $ 11,260 | [3],[6] | $ 11,440 | [1],[12] | ||||||||||||||
2nd Lien/Senior Secured Debt | Spectrum Plastics Group, Inc. | Containers & Packaging | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7% | [3],[6],[22] | 7% | [1],[12],[23] | 7% | [3],[6],[22] | 7% | [3],[6],[22] | 7% | [3],[6],[22] | 7% | [1],[12],[23] | 7% | [1],[12],[23] | 7% | [1],[12],[23] | ||
2nd Lien/Senior Secured Debt | YI, LLC (dba Young Innovations) | Health Care Equipment & Supplies | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.13% | [3],[5],[6],[22] | 8.75% | [1],[11],[12],[23] | 12.13% | [3],[5],[6],[22] | 12.13% | [3],[5],[6],[22] | 12.13% | [3],[5],[6],[22] | 8.75% | [1],[11],[12],[23] | 8.75% | [1],[11],[12],[23] | 8.75% | [1],[11],[12],[23] | ||
Floor (+) | [1],[11],[12],[23] | 1% | ||||||||||||||||
Maturity | Nov. 07, 2025 | [3],[5],[6] | Nov. 07, 2025 | [1],[11],[12] | Nov. 07, 2025 | [3],[5],[6] | Nov. 07, 2025 | [3],[5],[6] | Nov. 07, 2025 | [3],[5],[6] | Nov. 07, 2025 | [1],[11],[12] | Nov. 07, 2025 | [1],[11],[12] | Nov. 07, 2025 | [1],[11],[12] | ||
Par (++) | $ 36,844 | [3],[5],[6],[7] | $ 36,844 | [1],[11],[12],[13] | ||||||||||||||
Cost | 34,651 | [3],[5],[6] | 34,056 | [1],[11],[12] | ||||||||||||||
Fair Value | $ 34,909 | [3],[5],[6] | $ 36,199 | [1],[11],[12] | ||||||||||||||
2nd Lien/Senior Secured Debt | YI, LLC (dba Young Innovations) | Health Care Equipment & Supplies | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 7.75% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 7.75% | [3],[5],[6],[22] | 7.75% | [3],[5],[6],[22] | 7.75% | [3],[5],[6],[22] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | 7.75% | [1],[11],[12],[23] | ||
2nd Lien/Senior Secured Debt | Zep Inc. | Chemicals | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 12.98% | [3],[6],[22] | 9.25% | [1],[12],[23] | 12.98% | [3],[6],[22] | 12.98% | [3],[6],[22] | 12.98% | [3],[6],[22] | 9.25% | [1],[12],[23] | 9.25% | [1],[12],[23] | 9.25% | [1],[12],[23] | ||
Floor (+) | [1],[12],[23] | 1% | ||||||||||||||||
Maturity | Aug. 11, 2025 | [3],[6] | Aug. 11, 2025 | [1],[12] | Aug. 11, 2025 | [3],[6] | Aug. 11, 2025 | [3],[6] | Aug. 11, 2025 | [3],[6] | Aug. 11, 2025 | [1],[12] | Aug. 11, 2025 | [1],[12] | Aug. 11, 2025 | [1],[12] | ||
Par (++) | $ 53,049 | [3],[6],[7] | $ 53,049 | [1],[12],[13] | ||||||||||||||
Cost | 48,663 | [3],[6] | 47,350 | [1],[12] | ||||||||||||||
Fair Value | $ 31,830 | [3],[6] | $ 50,220 | [1],[12] | ||||||||||||||
2nd Lien/Senior Secured Debt | Zep Inc. | Chemicals | LIBOR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+) | 8.25% | [3],[6],[22] | 8.25% | [1],[12],[23] | 8.25% | [3],[6],[22] | 8.25% | [3],[6],[22] | 8.25% | [3],[6],[22] | 8.25% | [1],[12],[23] | 8.25% | [1],[12],[23] | 8.25% | [1],[12],[23] | ||
Unsecured Debt | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Cost | $ 8,787 | $ 2,558 | [1] | |||||||||||||||
Fair Value | $ 7,630 | $ 1,733 | [1] | |||||||||||||||
Unsecured Debt | ATX Networks Corp. | Communications Equipment | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | 10% | [6],[14],[22] | 10% | [1],[11],[16],[17],[23] | 10% | [6],[14],[22] | 10% | [6],[14],[22] | 10% | [6],[14],[22] | 10% | [1],[11],[16],[17],[23] | 10% | [1],[11],[16],[17],[23] | 10% | [1],[11],[16],[17],[23] | ||
Reference Rate and Spread (+), PIK | 10% | [5],[6],[8],[14],[22] | 10% | [1],[11],[16],[17],[23] | 10% | [5],[6],[8],[14],[22] | 10% | [5],[6],[8],[14],[22] | 10% | [5],[6],[8],[14],[22] | 10% | [1],[11],[16],[17],[23] | 10% | [1],[11],[16],[17],[23] | 10% | [1],[11],[16],[17],[23] | ||
Maturity | Sep. 01, 2028 | [5],[6],[8],[14] | Sep. 01, 2028 | [1],[11],[16],[17] | Sep. 01, 2028 | [5],[6],[8],[14] | Sep. 01, 2028 | [5],[6],[8],[14] | Sep. 01, 2028 | [5],[6],[8],[14] | Sep. 01, 2028 | [1],[11],[16],[17] | Sep. 01, 2028 | [1],[11],[16],[17] | Sep. 01, 2028 | [1],[11],[16],[17] | ||
Par (++) | $ 1,930 | [5],[6],[7],[8],[14] | $ 1,807 | [1],[11],[13],[16],[17] | ||||||||||||||
Cost | 1,662 | [5],[6],[8],[14] | 1,503 | [1],[11],[16],[17] | ||||||||||||||
Fair Value | $ 1,602 | [5],[6],[8],[14] | $ 1,333 | [1],[11],[16],[17] | ||||||||||||||
Unsecured Debt | CivicPlus LLC | Software | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Interest Rate (+) | [3],[5],[6],[22] | 16.54% | 16.54% | 16.54% | 16.54% | |||||||||||||
Maturity | [3],[5],[6] | Jun. 09, 2034 | Jun. 09, 2034 | Jun. 09, 2034 | Jun. 09, 2034 | |||||||||||||
Par (++) | [3],[5],[6],[7] | $ 6,247 | ||||||||||||||||
Cost | [3],[5],[6] | 6,070 | ||||||||||||||||
Fair Value | [3],[5],[6] | $ 6,028 | ||||||||||||||||
Unsecured Debt | CivicPlus LLC | Software | SOFR | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Reference Rate and Spread (+), PIK | [3],[5],[6],[22] | 11.75% | 11.75% | 11.75% | 11.75% | |||||||||||||
Unsecured Debt | Conergy Asia & ME Pte. LTD. | Construction & Engineering | ||||||||||||||||||
Schedule Of Investments [Line Items] | ||||||||||||||||||
Maturity | Jun. 30, 2023 | [2],[5],[6],[8],[14] | Jun. 30, 2022 | [1],[9],[11],[16],[17] | Jun. 30, 2023 | [2],[5],[6],[8],[14] | Jun. 30, 2023 | [2],[5],[6],[8],[14] | Jun. 30, 2023 | [2],[5],[6],[8],[14] | Jun. 30, 2022 | [1],[9],[11],[16],[17] | Jun. 30, 2022 | [1],[9],[11],[16],[17] | Jun. 30, 2022 | [1],[9],[11],[16],[17] | ||
Par (++) | $ 1,266 | [2],[5],[6],[7],[8],[14] | $ 1,266 | [1],[9],[11],[13],[16],[17] | ||||||||||||||
Cost | $ 1,055 | [2],[5],[6],[8],[14] | 1,055 | [1],[9],[11],[16],[17] | ||||||||||||||
Fair Value | [1],[9],[11],[16],[17] | $ 400 | ||||||||||||||||
[1] Assets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt.” Non-income producing security. Represent co-investments made with the Company’s affiliates in accordance with the terms of the exemptive relief received from the U.S. Securities and Exchange Commission. See Note 3 “Significant Agreements and Related Party Transactions”. Securities exempt from registration under the Securities Act of 1933, and may be deemed to be “restricted securities”. As of December 31, 2022, the aggregate fair value of these securities is $ 78,147 or 5.20 % of the Company's net assets. The initial acquisition dates have been included for such securities . PIK – Payment-In-Kind The fair value of the investment was determined using significant unobservable inputs. See Note 5 “Fair Value Measurement”. ssets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt”. Par amount is presented for debt investments, while the number of shares or units owned is presented for equity investments. Par amount is denominated in U.S. Dollars ("$") unless otherwise noted, Euro ("€"), Great British Pound (“GBP”), or Canadian dollar ("CAD"). The investment is not a qualifying asset under Section 55(a) of the Investment Company Act. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70 % of the Company’s total assets. As of December 31, 2022, the aggregate fair value of these securities is $ 184,642 or 5.14 % of the Company’s total assets. Non-income producing security. Securities exempt from registration under the Securities Act of 1933, and may be deemed to be “restricted securities”. As of December 31, 2021, the aggregate fair value of these securities is $ 84,967 or 5.26 % of the Company's net assets. The initial acquisition dates have been included for such securities. PIK – Payment-In-Kind The fair value of the investment was determined using significant unobservable inputs. See Note 5 “Fair Value Measurement.” epresent co-investments made with the Company’s affiliates in accordance with the terms of the exemptive relief received from the U.S. Securities and Exchange Commission. See Note 3 “Significant Agreements and Related Party Transactions.” Par amount is presented for debt investments, while the number of shares or units owned is presented for equity investments. Par amount is denominated in U.S. Dollars ("$") unless otherwise noted, Euro ("€"), Great British Pound (“GBP”), or Canadian dollar ("CAD"). As defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”), the investment is deemed to be an “affiliated person” of the Company because the Company owns, either directly or indirectly, 5 % or more of the portfolio company’s outstanding voting securities. See Note 3 “Significant Agreements and Related Party Transactions”. The investment is otherwise deemed to be an “affiliated person” of the Company. See Note 3 “Significant Agreements and Related Party Transactions”. The investment is not a qualifying asset under Section 55(a) of the Investment Company Act. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70 % of the Company’s total assets. As of December 31, 2021 the aggregate fair value of these securities is $ 154,694 or 4.36 % of the Company’s total assets. As defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”), the investment is deemed to be an “affiliated person” of the Company because the Company owns, either directly or indirectly, 5 % or more of the portfolio company’s outstanding voting securities. See Note 3 “Significant Agreements and Related Party Transactions.” As defined in the Investment Company Act, the investment is deemed to be a “controlled affiliated person” of the Company because the Company owns, either directly or indirectly, 25 % or more of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company. See Note 3 “Significant Agreements and Related Party Transactions”. As defined in the Investment Company Act, the investment is deemed to be a “controlled affiliated person” of the Company because the Company owns, either directly or indirectly, 25 % or more of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company. See Note 3 “Significant Agreements and Related Party Transactions.” The investment is on non-accrual status. See Note 2 "Significant Accounting Policies". The investment is on non-accrual status. See Note 2 "Significant Accounting Policies." Represents the actual interest rate for partially or fully funded debt in effect as of the reporting date. Certain investments are subject to an interest rate floor. Variable rate loans bear interest at a rate that may be determined by the larger of the floor or the reference to either LIBOR ("L"), SOFR including SOFR adjustment, if any, ("S"), SONIA ("SN"), CDOR ("C") or alternate base rate (commonly based on the U.S. Prime Rate ("P"), unless otherwise noted) at the borrower's option, which reset periodically based on the terms of the credit agreement. L and S loans are typically indexed to 12 month, 6 month, 3 month or 1 month L or S rates. As of December 31, 2022, rates for the 12 month, 6 month, 3 month and 1 month L are 5.48 %, 5.14 %, 4.77 % and 4.39 %, respectively. As of December 31, 2022, 1 month S was 4.06 %, 3 month S was 3.62 %, 3 month SN was 3.43 %, 3 month C was 4.94 %, P was 7.50 % and Canadian Prime rate ("CDN P") was 6.45 %. For investments with multiple reference rates or alternate base rates, the interest rate shown is the weighted average interest rate in effect at December 31, 2022. Represents the actual interest rate for partially or fully funded debt in effect as of the reporting date. Variable rate loans bear interest at a rate that may be determined by the larger of the floor or the reference to either LIBOR ("L"), SOFR ("S") or alternate base rate (commonly based on the U.S. Prime Rate ("P"), unless otherwise noted) at the borrower’s option, which reset periodically based on the terms of the credit agreement. L and S loans are typically indexed to 12 month, 6 month, 3 month, 2 month, 1 month or 1 week L or S rates. As of December 31, 2021, rates for the 12 month, 6 month, 3 month, 2 month, 1 month and 1 week L are 0.58 %, 0.34 %, 0.21 %, 0.15 %, 0.10 % and 0.08 %, respectively. As of December 31, 2021, 3 month S was 0.05 %, P was 3.25 %, and Canadian Prime rate ("CDN P") was 2.45 %. For investments with multiple reference rates or alternate base rates, the interest rate shown is the weighted average interest rate in effect at December 31, 2021. Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. The negative cost, if applicable, is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount on the loan. See Note 8 "Commitments and Contingencies". Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. The negative cost, if applicable, is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount on the loan. See Note 8 "Commitments and Contingencies." The investment includes an exit fee that is receivable upon repayment of the loan. See Note 2 “Significant Accounting Policies. Percentages are based on net assets. In exchange for the greater risk of loss, the “last-out” portion of the Company's unitranche loan investment generally earns a higher interest rate than the “first-out” portions. The “first-out” portion would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last-out” portion. In exchange for the greater risk of loss, the “last-out” portion of the Company's unitranche loan investment generally earns a higher interest rate than the “first- out” portions. The “first-out” portion would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last-out” portion. The investment is subject to Chapter 7 bankruptcy process filed by IHS Intermediate Inc. (dba Interactive Health Solutions). |
Consolidated Schedule of Inve_2
Consolidated Schedule of Investments (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||||
Dec. 31, 2022 | Dec. 31, 2021 | ||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | 233.38% | [1],[2] | 215.46% | [3] | |
Fair Value | $ 3,506,216 | $ 3,478,443 | |||
Investment interest rate description | Represents the actual interest rate for partially or fully funded debt in effect as of the reporting date. Certain investments are subject to an interest rate floor. Variable rate loans bear interest at a rate that may be determined by the larger of the floor or the reference to either LIBOR ("L"), SOFR including SOFR adjustment, if any, ("S"), SONIA ("SN"), CDOR ("C") or alternate base rate (commonly based on the U.S. Prime Rate ("P"), unless otherwise noted) at the borrower's option, which reset periodically based on the terms of the credit agreement. L and S loans are typically indexed to 12 month, 6 month, 3 month or 1 month L or S rates. As of December 31, 2022, rates for the 12 month, 6 month, 3 month and 1 month L are 5.48%, 5.14%, 4.77% and 4.39%, respectively. As of December 31, 2022, 1 month S was 4.06%, 3 month S was 3.62%, 3 month SN was 3.43%, 3 month C was 4.94%, P was 7.50% and Canadian Prime rate ("CDN P") was 6.45%. For investments with multiple reference rates or alternate base rates, the interest rate shown is the weighted average interest rate in effect at December 31, 2022. | Represents the actual interest rate for partially or fully funded debt in effect as of the reporting date. Variable rate loans bear interest at a rate that may be determined by the larger of the floor or the reference to either LIBOR ("L"), SOFR ("S") or alternate base rate (commonly based on the U.S. Prime Rate ("P"), unless otherwise noted) at the borrower’s option, which reset periodically based on the terms of the credit agreement. L and S loans are typically indexed to 12 month, 6 month, 3 month, 2 month, 1 month or 1 week L or S rates. As of December 31, 2021, rates for the 12 month, 6 month, 3 month, 2 month, 1 month and 1 week L are 0.58%, 0.34%, 0.21%, 0.15%, 0.10% and 0.08%, respectively. As of December 31, 2021, 3 month S was 0.05%, P was 3.25%, and Canadian Prime rate ("CDN P") was 2.45%. For investments with multiple reference rates or alternate base rates, the interest rate shown is the weighted average interest rate in effect at December 31, 2021. | |||
Fair value of securities | $ 78,147 | $ 84,967 | |||
Fair value percentage of net assets of company | 5.20% | 5.26% | |||
Fair Value, Recurring | |||||
Schedule Of Investments [Line Items] | |||||
Percentage of not qualifying assets | 5.14% | 4.36% | |||
Fair value of securities | $ 184,642 | $ 154,694 | |||
Affiliated Person | |||||
Schedule Of Investments [Line Items] | |||||
Percentage of outstanding voting securities | 5% | 5% | |||
Percentage of qualifying assets | 70% | 70% | |||
From controlled Affiliated Investments | |||||
Schedule Of Investments [Line Items] | |||||
Percentage of outstanding voting securities | 25% | 25% | |||
12 month LIBOR | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 5.48% | 0.58% | |||
6 month LIBOR | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 5.14% | 0.34% | |||
3 month LIBOR | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 4.77% | 0.21% | |||
2 month LIBOR | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 0.15% | ||||
1 month LIBOR | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 4.39% | 0.10% | |||
1 week LIBOR | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 0.08% | ||||
SONIA | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 3.43% | ||||
1 month SOFR | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 4.06% | ||||
3 month SOFR | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 3.62% | 0.05% | |||
3 month C | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 4.94% | ||||
U.S. Prime Rate | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 7.50% | 3.25% | |||
Canadian Prime Rate | |||||
Schedule Of Investments [Line Items] | |||||
Investment interest rate of percentage | 6.45% | 2.45% | |||
Preferred Stock - 2.82% | |||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | [1],[2] | 2.82% | |||
Common Stock - 2.36% | |||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | [1],[2] | 2.36% | |||
Warrants - 0.04% | |||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | [1],[2] | 0.04% | |||
Preferred Stock - 3.26% | |||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | 3.26% | ||||
Common Stock - 1.91% | |||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | [3] | 1.91% | |||
Warrants - 0.11% | |||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | [3] | 0.11% | |||
1st Lien/Senior Secured Debt | |||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | 208.31% | [1],[2] | 182.44% | ||
1st Lien/Last-Out Unitranche | |||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | 7.74% | [1],[2],[4] | 10.07% | ||
2nd Lien/Senior Secured Debt | |||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | 11.60% | [1],[2] | 17.56% | [3] | |
Unsecured Debt | |||||
Schedule Of Investments [Line Items] | |||||
Investment owned, percent of net assets | 0.51% | [1],[2] | 0.11% | [3] | |
[1] Percentages are based on net assets. ssets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt”. Assets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt.” In exchange for the greater risk of loss, the “last-out” portion of the Company's unitranche loan investment generally earns a higher interest rate than the “first-out” portions. The “first-out” portion would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last-out” portion. |
N-2
N-2 - USD ($) | 3 Months Ended | 12 Months Ended | ||||||||||||||||||||
Feb. 22, 2023 | Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | |
Cover [Abstract] | ||||||||||||||||||||||
Entity Central Index Key | 0001572694 | |||||||||||||||||||||
Amendment Flag | false | |||||||||||||||||||||
Securities Act File Number | 814-00998 | |||||||||||||||||||||
Document Type | 10-K | |||||||||||||||||||||
Entity Registrant Name | Goldman Sachs BDC, Inc. | |||||||||||||||||||||
Entity Address, Address Line One | 200 West Street | |||||||||||||||||||||
Entity Address, City or Town | New York | |||||||||||||||||||||
Entity Address, State or Province | NY | |||||||||||||||||||||
Entity Address, Postal Zip Code | 10282 | |||||||||||||||||||||
City Area Code | 212 | |||||||||||||||||||||
Local Phone Number | 902-0300 | |||||||||||||||||||||
Entity Well-known Seasoned Issuer | Yes | |||||||||||||||||||||
Entity Emerging Growth Company | false | |||||||||||||||||||||
Other Transaction Expenses [Abstract] | ||||||||||||||||||||||
Annual Expenses [Table Text Block] | Fees and Expenses The following table is intended to assist you in understanding the fees and expenses that an investor in our common stock will bear, directly or indirectly, based on the assumptions set forth below. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this Form 10-K contains a reference to our fees or expenses, we will pay such fees and expenses out of our net assets and, consequently, stockholders will indirectly bear such fees or expenses as investors in us. Stockholder transaction expenses (as a percentage of offering price): Sales load (as a percentage of offering price) None (1) Offering expenses (as a percentage of offering price) None (1) Dividend reinvestment plan expenses (3) None (2) Total stockholder transaction expenses (as a percentage of offering price) None Annual expenses (as a percentage of net assets attributable to common stock): (4) Base management fees (5) 2.29 % Incentive fees (6) 0.04 % Interest payments on borrowed funds (7) 5.99 % Other expenses (8) 1.39 % Total annual expenses 9.71 % (1) In the event that the securities are sold to or through underwriters or agents, a corresponding prospectus supplement will disclose the applicable sales load (underwriting discount or commission). (2) The applicable prospectus or prospectus supplement will disclose the estimated amount of offering expenses, the offering price and the offering expenses borne by us as a percentage of the offering price. (3) The expenses of the DRIP are included in “Other expenses.” The plan administrator’s fees will be paid by us. There will be no brokerage charges or other charges to stockholders who participate in the plan except that, if a participant elects by written notice to the plan administrator to have the plan administrator sell part or all of the shares held by the plan administrator in the participant’s account and remit the proceeds to the participant, the plan administrator is authorized to deduct a $15.00 transaction fee plus a $0.12 per share brokerage commission from the proceeds. See “Item 1. Business—Dividend Reinvestment Plan.” (4) “Net assets attributable to common stock” equals average net assets as of December 31, 2022. (5) Our management fee is calculated at (i) an annual rate of 1.00% (0.25% per quarter), of the average value of our gross assets (excluding cash or cash equivalents but including assets purchased with borrowed amounts) at the end of each of the two most recently completed calendar quarters. See “Item 1. Business —Management Agreements—Investment Management Agreement.” The management fee referenced in the table above is based on actual gross amounts incurred during the twelve months ended December 31, 2022. (6) The Incentive Fee payable to our Investment Adviser is based on our performance. It consists of two components, one based on income and the other based on capital gains, that are determined independent of each other, with the result that one component may be payable even if the other is not. For more detailed information about the Incentive Fee, see “Item 1. Business —Management Agreements—Investment Management Agreement.” The Incentive Fee referenced in the table above is based on actual net amounts incurred during the twelve months ended December 31, 2022. (7) Interest payments on borrowed funds represents borrowings under the $360.00 million aggregate principal amount of our 3.75% Notes due 2025 (the “2025 Notes”), and the $500.00 million of our 2.875% Notes due 2026 (the “2026 Notes”). In addition, interest payments on borrowed funds includes our annualized interest expense based on borrowings under the Revolving Credit Facility for the three months ended December 31, 2022, which bore a weighted average interest rate of 3.76%. We may borrow additional funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. We may also issue additional debt securities or preferred stock, subject to our compliance with applicable requirements under the Investment Company Act. (8) “Other expenses” includes overhead expenses, including payments under the administration agreement with our administrator (the “Administration Agreement”), and is based on actual amounts incurred during the twelve months ended December 31, 2022. See “Item 1. Business—Administration Agreement.” Although not reflected above, the Investment Adviser expects to continue to waive a portion of its management fee payable by us in an amount equal to any management fees it earns as an investment adviser for any affiliated money market funds in which we invest. | |||||||||||||||||||||
Management Fees [Percent] | 2.29% | |||||||||||||||||||||
Interest Expenses on Borrowings [Percent] | 5.99% | |||||||||||||||||||||
Incentive Fees [Percent] | 0.04% | |||||||||||||||||||||
Other Annual Expenses [Abstract] | ||||||||||||||||||||||
Other Annual Expenses [Percent] | 1.39% | |||||||||||||||||||||
Total Annual Expenses [Percent] | 9.71% | |||||||||||||||||||||
Expense Example [Table Text Block] | The following example demonstrates the projected dollar amount of total cumulative expenses that would be incurred over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed that our annual operating expenses remain at the lev els set forth in the table above, except for the Incentive Fee based on income. Transaction expenses are not included in the following example. 1 year 3 years 5 years 10 years You would pay the following expenses on a $1,000 common stock investment, assuming a 5% annual return (none of which is subject to the Incentive Fee based on capital gains) 94 270 430 769 You would pay the following expenses on a $1,000 common stock investment, assuming a 5% annual return resulting entirely from net realized capital gains (all of which is subject to the Incentive Fee based on capital gains) 104 299 475 847 | |||||||||||||||||||||
Expense Example, Year 01 | $ 94 | |||||||||||||||||||||
Expense Example, Years 1 to 3 | 270 | |||||||||||||||||||||
Expense Example, Years 1 to 5 | 430 | |||||||||||||||||||||
Expense Example, Years 1 to 10 | $ 769 | |||||||||||||||||||||
Purpose of Fee Table , Note [Text Block] | The foregoing table is to assist you in understanding the various costs and expenses that an investor in our common stock will bear directly or indirectly. While the example assumes, as required by the SEC, a 5% annual return, our performance will vary and may result in a return greater or less than 5%. The Incentive Fee under our Investment Management Agreement, which, assuming a 5% annual return, would either not be payable or would have an insignificant impact on the expense amounts shown above, is not included in the example. The example assumes reinvestment of all distributions at NAV. In addition, while the example assumes reinvestment of all dividends and distributions at NAV, under certain circumstances, reinvestment of dividends and other distributions under our DRIP may occur at a price per share that differs from NAV. See “Item 1. Business—Dividend Reinvestment Plan.” | |||||||||||||||||||||
Financial Highlights [Abstract] | ||||||||||||||||||||||
Senior Securities [Table Text Block] | Senior Securities Information about our senior securities is shown in the following tables as of the end of the last ten fiscal years. The report of our independent registered public accounting firm, PricewaterhouseCoopers LLP, as of December 31, 2022, is included within “Item 8. Consolidated Financial Statements and Supplementary Data." Class and Year Total Amount Outstanding Exclusive of Treasury Securities (1) Asset Coverage (2) Involuntary Liquidating (3) Average Market (4) Revolving Credit Facility (in millions) December 31, 2022 $ 1,161.40 $ 1,740.41 — N/A December 31, 2021 $ 858.72 $ 1,860.46 — N/A December 31, 2020 $ 629.38 $ 1,979.61 — N/A December 31, 2019 $ 618.41 $ 1,869.46 — N/A December 31, 2018 $ 509.42 $ 2,062.21 — N/A December 31, 2017 $ 431.25 $ 2,328.75 — N/A December 31, 2016 $ 387.75 $ 2,323.00 — N/A December 31, 2015 $ 419.00 $ 2,643.56 — N/A December 31, 2014 $ 350.00 $ 2,641.66 — N/A December 31, 2013 $ — N/A — N/A Convertible Notes due 2022 (5) December 31, 2022 $ — N/A — N/A December 31, 2021 $ 155.00 $ 1,860.46 — N/A December 31, 2020 $ 155.00 $ 1,979.61 — N/A December 31, 2019 $ 155.00 $ 1,869.46 — N/A December 31, 2018 $ 155.00 $ 2,062.21 — N/A December 31, 2017 $ 115.00 $ 2,328.75 — N/A December 31, 2016 $ 115.00 $ 2,323.00 — N/A Unsecured Notes due 2025 December 31, 2022 $ 360.00 $ 1,740.41 — N/A December 31, 2021 $ 360.00 $ 1,860.46 — N/A December 31, 2020 $ 360.00 $ 1,979.61 — N/A Unsecured Notes due 2026 December 31, 2022 $ 500.00 $ 1,740.41 — N/A December 31, 2021 $ 500.00 $ 1,860.46 — N/A December 31, 2020 $ 500.00 $ 1,979.61 — N/A Foreign Currency Forward Contracts (6) December 31, 2022 $ 7.75 $ 1,740.41 — N/A December 31, 2021 $ 2.48 $ 1,860.46 — N/A December 31, 2020 $ 4.38 $ 1,979.61 — N/A December 31, 2019 $ 4.23 $ 1,869.46 — N/A December 31, 2018 $ 3.90 $ 2,062.21 — N/A (1) Total amount of each class of senior securities outstanding at the end of the period presented. (2) Asset coverage per unit is the ratio of the carrying value of our total consolidated assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness. As of December 31, 2022, our asset coverage per unit as calculated with respect to its aggregate secured senior securities was $3,040.76. (3) The amount to which such class of senior security would be entitled upon the voluntary liquidation of the issuer in preference to any security junior to it. The “—” in this column indicates that the SEC expressly does not require this information to be disclosed for certain types of senior securities. (4) Not applicable because such senior securities are not registered for public trading. (5) The Convertible Notes due 2022 matured and were fully repaid on April 1, 2022. (6) We enter into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of our investments denominated in foreign currencies. The above table sets forth our net exposure to foreign currency forward contracts. | |||||||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||||||||
Investment Objectives and Practices [Text Block] | The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including first lien debt, unitranche loans, including last-out portions of such loans, and second lien debt, and unsecured debt, including mezzanine debt, as well as through select equity investments. | |||||||||||||||||||||
Risk Factors [Table Text Block] | ITEM 1A. RISK FACTORS Investing in our securities involves certain risks relating to our structure and investment objective. You should carefully consider these risk factors, together with all of the other information included in this report, before you decide whether to make an investment in our securities. The risks set forth below are not the only risks we face, and we may face other risks that we have not yet identified, which we do not currently deem material or which are not yet predictable. If any of the following risks occur, our business, financial condition and results of operations could be materially adversely affected. In such case, our NAV and the trading price of our securities could decline, and you may lose all or part of your investment. Summary Risk Factors Investing in our securities involves a high degree of risk. The following is a summary of certain of the principal risks that should be carefully considered before investing in our securities: • The capital markets are currently in a period of economic uncertainty. Such market conditions have materially and adversely affected debt and equity capital markets, which have had, and may continue to have, a negative impact on our business and operations. • Political, social and economic uncertainty, including uncertainty related to the COVID-19 pandemic and Russia’s military invasion of Ukraine, create and exacerbate risks. • Terrorist attacks, acts of war, global health emergencies or natural disasters may impact the businesses in which we invest and harm our business, operating results and financial condition. • Our operation as a BDC imposes numerous constraints on us and significantly reduces our operating flexibility. If we fail to maintain our status as a BDC, we might be regulated as a registered closed-end investment company, which would subject us to additional regulatory restrictions. We will be subject to corporate-level U.S. federal income tax on all of our income if we are unable to maintain our qualification for tax treatment as a RIC. • Regulations governing our operations as a BDC affect our ability to, and the way in which we, raise additional capital. These constraints may hinder our Investment Adviser’s ability to take advantage of attractive investment opportunities and to achieve our investment objective. • Our ability to enter into transactions with our affiliates is restricted. • Our activities may be limited as a result of potentially being deemed to be controlled by GS Group Inc., a bank holding company. • Commodity Futures Trading Commission (“CFTC”) rules may have a negative impact on us and our Investment Adviser. Our ability to enter into transactions involving derivatives and financial commitment transactions may be limited. • Certain investors are limited in their ability to make significant investments in us. • We depend upon management personnel of our Investment Adviser for our future success. • We operate in a highly competitive market for investment opportunities. • Failures in information systems and cyber incidents may have adverse impacts on us and/or our portfolio companies. • Global economic, political and market conditions may adversely affect our business, financial condition and results of operations, including our revenue growth and profitability. • Our Investment Adviser, its principals, investment professionals and employees and the members of its BDC Investment Committee may have certain conflicts of interest. • Goldman Sachs’s financial and other interests may incentivize our Investment Adviser to favor other Accounts. • Our financial condition and results of operations depend on our Investment Adviser’s ability to manage our future growth effectively. • Our ability to grow depends on our access to adequate capital. • We borrow money, which may magnify the potential for gain or loss and may increase the risk of investing in us. • The Incentive Fee based on income takes into account our past performance, and we may be obligated to pay the Investment Adviser incentive compensation even if we incur a net loss due to a decline in the value of our portfolio. The conflicts of interest faced by the Investment Adviser caused by compensation arrangements with us could result in actions that are not in the best interests of our stockholders. Potential conflicts of interest with other businesses of Goldman Sachs could have a negative impact on our investment returns. • Goldman Sachs has influence, and may continue to exert influence, over our management and affairs and over most votes requiring stockholder approval. • Our Board of Directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval. • We may experience fluctuations in our quarterly results. • Our investments are very risky and highly speculative. • Investing in middle market companies involves a number of significant risks. • We have exposure to credit risk and other risks related to credit investments. • Inflation may adversely affect the business, results of operations and financial condition of our portfolio companies. • We are exposed to risks associated with changes in interest rates, including the current rising interest rate environment. • Many of our portfolio securities do not have a readily available market price, and we value these securities at fair value as determined in good faith in accordance with the Investment Company Act, which valuation is inherently subjective and may not reflect what we may actually realize for the sale of the investment. • The lack of liquidity in our investments may adversely affect our business. • Our portfolio may be focused in a limited number of portfolio companies, which will subject us to a risk of significant loss if any of these companies defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry. • We may not be in a position to exercise control over our portfolio companies or to prevent decisions by management of our portfolio companies that could decrease the value of our investments. • Our failure or inability to make follow-on investments in our portfolio companies could impair the value of our portfolio. • Our portfolio companies may prepay loans, which may reduce stated yields in the future if the capital returned cannot be invested in transactions with equal or greater expected yields. • By originating loans to companies that are experiencing significant financial or business difficulties, we may be exposed to distressed lending risks. • Declines in market prices and liquidity in the corporate debt markets can result in significant net unrealized depreciation of our portfolio, which in turn would affect our results of operations. • Economic recessions or downturns could impair our portfolio companies and harm our operating results. • Our portfolio companies may be highly leveraged. • Investing in our securities involves an above-average degree of risk. • The market price of our securities may fluctuate significantly. • Shares of closed-end investment companies, including BDCs, frequently trade at a discount to their NAV per share. • Certain provisions of our certificate of incorporation and bylaws and the Delaware General Corporation Law (“DGCL”), as well as other aspects of our structure, including the substantial ownership interest of GS Group Inc., could deter takeover attempts and have an adverse impact on the price of our common stock. • Our stockholders will experience dilution in their ownership percentage if they opt out of our DRIP. • Our stockholders that do not opt out of our DRIP should generally expect to have current tax liabilities without receiving cash to pay such liabilities. • Investors may face various tax risks and consequences as a result of their investment in us. • Purchases of our common stock pursuant to any 10b5-1 plan or otherwise may result in the price of our common stock being higher than the price that otherwise might exist in the open market. Purchases of our common stock by us under any 10b5-1 plan or otherwise may result in dilution to our NAV per share. • To the extent OID and PIK interest constitute a portion of our income, we will be exposed to typical risks associated with such income being required to be included in taxable and accounting income prior to receipt of cash representing such income. • Our credit ratings may not reflect all risks of an investment in our debt securities. • Holders of any preferred stock we might issue would have the right to elect members of the board of directors and class voting rights on certain matters. Market Developments and General Business Environment The capital markets are currently in a period of disruption and economic uncertainty. Such market conditions have materially and adversely affected debt and equity capital markets, which have had, and may continue to have, a negative impact on our business and operations. From time to time, capital markets experience periods of disruption and instability. Social and political tensions in the United States and around the world, may contribute to increased market volatility, may have long-term effects on the U.S. and worldwide financial markets, and may cause economic uncertainties or deterioration in the United States and worldwide. The U.S. capital markets have experienced extreme disruption since the global outbreak of COVID-19. Such disruptions have been evidenced by volatility in global stock markets as a result of, among other things, uncertainty regarding the COVID-19 pandemic, the fluctuating price of commodities such as oil, and Russia’s military invasion of Ukraine. Despite remedial actions of the U.S. federal government and foreign governments, these events have contributed to worsening general economic conditions that are materially and adversely impacting broader financial and credit markets and reducing the availability of debt and equity capital for the market as a whole. These and any other unfavorable economic conditions could increase our funding costs and/or limit our access to the capital markets. These conditions could continue for a prolonged period of time or worsen in the future. Significant changes or volatility in the capital markets may negatively affect the valuations of our investments. While most of our investments are not publicly traded, applicable accounting standards require us to assume as part of our valuation process that our investments are sold in a principal market to market participants (even if we plan to hold an investment to maturity). Significant changes in the capital markets may also affect the pace of our investment activity and the potential for liquidity events involving our investments. Our valuations, and particularly valuations of private investments and private companies, are inherently uncertain, fluctuate over short periods of time and are often based on estimates, comparisons and qualitative evaluations of private information that may not reflect the full impact of the COVID-19 pandemic, Russia’s military invasion of Ukraine, and measures taken in response thereto. Any public health emergency, including the COVID-19 pandemic or an outbreak of other existing or new epidemic diseases, or the threat thereof, and the resulting financial and economic market uncertainty could have a significant adverse impact on us and the fair value of our investments and our portfolio companies. Disruptions in economic activity, such as those caused by the COVID-19 pandemic and Russia’s military invasion of Ukraine, have limited and could continue to limit our investment originations, limit our ability to grow, increase our funding costs, and have a material negative impact on our and our portfolio companies’ operating results and the fair values of our debt and equity investments. Additionally, the recent disruption in economic activity caused by the COVID-19 pandemic and Russia’s military invasion of Ukraine has had, and may continue to have, a negative effect on the potential for liquidity events involving our investments. The illiquidity of our investments may make it difficult for us to sell such investments to access capital, if required. As a result, we could realize significantly less than the value at which we have recorded our investments if we were required to sell them to increase our liquidity. An inability on our part to raise incremental capital, and any required sale of all or a portion of our investments as a result, could have a material adverse effect on our business, financial condition or results of operations. Current market conditions may make it difficult to raise equity capital, extend the maturity of or refinance our existing indebtedness or obtain new indebtedness with similar terms and any failure to do so could have a material adverse effect on our business. In addition, market conditions (including inflation, supply chain issues and decreased consumer demand) have adversely impacted, and could in the future have further negative impact on the operations of certain of our portfolio companies. If the financial results of middle-market companies, like those in which we invest, experience deterioration, it could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults. Further deterioration in market conditions may further depress the outlook for those companies. The debt capital available to us in the future, if available at all, may bear a higher interest rate and may be available only on terms and conditions less favorable than those of our existing debt and such debt may need to be incurred in a rising interest rate environment. If we are unable to raise new debt or refinance our existing debt, then our equity investors will not benefit from the potential for increased returns on equity resulting from leverage, and we may be unable to make new commitments or to fund existing commitments to our portfolio companies. Any inability to extend the maturity of or refinance our existing debt, or to obtain new debt, could have a material adverse effect on our business, financial condition or results of operations. Political, social and economic uncertainty, including uncertainty related to the COVID-19 pandemic, and Russia’s military invasion of Ukraine, create and exacerbate risks. Social, political, economic and other conditions and events in the U.S., the United Kingdom, the European Union and China (such as natural disasters, epidemics and pandemics, terrorism, military conflicts and social unrest) may occur that create uncertainty and have significant impacts on issuers, industries, governments and other systems, including the financial markets, to which companies and their investments are exposed. The uncertainties caused by these conditions and events could result in or coincide with, among other things: increased volatility in the financial markets for securities, derivatives, loans, credit and currency; a decrease in the reliability of market prices and difficulty in valuing assets (including portfolio company assets); greater fluctuations in spreads on debt investments and currency exchange rates; increased risk of default (by both government and private obligors and issuers); changes to governmental regulation and supervision of the loan, securities, derivatives and currency markets and market participants; limitations on the activities of investors in the financial markets; and substantial, and in some periods extremely high, rates of inflation, which can last many years and have substantial negative effects on credit and securities markets. While financial markets have rebounded from the significant declines that occurred early in the pandemic and global economic conditions generally improved in 2021, certain of the circumstances that arose or became more pronounced after the onset of the COVID-19 pandemic have persisted, including (i) relatively weak consumer confidence; (ii) ongoing heightened credit risk with regard to industries that have been most severely impacted by the pandemic, including, at times, oil and gas, gaming and lodging, and airlines; (iii) higher cyber security, information security and operational risks; and (iv) interruptions in the supply chain that have adversely affected many businesses and have contributed to higher rates of inflation. For example, the COVID-19 pandemic has created disruptions in supply chains and economic activity and contributed to labor difficulties. Depending on the duration and severity of the pandemic going forward, as well as the effects of the pandemic on consumer and corporate confidence, the conditions noted above could continue for an extended period and other adverse developments may occur or reoccur, including (i) the decline in value and performance of us and our portfolio companies, (ii) the ability of our borrowers to continue to meet loan covenants or repay loans provided by us on a timely basis or at all, which may require us to restructure our investments or write down the value of our investments, (iii) our ability to comply with the covenants and other terms of our debt obligations and to repay such obligations, on a timely basis or at all, (iv) our ability to comply with certain regulatory requirements, such as asset coverage requirements under the Investment Company Act, (v) our ability to maintain our distributions at their current level or to pay them at all, or (vi) our ability to source, manage and divest investments and achieve our investment objectives, all of which could result in significant losses to us. We will also be negatively affected if the operations and effectiveness of any of our portfolio companies (or any of the key personnel or service providers of the foregoing) is compromised or if necessary or beneficial systems and processes are disrupted. Even after the COVID-19 pandemic subsides, the U.S. economy, as well as most other major economies, may experience economic recession, and we anticipate our businesses could be materially and adversely affected by a prolonged recession in the United States and other major global markets. See “— The capital markets are currently in a period of disruption and economic uncertainty. Such market conditions have materially and adversely affected debt and equity capital markets, which have had, and may continue to have, a negative impact on our business and operations .” Disruptions in the capital markets, including disruptions resulting from inflation, a rising interest-rate environment, and uncertainties caused by the COVID-19 pandemic and Russia’s military invasion of Ukraine, have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets, significant write-offs in the financial sector, and re-pricing of credit risk in the broadly syndicated market. These and future market disruptions and/or illiquidity can be expected to have an adverse effect on our business, financial condition, results of operations and cash flows. Unfavorable economic conditions also would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events could limit our investment originations, limit our ability to grow and have a material negative impact on our and our portfolio companies’ operating results and the fair values of our debt and equity investments. In addition, Russia’s invasion of Ukraine in February 2022 and corresponding events have had, and could continue to have, severe adverse effects on regional and global economic markets. Following Russia’s actions, various governments, including the government of the United States, have issued broad-ranging economic sanctions against Russia, including, among other actions, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications, the electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. The duration of hostilities and the vast array of sanctions and related events (including cyber incidents and espionage) cannot be predicted. Those events present material uncertainty and risk with respect to markets globally, which pose potential adverse risks to us and the performance of our investments and operations. Any such market disruptions could affect our portfolio companies’ operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations. Terrorist attacks, acts of war, global health emergencies or natural disasters may impact the businesses in which we invest and harm our business, operating results and financial condition. Terrorist acts, acts of war, global health emergencies or natural disasters may disrupt our operations, as well as the operations of the businesses in which we invest. Such acts have created, and continue to create, economic and political uncertainties and have contributed to global economic instability. See “— Political, social and economic uncertainty, including uncertainty related to the COVID-19 pandemic and Russia’s military invasion of Ukraine, create and exacerbate risks.” Any market disruptions as a result of such acts could affect our portfolio companies’ operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations. Legal and Regulatory Our operation as a BDC imposes numerous constraints on us and significantly reduces our operating flexibility. In addition, if we fail to maintain our status as a BDC, we might be regulated as a registered closed-end investment company, which would subject us to additional regulatory restrictions. The Investment Company Act imposes numerous constraints on the operations of BDCs. For example, BDCs generally are required to invest at least 70% of their total assets primarily in securities of qualifying U.S. private companies or thinly traded public companies, cash, cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less from the time of investment. These constraints may hinder our Investment Adviser’s ability to take advantage of attractive investment opportunities and to achieve our investment objective. Furthermore, any failure to comply with the requirements imposed on BDCs by the Investment Company Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. We may be precluded from investing in what our Investment Adviser believes are attractive investments if such investments are not qualifying assets for purposes of the Investment Company Act. If we do not invest a sufficient portion of our assets in qualifying assets, we will be prohibited from making any additional investment that is not a qualifying asset and could be forced to forgo attractive investment opportunities. Similarly, these rules could prevent us from making follow-on investments in existing portfolio companies (which could result in the dilution of our position). If we fail to maintain our status as a BDC, we might be regulated as a closed-end investment company that is required to register under the Investment Company Act. This would subject us to additional regulatory restrictions and significantly decrease our operating flexibility. In addition, any such failure could cause us to lose our RIC status or cause an event of default under any outstanding indebtedness we might have, which could have a material adverse effect on our business, financial condition or results of operations. We will be subject to U.S. federal income tax at corporate rates (and any applicable U.S. state and local taxes) on all of our income if we are unable to maintain our qualification for tax treatment as a RIC, which would have a material adverse effect on our financial performance. Although we have elected to be treated as a RIC, and we intend to qualify for tax treatment as a RIC annually, we cannot assure you that we will be able to do so. To maintain RIC status and be relieved of U.S. federal income taxes on income and gains distributed to our stockholders, we must meet the annual distribution, source-of-income and quarterly-asset diversification requirements described below. • The annual distribution requirement for a RIC will generally be satisfied if we distribute to our stockholders on an annual basis at least 90% of our investment company taxable income (generally, our net ordinary income plus the excess of our realized net short-term capital gains over realized net long-term capital losses, determined without regard to the dividends paid deduction) for each taxable year (the “Annual Distribution Requirement”). Because we use debt financing, we are subject to an asset coverage ratio requirement under the Investment Company Act, and we are subject to certain covenants contained in our credit agreements and other debt financing agreements. This asset coverage ratio requirement and these covenants could, under certain circumstances, restrict us from making distributions to our stockholders that are necessary for us to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, and thus are unable to make sufficient distributions to our stockholders, we could fail to maintain our qualification for RIC tax treatment and thus become subject to corporate-level U.S. federal income tax (and any applicable U.S. state and local taxes). • The source-of-income requirement will be satisfied if at least 90% of our gross income for each year is derived from dividends, interest, gains from the sale of stock or securities or foreign currencies, payments with respect to loans of certain securities, net income derived from an interest in a “qualified publicly traded partnership” or other income derived with respect to our business of investing in such stock or securities or foreign currencies. • The asset diversification requirement will be satisfied if, at the end of each quarter of our taxable year, at least 50% of the value of our assets consists of cash, cash equivalents, U.S. government securities, securities of other RICs and other acceptable securities, and no more than 25% of the value of our assets is invested in (i) the securities (other than U.S. government securities or securities of other RICs) of one issuer, (ii) the securities (other than the securities of other RICs) of two or more issuers that are controlled, as determined under applicable Code rules, by us and that are engaged in the same or similar or related trades or businesses or (iii) the securities of certain “qualified publicly traded partnerships.” Failure to meet these requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of our RIC status. Because most of our investments will be made in private companies, and therefore will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses. If we fail to maintain our qualification for tax treatment as a RIC for any reason, and we do not qualify for certain relief provisions under the Code, we would be subject to U.S. federal income tax at corporate rates (and any applicable U.S. state and local taxes). In this event, the resulting taxes and any resulting penalties could substantially reduce our net assets, the amount of our income available for distribution and the amount of our distributions to our stockholders, which would have a material adverse effect on our financial performance. Regulations governing our operations as a BDC affect our ability to, and the way in which we, raise additional capital. These constraints may hinder our Investment Adviser’s ability to take advantage of attractive investment opportunities and to achieve our investment objective. Regulations governing our operation as a BDC affect our ability to raise additional capital, and the ways in which we can do so. Raising additional capital may expose us to risks, including the typical risks associated with leverage, and may result in dilution to our current stockholders. The Investment Company Act limits our ability to borrow amounts or issue debt securities or preferred stock, which we refer to collectively as “senior securities,” to amounts such that our asset coverage ratio, as defined under the Investment Company Act, equals at least 150% immediately after such borrowing or issuance if certain requirements are met, rather than 200%, as previously required and as described below. Consequently, if the value of our assets declines, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when this may be disadvantageous to us and, as a result, our stockholders. The Small Business Credit Availability Act modified the applicable provisions of the Investment Company Act to reduce the required asset coverage ratio applicable to BDCs to 150%, subject to certain approval and disclosure requirements. Under this legislation, BDCs are able to increase their leverage capacity if stockholders approve a proposal to do so. At our 2018 annual meeting of stockholders held on June 15, 2018, our stockholders approved the proposal to apply the modified asset coverage requirements in Section 61(a)(2) of the Investment Company Act to us. We are generally not able to issue and sell our common stock at a price per share below NAV per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current NAV per share of our common stock (i) with the consent of a majority of our common stockholders (and a majority of our common stockholders who are not affiliates of ours), and (ii) if, among other things, a majority of our Independent Directors and a majority of our directors who have no financial interest in the transaction determine that a sale is in the best interests of us and our stockholders. If our common stock trades at a discount to NAV, this restriction could adversely affect our ability to raise capital. We incur significant costs as a result of being subject to the reporting requirements under the Exchange Act. We incur legal, accounting and other expenses, including costs associated with the periodic reporting requirements applicable to a company whose securities are registered under the Exchange Act, as well as additional corporate governance requirements, including requirements under the Sarbanes-Oxley Act, and other rules implemented by the SEC. These requirements may place a strain on our systems and resources. The Exchange Act requires that we file annual, quarterly and current reports with respect to our business and financial condition. The Sarbanes-Oxley Act requires that we maintain effective disclosure controls and procedures and internal control over financial reporting, which requires significant resources and management oversight. See “ Item 1. Business—Compliance with the Sarbanes-Oxley Act .” We have implemented procedures, processes, policies and practices for the purpose of addressing the standards and requirements applicable to public companies. These activities may divert management’s attention from other business concerns, which could have a material adverse effect on our business, financial condition, results of operations and cash flows. We have incurred, and expect to continue to incur, significant annual expenses related to these steps and directors’ and officers’ liability insurance, director fees, reporting requirements of the SEC, transfer agent fees, additional administrative expenses payable to our administrator to compensate it for hiring additional accounting, legal and administrative personnel, increased auditing and legal fees and similar expenses associated with being subject to these reporting requirements. Efforts to comply with Section 404 of the Sarbanes-Oxley Act involve significant expenditures, and noncompliance with Section 404 of the Sarbanes-Oxley Act may adversely affect us and the market price of our securities. We are subject to the Sarbanes-Oxley Act, and the related rules and regulations promulgated by the SEC. Under current SEC rules, | |||||||||||||||||||||
Effects of Leverage [Table Text Block] | The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below. Assumed Return on Our Portfolio (Net of Expenses) (10.00 )% (5.00 )% 0.00 % 5.00 % 10.00 % Corresponding Return to Common Stockholder (1) (28.74 )% (16.76 )% (4.78 )% 7.20 % 19.19 % (1) Based on (i) $3,600.05 million in total assets including debt issuance costs as of December 31, 2022, (ii) $2,021.40 million in outstanding indebtedness as of December 31, 2022, (iii) $1,502.39 million in net assets as of December 31, 2022 and (iv) an annualized average interest rate on our indebtedness, as of December 31, 2022, excluding fees (such as fees on undrawn amounts and amortization of financing costs), of 3.55%. | |||||||||||||||||||||
Share Price [Table Text Block] | The following table sets forth, for each fiscal quarter for the fiscal years ended December 31, 2022, 2021 and 2020, the NAV per share of our common stock, the range of high and low closing sales prices of our common stock, the closing sales price as a premium (discount) to NAV and the dividends or distributions declared by us. On February 22, 2023, the last reported closing sales price of our common stock on the NYSE was $ 15.55 per share, which represented a premium of approximately 6.43 % to the NAV per share reported by us as of December 31, 2022. Closing Sales Price NAV (1) High Low Premium or (Discount) of High Sales Price to NAV (2) Premium or (Discount) of (2) Declared Distribution (3) For the Year Ended December 31, 2022 Fourth Quarter $ 14.61 $ 16.07 $ 13.72 10.0 % ( 6.1 )% $ 0.45 Third Quarter $ 15.02 $ 18.05 $ 14.45 20.2 % ( 3.8 )% $ 0.45 Second Quarter $ 15.53 $ 20.33 $ 16.53 30.9 % 6.4 % $ 0.45 First Quarter $ 15.80 $ 20.59 $ 19.06 30.3 % 20.6 % $ 0.45 For the Year Ended December 31, 2021 Fourth Quarter $ 15.86 $ 19.51 $ 18.49 23.0 % 16.6 % $ 0.45 Third Quarter $ 15.92 $ 19.88 $ 18.35 24.9 % 15.3 % $ 0.45 Second Quarter $ 16.05 $ 20.52 $ 18.90 27.9 % 17.8 % $ 0.45 First Quarter $ 16.00 $ 20.26 $ 17.54 26.6 % 9.6 % $ 0.45 For the Year Ended December 31, 2020 Fourth Quarter $ 15.91 $ 19.57 $ 14.95 23.0 % ( 6.0 )% $ 0.60 (4) Third Quarter $ 15.49 $ 16.35 $ 14.99 5.6 % ( 3.2 )% $ 0.45 Second Quarter $ 15.14 $ 18.09 $ 11.40 19.5 % ( 24.7 )% $ 0.45 First Quarter $ 14.72 $ 22.45 $ 8.38 52.5 % ( 43.1 )% $ 0.45 (1) NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low closing sales prices. The NAVs shown are based on outstanding shares at the end of the relevant quarter. (2) Calculated as the respective high or low closing sales price, less NAV, divided by NAV as of the last day in the relevant quarter. (3) Represents the dividend or distribution declared in the relevant quarter. (4) Consists of a quarterly dividend of $0.45 per share and additional special dividends in aggregate of $0.15 per share, all of which were declared in the fourth quarter of 2020. | |||||||||||||||||||||
Lowest Price or Bid | $ 13.72 | $ 14.45 | $ 16.53 | $ 19.06 | $ 18.49 | $ 18.35 | $ 18.90 | $ 17.54 | $ 14.95 | $ 14.99 | $ 11.40 | $ 8.38 | ||||||||||
Highest Price or Bid | $ 16.07 | $ 18.05 | $ 20.33 | $ 20.59 | $ 19.51 | $ 19.88 | $ 20.52 | $ 20.26 | $ 19.57 | $ 16.35 | $ 18.09 | $ 22.45 | ||||||||||
Highest Price or Bid, Premium (Discount) to NAV [Percent] | 10% | 20.20% | 30.90% | 30.30% | 23% | 24.90% | 27.90% | 26.60% | 23% | 5.60% | 19.50% | 52.50% | ||||||||||
Lowest Price or Bid, Premium (Discount) to NAV [Percent] | (6.10%) | (3.80%) | 6.40% | 20.60% | 16.60% | 15.30% | 17.80% | 9.60% | (6.00%) | (3.20%) | (24.70%) | (43.10%) | ||||||||||
Latest Share Price | $ 15.55 | |||||||||||||||||||||
Latest Premium (Discount) to NAV [Percent] | 6.43% | |||||||||||||||||||||
Market Developments and General Business Environment [Member] | ||||||||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||||||||
Risk [Text Block] | Market Developments and General Business Environment The capital markets are currently in a period of disruption and economic uncertainty. Such market conditions have materially and adversely affected debt and equity capital markets, which have had, and may continue to have, a negative impact on our business and operations. From time to time, capital markets experience periods of disruption and instability. Social and political tensions in the United States and around the world, may contribute to increased market volatility, may have long-term effects on the U.S. and worldwide financial markets, and may cause economic uncertainties or deterioration in the United States and worldwide. The U.S. capital markets have experienced extreme disruption since the global outbreak of COVID-19. Such disruptions have been evidenced by volatility in global stock markets as a result of, among other things, uncertainty regarding the COVID-19 pandemic, the fluctuating price of commodities such as oil, and Russia’s military invasion of Ukraine. Despite remedial actions of the U.S. federal government and foreign governments, these events have contributed to worsening general economic conditions that are materially and adversely impacting broader financial and credit markets and reducing the availability of debt and equity capital for the market as a whole. These and any other unfavorable economic conditions could increase our funding costs and/or limit our access to the capital markets. These conditions could continue for a prolonged period of time or worsen in the future. Significant changes or volatility in the capital markets may negatively affect the valuations of our investments. While most of our investments are not publicly traded, applicable accounting standards require us to assume as part of our valuation process that our investments are sold in a principal market to market participants (even if we plan to hold an investment to maturity). Significant changes in the capital markets may also affect the pace of our investment activity and the potential for liquidity events involving our investments. Our valuations, and particularly valuations of private investments and private companies, are inherently uncertain, fluctuate over short periods of time and are often based on estimates, comparisons and qualitative evaluations of private information that may not reflect the full impact of the COVID-19 pandemic, Russia’s military invasion of Ukraine, and measures taken in response thereto. Any public health emergency, including the COVID-19 pandemic or an outbreak of other existing or new epidemic diseases, or the threat thereof, and the resulting financial and economic market uncertainty could have a significant adverse impact on us and the fair value of our investments and our portfolio companies. Disruptions in economic activity, such as those caused by the COVID-19 pandemic and Russia’s military invasion of Ukraine, have limited and could continue to limit our investment originations, limit our ability to grow, increase our funding costs, and have a material negative impact on our and our portfolio companies’ operating results and the fair values of our debt and equity investments. Additionally, the recent disruption in economic activity caused by the COVID-19 pandemic and Russia’s military invasion of Ukraine has had, and may continue to have, a negative effect on the potential for liquidity events involving our investments. The illiquidity of our investments may make it difficult for us to sell such investments to access capital, if required. As a result, we could realize significantly less than the value at which we have recorded our investments if we were required to sell them to increase our liquidity. An inability on our part to raise incremental capital, and any required sale of all or a portion of our investments as a result, could have a material adverse effect on our business, financial condition or results of operations. Current market conditions may make it difficult to raise equity capital, extend the maturity of or refinance our existing indebtedness or obtain new indebtedness with similar terms and any failure to do so could have a material adverse effect on our business. In addition, market conditions (including inflation, supply chain issues and decreased consumer demand) have adversely impacted, and could in the future have further negative impact on the operations of certain of our portfolio companies. If the financial results of middle-market companies, like those in which we invest, experience deterioration, it could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults. Further deterioration in market conditions may further depress the outlook for those companies. The debt capital available to us in the future, if available at all, may bear a higher interest rate and may be available only on terms and conditions less favorable than those of our existing debt and such debt may need to be incurred in a rising interest rate environment. If we are unable to raise new debt or refinance our existing debt, then our equity investors will not benefit from the potential for increased returns on equity resulting from leverage, and we may be unable to make new commitments or to fund existing commitments to our portfolio companies. Any inability to extend the maturity of or refinance our existing debt, or to obtain new debt, could have a material adverse effect on our business, financial condition or results of operations. Political, social and economic uncertainty, including uncertainty related to the COVID-19 pandemic, and Russia’s military invasion of Ukraine, create and exacerbate risks. Social, political, economic and other conditions and events in the U.S., the United Kingdom, the European Union and China (such as natural disasters, epidemics and pandemics, terrorism, military conflicts and social unrest) may occur that create uncertainty and have significant impacts on issuers, industries, governments and other systems, including the financial markets, to which companies and their investments are exposed. The uncertainties caused by these conditions and events could result in or coincide with, among other things: increased volatility in the financial markets for securities, derivatives, loans, credit and currency; a decrease in the reliability of market prices and difficulty in valuing assets (including portfolio company assets); greater fluctuations in spreads on debt investments and currency exchange rates; increased risk of default (by both government and private obligors and issuers); changes to governmental regulation and supervision of the loan, securities, derivatives and currency markets and market participants; limitations on the activities of investors in the financial markets; and substantial, and in some periods extremely high, rates of inflation, which can last many years and have substantial negative effects on credit and securities markets. While financial markets have rebounded from the significant declines that occurred early in the pandemic and global economic conditions generally improved in 2021, certain of the circumstances that arose or became more pronounced after the onset of the COVID-19 pandemic have persisted, including (i) relatively weak consumer confidence; (ii) ongoing heightened credit risk with regard to industries that have been most severely impacted by the pandemic, including, at times, oil and gas, gaming and lodging, and airlines; (iii) higher cyber security, information security and operational risks; and (iv) interruptions in the supply chain that have adversely affected many businesses and have contributed to higher rates of inflation. For example, the COVID-19 pandemic has created disruptions in supply chains and economic activity and contributed to labor difficulties. Depending on the duration and severity of the pandemic going forward, as well as the effects of the pandemic on consumer and corporate confidence, the conditions noted above could continue for an extended period and other adverse developments may occur or reoccur, including (i) the decline in value and performance of us and our portfolio companies, (ii) the ability of our borrowers to continue to meet loan covenants or repay loans provided by us on a timely basis or at all, which may require us to restructure our investments or write down the value of our investments, (iii) our ability to comply with the covenants and other terms of our debt obligations and to repay such obligations, on a timely basis or at all, (iv) our ability to comply with certain regulatory requirements, such as asset coverage requirements under the Investment Company Act, (v) our ability to maintain our distributions at their current level or to pay them at all, or (vi) our ability to source, manage and divest investments and achieve our investment objectives, all of which could result in significant losses to us. We will also be negatively affected if the operations and effectiveness of any of our portfolio companies (or any of the key personnel or service providers of the foregoing) is compromised or if necessary or beneficial systems and processes are disrupted. Even after the COVID-19 pandemic subsides, the U.S. economy, as well as most other major economies, may experience economic recession, and we anticipate our businesses could be materially and adversely affected by a prolonged recession in the United States and other major global markets. See “— The capital markets are currently in a period of disruption and economic uncertainty. Such market conditions have materially and adversely affected debt and equity capital markets, which have had, and may continue to have, a negative impact on our business and operations .” Disruptions in the capital markets, including disruptions resulting from inflation, a rising interest-rate environment, and uncertainties caused by the COVID-19 pandemic and Russia’s military invasion of Ukraine, have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets, significant write-offs in the financial sector, and re-pricing of credit risk in the broadly syndicated market. These and future market disruptions and/or illiquidity can be expected to have an adverse effect on our business, financial condition, results of operations and cash flows. Unfavorable economic conditions also would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events could limit our investment originations, limit our ability to grow and have a material negative impact on our and our portfolio companies’ operating results and the fair values of our debt and equity investments. In addition, Russia’s invasion of Ukraine in February 2022 and corresponding events have had, and could continue to have, severe adverse effects on regional and global economic markets. Following Russia’s actions, various governments, including the government of the United States, have issued broad-ranging economic sanctions against Russia, including, among other actions, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications, the electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. The duration of hostilities and the vast array of sanctions and related events (including cyber incidents and espionage) cannot be predicted. Those events present material uncertainty and risk with respect to markets globally, which pose potential adverse risks to us and the performance of our investments and operations. Any such market disruptions could affect our portfolio companies’ operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations. Terrorist attacks, acts of war, global health emergencies or natural disasters may impact the businesses in which we invest and harm our business, operating results and financial condition. Terrorist acts, acts of war, global health emergencies or natural disasters may disrupt our operations, as well as the operations of the businesses in which we invest. Such acts have created, and continue to create, economic and political uncertainties and have contributed to global economic instability. See “— Political, social and economic uncertainty, including uncertainty related to the COVID-19 pandemic and Russia’s military invasion of Ukraine, create and exacerbate risks.” Any market disruptions as a result of such acts could affect our portfolio companies’ operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations. | |||||||||||||||||||||
Legal and Regulatory [Member] | ||||||||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||||||||
Risk [Text Block] | Legal and Regulatory Our operation as a BDC imposes numerous constraints on us and significantly reduces our operating flexibility. In addition, if we fail to maintain our status as a BDC, we might be regulated as a registered closed-end investment company, which would subject us to additional regulatory restrictions. The Investment Company Act imposes numerous constraints on the operations of BDCs. For example, BDCs generally are required to invest at least 70% of their total assets primarily in securities of qualifying U.S. private companies or thinly traded public companies, cash, cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less from the time of investment. These constraints may hinder our Investment Adviser’s ability to take advantage of attractive investment opportunities and to achieve our investment objective. Furthermore, any failure to comply with the requirements imposed on BDCs by the Investment Company Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. We may be precluded from investing in what our Investment Adviser believes are attractive investments if such investments are not qualifying assets for purposes of the Investment Company Act. If we do not invest a sufficient portion of our assets in qualifying assets, we will be prohibited from making any additional investment that is not a qualifying asset and could be forced to forgo attractive investment opportunities. Similarly, these rules could prevent us from making follow-on investments in existing portfolio companies (which could result in the dilution of our position). If we fail to maintain our status as a BDC, we might be regulated as a closed-end investment company that is required to register under the Investment Company Act. This would subject us to additional regulatory restrictions and significantly decrease our operating flexibility. In addition, any such failure could cause us to lose our RIC status or cause an event of default under any outstanding indebtedness we might have, which could have a material adverse effect on our business, financial condition or results of operations. We will be subject to U.S. federal income tax at corporate rates (and any applicable U.S. state and local taxes) on all of our income if we are unable to maintain our qualification for tax treatment as a RIC, which would have a material adverse effect on our financial performance. Although we have elected to be treated as a RIC, and we intend to qualify for tax treatment as a RIC annually, we cannot assure you that we will be able to do so. To maintain RIC status and be relieved of U.S. federal income taxes on income and gains distributed to our stockholders, we must meet the annual distribution, source-of-income and quarterly-asset diversification requirements described below. • The annual distribution requirement for a RIC will generally be satisfied if we distribute to our stockholders on an annual basis at least 90% of our investment company taxable income (generally, our net ordinary income plus the excess of our realized net short-term capital gains over realized net long-term capital losses, determined without regard to the dividends paid deduction) for each taxable year (the “Annual Distribution Requirement”). Because we use debt financing, we are subject to an asset coverage ratio requirement under the Investment Company Act, and we are subject to certain covenants contained in our credit agreements and other debt financing agreements. This asset coverage ratio requirement and these covenants could, under certain circumstances, restrict us from making distributions to our stockholders that are necessary for us to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, and thus are unable to make sufficient distributions to our stockholders, we could fail to maintain our qualification for RIC tax treatment and thus become subject to corporate-level U.S. federal income tax (and any applicable U.S. state and local taxes). • The source-of-income requirement will be satisfied if at least 90% of our gross income for each year is derived from dividends, interest, gains from the sale of stock or securities or foreign currencies, payments with respect to loans of certain securities, net income derived from an interest in a “qualified publicly traded partnership” or other income derived with respect to our business of investing in such stock or securities or foreign currencies. • The asset diversification requirement will be satisfied if, at the end of each quarter of our taxable year, at least 50% of the value of our assets consists of cash, cash equivalents, U.S. government securities, securities of other RICs and other acceptable securities, and no more than 25% of the value of our assets is invested in (i) the securities (other than U.S. government securities or securities of other RICs) of one issuer, (ii) the securities (other than the securities of other RICs) of two or more issuers that are controlled, as determined under applicable Code rules, by us and that are engaged in the same or similar or related trades or businesses or (iii) the securities of certain “qualified publicly traded partnerships.” Failure to meet these requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of our RIC status. Because most of our investments will be made in private companies, and therefore will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses. If we fail to maintain our qualification for tax treatment as a RIC for any reason, and we do not qualify for certain relief provisions under the Code, we would be subject to U.S. federal income tax at corporate rates (and any applicable U.S. state and local taxes). In this event, the resulting taxes and any resulting penalties could substantially reduce our net assets, the amount of our income available for distribution and the amount of our distributions to our stockholders, which would have a material adverse effect on our financial performance. Regulations governing our operations as a BDC affect our ability to, and the way in which we, raise additional capital. These constraints may hinder our Investment Adviser’s ability to take advantage of attractive investment opportunities and to achieve our investment objective. Regulations governing our operation as a BDC affect our ability to raise additional capital, and the ways in which we can do so. Raising additional capital may expose us to risks, including the typical risks associated with leverage, and may result in dilution to our current stockholders. The Investment Company Act limits our ability to borrow amounts or issue debt securities or preferred stock, which we refer to collectively as “senior securities,” to amounts such that our asset coverage ratio, as defined under the Investment Company Act, equals at least 150% immediately after such borrowing or issuance if certain requirements are met, rather than 200%, as previously required and as described below. Consequently, if the value of our assets declines, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when this may be disadvantageous to us and, as a result, our stockholders. The Small Business Credit Availability Act modified the applicable provisions of the Investment Company Act to reduce the required asset coverage ratio applicable to BDCs to 150%, subject to certain approval and disclosure requirements. Under this legislation, BDCs are able to increase their leverage capacity if stockholders approve a proposal to do so. At our 2018 annual meeting of stockholders held on June 15, 2018, our stockholders approved the proposal to apply the modified asset coverage requirements in Section 61(a)(2) of the Investment Company Act to us. We are generally not able to issue and sell our common stock at a price per share below NAV per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current NAV per share of our common stock (i) with the consent of a majority of our common stockholders (and a majority of our common stockholders who are not affiliates of ours), and (ii) if, among other things, a majority of our Independent Directors and a majority of our directors who have no financial interest in the transaction determine that a sale is in the best interests of us and our stockholders. If our common stock trades at a discount to NAV, this restriction could adversely affect our ability to raise capital. We incur significant costs as a result of being subject to the reporting requirements under the Exchange Act. We incur legal, accounting and other expenses, including costs associated with the periodic reporting requirements applicable to a company whose securities are registered under the Exchange Act, as well as additional corporate governance requirements, including requirements under the Sarbanes-Oxley Act, and other rules implemented by the SEC. These requirements may place a strain on our systems and resources. The Exchange Act requires that we file annual, quarterly and current reports with respect to our business and financial condition. The Sarbanes-Oxley Act requires that we maintain effective disclosure controls and procedures and internal control over financial reporting, which requires significant resources and management oversight. See “ Item 1. Business—Compliance with the Sarbanes-Oxley Act .” We have implemented procedures, processes, policies and practices for the purpose of addressing the standards and requirements applicable to public companies. These activities may divert management’s attention from other business concerns, which could have a material adverse effect on our business, financial condition, results of operations and cash flows. We have incurred, and expect to continue to incur, significant annual expenses related to these steps and directors’ and officers’ liability insurance, director fees, reporting requirements of the SEC, transfer agent fees, additional administrative expenses payable to our administrator to compensate it for hiring additional accounting, legal and administrative personnel, increased auditing and legal fees and similar expenses associated with being subject to these reporting requirements. Efforts to comply with Section 404 of the Sarbanes-Oxley Act involve significant expenditures, and noncompliance with Section 404 of the Sarbanes-Oxley Act may adversely affect us and the market price of our securities. We are subject to the Sarbanes-Oxley Act, and the related rules and regulations promulgated by the SEC. Under current SEC rules, we are required to report on internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act and regulations of the SEC thereunder, and our independent registered public accounting firm must audit this report. We are required to review on an annual basis our internal control over financial reporting, and on a quarterly and annual basis to evaluate and disclose changes in our internal control over financial reporting. As a result, we incur additional expenses that may negatively impact our financial performance and our ability to make distributions. This process also may result in a diversion of management’s time and attention. We cannot be certain as to the timing of completion of any evaluation, testing and remediation actions or the impact of the same on our operations, and we may not be able to ensure that the process is effective or that our internal control over financial reporting is or will be effective in a timely manner. In the event that we are unable to maintain or achieve compliance with Section 404 of the Sarbanes-Oxley Act and related rules, we and the market price of our common stock would be adversely affected. Changes in laws or regulations governing our operations or the operations of our portfolio companies, changes in the interpretation thereof or newly enacted laws or regulations, or any failure by us or our portfolio companies to comply with these laws or regulations, could require changes to certain of our or our portfolio companies’ business practices, negatively impact our or our portfolio companies’ operations, cash flows or financial condition, impose additional costs on us or our portfolio companies or otherwise adversely affect our business or the business of our portfolio companies. We and our portfolio companies are subject to regulation at the local, state, federal and, in some cases, foreign levels. These laws and regulations, as well as their interpretation, are likely to change from time to time, and new laws and regulations may be enacted. Accordingly, any change in these laws or regulations, changes in their interpretation, or newly enacted laws or regulations, or any failure by us or our portfolio companies to comply with these laws or regulations, could require changes to certain of our or our portfolio companies’ business practices, negatively impact our or our portfolio companies’ operations, cash flows or financial condition, impose additional costs on us or our portfolio companies or otherwise adversely affect our business or the business of our portfolio companies. In addition to the legal, tax and regulatory changes that are expected to occur, there may be unanticipated changes and uncertainty regarding any such changes. The legal, tax and regulatory environment for BDCs, investment advisers and the instruments that they utilize (including derivative instruments) is continuously evolving. In addition, there is significant uncertainty regarding certain legislation and the regulations that have been adopted (and future regulations that will need to be adopted pursuant to such legislation) and, consequently, the full impact that such legislation will ultimately have on us and the markets in which we trade and invest is not fully known. Such uncertainty and any resulting confusion may itself be detrimental to the efficient functioning of the markets and the success of certain investment strategies. Legislative and regulatory proposals directed at the financial services industry that are proposed or pending in the U.S. Congress may negatively impact the operations, cash flows or financial condition of us and our portfolio companies, impose additional costs on us and our portfolio companies, intensify the regulatory supervision of us and our portfolio companies or otherwise adversely affect our business or the business of our portfolio companies. Over the last several years, there also has been an increase in regulatory attention to the extension of credit outside of the traditional banking sector, raising the possibility that some portion of the non-bank financial sector will be subject to new regulation. While we do not know whether any such regulation will be implemented or what form it would take, increased regulation of non-bank credit extension would negatively impact our operations, cash flows or financial condition, impose additional costs on us, intensify the regulatory supervision of us or otherwise adversely affect our business. We may be materially affected by market, economic and political conditions globally and in the jurisdictions and sectors in which we invest or operate, including economic outlook, factors affecting interest rates, the availability of credit, currency exchange rates and trade barriers. Recent populist and anti-globalization movements, particularly in the United States, may result in material changes in economic trade and immigration policies, all of which could lead to significant disruption of global markets and could have adverse consequences for our investments. We cannot predict how new tax legislation will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business. Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. Congress has recently enacted significant changes to the existing U.S. tax rules. The likelihood of any new legislation being enacted is uncertain, but new legislation and any U.S. Treasury regulations, administrative interpretations or court decisions interpreting such legislation could significantly and negatively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our stockholders of such qualification and could have other adverse consequences. Stockholders are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock. Our ability to enter into transactions with our affiliates is restricted. As a BDC, we are prohibited under the Investment Company Act from knowingly participating in certain transactions with our affiliates without the prior approval of a majority of our Independent Directors who have no financial interest in the transaction, or in some cases, the prior approval of the SEC. For example, any person that owns, directly or indirectly, 5% or more of our outstanding voting securities is deemed our affiliate for purposes of the Investment Company Act. If this is the only reason such person is our affiliate, we are generally prohibited from buying any asset from or selling any asset (other than our capital stock) to, such affiliate, absent the prior approval of such directors. The Investment Company Act also prohibits “joint” transactions with an affiliate, which could include joint investments in the same portfolio company, without approval of our Independent Directors or in some cases the prior approval of the SEC. Moreover, except in certain limited circumstances, we are prohibited from buying any asset from or selling any asset to a holder of more than 25% of our voting securities, absent prior approval of the SEC. The analysis of whether a particular transaction constitutes a joint transaction requires a review of the relevant facts and circumstances then existing. In certain circumstances, we and other Accounts (which may include proprietary accounts of Goldman Sachs) can make negotiated co-investments pursuant to an order from the SEC permitting us to do so. On November 16, 2022, the SEC granted the Relief to the Investment Adviser, the BDCs advised by the Investment Adviser and certain other affiliated applicants. Additionally, if our Investment Adviser forms other funds in the future, we may co-invest alongside such other affiliates, subject to compliance with the Relief, applicable regulations and regulatory guidance, as well as applicable allocation procedures. As a result of the Relief, there could be significant overlap in our investment portfolio and the investment portfolios of other Accounts, including, in some cases, proprietary accounts of Goldman Sachs. In addition, we have filed an application to amend the Relief to permit us to participate in follow-on investments in our existing portfolio companies with certain affiliates covered by the Relief if such affiliates, that are not BDCs or registered investment companies, did not have an investment in such existing portfolio company. There can be no assurance if and when we will receive the amended exemptive order. Our activities may be limited as a result of potentially being deemed to be controlled by GS Group Inc., a bank holding company. GS Group Inc. is a BHC under the BHCA and therefore subject to supervision and regulation by the Federal Reserve. In addition, GS Group Inc. is a FHC under the BHCA, which is a status available to BHCs that meet certain criteria. FHCs may engage in a broader range of activities than BHCs that are not FHCs. However, the activities of FHCs and their affiliates remain subject to certain restrictions imposed by the BHCA and related regulations. Because GS Group Inc. may be deemed to “control” us within the meaning of the BHCA, these restrictions could apply to us as well. Accordingly, the BHCA and other applicable banking laws, rules, regulations and guidelines, and their interpretation and administration by the appropriate regulatory agencies, including the Federal Reserve, may restrict our investments, transactions and operations and may restrict the transactions and relationships between our Investment Adviser, GS Group Inc. and their respective affiliates, on the one hand, and us, on the other hand. For example, the BHCA regulations applicable to GS Group Inc. and to us may restrict our ability to make certain investments or the size of certain investments, impose a maximum holding period on some or all of our investments and restrict our and our Investment Adviser’s ability to participate in the management and operations of the companies in which we invest. In addition, certain BHCA regulations may require aggregation of the positions owned, held or controlled by related entities. Thus, in certain circumstances, positions held by GS Group Inc. and its affiliates (including our Investment Adviser) for client and proprietary accounts may need to be aggregated with positions held by us. In this case, where BHCA regulations impose a cap on the amount of a position that may be held, GS Group Inc. may utilize available capacity to make investments for its proprietary accounts or for the accounts of other clients, which may require us to limit and/or liquidate certain investments. These restrictions may materially adversely affect us by affecting our Investment Adviser’s ability to pursue certain strategies within our investment program or trade in certain securities. In addition, GS Group Inc. may cease in the future to qualify as an FHC, which may subject us to additional restrictions. Moreover, we can offer no assurance that the bank regulatory requirements applicable to GS Group Inc. and us, or the interpretation thereof, will not change, or that any such change will not have a material adverse effect on us. GS Group Inc. may in the future, in its sole discretion and without notice to investors, engage in activities impacting us and/or our Investment Adviser in order to comply with the BHCA or other legal requirements applicable to, or reduce or eliminate the impact or applicability of any bank regulations or other restrictions on, GS Group Inc., us or other accounts managed by our Investment Adviser and its affiliates. GS Group Inc. may seek to accomplish this result by causing Goldman Sachs Asset Management to resign as our Investment Adviser, voting for changes to our Board of Directors, causing Goldman Sachs personnel to resign from our Board of Directors, reducing the amount of GS Group Inc.’s investment in us (if any), revoking our right to use the Goldman Sachs name or any combination of the foregoing, or by such other means as it determines in its sole discretion. Any replacement investment adviser appointed by us may be unaffiliated with Goldman Sachs. Commodity Futures Trading Commission rules may have a negative impact on us and our Investment Adviser. The CFTC and the SEC have issued final rules establishing that certain swap transactions are subject to CFTC regulation. Engaging in such swap or other commodity interest transactions such as futures contracts or options on futures contracts may cause us to fall within the definition of “commodity pool” under the Commodity Exchange Act and related CFTC regulations. Our Investment Adviser has claimed relief from CFTC registration and regulation as a commodity pool operator pursuant to CFTC Rule 4.5 with respect to our operations, with the result that we will be limited in our ability to use futures contracts or options on futures contracts or engage in swap transactions. Specifically, CFTC Rule 4.5 imposes strict limitations on using such derivatives other than for hedging purposes, whereby the use of derivatives not used solely for hedging purposes is generally limited to situations where (i) the aggregate initial margin and premiums required to establish such positions does not exceed five percent of the liquidation value of our portfolio, after taking into account unrealized profits and unrealized losses on any such contracts it has entered into; or (ii) the aggregate net notional value of such derivatives does not exceed 100% of the liquidation value of our portfolio. Moreover, we anticipate entering into transactions involving such derivatives to a very limited extent solely for hedging purposes or otherwise within the limitations of CFTC Rule 4.5. Our ability to enter into transactions involving derivatives and financial commitment transactions may be limited. In August 2022, Rule 18f-4 under the Investment Company Act, regarding the ability of a BDC (or a registered investment company) to use derivatives and other transactions that create future payment or delivery obligations (including reverse repurchase agreements and similar financing transactions), became effective. Under the newly adopted rule, BDCs that make significant use of derivatives are subject to a value-at-risk leverage limit, a derivatives risk management program, testing requirements, and requirements related to board reporting. These new requirements will apply unless the BDC qualifies as a “limited derivatives user,” as defined in the rule. Under the new rule, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has, among other things, a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. Under the final rule, when we trade reverse repurchase agreements or similar financing transactions, including certain tender option bonds, we need to aggregate the amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing indebtedness (e.g., bank borrowings, if applicable) when calculating our asset coverage ratio. We currently operate as a “limited derivatives user” and these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts. Certain investors are limited in their ability to make significant investments in us. Private funds that are excluded from the definition of “investment company” either pursuant to Section 3(c)(1) or 3(c)(7) of the Investment Company Act and certain other unregistered investment companies are restricted from acquiring directly or through a controlled entity more than 3% of our total outstanding voting stock other than in accordance with the Investment Company Act (measured at the time of the acquisition, including through conversion of convertible securities). Investment companies registered under the Investment Company Act and BDCs are also subject to this restriction as well as other regulatory limitations that restrict the amount that they are able to invest in our securities. As a result, certain investors may be precluded from acquiring additional shares at a time that they might desire to do so. | |||||||||||||||||||||
Competition [Member] | ||||||||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||||||||
Risk [Text Block] | Competition We depend upon management personnel of our Investment Adviser for our future success. We do not have any employees. We depend on the experience, diligence, skill and network of business contacts of Goldman Sachs Asset Management Private Credit together with other investment professionals that our Investment Adviser currently retains or may subsequently retain, to identify, evaluate, negotiate, structure, close, monitor and manage our investments. Our future success will depend to a significant extent on the continued service and coordination of our Investment Adviser’s senior investment professionals. The departure of any of our Investment Adviser’s key personnel, including members of the BDC Investment Committee, or of a significant number of the investment professionals of our Investment Adviser, could have a material adverse effect on our business, financial condition or results of operations. In addition, we cannot assure stockholders that our Investment Adviser will remain our investment adviser or that we will continue to have access to our Investment Adviser or its investment professionals. See “— Our Business and Structure —Our Investment Adviser can resign on 60 days’ notice. We may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations.” We operate in a highly competitive market for investment opportunities. A number of entities, including the Accounts and other entities, compete with us to make the types of investments that we make. We compete with other BDCs, commercial and investment banks, commercial financing companies, collateralized loan obligations (“CLOs”), private funds, including hedge funds, and, to the extent they provide an alternative form of financing, private equity funds. Many of our competitors are more experienced, substantially larger and have considerably greater financial, technical and marketing resources than we do. Some competitors may have a lower cost of funds, perpetual fund lives, and/or access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of investments and establish more relationships than us. Certain of our competitors are not subject to the regulatory restrictions that the Investment Company Act imposes on us as a BDC and that the Code imposes on us as a RIC. Additionally, an investment opportunity may be appropriate for one or more of us and other Accounts or any other entities managed by our Investment Adviser, and co-investment may not be possible. In such circumstances, the Investment Adviser will adhere to its investment allocation policy in order to determine the Accounts to which to allocate investment opportunities. Also, as a result of this competition, we may not be able to secure attractive investment opportunities from time to time. We do not seek to compete primarily based on the interest rates we offer, and the Investment Adviser believes that some of our competitors may make loans with interest rates that are comparable to or lower than the rates we offer. Rather, we believe our competitive strengths include: (i) the positioning of Goldman Sachs Asset Management Private Credit within Goldman Sachs, given its associated relationship, sourcing and expertise advantages; (ii) Goldman Sachs Asset Management Private Credit’s experience and breadth as an investor; (iii) Goldman Sachs Asset Management Private Credit’s experienced team and history of investment performance; (iv) Goldman Sachs Asset Management Private Credit’s depth, breadth and duration of relationships with financial sponsors, companies, borrowers and other industry participants; and(v) the alignment of interest between the Company and the Goldman Sachs private credit platform through side-by-side investments alongside institutional and retail-focused private credit Accounts, which may include proprietary accounts of Goldman Sachs. For a further discussion of our competitive strengths, see “Item 1. Business—Competitive Advantages.” We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. If we match our competitors’ pricing, terms and structure, we may experience decreased net interest income and increased risk of credit loss. As a result of operating in such a competitive environment, we may make investments that are on less favorable terms than what we may have originally anticipated, which may impact our return on these investments. We cannot assure investors that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations. | |||||||||||||||||||||
Operational [Member] | ||||||||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||||||||
Risk [Text Block] | Operational We are dependent on information systems, and systems failures, as well as operating failures, could significantly disrupt our business, which may, in turn, negatively affect our liquidity, financial condition or results of operations. Our business is dependent on our Investment Adviser’s and third parties’ communications and information systems. Any failure or interruption of those systems, including as a result of the termination of the Investment Management Agreement or an agreement with any third-party service providers, could cause delays or other problems in our activities. Our financial, accounting, data processing, backup or other operating systems and facilities may fail to operate properly or become disabled or damaged as a result of a number of factors including events that are wholly or partially beyond our control and adversely affect our business. There could be: • sudden electrical or telecommunications outages; • natural disasters such as earthquakes, tornadoes and hurricanes; • disease pandemics; • events arising from local or larger scale political or social matters, including terrorist acts and acts of war; and/or • cyber incidents. In addition to our dependence on information systems, poor operating performance by our service providers could adversely impact us. These events, in turn, could have a material adverse effect on our operating results and negatively affect the market price of our securities and our ability to pay distributions to our stockholders. Cybersecurity risks and cyber incidents may adversely affect our business or the business of our portfolio companies by causing a disruption to our operations or the operations of our portfolio companies, a compromise or corruption of our confidential information or the confidential information of our portfolio companies and/or damage to our business relationships or the business relationships of our portfolio companies, all of which could negatively impact the business, financial condition and operating results of us or our portfolio companies. Cybersecurity risks and cyber incidents have been occurring globally at a more frequent and severe level, and will likely continue to increase in frequency in the future. The occurrence of a disaster, such as a cyber incident against us, any of our portfolio companies, or against a third-party that has access to our data or networks, a natural catastrophe, an industrial accident, failure of our disaster recovery systems, or consequential employee error, could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data. We and our portfolio companies depend heavily upon computer systems to perform necessary business functions. Despite the implementation of a variety of security measures, computer systems, networks, and data, like those of other companies, could be subject to cyber incidents and unauthorized access, use, alteration, or destruction, such as from physical and electronic break-ins or unauthorized tampering. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, and other information processed, stored in, and transmitted through our computer systems and networks, or otherwise cause interruptions or malfunctions in our operations, which could result in financial losses, litigation, regulatory penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. Third-party service providers with which we do business may also be sources of cybersecurity or other technological risk. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee, and borrower information. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, loss, exposure, destruction, or other cybersecurity incidents that adversely affects our data, resulting in increased costs and other consequences as described above. Moreover, the increased use of mobile and cloud technologies due to the proliferation of remote work resulting from the COVID-19 pandemic could heighten these and other operational risks as certain aspects of the security of such technologies may be complex and unpredictable. Reliance on mobile or cloud technology or any failure by mobile technology and cloud service providers to adequately safeguard their systems and prevent cyber incidents could disrupt our operations, the operations of a portfolio company or the operations of our or their service providers and result in misappropriation, corruption or loss of personal, confidential or proprietary information or the inability to conduct ordinary business operations. In addition, there is a risk that encryption and other protective measures may be circumvented, particularly to the extent that new computing technologies increase the speed and computing power available. Extended periods of remote working, whether by us, our portfolio companies, or our service providers, could strain technology resources, introduce operational risks and otherwise heighten the risks described above. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts. Accordingly, the risks described above, are heightened under the current conditions. Goldman Sachs and these third-party service providers have implemented processes, procedures and internal controls to help mitigate cybersecurity risks and cyber intrusions, but these measures, as well as our increased awareness of the nature and extent of a risk of a cyber incident, do not guarantee that a cyber incident will not occur and/or that our financial results, operations or confidential information will not be negatively impacted by such an incident. In addition, cybersecurity has become a top priority for lawmakers and regulators around the world, and some jurisdictions have proposed or enacted laws requiring companies to notify regulators and individuals of data security breaches involving certain types of personal data. Compliance with such laws and regulations may result in cost increases due to system changes and the development of new administrative processes. If we or our Investment Adviser or certain of its affiliates, fail to comply with the relevant and increasing laws and regulations, we could suffer financial losses, a disruption of our businesses, liability to investors, regulatory intervention or reputational damage. | |||||||||||||||||||||
Our Business and Structure [Member] | ||||||||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||||||||
Risk [Text Block] | Our Business and Structure Global economic, political and market conditions may adversely affect our business, financial condition and results of operations, including our revenue growth and profitability. The current worldwide financial market situation, as well as various social and political tensions in the United States and around the world, have contributed and may continue to contribute to increased market volatility, may have long-term effects on the United States and worldwide financial markets, and may cause economic uncertainties or deterioration in the United States and worldwide. We monitor developments and seek to manage our investments in a manner consistent with achieving our investment objective, but we can offer no assurance that we will be successful in doing so. Our business is directly influenced by the economic cycle, and could be negatively impacted by a downturn in economic activity in the United States as well as globally. Fiscal and monetary actions taken by United States and non-U.S. government and regulatory authorities could have a material adverse impact on our business. To the extent uncertainty regarding the U.S. or global economy negatively impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be adversely affected. Moreover, Federal Reserve policy, including with respect to certain interest rates, along with the general policies of the current Presidential administration, may also adversely affect the value, volatility and liquidity of dividend- and interest-paying securities. These conditions, government actions and future developments may cause interest rates and borrowing costs to rise, which may adversely affect our ability to access debt financing on favorable terms and may increase the interest costs of our borrowers, hampering their ability to repay us. Continued or future adverse economic conditions could have a material adverse effect on our business, financial condition and results of operations. If key economic indicators, such as the unemployment rate or inflation, do not progress at a rate consistent with the Federal Reserve’s objectives, the target range for the federal funds rate may increase and cause interest rates and borrowing costs to rise, which may negatively impact our ability to access the debt markets on favorable terms and may also increase the costs of our borrowers, hampering their ability to repay us. In addition, in 2022, the Federal Reserve raised short-term interest rates and has indicated additional interest rate increases may come. Legislation may be adopted that could significantly affect the regulation of U.S. financial markets. Areas subject to potential change, amendment or repeal include the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) and the authority of the Federal Reserve and the Financial Stability Oversight Council. These or other regulatory changes could result in greater competition from banks and other lenders with which we compete for lending and other investment opportunities. The United States may also potentially withdraw from or renegotiate various trade agreements and take other actions that would change current trade policies of the United States. We cannot predict which, if any, of these actions will be taken or, if taken, their effect on the financial stability of the United States. Such actions could have a material adverse effect on our business, financial condition and results of operations. Our Investment Adviser, its principals, investment professionals and employees and the members of its BDC Investment Committee may have certain conflicts of interest. Our Investment Adviser, its principals, affiliates, investment professionals and employees, the members of its BDC Investment Committee and our officers and directors serve and may serve in the future as investment advisers, officers, directors, principals of, or in other capacities with respect to, public or private entities (including other BDCs and other investment funds) that operate in the same or a related line of business as us. Certain of these individuals could have obligations to investors in other Accounts, the fulfillment of which is not in our best interests or the best interests of our stockholders and we expect that investment opportunities will satisfy the investment criteria for both us and such other Accounts. In addition, Goldman Sachs Asset Management and its affiliates also manage other accounts, and expect to manage other vehicles or accounts in the future, that have investment mandates that are similar, in whole or in part, to ours and, accordingly, may invest in asset classes similar to those targeted by us. As a result, the Investment Adviser and/or its affiliates may face conflicts in allocating investment opportunities between us and such other entities. The fact that our investment advisory fees may be lower than those of certain other funds advised by Goldman Sachs Asset Management could result in this conflict of interest affecting us adversely relative to such other funds. Subject to applicable law, we may invest alongside Goldman Sachs and other Accounts. As a result of the Relief, there could be significant overlap in our investment portfolio and the investment portfolios of other Accounts, including, in some cases, proprietary accounts of Goldman Sachs. In such circumstances, the Investment Adviser will adhere to its investment allocation policy in order to determine the Accounts to which to allocate investment opportunities. If we are unable to rely on the Relief for a particular opportunity, when our Investment Adviser identifies certain investments, it will be required to determine which Accounts should make the investment at the potential exclusion of other Accounts. Accordingly, it is possible that we may not be given the opportunity to participate in investments made by other Accounts. See “— Legal and Regulatory—Our ability to enter into transactions with our affiliates is restricted .” Goldman Sachs’s financial and other interests may incentivize our Investment Adviser to favor other Accounts. Our Investment Adviser receives performance-based compensation in respect of its investment management activities on our behalf, which rewards our Investment Adviser for positive performance of our investment portfolio. As a result, our Investment Adviser may make investments for us that present a greater potential for return but also a greater risk of loss or that are more speculative than would be the case in the absence of performance-based compensation. In addition, the Investment Adviser may simultaneously manage other Accounts for which the Investment Adviser may be entitled to receive greater fees or other compensation (as a percentage of performance or otherwise) than it receives in respect of us. In addition, subject to applicable law, Goldman Sachs may invest in other Accounts, and such investments may constitute all or substantial percentages of such other Accounts’ outstanding equity interests. Therefore, the Investment Adviser may have an incentive to favor such other Accounts over us. To address these types of conflicts, the Investment Adviser has adopted policies and procedures under which investment opportunities will be allocated in a manner that it believes is consistent with its obligations as an investment adviser. However, the amount, timing, structuring or terms of an investment by us may differ from, and performance may be different from, the investments and performance of other Accounts. Our financial condition and results of operations depend on our Investment Adviser’s ability to manage our future growth effectively. Our ability to achieve our investment objective depends on our Investment Adviser’s ability to identify, invest in and monitor companies that meet our investment criteria. Accomplishing this result on a cost-effective basis is largely a function of the structuring of our investment process and the ability of our Investment Adviser to provide competent, attentive and efficient services to us. Our executive officers and the members of the BDC Investment Committee have substantial responsibilities in connection with their roles at our Investment Adviser, with the Accounts, as well as responsibilities under the Investment Management Agreement. We may also be called upon to provide significant managerial assistance to certain of our portfolio companies. These demands on their time, which will increase as the number of investments grow, may distract them or slow the rate of investment. In order to grow, our Investment Adviser may need to hire, train, supervise, manage and retain new employees. However, we cannot assure investors that they will be able to do so effectively. Any failure to manage our future growth effectively could have a material adverse effect on our business, financial condition and results of operations. Our ability to grow depends on our access to adequate capital. If we do not have adequate capital available for investment, our performance could be adversely affected. In addition, we elected to be treated as a RIC, and we expect to qualify annually for tax treatment as a RIC, commencing with our taxable year ended December 31, 2013. To maintain our qualification for tax treatment as a RIC, among other requirements, we are required to timely distribute to our stockholders at least 90% of our investment company taxable income (determined without regard to the dividends paid deduction), which is generally our net ordinary income plus the excess of realized net short-term capital gains over realized net long-term capital losses, if any, for each taxable year. Consequently, such distributions will not be available to fund new investments. We expect to use debt financing and issue additional securities to fund our growth, if any. Unfavorable economic or capital market conditions may increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. An inability to successfully access the capital markets could limit our ability to grow our business and fully execute our business strategy and could decrease our earnings, if any. We may pursue growth through acquisitions or strategic investments in new businesses. Completion and timing of any such acquisitions or strategic investments may be subject to a number of contingencies and risks. We can offer no assurance that the integration of an acquired business will be successful or that an acquired business will prove to be profitable or sustainable. We borrow money, which may magnify the potential for gain or loss and may increase the risk of investing in us. As part of our business strategy, we may borrow from and issue senior debt securities to banks, insurance companies and other lenders or investors. Holders of these senior securities or other credit facilities will have claims on our assets that are superior to the claims of our common stockholders. If the value of our assets decreases, leveraging would cause NAV to decline more sharply than it otherwise would have if we did not employ leverage. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to make distributions to our common stockholders. In addition, we would have to service any additional debt that we incur, including interest expense on debt and dividends on preferred stock that we may issue, as well as the fees and costs related to the entry into or amendments to debt facilities. These expenses (which may be higher than the expenses on our current borrowings due to the rising interest rate environment) would decrease net investment income, and our ability to pay such expenses will depend largely on our financial performance and will be subject to prevailing economic conditions and competitive pressures. Moreover, leverage will increase the Management Fee payable to our Investment Adviser, which is based on our gross assets, including those assets acquired through the use of leverage but excluding cash and cash equivalents. Additionally, we will be able to incur additional leverage if we are able to obtain exemptive relief from the SEC to exclude the debt of any small business investment company (“SBIC”) subsidiary we may form in the future from the leverage requirements otherwise applicable to BDCs. We have not yet applied to the Small Business Administration for approval to form a SBIC and may decide not to do so. We can offer no assurances as to whether or when we may form a SBIC subsidiary. In addition to having claims on our assets that are superior to the claims of our common stockholders, any obligations to the lenders will be secured by a first priority security interest in our portfolio of investments and cash. In the case of a liquidation event, those lenders would receive proceeds to the extent of their security interest before any distributions are made to our stockholders. Furthermore, our senior secured revolving credit agreement with Truist Bank (formerly known as SunTrust Bank), as administrative agent, and reBank of America, N.A., as syndication agent (as amended, the “Revolving Credit Facility”) imposes, and any credit agreement or other debt financing agreement into which we may enter may impose, financial and operating covenants that restrict our investment activities (including restrictions on industry concentrations), remedies on default and similar matters. In connection with any future borrowings, our lenders may also require us to pledge assets. In addition, we may be unable to obtain our desired leverage, which would, in turn, affect a stockholder’s return on investment. The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio, net of expenses. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below. Assumed Return on Our Portfolio (Net of Expenses) (10.00 )% (5.00 )% 0.00 % 5.00 % 10.00 % Corresponding Return to Common Stockholder (1) (28.74 )% (16.76 )% (4.78 )% 7.20 % 19.19 % (1) Based on (i) $3,600.05 million in total assets including debt issuance costs as of December 31, 2022, (ii) $2,021.40 million in outstanding indebtedness as of December 31, 2022, (iii) $1,502.39 million in net assets as of December 31, 2022 and (iv) an annualized average interest rate on our indebtedness, as of December 31, 2022, excluding fees (such as fees on undrawn amounts and amortization of financing costs), of 3.55%. Our Investment Adviser will be paid the Management Fee even if the value of an investment in the Company declines and our Investment Adviser’s Incentive Fee may create incentives for it to make certain kinds of investments. The Management Fee is payable even in the event the value of a stockholder’s investment declines. The Investment Adviser receives substantial fees from us in return for its services, and these fees could influence the advice provided to us. The Management Fee is calculated as a percentage of the average value of our gross assets including borrowed funds (excluding cash or cash equivalents) at the end of the prior two completed calendar quarters. Accordingly, the Management Fee is payable regardless of whether the value of our gross assets and/or an investment in the Company has decreased during the then-current quarter and creates an incentive for the Investment Adviser to incur leverage. The Incentive Fee payable by us to our Investment Adviser may create an incentive for our Investment Adviser tobased on (i) $3,600Goldman sachs make investments on our behalf that are risky or more speculative than would be the case in the absence of such a compensation arrangement and also to incur leverage, which will tend to enhance returns where our portfolio has positive returns. Our Investment Adviser receives the Incentive Fee based, in part, upon capital gains realized on our investments. As a result, our Investment Adviser may have an incentive to invest more in companies whose securities are likely to yield capital gains, as compared to income-producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during cyclical economic downturns. The Incentive Fee payable by us to our Investment Adviser also may create an incentive for our Investment Adviser to invest on our behalf in instruments that have a deferred interest feature. Under these investments, we accrue the interest over the life of the investment but do not receive the cash income from the investment until the end of the term. Our net investment income used to calculate the income portion of our Incentive Fee, however, includes accrued interest. Thus, a portion of this Incentive Fee is based on income that we have not yet received in cash. This risk could be increased because our Investment Adviser is not obligated to reimburse us for any Incentive Fees received even if we subsequently incur losses or never receive in cash the accrued income (including accrued income with respect to original issue discount (“OID”), payment-in-kind (“PIK”) interest and zero-coupon securities). If we increase leverage, the management fees payable to our Investment Adviser will be higher than if we did not use leverage, irrespective of the return on the incremental assets. In addition, as leverage generally would magnify positive returns, if any, on our portfolio, as noted above, the use of leverage may cause our net investment income to exceed the quarterly hurdle rate for the Incentive Fee on income payable to our Investment Adviser at a lower average return on our portfolio. The Incentive Fee based on income takes into account our past performance. The Incentive Fee based on income will be determined and paid quarterly in arrears at the end of each calendar quarter by reference to our aggregate net investment income, as adjusted, from the Trailing Twelve Quarters. The effect of calculating the Incentive Fee using reference to the Trailing Twelve Quarters is that, in certain limited circumstances, an Incentive Fee based on income will be payable to our Investment Adviser although our net income for such quarter did not exceed the hurdle rate or the Incentive Fee will be higher than it would have been if calculated based on our performance for the applicable quarter without taking into account the Trailing Twelve Quarters. For example, if we experience a net loss for any particular quarter, an Incentive Fee may still be paid to our Investment Adviser if such net loss is less than the net loss for the most recent quarter that preceded the Trailing Twelve Quarters. In such circumstances, our Investment Adviser would be entitled to an Incentive Fee whereas it would not have been entitled to an Incentive Fee if calculated solely on the basis of our performance for the applicable quarter. Potential conflicts of interest with other businesses of Goldman Sachs could impact our investment returns. There are significant potential conflicts of interest that could negatively impact our investment returns. A number of these potential conflicts of interest with affiliates of our Investment Adviser and GS Group Inc. are discussed in more detail elsewhere in this report. GS Group Inc. is a publicly held FHC and a leading global financial institution that provides investment banking, securities, and investment management services to a diversified client base, including companies and high-net-worth individuals, among others. As such, it acts as an investor, investment banker, research provider, investment manager, financier, adviser, market maker, trader, prime broker, derivatives dealer, lender, counterparty, agent and principal. In those and other capacities, Goldman Sachs and its affiliates advise clients in all markets and transactions and purchase, sell, hold and recommend a broad array of investments, including securities, derivatives, loans, commodities, currencies, credit default swaps, indices, baskets and other financial instruments and products for its own accounts or for the accounts of their customers, and have other direct and indirect interests, in the global fixed income, currency, commodity, equity, bank loans and other markets in which we invest or may invest. Such additional businesses and interests will likely give rise to potential conflicts of interest and may restrict the way we operate our business. For example, (1) we may not be able to conduct transactions relating to investments in portfolio companies because our Investment Adviser is not permitted to obtain or use material nonpublic information in effecting purchases and sales in public securities transactions for us or (2) Goldman Sachs, the clients it advises, and its personnel may engage (or consider engaging) in commercial arrangements or transactions with us (subject to any limitations under the law), and/or may compete for commercial arrangements or transactions in the same types of companies, assets, securities or other assets or instruments as us. Transactions by, advice to and activities of such accounts (including potentially Goldman Sachs acting on a proprietary basis), may involve the same or related companies, securities or other assets or instruments as those in which we invest and may negatively affect us (including our ability to engage in a transaction or other activities) or the prices or terms at which our transactions or other activities may be effected. For example, Goldman Sachs may be engaged to provide advice to an account that is considering entering into a transaction with us, and Goldman Sachs may advise the account not to pursue the transaction with us, or otherwise in connection with a potential transaction provide advice to the account that would be adverse to us. See “—Our Investment Adviser, its principals, investment professionals and employees and the members of its BDC Investment Committee may have certain conflicts of interest” and “—Legal and Regulatory—Our ability to enter into transactions with our affiliates is restricted.” In addition, subject to applicable law, GS & Co. may, to the extent permitted by applicable law, including the limitations set forth in Section 57(k) of the Investment Company Act, receive compensation from us or from the borrowers if we make any investments based on opportunities that such employees or personnel of GS & Co. have referred to us. Such compensation might incentivize GS & Co. or its employees or personnel to refer opportunities or to recommend investments that might otherwise be unsuitable for us. Further, any such compensation paid by us, or paid by the borrower (to which we would otherwise have been entitled) in connection with such investments, may negatively impact our returns. Furthermore, Goldman Sachs is currently, and in the future expects to be, raising capital for new public and private investment vehicles that have, or when formed will have, the primary purpose of directly originating senior secured corporate credit. These investment vehicles, as well as existing investment vehicles (including other Accounts), will compete with us for investments. Although our Investment Adviser and its affiliates will endeavor to allocate investment opportunities among its clients, including us, in a fair and equitable manner and consistent with applicable allocation procedures, it is expected that, in the future, we may not be given the opportunity to participate in investments made by other Accounts or that we may participate in such investments to a lesser extent due to participation by such other Accounts. In addition, Goldman Sachs or another investment account or vehicle managed or controlled by Goldman Sachs or another client of the Investment Adviser may hold securities, loans or other instruments of a portfolio company in a different class or a different part of the capital structure than securities, loans or other instruments of such portfolio company held by us. As a result, Goldman Sachs or such other investment account or vehicle or such other client of the Investment Adviser may pursue or enforce rights or activities, or refrain from pursuing or enforcing rights or activities, on behalf of its own account, that could have an adverse effect on us. In addition, to the extent Goldman Sachs has invested in a portfolio company for its own account, Goldman Sachs may limit the transactions engaged in by us with respect to such portfolio company or issuer for reputational, legal, regulatory or other reasons. Stockholders should note the matters discussed in “—Legal and Regulatory—Our ability to enter into transactions with our affiliates is restricted.” Goldman Sachs has influence, and may continue to exert influence, over our management and affairs and over most votes requiring stockholder approval. GS Group Inc. has owned a significant portion of our common stock since the inception of our operations. As of December 31, 2022, GS Group Inc. owned 6.3% of our outstanding common stock. GS & Co., a wholly owned subsidiary of GS Group Inc., has acquired shares of our common stock pursuant to a 10b5-1 plan, and may in the future acquire additional shares of our common stock in the open market, but GS & Co. will limit its collective ownership with GS Group Inc. to below 25.0% of our outstanding common stock. Therefore, GS Group Inc. is able to exert, and may be able to continue to exert, influence over our management and policies and have significant voting influence on most votes requiring stockholder approval. This concentration of ownership may also have the effect of delaying, preventing or deterring a change of control of us, could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of us and might ultimately affect the market price of our common stock. Our Investment Adviser has the authority to vote securities held by GS Group Inc., including on matters that may present a conflict of interest between our Investment Adviser and other stockholders. Our Board of Directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval. Our Board of Directors has the authority to modify or waive certain of our operating policies and strategies without prior notice (except as required by the Investment Company Act or other applicable laws) and without stockholder approval. However, absent stockholder approval, we may not change the nature of our business so as to cease to be, or withdraw our election as, a BDC. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, operating results and market price of our securities. Nevertheless, the effects may adversely affect our business and impact our ability to make distributions or make payments with respect to our indebtedness. Our Investment Adviser can resign on 60 days’ notice. We may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations. Our Investment Adviser has the right, under the Investment Management Agreement, to resign at any time upon 60 days’ written notice, regardless of whether we have found a replacement. If our Investment Adviser resigns, we may not be able to find a new external investment adviser or hire internal management with similar expertise and ability to provide the same or equivalent services on acceptable terms within 60 days, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected, and the market price of our securities may decline. Our Investment Adviser’s responsibilities and its liability to us are limited under the Investment Management Agreement, which may lead our Investment Adviser to act in a riskier manner on our behalf than it would when acting for its own account. Our Investment Adviser has not assumed any responsibility to us other than to render the services described in the Investment Management Agreement, and it will not be responsible for any action of our Board of Directors in declining to follow our Investment Adviser’s advice or recommendations. Pursuant to the Investment Management Agreement, our Investment Adviser and its directors, members, stockholders, partners, officers, employees or controlling persons will not be liable to us for its acts under the Investment Management Agreement, absent willful misfeasance, bad faith or gross negligence in the performance of its duties, or by reason of its reckless disregard of its obligations and duties under the Investment Management Agreement. These protections may lead our Investment Adviser to act in a riskier manner when acting on our behalf than it would when acting for its own account. See “—Our Investment Adviser will be paid the Management Fee even if the value of an investment in the Company declines and our Investment Adviser’s Incentive Fee may create incentives for it to make certain kinds of investments.” We may experience fluctuations in our quarterly results. We could experience fluctuations in our quarterly operating results due to a number of factors, including interest rates payable on debt investments we make, default rates on such investments, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in certain markets and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods or the full fiscal year. We are subject to risks related to corporate social responsibility. Our business faces increasing public scrutiny related to environmental, social and governance (“ESG”) activities, which are increasingly considered to contribute to the long-term sustainability of a company’s performance. A variety of organizations measure the performance of companies on ESG topics, and the results of these assessments are widely publicized. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. Our brand and reputation may be negatively impacted if we fail to act responsibly in a number of areas, such as considering ESG factors in our investment processes. Adverse incidents with respect to ESG activities could impact the value of our brand and our relationships with investors, which could adversely affect our business and results of operations. Additionally, new regulatory initiatives related to ESG could adversely affect our business. The SEC has proposed rules that, in addition to other matters, would establish a framework for reporting of climate-related risks. For example, the SEC has announced that it may require disclosure of certain ESG-related matters. There is a risk that a significant reorientation in the market following the implementation of these and further measures could be adverse to our portfolio companies if they are perceived to be less valuable as a consequence of, for example, their carbon footprint or “greenwashing” (i.e., the holding out of a product as having green or sustainable characteristics where this is not, in fact, the case). We are, and our portfolio companies may be, or could in the future become subject to the risk that similar measures might be introduced in other jurisdictions in the future. At this time, there is uncertainty regarding the scope of such proposals or when they would become effective (if at all). Compliance with any new laws or regulations increases our regulatory burden and could make compliance more difficult and expensive, affect the manner in which we or our portfolio companies conduct our businesses and adversely affect our profitability. | |||||||||||||||||||||
Our Investments [Member] | ||||||||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||||||||
Risk [Text Block] | Our Investments Our investments are very risky and highly speculative. We invest primarily through direct originations of secured debt, including first lien, unitranche, and last-out portions of such loans; second-lien debt; unsecured debt, including mezzanine debt; and select equity investments. The securities in which we invest typically are not rated by any rating agency, and if they were rated, they would be below investment grade (rated lower than “Baa3” by Moody’s Investors Service, Inc. and lower than “BBB-” by Fitch Ratings or Standard & Poor’s Ratings Services). These securities, which may be referred to as “junk bonds,” “high yield bonds” or “leveraged loans,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal. In addition, we may also originate “covenant-lite” loans, which are loans with fewer financial maintenance covenants than other obligations, or no financial maintenance covenants. Such covenant-lite loans may not include terms that allow the lender to monitor the performance of the borrower or to declare a default if certain criteria are breached. These flexible covenants (or the absence of covenants) could permit borrowers to experience a significant downturn in their results of operations without triggering any default that would permit holders of their debt (such as the Company) to accelerate indebtedness or negotiate terms and pricing. Accordingly, to the extent we invest in “covenant-lite” loans, we may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants. Therefore, our investments may result in an above-average amount of risk and volatility or loss of principal. We also may invest in other assets, including U.S. government securities and structured securities. These investments entail additional risks that could adversely affect our investment returns. Secured Debt. When we make a secured debt investment, we generally take a security interest in the available assets of the portfolio company, including the equity interests of any subsidiaries, which we expect to help mitigate the risk that we will not be repaid. However, there is a risk that the collateral securing our debt investment may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. In some circumstances, our lien could be subordinated to claims of other creditors, such as trade creditors. In addition, deterioration in a portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the debt investment. Consequently, the fact that our debt is secured does not guarantee that we will receive principal and interest payments according to the debt investment’s terms, or at all, or that we will be able to collect on the loan, in full or at all, should we enforce our remedies. Unsecured Debt, including Mezzanine Debt. Our unsecured debt investments, including mezzanine debt investments, generally will be subordinated to senior debt in the event of an insolvency. This may result in an above average amount of risk and loss of principal. Revolving Credit Facilities. From time to time we may acquire or originate revolving credit facilities in connection with our investments in other assets, which may result in our holding unemployed funds, negatively impacting our returns. Equity Investments. When we invest in secured debt or unsecured debt, including mezzanine debt, we may acquire equity securities from the company in which we make the investment. In addition, we may invest in the equity securities of portfolio companies independent of any debt investment. Our goal is ultimately to dispose of such equity interests and realize gains upon our disposition of such interests. However, the equity interests we hold may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. Investing in middle-market companies involves a number of significant risks. Investing in middle-market companies involves a number of significant risks, including: • such companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment; • such companies typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns; • such companies are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; • such companies generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position; • there is generally little public information about these companies, they and their financial information are not subject to the reporting requirements of the Exchange Act and other regulations that govern public companies and we may be unable to uncover all material information about these companies, which may prevent us from making a fully informed investment decision and cause us to lose money on our investments; • our executive officers, directors and Investment Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and • such companies may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness, including any debt securities held by us, upon maturity. We have exposure to credit risk and other risks related to credit investments. Our investments are subject to liquidity, market value, credit, interest rate and certain other risks. In addition, we cannot assure you that the Investment Adviser will correctly evaluate the nature and magnitude of the various factors that could affect the value and return of our investments. These risks could be exacerbated to the extent that the portfolio is concentrated in one or more particular types of investments or industry sectors or regions. Prices of our investments may be volatile and may fluctuate as a result of a variety of factors that are inherently difficult to predict, including changes in interest rates, prevailing credit spreads, general economic conditions, financial market conditions, domestic and international economic or political events, developments or trends in any particular industry, and the financial condition of the issuers or obligors of the investments. Investments that become non-performing, or defaulted loans or securities may become subject to a workout negotiation or restructuring. This may entail a substantial reduction in the interest rate, a substantial write-down of principal, and a substantial change in the terms, conditions and covenants of these investments. To the extent that defaulted investments are sold, it is unlikely that the sale proceeds will be equal to the amount of unpaid principal and interest thereon. In addition, we may incur additional expenses to the extent we are required to seek recovery upon a default or to participate in the restructuring of a non-performing or defaulted investment. We can offer no assurance as to the levels of defaults and/or recoveries that may be experienced on the investments. Secured investments may also be subject to the risk that the security interests granted by the portfolio company obligors in the underlying collateral are not properly or fully perfected in favor of lenders (or their agents). Compounding these risks, the collateral securing the secured investments may be subject to casualty, impairment or devaluation risks. Portfolio companies may also be permitted to issue additional indebtedness that would increase the overall leverage and fixed charges to which the portfolio companies are subject. Such additional indebtedness could have structural or contractual priority, either as to specific assets or generally, over the ranking of the investments held by us or could rank on a parity or seniority basis with respect to our investments. In the event of any default, restructuring or insolvency event of a portfolio company, we could be subordinated to, or be required to share on a ratable basis with, any recoveries in favor of the holders of such other or additional indebtedness. Our recoveries may be impaired as a result of the rights of holders of other indebtedness under any intercreditor agreement governing the relative rights of the indebtedness. Our debt investments may also have no amortization and limited interim repayment requirements, which may increase the risk that a portfolio company will not be able to repay or refinance the debt investment when it comes due at its final stated maturity. Inflation may adversely affect the business, results of operations and financial condition of our portfolio companies. Certain of our portfolio companies may be impacted by inflation, such as current inflation related to global supply chain disruptions. Recent inflationary pressures have increased the costs of labor, energy and raw materials and have adversely affected consumer spending, economic growth and our portfolio companies’ operations. Certain of our portfolio companies may be in industries that have been, or are expected to be, affected by inflation. If such portfolio companies are unable to pass any increases in their costs along to their customers, it could adversely affect their results and impact their ability to pay interest and principal on our loans. In addition, any projected future decreases in our portfolio companies’ operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in unrealized losses and therefore reduce our net assets resulting from operations. While the United States and other developed economies are experiencing higher-than-normal inflation rates, it remains uncertain whether substantial inflation will be sustained over an extended period of time or have a significant effect on the U.S. economy or other economies. Inflation may affect our investments adversely in a number of ways, including those noted above. During periods of rising inflation, interest and dividend rates of any instruments we or our portfolio companies may have issued could increase, which would tend to reduce returns to our investors. Inflationary expectations or periods of rising inflation could also be accompanied by the rising prices of commodities that are critical to the operation of portfolio companies as noted above. Portfolio companies may have fixed income streams and, therefore, be unable to pay their debts when they become due. The market value of such investments may decline in value in times of higher inflation rates. Some of our portfolio investments may have income linked to inflation through contractual rights or other means. However, as inflation may affect both income and expenses, any increase in income may not be sufficient to cover increases in expenses. Governmental efforts to curb inflation often have negative effects on the level of economic activity. In an attempt to stabilize inflation, certain countries have imposed wage and price controls at times. Past governmental efforts to curb inflation have also involved more drastic economic measures that have had a materially adverse effect on the level of economic activity in the countries where such measures were employed. We can offer no assurance that continued and more widespread inflation in the United States and/or other economies will not become a serious problem in the future and have a material adverse impact on us. We are exposed to risks associated with changes in interest rates, including the current rising interest rate environment. Debt investments that we make may be based on floating rates, such as SOFR (as defined below), LIBOR, the Euro Interbank Offered Rate, the Federal Funds Rate or the Prime Rate. General interest rate fluctuations may have a substantial negative impact on our investments, the value of our securities and our rate of return on invested capital. It is unclear how increased regulatory oversight and the future of LIBOR may affect market liquidity and the value of the financial obligations to be held by or issued to us that are linked to LIBOR, or how such changes could affect our investments and transactions and financial condition or results of operations. Historically, the London Inter-Bank Offered Rate (“LIBOR”) was the basic rate of interest used in lending transactions between banks on the London interbank market and is widely used as a reference for setting the interest rate on loans globally. In July 2017, the Financial Conduct Authority announced its intention to cease sustaining the LIBOR, by the end of 2021. As of January 1, 2023, US-dollar (“USD”) LIBOR is available in five settings (overnight, one-month, three-month, six-month and 12-month). The ICE Benchmark Administration has stated that it will cease to publish all remaining USD LIBOR settings immediately following their publication on June 30, 2023. Recently the ICE Benchmark Administration further announced that it will publish “synthetic” USD LIBOR rates until September 2024. It is not yet known how synthetic LIBOR will be incorporated into credit facilities, if at all. In April 2018, the Federal Reserve Bank of New York began publishing its alternative rate, the Secured Overnight Financing Rate (“SOFR”). The Bank of England followed suit in April 2018 by publishing its proposed alternative rate, the Sterling Overnight Index Average (“SONIA”). Each of SOFR and SONIA significantly differ from LIBOR in how each rate is calculated and potentially in the actual rate as well. Since January 1, 2022, our new investments are generally indexed to SOFR; however, we have prior contracts that remain indexed to LIBOR. Certain contracts have an orderly market transition already in process; however, other contracts will need to be renegotiated to replace LIBOR with an alternative reference rate. We expect that, going forward, all our new USD-denominated investments will be indexed to SOFR, absent a significant market shift away from such rate as an accepted replacement for LIBOR. A reduction in the interest rates on new investments relative to interest rates on current investments could also have an adverse impact on our net interest income. However, an increase in interest rates could decrease the value of any investments we hold which earn fixed interest rates, including subordinated loans, senior and junior secured and unsecured debt securities and loans and high yield bonds, and also could increase our interest expense, thereby decreasing our net income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our dividend rate, which could reduce the value of our common stock. Further, rising interest rates could also adversely affect our performance if such increases cause our borrowing costs to rise at a rate in excess of the rate that our investments yield. In 2022, the Federal Reserve raised short-term interest rates and has indicated additional interest rate increases may come. Changing interest rates may have unpredictable effects on markets, may result in heightened market volatility and may detract from our performance to the extent we are exposed to such interest rates and/or volatility. In periods of rising interest rates, such as the current interest rate environment, to the extent we borrow money subject to a floating interest rate, our cost of funds would increase, which could reduce our net investment income. Further, rising interest rates could also adversely affect our performance if such increases cause our borrowing costs to rise at a rate in excess of the rate that our investments yield. Further, rising interest rates could also adversely affect our performance if we hold investments with floating interest rates, subject to specified minimum interest rates (such as a LIBOR or SOFR floor, as applicable), while at the same time engaging in borrowings subject to floating interest rates not subject to such minimums. In such a scenario, rising interest rates may increase our interest expense, even though our interest income from investments is not increasing in a corresponding manner as a result of such minimum interest rates. If general interest rates continue to rise, there is a risk that the portfolio companies in which we hold floating rate securities will be unable to pay escalating interest amounts, which could result in a default under their loan documents with us. Rising interest rates could also cause portfolio companies to shift cash from other productive uses to the payment of interest, which may have a material adverse effect on their business and operations and could, over time, lead to increased defaults. In addition, rising interest rates may increase pressure on us to provide fixed rate loans to our portfolio companies, which could adversely affect our net investment income, as increases in our cost of borrowed funds would not be accompanied by increased interest income from such fixed-rate investments. A change in the general level of interest rates can be expected to lead to a change in the interest rates we receive on many of our debt investments. Accordingly, a change in the interest rate could make it easier for us to meet or exceed the performance threshold in the Investment Management Agreement and may result in a substantial increase in the amount of incentive fees payable to our Investment Adviser with respect to the portion of the Incentive Fee based on income. Many of our portfolio securities do not have a readily available market price, and we value these securities at fair value as determined in good faith in accordance with the Investment Company Act, which valuation is inherently subjective and may not reflect what we may actually realize for the sale of the investment. The majority of our investments are, and are expected to continue to be, in debt instruments that do not have readily ascertainable market prices. The fair value of assets that are not publicly traded or whose market prices are not readily available are determined in good faith under procedures adopted by the Investment Adviser, as the valuation designee. As the valuation designee, the Investment Adviser is primarily responsible for the valuation of our assets, subject to the oversight of the Board, in accordance with Rule 2a-5 under the Investment Company Act. As the valuation designee, the Investment Adviser utilizes the services of independent third-party valuation firms (“Independent Valuation Advisors”) engaged by us in determining the fair value of a portion of the securities in our portfolio. Investment professionals from our Investment Adviser also recommend portfolio company valuations using sources and/or proprietary models depending on the availability of information on our assets and the type of asset being valued, all in accordance with our valuation policy. The participation of our Investment Adviser in our valuation process could result in a conflict of interest, as the Management Fee is based in part on our gross assets and also because our Investment Adviser is receiving a performance-based Incentive Fee. In addition, the Investment Adviser may value an identical asset differently than Goldman Sachs, another division or unit within Goldman Sachs, or another Account values the asset, including because Goldman Sachs, or such other division, or unit, or Account has information or uses valuation techniques and models that it does not share with, or that are different from those of the Investment Adviser or from us. These valuation differences for the same asset can result in significant differences in the treatment of such asset by the Investment Adviser, Goldman Sachs, and other divisions or units of Goldman Sachs, and/or among Accounts (for example, with respect to an asset that is a loan, there can be differences when it is determined that such loan is deemed to be on nonaccrual status and/or in default). See“—Potential conflicts of interest with other businesses of Goldman Sachs could impact our investment returns.” Because fair valuations, and particularly fair valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and are often based to a large extent on estimates, comparisons and qualitative evaluations of private information, it may be more difficult for investors to value accurately our investments and could lead to undervaluation or overvaluation of our common stock. In addition, the valuation of these types of securities may result in substantial write-downs and earnings volatility. On December 3, 2020, the SEC announced that it adopted Rule 2a-5 under the Investment Company Act, which establishes an updated regulatory framework for determining fair value in good faith for purposes of the Investment Company Act. The new rule clarifies how fund boards can satisfy their valuation obligations in light of recent market developments. The rule will permit boards, subject to board oversight and certain other conditions, to designate certain parties to perform the fair value determinations. The new rule went into effect on March 8, 2021 and had a compliance date of September 8, 2022. In accordance with this rule and as discussed above, our Board of Directors has designated our Investment Adviser as the valuation designee primarily responsible for the valuation of our assets, subject to the oversight of the Board of Directors, and we are in compliance with this rule. Our NAV as of a particular date may be materially greater than or less than the value that would be realized if our assets were to be liquidated as of such date. For example, if we were required to sell a certain asset or all or a substantial portion of our assets on a particular date, the actual price that we would realize upon the disposition of such asset or assets could be materially less than the value of such asset or assets as reflected in our NAV. Volatile market conditions could also cause reduced liquidity in the market for certain assets, which could result in liquidation values that are materially less than the values of such assets as reflected in our NAV. The lack of liquidity in our investments may adversely affect our business. Various restrictions render our investments relatively illiquid, which may adversely affect our business. As we generally make investments in private companies, substantially all of these investments are subject to legal and other restrictions on resale or are otherwise less liquid than publicly traded securities. Our Investment Adviser is not permitted to obtain or use material non-public information in effecting purchases and sales in public securities transactions for us, which could create an additional limitation on the liquidity of our investments. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. Therefore, if we are required to or desire to liquidate all or a portion of our portfolio quickly, we could realize significantly less than the value at which we have recorded our investments or could be unable to dispose of our investments in a timely manner or at such times as we deem advisable. Our portfolio may be focused in a limited number of portfolio companies, which will subject us to a risk of significant loss if any of these companies defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry. We are classified as a non-diversified investment company within the meaning of the Investment Company Act, which means that we are not limited by the Investment Company Act with respect to the proportion of our assets that we may invest in securities of a single issuer, excluding limitations on investments in certain other financial and investment companies. To the extent that we assume large positions in the securities of a small number of issuers or industries, our NAV may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. We may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. In addition, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, a downturn in any particular industry in which we are invested could significantly affect our aggregate returns. Further, any industry in which we are meaningfully concentrated at any given time could be subject to significant risks that could adversely impact our aggregate returns. For example, as of December 31, 2022, Health Care Technology, together with Health Care Providers & Services and Health Care Equipment & Supplies, represented 23.3% of our portfolio at fair value. Our investments in Health Care Technology, Health Care Providers & Services and Health Care Equipment & Supplies are subject to substantial risks, including, but not limited to, the risk that the laws and regulations governing the business of health care companies, and interpretations thereof, may change frequently. Current or future laws and regulations could force our portfolio companies engaged in health care, to change their policies related to how they operate, restrict revenue, change costs, change reserve levels and change business practices. In addition, as of December 31, 2022, Software represented 14.7% of our portfolio at fair value. Our investments in Software are subject to substantial risks, including, but not limited to, intense competition, changing technology, shifting user needs, frequent introductions of new products and services, competitors in different industries and ranging from large established companies to emerging startups, decreasing average selling prices of products and services resulting from rapid technological changes, cybersecurity risks and cyber incidents and various legal and regulatory risks. In addition, as of December 31, 2022, our investments in Diversified Financial Services represented 11.3% of our portfolio at fair value. Our investments in Diversified Financial Services are subject to a variety of risks, including, but not limited to, market uncertainty, additional or changing government regulations, disclosure requirements, limits on fees, increasing borrowing costs or limits on the terms or availability of credit to such portfolio companies, and other regulatory requirements, each of which may impact the conduct of such portfolio companies. Compliance with changing regulatory requirements will likely impose staffing, legal, compliance and other costs, and administrative burdens upon our funds’ investments in financial services. We may not be in a position to exercise control over our portfolio companies or to prevent decisions by management of our portfolio companies that could decrease the value of our investments. We do not generally hold controlling equity positions in our portfolio companies. While we are obligated as a BDC to offer to make managerial assistance available to our portfolio companies, we can offer no assurance that management personnel of our portfolio companies will accept or rely on such assistance. To the extent that we do not hold a controlling equity interest in a portfolio company, we are subject to the risk that such portfolio company may make business decisions with which we disagree, and the stockholders and management of such portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity for the debt and equity investments that we typically hold in our portfolio companies, we may not be able to dispose of our investments in the event we disagree with the actions of a portfolio company and may therefore suffer a decrease in the value of our investments. In addition, we may not be in a position to control any portfolio company by investing in its debt securities. As a result, we are subject to the risk that a portfolio company in which we invest may make business decisions with which we disagree and the management of such company, as representatives of the holders of their common equity, may take risks or otherwise act in ways that do not serve our interests as debt investors. We may be subject to risks associated with subordinated debt. We may acquire and/or originate junior lien or subordinated debt investments. If a borrower defaults on a junior lien or subordinated loan or on debt senior in right of payment or as to the proceeds of collateral to our debt investment, or in the event of the bankruptcy of a borrower, the debt investment will be satisfied only after, in the case of junior lien debt, the proceeds of collateral are applied to repay senior lien debt or, in the case of subordinated debt, the senior debt is repaid in full. Under the terms of typical intercreditor or subordination agreements, senior creditors may be able to block the exercise of remedies or the acceleration of the subordinated debt or the exercise by holders of junior lien or subordinated debt of other rights they may have as creditors or in respect of collateral. Accordingly, we may not be able to take the steps necessary or sufficient to protect our investments in a timely manner or at all. In addition, junior lien or subordinated debt may not always be protected by financial covenants or limitations upon additional indebtedness, may have limited liquidity and may not be rated by a credit rating agency. If a borrower declares bankruptcy, we may not have full or any recourse to the assets of the borrower, or the assets of the borrower may not be sufficient to satisfy the loan. Further, the Investment Adviser’s ability to amend the terms of our loans, assign its loans, accept prepayments, exercise its remedies and control decisions made in bankruptcy proceedings may be limited by intercreditor arrangements. In addition, the risks associated with junior lien or subordinated debt include a greater possibility that adverse changes in the financial condition of the obligor or in general economic conditions (including a sustained period of rising interest rates or an economic downturn) may adversely affect the borrower’s ability to pay principal and interest on its debt. Many obligors on junior lien or subordinated loan securities are highly leveraged, and specific developments affecting such obligors, including reduced cash flow from operations or the inability to refinance debt at maturity, may also adversely affect such obligors’ ability to meet debt service obligations. The level of risk associated with investments in subordinated debt increases if such investments are debt of distressed or below investment grade issuers. Default rates for junior lien or subordinated debt securities have historically been higher than has been the case for investment grade securities. We may be subject to risks associated with unsecured debt. We may invest in unsecured indebtedness in portfolio companies where a significant portion of such companies’ senior or junior lien indebtedness ma | |||||||||||||||||||||
Our Securities [Member] | ||||||||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||||||||
Risk [Text Block] | Our Securities Investing in our securities involves an above-average degree of risk. The investments we make in accordance with our investment objective may result in a higher amount of risk than alternative investment options and volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive. Therefore, an investment in our securities may not be suitable for an investor with a lower risk tolerance. The market price of our securities may fluctuate significantly. The market price and liquidity of the market for our securities may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include: • significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies; • price and volume fluctuations in the overall stock market from time to time; • the inclusion or exclusion of our securities from certain indices; • changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs; • any loss of qualification for RIC tax treatment or BDC status; • changes in earnings or perceived changes or variations in operating results; • changes or perceived changes in the value of our portfolio of investments; • changes in accounting guidelines governing valuation of our investments; • any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts; • resignation of the Investment Adviser or departure of certain of its key personnel; • short-selling pressure with respect to shares of our common stock or BDCs generally; • future sales of our securities convertible into or exchangeable or exercisable for our common stock or the conversion of such securities; • operating performance of companies comparable to us; • general economic trends and other external factors; and • loss of a major funding source. In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been brought against that company. If our stock price fluctuates significantly, we may be the target of securities litigation in the future. Securities litigation could result in substantial costs and divert management’s attention and resources from our business. Shares of closed-end investment companies, including BDCs, frequently trade at a discount to their NAV per share. We cannot predict the prices at which our common stock will trade. Shares of closed-end investment companies, including BDCs, frequently trade at a discount from their NAV and our common stock may also be discounted in the market. This characteristic of closed-end investment companies is separate and distinct from the risk that our NAV per share of common stock may decline. We cannot predict whether our common stock will trade at, above or below NAV. In addition, if our common stock trades below its NAV, we will generally not be able to sell additional shares of our common stock to the public at its market price without first obtaining the approval of a majority of our stockholders (including a majority of our unaffiliated stockholders) and our Independent Directors for such issuance. Sales of substantial amounts of our common stock in the public market may have a material adverse effect on the market price of our common stock. Sales of substantial amounts of our common stock, the availability of such common stock for sale or the perception that such sales could occur could materially adversely affect the prevailing market price for our common stock. Both the sale of a substantial amount of our securities and the perception that such sales could occur could impair our ability to raise additional capital through the sale of equity securities should we desire to do so. Additionally, as an owner of approximately 6.3% of our common stock as of December 31, 2022, GS Group Inc. is a significant stockholder that may decide to sell a substantial amount of its common stock, subject to applicable securities laws, and such a sale would exacerbate the effects described above. Our stockholders will experience dilution in their ownership percentage if they opt out of our DRIP. We have adopted the DRIP pursuant to which we automatically reinvest all cash distributions declared by the Board of Directors on behalf of investors who do not elect to receive their distributions in cash. As a result, if the Board of Directors declares a cash distribution, then our stockholders who have not opted out of our DRIP will have their cash distributions automatically reinvested in additional shares of our common stock, rather than receiving the cash distribution. See “ Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities—Price Range of Common Stock and Distributions ” and “ Item 1. Business—Dividend Reinvestment Pla n” for a description of our distribution policy and obligations. If, on the payment date for any distribution, the most recently computed NAV per share is equal to or less than the closing market price plus estimated per share fees (which include any applicable brokerage commissions the plan agent is required to pay), the plan agent will invest the distribution amount in newly issued shares on behalf of the participants. The number of newly issued shares to be credited to a participant’s account will be determined by dividing the dollar amount of the distribution by the most recently computed NAV per share provided that, if the NAV is less than or equal to 95% of the then current market price per share, the dollar amount of the distribution will be divided by 95% of the market price on the payment date. Accordingly, participants in the DRIP may receive a greater number shares of our common stock than the number of shares associated with the market price of our common stock, resulting in dilution for other stockholders. Stockholders that opt out of our DRIP will experience dilution in their ownership percentage of our common stock over time. See “ Item 1. Business—Dividend Reinvestment Plan .” Our stockholders that do not opt out of our DRIP should generally expect to have current tax liabilities without receiving cash to pay such liabilities. Under our DRIP, if we declare a cash distribution, our stockholders who have not elected to “opt out” will have their cash distributions automatically reinvested in additional shares of our common stock, rather than receiving the cash distributions. Stockholders who receive distributions in the form of shares of our common stock generally are subject to the same U.S. federal, state and local tax consequences as stockholders who elect to receive their distributions in cash. However, because their distributions will be reinvested, those stockholders will not receive cash with which to pay any applicable taxes on such reinvested distributions. As a result, stockholders that have not opted out of our DRIP may have to use funds from other sources to pay any tax liabilities imposed upon them based on the value of the common stock received. See “ Item 1. Business—Dividend Reinvestment Plan .” We may in the future determine to issue preferred stock, which could adversely affect the market value of our common stock. The issuance of shares of preferred stock with dividend or conversion rights, liquidation preferences or other economic terms favorable to the holders of preferred stock could adversely affect the market price for our common stock by making an investment in the common stock less attractive. In addition, the dividends on any preferred stock we issue must be cumulative. Payment of dividends and repayment of the liquidation preference of preferred stock must take preference over any distributions or other payments to our common stockholders, and holders of preferred stock are not subject to any of our expenses or losses and are not entitled to participate in any income or appreciation in excess of their stated preference (other than convertible preferred stock that converts into common stock). In addition, under the Investment Company Act, participating preferred stock and preferred stock constitutes a “senior security” for purposes of the 150% asset coverage test. See “— Regulations governing our operations as a BDC affect our ability to, and the way in which we, raise additional capital. These constraints may hinder our Investment Adviser’s ability to take advantage of attractive investment opportunities and to achieve our investment objective .” Certain provisions of our certificate of incorporation and bylaws and the Delaware General Corporation Law (“DGCL”), as well as other aspects of our structure, including the substantial ownership interest of GS Group Inc., could deter takeover attempts and have an adverse impact on the price of our common stock. Our certificate of incorporation and bylaws, as well as the DGCL, contain provisions that may have the effect of discouraging a third party from making an acquisition proposal for us. Among other things, our certificate of incorporation and bylaws: • provide that our Board of Directors is classified, which may delay the ability of our stockholders to change the membership of a majority of our Board of Directors; • do not provide for cumulative voting; • provide that vacancies on our Board of Directors, including newly created directorships, may be filled only by a majority vote of directors then in office; • provide that our directors may be removed only for cause, and only by a supermajority vote of the stockholders entitled to elect such directors; • provide that stockholders may take action only at an annual or special meeting of stockholders, and may not act by written consent; • restrict stockholders’ ability to call special meetings; • require a supermajority vote of stockholders to effect certain amendments to our certificate of incorporation and bylaws; and • require stockholders to provide advance notice of new business proposals and director nominations under specific procedures. We have provisions comparable to those of Section 203 of the DGCL (other than with respect to GS Group Inc. and its affiliates and certain of its or their direct or indirect transferees and any group as to which such persons are a party). These provisions generally prohibit us from engaging in mergers, business combinations and certain other types of transactions with “interested stockholders” (generally defined as persons or entities that beneficially own 15% or more of our voting stock), other than the exempt parties as described above, for a period of three years following the date the person became an interested stockholder unless, prior to such stockholder becoming an interested stockholder, our Board of Directors has approved the “business combination” that would otherwise be restricted or the transaction that resulted in the interested stockholder becoming an interested stockholder or the subsequent transaction with the interested stockholder has been approved by our Board of Directors and 66 2/3% of our outstanding voting stock (other than voting stock owned by the interested stockholder). Such provisions may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer. These anti-takeover provisions may inhibit a change of control in circumstances that could give the holders of our common stock the opportunity to realize a premium over the market price for the common stock. In addition, certain aspects of our structure, including the substantial ownership interest of GS Group Inc., may have the effect of discouraging a third party from making an acquisition proposal for us. We may not be able to pay distributions to holders of our common stock or preferred stock, our distributions to holders of our common stock or preferred stock may not grow over time, and a portion of our distributions to holders of our common stock or preferred stock may be a return of capital for U.S. federal income tax purposes. We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. We cannot assure you that we will achieve investment results that will allow us to make a specified level of cash distributions or year-to-year increases in cash distributions. If we are unable to satisfy the asset coverage test applicable to us as a BDC, or if we violate certain covenants under our Revolving Credit Facility and other debt financing agreements, our ability to pay distributions to our stockholders could be limited. All distributions will be paid at the discretion of our Board of Directors and will depend on our earnings, financial condition, maintenance of our qualification for RIC tax treatment, compliance with applicable BDC regulations, compliance with covenants under our Revolving Credit Facility and other debt financing agreements, if any, and such other factors as our Board of Directors may deem relevant from time to time. The distributions we pay to our stockholders in a year may exceed our net ordinary income and capital gains for that year and, accordingly, a portion of such distributions may constitute a return of capital for U.S. federal income tax purposes that would reduce a stockholder’s adjusted tax basis in its shares of our common stock or preferred stock and correspondingly increase such stockholder’s gain, or reduce such stockholder’s loss, on disposition of such shares. Distributions in excess of a stockholder’s adjusted tax basis in its shares of our common stock or preferred stock will generally constitute capital gains to such stockholder. Stockholders who periodically receive the payment of a distribution from a RIC consisting of a return of capital for U.S. federal income tax purposes may be under the impression that they are receiving a distribution of the RIC’s net ordinary income or capital gains when they are not. Accordingly, stockholders should read carefully any written disclosure accompanying a distribution from us and the information about the specific tax characteristics of our distributions provided to stockholders after the end of each calendar year, and should not assume that the source of any distribution is our net ordinary income or capital gains. The tax treatment of a non-U.S. stockholder in its jurisdiction of tax residence will depend entirely on the laws of such jurisdiction, and may vary considerably from jurisdiction to jurisdiction. Depending on (i) the laws of such non-U.S. stockholder’s jurisdiction of tax residence, (ii) how we, the investments and/or any other investment vehicles through which we directly or indirectly invest are treated in such jurisdiction, and (iii) the activities of any such entities, an investment in us could result in such non-U.S. stockholder recognizing adverse tax consequences in its jurisdiction of tax residence, including (a) with respect to any generally required or additional tax filings and/or additional disclosure required in such filings in relation to the treatment for tax purposes in the relevant jurisdiction of an interest in us, the investments and/or any other investment vehicles through which we directly or indirectly invest and/or of distributions from such entities and any uncertainties arising in that respect (such entities not being established under the laws of the relevant jurisdiction), (b) the possibility of taxable income significantly in excess of cash distributed to a non-U.S. stockholder, and possibly in excess of our actual economic income, (c) the possibilities of losing deductions or the ability to utilize tax basis and of sums invested being returned in the form of taxable income or gains, and (d) the possibility of being subject to tax at unfavorable tax rates. A non-U.S. stockholder may also be subject to restrictions on the use of its share of our deductions and losses in its jurisdiction of tax residence. Each prospective investor is urged to consult its own tax advisors with respect to the tax and tax filing consequences, if any, in its jurisdiction of tax residence of an investment in us, as well as any other jurisdiction in which such prospective investor is subject to taxation. We may have difficulty paying our required distributions if we recognize taxable income before or without receiving cash representing such income. For U.S. federal income tax purposes, we will include in our taxable income certain amounts that we have not yet received in cash, such as OID, which may occur if we receive warrants in connection with the origination of a loan or possibly in other circumstances or contracted PIK interest, which generally represents contractual interest added to the loan balance and due at the end of the loan term. Such OID, which could be significant relative to our overall investment assets, and increases in loan balances as a result of PIK interest will be included in our taxable income before we receive any corresponding cash payments. We also may be required to include in our taxable income certain other amounts that we have not yet received or will not receive in cash, such as accruals on a contingent payment debt instrument, accruals of interest income and/or OID on defaulted debt, or deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. Moreover, we generally will be required to take certain amounts into income no later than the time such amounts are reflected on our financial statements. The credit risk associated with the collectability of deferred payments may be increased as and when a portfolio company increases the amount of interest on which it is deferring cash payment through deferred interest features. Our investments with a deferred interest feature may represent a higher credit risk than loans for which interest must be paid in full in cash on a regular basis. For example, even if the accounting conditions for income accrual are met, the borrower could still default when our actual collection is scheduled to occur upon maturity of the obligation. Because in certain cases we may recognize taxable income before or without receiving cash representing such income, we may have difficulty making distributions to our stockholders that will be sufficient to enable us to meet the Annual Distribution Requirement necessary for us to maintain our qualification for tax treatment as a RIC. Accordingly, we may need to sell some of our assets at times and/or at prices that we would not consider advantageous, we may need to raise additional equity or debt capital, or we may need to forego new investment opportunities or otherwise take actions that are disadvantageous to our business (or be unable to take actions that are advantageous to our business) to enable us to make distributions to our stockholders that will be sufficient to enable us to meet the Annual Distribution Requirement. If we are unable to obtain cash in the amount required for us to make, or if we are restricted from making, sufficient distributions to our stockholders to meet the Annual Distribution Requirement, we may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to a corporate-level U.S. federal income tax (and any applicable U.S. state and local taxes). Our stockholders may receive shares of our common stock or preferred stock as distributions, which could result in adverse tax consequences to them. In order to satisfy the Annual Distribution Requirement applicable to RICs, we will have the ability to declare a large portion of a distribution in shares of our common stock or preferred stock instead of in cash. We are not subject to restrictions on the circumstances in which we may declare a portion of a distribution in shares of our stock but would generally anticipate doing so only in unusual situations, such as, for example, if we do not have sufficient cash to meet our RIC distribution requirements under the Code. Generally, were we to declare such a distribution, we would allow stockholders to elect payment in cash and/or shares of our stock of equivalent value. Under published IRS guidance, the entire distribution by a publicly offered RIC will generally be treated as a taxable distribution for U.S. federal income tax purposes, and count towards our RIC distribution requirements under the Code, if certain conditions are satisfied. Among other things, the aggregate amount of cash available to be distributed to all stockholders is required to be at least 20% of the aggregate declared distribution. If too many stockholders elect to receive cash, the cash available for distribution is required to be allocated among the stockholders electing to receive cash (with the balance of the distribution paid in stock) under a formula provided in the applicable IRS guidance. The number of shares of our stock distributed would thus depend on the applicable percentage limitation on cash available for distribution, the stockholders’ individual elections to receive cash or stock, and the value of the shares of our stock. Each stockholder generally would be treated as having received a taxable distribution (including for purposes of the withholding tax rules applicable to a Non-U.S. stockholder) on the date the distribution is received in an amount equal to the cash that such stockholder would have received if the entire distribution had been paid in cash, even if the stockholder received all or most of the distribution in shares of our common stock or preferred stock. We currently do not intend to pay distributions in shares of our common stock or preferred stock, but we can offer no assurance that we will not do so in the future. If we are not treated as a “publicly offered regulated investment company,” as defined in the Code, U.S. stockholders that are individuals, trusts or estates will be taxed as though they received a distribution of some of our expenses. During the period when we have elected to be treated as a RIC, we expect to be treated as a “publicly offered regulated investment company” (within the meaning of Section 67 of the Code) as a result of either (i) shares of our common stock being held by at least 500 persons at all times during a taxable year or (ii) shares of our common stock being treated as regularly traded on an established securities market. However, we cannot assure investors that we will be treated as a publicly offered regulated investment company for all years. If we are not treated as a publicly offered regulated investment company for any calendar year, each U.S. stockholder that is an individual, trust or estate will be treated as having received a dividend from us in the amount of such U.S. stockholder’s allocable share of the management and incentive fees paid to our Investment Adviser and certain of our other expenses for the calendar year, and these fees and expenses will be treated as miscellaneous itemized deductions of such U.S. stockholder. Miscellaneous itemized deductions of a U.S. stockholder that is an individual, trust or estate are disallowed for tax years beginning before January 1, 2026 and thereafter generally are (i) deductible by such U.S. stockholders only to the extent that the aggregate of such U.S. stockholder’s miscellaneous itemized deductions exceeds 2% of such U.S. stockholder’s adjusted gross income for U.S. federal income tax purposes, (ii) not deductible for purposes of the alternative minimum tax and (iii) subject to the overall limitation on itemized deductions under the Code. Non-U.S. stockholders may be subject to withholding of U.S. federal income tax on dividends we pay. Distributions of our “investment company taxable income” to a non-U.S. stockholder that are not effectively connected with the non-U.S. stockholder’s conduct of a trade or business within the United States will generally be subject to withholding of U.S. federal income tax at a 30% rate (or lower rate provided by an applicable income tax treaty) to the extent paid out of our current or accumulated earnings and profits. Certain properly reported distributions are generally exempt from withholding of U.S. federal income tax where they are paid in respect of our (i) “qualified net interest income” (generally, our U.S.-source interest income, other than certain contingent interest and interest from obligations of a corporation or partnership in which we or the non-U.S. stockholder are at least a 10% stockholder, reduced by expenses that are allocable to such income) or (ii) “qualified short-term capital gains” (generally, the excess of our net short-term capital gain over our net long-term capital loss for such taxable year), and certain other requirements are satisfied. NO ASSURANCE CAN BE GIVEN AS TO WHETHER ANY OF OUR DISTRIBUTIONS WILL BE ELIGIBLE FOR THIS EXEMPTION FROM WITHHOLDING OF U.S. FEDERAL INCOME TAX. IN PARTICULAR, THIS EXEMPTION WILL NOT APPLY TO OUR DISTRIBUTIONS PAID IN RESPECT OF OUR NON-U.S. SOURCE INTEREST INCOME OR OUR DIVIDEND INCOME (OR ANY OTHER TYPE OF INCOME OTHER THAN GENERALLY OUR NON-CONTINGENT U.S. SOURCE INTEREST INCOME RECEIVED FROM UNRELATED OBLIGORS AND OUR QUALIFIED SHORT-TERM CAPITAL GAINS). IN THE CASE OF OUR COMMON STOCK OR PREFERRED STOCK HELD THROUGH AN INTERMEDIARY, THE INTERMEDIARY MAY WITHHOLD U.S. FEDERAL INCOME TAX EVEN IF WE REPORT THE PAYMENT AS QUALIFIED NET INTEREST INCOME OR QUALIFIED SHORT-TERM CAPITAL GAIN. Purchases of our common stock pursuant to any 10b5-1 plan or otherwise may result in the price of our common stock being higher than the price that otherwise might exist in the open market. We are authorized to purchase up to $75.00 million of shares of our common stock if the stock trades below the most recently announced NAV per share (including any updates, corrections or adjustments publicly announced by us to any previously announced NAV per share), subject to certain limitations, commencing on a date to be determined by one or more of our officers. Any such purchases will be conducted in accordance with applicable securities laws. Whether purchases will be made under any 10b5-1 plan we may adopt or otherwise and how much will be purchased at any time is uncertain, dependent on prevailing market prices and trading volumes, all of which we cannot predict. These activities may have the effect of maintaining the market price of our common stock or retarding a decline in the market price of the common stock, and, as a result, the price of our common stock may be higher than the price that otherwise might exist in the open market. Purchases of our common stock by us under any 10b5-1 plan or otherwise may result in dilution to our NAV per share. We are authorized to repurchase shares of common stock when the market price per share is below the most recently reported NAV per share (including any updates, corrections or adjustments publicly announced by us to any previously announced NAV per share), including under any 10b5-1 plan we may adopt, commencing on a date to be determined by one or more of our officers. Because purchases may be made beginning at any price below our most recently reported NAV per share, if our NAV per share decreases after the date as of which NAV per share was last reported, such purchases may result in dilution to our NAV per share. This dilution would occur because we would repurchase shares at a price above the then-current NAV per share, which would cause a proportionately smaller increase in our stockholders’ interest in our earnings and assets and their voting interest in us than the decrease in our assets resulting from such repurchase. As a result of any such dilution, our market price per share may decline. The actual dilutive effect will depend on the number of shares of common stock that could be so repurchased, the price and the timing of any repurchases. To the extent OID and PIK interest constitute a portion of our income, we will be exposed to typical risks associated with such income being required to be included in taxable and accounting income prior to receipt of cash representing such income. Our investments may include OID instruments and PIK, interest arrangements, which represents contractual interest added to a loan balance and due at the end of such loan’s term. To the extent OID or PIK interest constitute a portion of our income, we are exposed to typical risks associated with such income being required to be included in taxable and accounting income prior to receipt of cash, including the following: • The higher interest rates of OID and PIK instruments reflect the payment deferral and increased credit risk associated with these instruments, and OID and PIK instruments generally represent a significantly higher credit risk than coupon loans. • Even if the accounting conditions for income accrual are met, the borrower could still default when our actual collection is supposed to occur at the maturity of the obligation. • OID and PIK instruments may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. OID and PIK income may also create uncertainty about the source of our cash distributions. • For accounting purposes, any cash distributions to stockholders representing OID and PIK income are not treated as coming from paid-in capital, even if the cash to pay them comes from offering proceeds. As a result, despite the fact that a distribution representing OID and PIK income could be paid out of amounts invested by our stockholders, the Investment Company Act does not require that stockholders be given notice of this fact by reporting it as a return of capital. In addition, investments in PIK and OID instruments may provide certain benefits to the Investment Adviser, including increasing management fees and incentive fees prior to the receipt of cash with respect to accrued interest payments. Terms relating to redemption may materially adversely affect an investor’s return on any debt securities that we may issue. If our noteholders’ debt securities are redeemable at our option, we may choose to redeem debt securities at times when prevailing interest rates are lower than the interest rate paid on such debt securities. In addition, if our noteholders’ debt securities are subject to mandatory redemption, we may be required to redeem such debt securities also at times when prevailing interest rates are lower than the interest rate paid on such debt securities. In this circumstance, a noteholder may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as the debt securities being redeemed. Our credit ratings may not reflect all risks of an investment in our debt securities. Our credit ratings are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our debt securities. Our credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of or trading market for the publicly issued debt securities. Holders of any preferred stock we might issue would have the right to elect members of the board of directors and class voting rights on certain matters. Holders of any preferred stock we might issue, voting separately as a single class, would have the right to elect two members of the board of directors at all times and in the event dividends become two full years in arrears would have the right to elect a majority of the directors until such arrearage is completely eliminated. In addition, preferred stockholders have class voting rights on certain matters, including changes in fundamental investment restrictions and conversion to open-end status, and accordingly can veto any such changes. Restrictions imposed on the declarations and payment of dividends or other distributions to the holders of our common stock and preferred stock, both by the Investment Company Act and by requirements imposed by rating agencies or the terms of our credit facilities, might impair our ability to maintain our qualification for tax treatment as a RIC. While we would intend to redeem our preferred stock to the extent necessary to enable us to distribute our inco | |||||||||||||||||||||
2025 Notes | ||||||||||||||||||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||||||||||||||||||
Long Term Debt, Title [Text Block] | 2025 Notes | |||||||||||||||||||||
Long Term Debt, Principal | $ 360,000,000 | |||||||||||||||||||||
Long Term Debt, Structuring [Text Block] | The 2025 Notes bear interest at a rate of 3.75% per year, payable semi-annually in arrears on February 10 and August 10 of each year, commencing on August 10, 2020. The 2025 Notes will mature on February 10, 2025 and may be redeemed in whole or in part at our option at any time or from time to time at the redemption prices set forth in the indenture. | |||||||||||||||||||||
2026 Notes | ||||||||||||||||||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||||||||||||||||||
Long Term Debt, Title [Text Block] | 2026 Notes | |||||||||||||||||||||
Long Term Debt, Principal | $ 500,000,000 | |||||||||||||||||||||
Long Term Debt, Structuring [Text Block] | The 2026 Notes bear interest at a rate of 2.875% per year, payable semi-annually in arrears on January 15 and July 15 of each year, commencing on July 15, 2021. The 2026 Notes will mature on January 15, 2026 and may be redeemed in whole or in part at our option at any time or from time to time at the redemption prices set forth in the indenture. | |||||||||||||||||||||
Revolving Credit Facility | ||||||||||||||||||||||
Financial Highlights [Abstract] | ||||||||||||||||||||||
Senior Securities Amount | $ 1,161,400,000 | $ 858,720,000 | $ 629,380,000 | $ 618,410,000 | $ 509,420,000 | $ 431,250,000 | $ 387,750,000 | $ 419,000,000 | $ 350,000,000 | |||||||||||||
Senior Securities Coverage per Unit | $ 1,740.41 | $ 1,860.46 | $ 1,979.61 | $ 1,869.46 | $ 2,062.21 | $ 2,328.75 | $ 2,323 | $ 2,643.56 | $ 2,641.66 | |||||||||||||
Convertible Notes due 2022 | ||||||||||||||||||||||
Financial Highlights [Abstract] | ||||||||||||||||||||||
Senior Securities Amount | $ 155,000,000 | $ 155,000,000 | $ 155,000,000 | $ 155,000,000 | $ 115,000,000 | $ 115,000,000 | ||||||||||||||||
Senior Securities Coverage per Unit | $ 1,860.46 | $ 1,979.61 | $ 1,869.46 | $ 2,062.21 | $ 2,328.75 | $ 2,323 | ||||||||||||||||
Unsecured Notes due 2025 | ||||||||||||||||||||||
Financial Highlights [Abstract] | ||||||||||||||||||||||
Senior Securities Amount | $ 360,000,000 | $ 360,000,000 | $ 360,000,000 | |||||||||||||||||||
Senior Securities Coverage per Unit | $ 1,740.41 | $ 1,860.46 | $ 1,979.61 | |||||||||||||||||||
Unsecured Notes due 2026 | ||||||||||||||||||||||
Financial Highlights [Abstract] | ||||||||||||||||||||||
Senior Securities Amount | $ 500,000,000 | $ 500,000,000 | $ 500,000,000 | |||||||||||||||||||
Senior Securities Coverage per Unit | $ 1,740.41 | $ 1,860.46 | $ 1,979.61 | |||||||||||||||||||
Foreign Currency Forward Contracts | ||||||||||||||||||||||
Financial Highlights [Abstract] | ||||||||||||||||||||||
Senior Securities Amount | $ 7,750,000 | $ 2,480,000 | $ 4,380,000 | $ 4,230,000 | $ 3,900,000 | |||||||||||||||||
Senior Securities Coverage per Unit | $ 1,740.41 | $ 1,860.46 | $ 1,979.61 | $ 1,869.46 | $ 2,062.21 |
Organization
Organization | 12 Months Ended |
Dec. 31, 2022 | |
Organization Consolidation And Presentation Of Financial Statements [Abstract] | |
Organization | 1. ORGANIZATION Goldman Sachs BDC, Inc. (the “Company,” which term refers to either Goldman Sachs BDC, Inc. or Goldman Sachs BDC, Inc. together with its consolidated subsidiaries, as the context may require) was initially established as Goldman Sachs Liberty Harbor Capital, LLC, a single member Delaware limited liability company (“SMLLC”), on September 26, 2012 and commenced operations on November 15, 2012 with The Goldman Sachs Group, Inc. (“GS Group Inc.”) as its sole member. On March 29, 2013, the Company elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Effective April 1, 2013, the Company converted from a SMLLC to a Delaware corporation. In addition, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2013. The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including first lien debt, unitranche loans, including last-out portions of such loans, and second lien debt, and unsecured debt, including mezzanine debt, as well as through select equity investments. Goldman Sachs Asset Management, L.P. (“GSAM”), a Delaware limited partnership and an affiliate of Goldman Sachs & Co. LLC (including its predecessors, “GS & Co.”), is the investment adviser (the “Investment Adviser”) of the Company. The term “Goldman Sachs” refers to GS Group Inc., together with GS & Co., GSAM and its other subsidiaries. On March 23, 2015, the Company completed its initial public offering and the Company’s common stock began trading on the New York Stock Exchange under the symbol “GSBD.” The Company has formed wholly owned subsidiaries, which are structured as Delaware limited liability companies, to hold certain equity or equity-like investments in portfolio companies. The Merger with Goldman Sachs Middle Market Lending Corp. On October 12, 2020 , the Company completed its merger (the “Merger”) with Goldman Sachs Middle Market Lending Corp. (“GS MMLC”) pursuant to the Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of June 11, 2020. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of GS MMLC common stock was converted into the right to receive, for each share of GS MMLC common stock, that number of shares of the Company’s common stock, par value $ 0.001 per share (“Common Stock”), with a net asset value (“NAV”) equal to the NAV per share of GS MMLC common stock, in each case calculated as of October 9, 2020. As a result of the Merger, the Company issued an aggregate of 61,037,311 shares of Common Stock to former GS MMLC stockholders. For further information, see Note 13 “Merger with GS MMLC.” |
Significant Accounting Policies
Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | 2. SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The Company’s functional currency is U.S. dollars (“USD”) and these consolidated financial statements have been prepared in that currency. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to Regulation S-X. This requires the Company to make certain estimates and assumptions that may affect the amounts reported on the consolidated financial statements and accompanying notes. These consolidated financial statements reflect normal and recurring adjustments that in the opinion of the Company are necessary for the fair statement of the results for the periods presented. Actual results may differ from the estimates and assumptions included on the consolidated financial statements. Certain prior period information has been reclassified to conform to the current period presentation. The reclassification has no effect on the Company’s consolidated financial position or the consolidated results of operations as previously reported. As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (“ASC”) Topic 946, Financial Services – Investment Companies (“ASC 946”) issued by the Financial Accounting Standards Board (“FASB”). Basis of Consolidation As provided under ASC 946, the Company will not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. Accordingly, the Company consolidated the financial position and results of operations of its wholly owned subsidiaries, BDC Blocker I, LLC (formerly known as My-On BDC Blocker, LLC), GSBD Blocker II, LLC, GSBD Wine I, LLC, GSBD Blocker III, LLC, GSBD Blocker IV, LLC, GSBD Blocker V, LLC, MMLC Blocker I, LLC, MMLC Blocker II, LLC, MMLC Wine I, LLC, and MMLC Blocker III, LLC. All significant intercompany transactions and balances have been eliminated in consolidation. Revenue Recognition The Company records its investment transactions on a trade date basis, which is the date when the Company assumes the risks for gains and losses related to that instrument. Realized gains and losses are based on the specific identification method. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis. Discounts and premiums to par value on investments purchased are accreted and amortized into interest income over the life of the respective investment using the effective interest method. Loan origination fees, original issue discount (“OID”) and market discounts or premiums are capitalized and amortized into interest income using the effective interest method or straight-line method, as applicable. Exit fees that are receivable upon repayment of a loan or debt security are amortized into interest income over the life of the respective investment. Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income, for which the Company has earned the following: For the Years Ended December 31, 2022 2021 2020 Prepayment premiums $ 1,676 $ 3,224 $ 1,822 Accelerated amortization of upfront loan origination fees and unamortized discounts $ 12,536 $ 54,467 $ 9,494 Fees received from portfolio companies (directors’ fees, consulting fees, administrative fees, tax advisory fees and other similar compensation) are paid to the Company, unless, to the extent required by applicable law or exemptive relief, if any, therefrom, the Company only receives its allocable portion of such fees when invested in the same portfolio company as another account managed by the Investment Adviser. Dividend income on preferred equity investments is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity investments is recorded on the record date for private portfolio companies and on the ex-dividend date for publicly traded portfolio companies. Interest and dividend income are presented net of withholding tax, if any. Certain investments may have contractual payment-in-kind (“PIK”) interest or dividends. PIK represents accrued interest or accumulated dividends that are added to the principal amount or shares (if equity) of the investment on the respective interest or dividend payment dates rather than being paid in cash and generally becomes due at maturity or upon the investment being called by the issuer. PIK is recorded as interest or dividend income, as applicable. If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest or dividends are generally reversed through interest or dividend income. Certain structuring fees, amendment fees, syndication fees and commitment fees are recorded as other income when earned. Administrative agent fees received by the Company are recorded as other income when the services are rendered over time. Acquisition Accounting On October 12, 2020, the Company completed its merger with GS MMLC pursuant to the Merger Agreement, dated as of June 11, 2020. The Merger was accounted for as an asset acquisition in accordance with ASC 805-50, Business Combinations - Related Issues. See Note 13 “Merger with GS MMLC" for further details. Non-Accrual Investments Investments are placed on non-accrual status when it is probable that principal, interest or dividends will not be collected according to the contractual terms. Accrued interest or dividends generally are reversed when an investment is placed on non-accrual status. Interest or dividend payments received on non-accrual investments may be recognized as income or applied to principal depending upon management’s judgment. Non-accrual investments are restored to accrual status when past due principal and interest or dividends are paid and, in management’s judgment, principal and interest or dividend payments are likely to remain current. The Company may make exceptions to this treatment if an investment has sufficient collateral value and is in the process of collection. As of December 31, 2022, the Company had certain investments held in eight portfolio companies on non-accrual status, which represented 2.1 % and 0.3 % of the total investments (excluding investments in money market funds, if any) at amortized cost and at fair value. As of December 31, 2021, the Company had certain investments held in four portfolio companies on non-accrual status, which represented 2.5 % and 1.8 % of the total investments (excluding investments in money market funds, if any) at amortized cost and at fair value. Investments The Company carries its investments in accordance with ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), issued by the FASB, which defines fair value, establishes a framework for measuring fair value and requires disclosures about fair value measurements. Fair value is generally based on quoted market prices provided by independent price sources. In the absence of quoted market prices, investments are measured at fair value as determined by the Investment Adviser, as the valuation designee ("Valuation Designee") designated by the board of directors of the Company (the “Board of Directors”or the “Board”), pursuant to Rule 2a-5 under the Investment Company Act. Due to the inherent uncertainties of valuation, certain estimated fair values may differ significantly from the values that would have been realized had a ready market for these investments existed, and these differences could be material. See Note 5 “Fair Value Measurement.” The Company generally invests in illiquid securities, including debt and equity investments, of middle-market companies. The Board of Directors has designated to the Investment Adviser day-to-day responsibilities for implementing and maintaining internal controls and procedures related to the valuation of the Company’s portfolio investments. Under valuation procedures approved by the Board of Directors and adopted by the Valuation Designee, market quotations are generally used to assess the value of the investments for which market quotations are readily available (as defined in Rule 2a-5). The Investment Adviser obtains these market quotations from independent pricing sources. If market quotations are not readily available, the Investment Adviser prices securities at the bid prices obtained from at least two brokers or dealers, if available; otherwise, the Investment Adviser obtains prices from a principal market maker or a primary market dealer. To assess the continuing appropriateness of pricing sources and methodologies, the Investment Adviser regularly performs price verification procedures and issues challenges as necessary to independent pricing sources or brokers, and any differences are reviewed in accordance with the valuation procedures. If the Valuation Designee believes any such market quotation does not reflect the fair value of an investment, it may independently value such investment in accordance with valuation procedures for investments for which market quotations are not readily available. With respect to investments for which market quotations are not readily available, or for which market quotations are deemed not reflective of the fair value, the valuation procedures approved by the Board of Directors and adopted by the Valuation Designee, contemplate a multi-step valuation process conducted by the Investment Adviser each quarter and more frequently as needed. As the valuation designee, the Investment Adviser is primarily responsible for the valuation of the Company’s assets, subject to the oversight of the Board of Directors, as described below: (1) The quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the valuation of the portfolio investment; (2) The Valuation Designee also engages independent valuation firms (the “Independent Valuation Advisors”) to provide independent valuations of the investments for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of an investment. The Independent Valuation Advisors independently value such investments using quantitative and qualitative information. The Independent Valuation Advisors also provide analyses to support their valuation methodology and calculations. The Independent Valuation Advisors provide an opinion on a final range of values on such investments to the Valuation Designee. The Independent Valuation Advisors define fair value in accordance with ASC 820 and utilize valuation approaches including the market approach, the income approach or both. A portion of the portfolio is reviewed on a quarterly basis, and all investments in the portfolio for which market quotations are not readily available, or are readily available, but deemed not reflective of the fair value of an investment, are reviewed at least annually by an Independent Valuation Advisor; (3) The Independent Valuation Advisor’s preliminary valuations are reviewed by the Investment Adviser and the Valuation Oversight Group (“VOG”), a team that is part of the controllers group of Goldman Sachs. The Independent Valuation Advisors’ valuation ranges are compared to the Investment Adviser’s valuations to ensure the Investment Adviser’s valuations are reasonable. VOG presents the valuations to the Asset Management Private Investment Valuation and Side Pocket Working Group of the Asset Management Valuation Committee (the “Asset Management Private Investment Valuation and Side Pocket Working Group”), which is comprised of a number of representatives from different functions and areas of expertise related to GSAM’s business and controls who are independent of the investment decision making process; (4) The Asset Management Private Investment Valuation and Side Pocket Working Group reviews and preliminarily approves the fair valuations and makes fair valuation recommendations to the Asset Management Valuation Committee; (5) The Asset Management Valuation Committee reviews the valuation information provided by the Asset Management Private Investment Valuation and Side Pocket Working Group, the VOG, the investment professionals of the Investment Adviser responsible for valuations, and the Independent Valuation Advisors. The Asset Management Valuation Committee then assesses such valuation recommendations; and (6) Through the Asset Management Valuation Committee, the Valuation Designee discusses the valuations, provides written reports to the Board of Directors on at least a quarterly basis, and, within the meaning of the Investment Company Act, determines the fair value of the investments in good faith, based on the inputs of the Asset Management Valuation Committee, the Asset Management Private Investment Valuation and Side Pocket Working Group, the VOG, the investment professionals of the Investment Adviser responsible for valuations, and the Independent Valuation Advisors. Money Market Funds Investments in money market funds are valued at NAV per share and are considered cash equivalents for the purposes of the management fee paid to the Investment Adviser. See Note 3 “Significant Agreements and Related Party Transactions.” Cash Cash consists of deposits held at a custodian bank. As of December 31, 2022 and December 31, 2021, the Company held an aggregate cash balance of $ 39,602 and $ 33,764 . Foreign currency of $ 1,037 and $ 2,614 (acquisition cost of $ 1,035 and $ 2,760 ) is included in cash as of December 31, 2022 and December 31, 2021. Foreign Currency Translation Amounts denominated in foreign currencies are translated into USD on the following basis: (i) investments and other assets and liabilities denominated in foreign currencies are translated into USD based upon currency exchange rates effective on the last business day of the period; and (ii) purchases and sales of investments, borrowings and repayments of such borrowings, income, and expenses denominated in foreign currencies are translated into USD based upon currency exchange rates prevailing on the transaction dates. The Company does not isolate the portion of the results of operations resulting from changes in foreign exchange rates on investments from fluctuations arising from changes in market prices of securities held. Such fluctuations are included within the net realized and unrealized gains or losses on investments. Fluctuations arising from the translation of non-investment assets and liabilities, if any, are included with the net change in unrealized gains (losses) on foreign currency translations on the Consolidated Statements of Operations. Foreign securities and currency translations may involve certain considerations and risks not typically associated with investing in U.S. companies and U.S. government securities. These risks include, but are not limited to, currency fluctuations and revaluations and future adverse political, social and economic developments, which could cause investments in foreign markets to be less liquid and prices more volatile than those of comparable U.S. companies or U.S. government securities. Derivatives The Company may enter into foreign currency forward contracts to reduce the Company’s exposure to foreign currency exchange rate fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another, at a pre-determined price at a future date. Forward foreign currency contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Notional amounts of foreign currency forward contract assets and liabilities are presented separately on the Consolidated Schedules of Investments. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting and as such, the Company recognizes its derivatives at fair value, and records changes in the net unrealized appreciation (depreciation) on foreign currency forward contracts in the Consolidated Statements of Operations. Income Taxes The Company recognizes tax positions in its consolidated financial statements only when it is more likely than not that the position will be sustained upon examination by the relevant taxing authority based on the technical merits of the position. A position that meets this standard is measured at the largest amount of benefit that will more likely than not be realized upon settlement. The Company reports any interest expense related to income tax matters in income tax expense and any income tax penalties under expenses on the Consolidated Statements of Operations. The Company’s tax positions have been reviewed based on applicable statutes of limitation for tax assessments, which may vary by jurisdiction, and based on such review, the Company has concluded that no additional provision for income tax is required on the consolidated financial statements. The Company is subject to potential examination by certain taxing authorities in various jurisdictions. The Company’s tax positions are subject to ongoing interpretation of laws and regulations by taxing authorities. The Company has elected to be treated as a RIC commencing with its taxable year ended December 31, 2013. So long as the Company maintains its status as a RIC, it will generally not be required to pay corporate-level U.S. federal income tax on any ordinary income or capital gains that it distributes at least annually to its stockholders as dividends. As a result, any U.S. federal income tax liability related to income earned and distributed by the Company represents obligations of the Company’s stockholders and will not be reflected on the consolidated financial statements of the Company. To maintain its tax treatment as a RIC, the Company must meet specified source-of-income and asset diversification requirements and timely distribute to its stockholders for each taxable year at least 90% of its investment company taxable income (generally, its net ordinary income plus the excess of its realized net short-term capital gains over realized net long-term capital losses, determined without regard to the dividends paid deduction). In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income as required. For the years ended December 31, 2022, 2021 and 2020 the Company accrued excise taxes of $ 4,519 , $ 1,254 and $ 1,443 . As of December 31, 2022, $ 3,494 of accrued excise taxes remained payable. Certain of the Company’s consolidated subsidiaries are subject to U.S. federal and state corporate-level income taxes. Income tax expense, if any, is included under the income category for which it applies on the Consolidated Statements of Operations. Distributions Distributions from net investment income and net realized capital gains are determined in accordance with U.S. federal income tax regulations, which may differ from those amounts determined in accordance with GAAP. The Company may pay distributions in excess of its taxable net investment income. This excess would be a tax-free return of capital in the period and reduce the stockholder’s tax basis in its shares. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent they are charged or credited to paid-in capital in excess of par or distributable earnings, as appropriate, in the period that the differences arise. Temporary and permanent differences are primarily attributable to differences in the tax treatment of certain loans and the tax characterization of income and non-deductible expenses. These differences are generally determined in conjunction with the preparation of the Company’s annual RIC tax return. Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a distribution is determined by the Board of Directors each quarter and is generally based upon the earnings estimated by the Investment Adviser. The Company may pay distributions to its stockholders in a year in excess of its net ordinary income and capital gains for that year and, accordingly, a portion of such distributions may constitute a return of capital for U.S. federal income tax purposes. The Company intends to timely distribute to its stockholders substantially all of its annual taxable income for each year, except that the Company may retain certain net capital gains for reinvestment and, depending upon the level of the Company’s taxable income earned in a year, the Company may choose to carry forward taxable income for distribution in the following year and pay any applicable tax. The specific tax characteristics of the Company’s distributions will be reported to stockholders after the end of the calendar year. All distributions will be subject to available funds, and no assurance can be given that the Company will be able to declare such distributions in future periods. The Company has a voluntary dividend reinvestment plan (the “DRIP”) that provides for the automatic reinvestment of all cash distributions declared by the Board of Directors unless a stockholder elects to “opt out” of the plan. As a result, if the Board of Directors declares a cash distribution, then the stockholders who have not “opted out” of the DRIP will have their cash distributions automatically reinvested in additional shares of common stock, rather than receiving the cash distribution. If the distribution is subject to withholding tax as described above, only the net after-tax amount will be reinvested in additional Shares. Stockholders who receive distributions in the form of shares of common stock will generally be subject to the same U.S. federal, state and local tax consequences as if they received cash distributions and, for this purpose, stockholders receiving distributions in the form of stock will generally be treated as receiving distributions equal to the fair market value of the stock received through the plan; however, since their cash distributions will be reinvested, those stockholders will not receive cash with which to pay any applicable taxes. Due to regulatory considerations, GS Group Inc. has opted out of the dividend reinvestment plan, and GS & Co. has opted out of the dividend reinvestment plan in respect of shares of the Company’s common stock acquired through the 10b5-1 Plan. Deferred Financing and Debt Issuance Costs Deferred financing and debt issuance costs consist of fees and expenses paid in connection with the closing of and amendments to the Company’s borrowings. The aforementioned costs are amortized using the straight-line method over each instrument’s term. Deferred financing costs related to a revolving credit facility is presented separately as an asset on the Company’s Consolidated Statements of Assets and Liabilities. Deferred debt issuance costs related to any notes are presented net against the outstanding debt balance on the Consolidated Statements of Assets and Liabilities. Equity Offering Costs Offering costs consist of fees and expenses paid in connection with equity offerings. Offering costs are charged against the proceeds from equity offerings when proceeds are received. |
Significant Agreements and Rela
Significant Agreements and Related Party Transactions | 12 Months Ended |
Dec. 31, 2022 | |
Related Party Transactions [Abstract] | |
Significant Agreements and Related Party Transactions | 3. SIGNIFICANT AGREEMENTS AND RELATED PARTY TRANSACTIONS Investment Management Agreement The Company entered into an investment management agreement (the “Investment Management Agreement”) with the Investment Adviser, pursuant to which the Investment Adviser manages the Company’s investment program and related activities. Management Fee The Company pays the Investment Adviser a management fee (the “Management Fee”), accrued and payable quarterly in arrears. The Management Fee is calculated at an annual rate of 1.00 % ( 0.25 % per quarter) of the average of the values of the Company’s gross assets (excluding cash or cash equivalents but including assets purchased with borrowed amounts) at the end of each of the two most recently completed calendar quarters. The Management Fee for any partial quarter will be appropriately prorated. The Investment Adviser waives a portion of its management fee payable by the Company in an amount equal to the management fees it earns as an investment adviser for any affiliated money market funds in which the Company invests. For the years ended December 31, 2022, 2021 and 2020, Management Fees amounted to $ 35,996 , $ 32,611 and $ 16,846 and the Investment Adviser has voluntarily agreed to waive $ 346 , $ 500 and $ 3,806 of Management Fees. As of December 31, 2022, $ 9,063 remained payable. Incentive Fee The incentive fee (the “Incentive Fee”) consists of two components that are determined independent of each other, with the result that one component may be payable even if the other is not. The Incentive Fee is calculated as follows: A portion of the Incentive Fee is based on income and a portion is based on capital gains, each as described below. The Investment Adviser is entitled to receive the Incentive Fee based on income if Ordinary Income (as defined below) exceeds a quarterly “hurdle rate” of 1.75 %. For this purpose, the hurdle is computed by reference to the Company’s NAV and does not take into account changes in the market price of the Company’s common stock. The Incentive Fee based on income is determined and paid quarterly in arrears at the end of each calendar quarter by reference to the Company’s aggregate net investment income, as adjusted as described below, from the calendar quarter then ending and the eleven preceding calendar quarters (such period the “Trailing Twelve Quarters”). The Incentive Fee based on capital gains is determined and paid annually in arrears at the end of each calendar year by reference to an “Annual Period,” which means the period beginning on January 1 of each calendar year and ending on December 31 of such calendar year or, in the case of the first and last year, the appropriate portion thereof. The hurdle amount for the Incentive Fee based on income is determined on a quarterly basis and is equal to 1.75 % multiplied by the Company’s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters. The hurdle amount is calculated after making appropriate adjustments for subscriptions (which includes all of the Company’s issuances of shares of its common stock, including issuances pursuant to its DRIP) and distributions that occurred during the relevant Trailing Twelve Quarters. The Incentive Fee for any partial period will be appropriately prorated. i. Quarterly Incentive Fee Based on Income For the portion of the Incentive Fee based on income, the Company pays the Investment Adviser a quarterly Incentive Fee based on the amount by which (A) aggregate net investment income (“Ordinary Income”) in respect of the relevant Trailing Twelve Quarters exceeds (B) the hurdle amount for such Trailing Twelve Quarters. The amount of the excess of (A) over (B) described in this paragraph for such Trailing Twelve Quarters is referred to as the “Excess Income Amount.” Ordinary Income is net of all fees and expenses, including the Management Fee but excluding any Incentive Fee. The Incentive Fee based on income for each quarter is determined as follows: • No Incentive Fee based on income is payable to the Investment Adviser for any calendar quarter for which there is no Excess Income Amount; • 100 % of the Ordinary Income, if any, that exceeds the hurdle amount, but is less than or equal to an amount, referred to as the “Catch-up Amount,” determined as the sum of 2.1875 % multiplied by the Company’s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters is included in the calculation of the Incentive Fee based on income; and • 20 % of the Ordinary Income that exceeds the Catch-up Amount is included in the calculation of the Incentive Fee based on income. The amount of the Incentive Fee based on income that is paid to the Investment Adviser for a particular quarter equals the excess of the Incentive Fee so calculated minus the aggregate Incentive Fees based on income that were paid in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters but not in excess of the Incentive Fee Cap (as described below). The Incentive Fee based on income that is paid to the Investment Adviser for a particular quarter is subject to a cap (the “Incentive Fee Cap”). The Incentive Fee Cap for any quarter is an amount equal to (a) 20 % of the Cumulative Net Return (as defined below) during the relevant Trailing Twelve Quarters minus (b) the aggregate Incentive Fees based on income that were paid in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters. “Cumulative Net Return” means (x) the Ordinary Income in respect of the relevant Trailing Twelve Quarters minus (y) any Net Capital Loss, if any, in respect of the relevant Trailing Twelve Quarters. If, in any quarter, the Incentive Fee Cap is zero or a negative value, the Company pays no Incentive Fee based on income to the Investment Adviser for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is a positive value but is less than the Incentive Fee based on income that is payable to the Investment Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company pays an Incentive Fee based on income to the Investment Adviser equal to the Incentive Fee Cap for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is equal to or greater than the Incentive Fee based on income that is payable to the Investment Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company pays an Incentive Fee based on income to the Investment Adviser equal to the Incentive Fee calculated as described above for such quarter without regard to the Incentive Fee Cap. “Net Capital Loss” in respect of a particular period means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in such period and (ii) aggregate capital gains, whether realized or unrealized, in such period. ii. Annual Incentive Fee Based on Capital Gains The portion of the Incentive Fee based on capital gains is calculated on an annual basis. For each Annual Period, the Company pays the Investment Adviser an amount equal to (A) 20 % of the difference, if positive, of the sum of the Company’s aggregate realized capital gains, if any, computed net of the Company’s aggregate realized capital losses, if any, and the Company’s aggregate unrealized capital depreciation, in each case from April 1, 2013 until the end of such Annual Period minus (B) the cumulative amount of Incentive Fees based on capital gains previously paid to the Investment Adviser from April 1, 2013. For the avoidance of doubt, unrealized capital appreciation is excluded from the calculation in clause (A) above. The Company accrues, but does not pay, a portion of the Incentive Fee based on capital gains with respect to net unrealized appreciation. Under GAAP, the Company is required to accrue an Incentive Fee based on capital gains that includes net realized capital gains and losses and net unrealized capital appreciation and depreciation on investments held at the end of each period. In calculating the accrual for the Incentive Fee based on capital gains, the Company considers the cumulative aggregate unrealized capital appreciation in the calculation, since an Incentive Fee based on capital gains would be payable if such unrealized capital appreciation were realized, even though such unrealized capital appreciation is not permitted to be considered in calculating the fee payable under the Investment Management Agreement. This accrual is calculated using the aggregate cumulative net realized capital gains and losses and aggregate cumulative net unrealized capital appreciation and depreciation. If such amount is positive at the end of a period, then the Company records a capital gains incentive fee equal to 20 % of such amount, minus the aggregate amount of actual Incentive Fees based on capital gains paid in all prior periods. If such amount is negative, then there is no accrual for such period. There can be no assurance that such unrealized capital appreciation will be realized in the future. For the years ended December 31, 2022, 2021 and 2020, Incentive Fees based on income amounted to $ 12,023 , $ 40,697 and $ 35,845 . GSAM voluntarily agreed to waive $ 11,378 of Incentive Fees for the year ended December 31, 2022. As of December 31, 2022, $ 0 remained payable. For the years ended December 31, 2022, 2021 and 2020, the Company did no t accrue or pay any Incentive Fees based on capital gains. In connection with the Merger, GSAM agreed to waive a portion of its Incentive Fee based on income to the extent incurred, for a period of nine quarters, commencing with the quarter ended December 31, 2019 and through and including the quarter ending December 31, 2021, otherwise payable by the Company under the Investment Management Agreement by and between the Company and GSAM, as applicable, for each such quarter in an amount sufficient to ensure that the Company’s net investment income per weighted share outstanding for such quarter is at least $ 0.48 per share. For the years ended December 31, 2021 and 2020, GSAM waived $ 4,544 and $ 23,070 of Incentive Fees. Additionally, GSAM voluntarily agreed to waive $ 26,534 and $ 10,110 of Incentive Fees for the years ended December 31, 2021 and 2020 attributable to the purchase discount resulting from the Merger. Administration and Custodian Fees The Company has entered into an administration agreement with State Street Bank and Trust Company (the “Administrator”) under which the Administrator provides various accounting and administrative services to the Company. The Company pays the Administrator fees for its services as it determines to be commercially reasonable in its sole discretion. The Company also reimburses the Administrator for all reasonable expenses. To the extent that the Administrator outsources any of its functions, the Administrator pays any compensation associated with such functions. The Administrator also serves as the Company’s custodian (the “Custodian”). For the years ended December 31, 2022, 2021 and 2020, the Company incurred expenses for services provided by the Administrator and the Custodian of $ 2,094 , $ 1,954 and $ 1,151 . As of December 31, 2022, $ 518 remained payable. Transfer Agent Fees The Company has entered into a transfer agency and services agreement pursuant to which Computershare Trust Company, N.A. serves as the Company’s transfer agent (the “Transfer Agent”), dividend agent and registrar. For the years ended December 31, 2022, 2021 and 2020, the Company incurred expenses for services provided by the Transfer Agent of $ 38 , $ 38 and $ 25 . As of December 31, 2022, $ 25 remained payable. Common Stock Repurchase Plans In November 2020, our Board of Directors authorized the adoption of a new common stock repurchase plan (the “2020 10b5-1 Plan”), which provided for us to repurchase up to $ 75,000 of shares of our common stock if the stock trades below the most recently announced quarter-end NAV per share, subject to limitations. The 2020 10b5-1 Plan was adopted and took effect on November 9, 2020 . The 2020 10b5-1 Plan expired on November 9, 2021 . We did not repurchase any of our common stock pursuant to the 2020 10b5-1 Plan or otherwise. In November 2021, the Board of Directors approved and authorized a new 10b5-1 stock repurchase plan (the "10b5-1 Plan"), which provides for the Company to repurchase up to $ 75,000 of shares of the Company’s common stock if the stock trades below the most recently announced quarter-end NAV per share, subject to certain limitations. Under this 10b5-1 Plan, no purchases will be made if such purchases would cause the Company’s Debt/Equity Ratio to exceed the lower of (a) 1.30 or (b) the Maximum Debt/Equity Ratio. In the 10b5-1 Plan, “Debt/Equity Ratio” means the sum of debt on the Consolidated Statements of Assets and Liabilities and the total notional value of the Company’s unfunded commitments divided by net assets, as of the most recent reported financial statement end date, and “Maximum Debt/Equity Ratio” means the sum of debt on the Consolidated Statements of Assets and Liabilities and committed uncalled debt divided by net assets, as of the most recent reported financial statement end date. The 10b5-1 Plan became effective on August 17, 2022 and commenced on September 16, 2022 . The 10b5-1 Plan will expire on August 17, 2023 . Purchases under the 10b5-1 Plan will be conducted on a programmatic basis in accordance with Rules 10b5-1 and 10b-18 under the Exchange Act and other applicable securities laws. The Company’s repurchase of its common stock under the 10b5-1 Plan or otherwise may result in the price of the Company’s common stock being higher than the price that otherwise might exist in the open market. The Company did not repurchase any of its common stock pursuant to the 10b5-1 Plan or otherwise. Affiliates GS Group Inc. owned 6.3 % as of December 31, 2022 and 6.4 % as of December 31, 2021 of the outstanding shares of the Company’s common stock. The table below presents the Company’s affiliated investments: Beginning Fair Value Balance Gross (1) Gross (2) Net Realized Net Change in Ending Fair Value Balance Dividend, For the Year Ended December 31, 2022 Controlled Affiliates Bolttech Mannings, Inc. $ 18,375 $ 22,066 $ ( 18,660 ) $ ( 14,414 ) $ ( 7,367 ) $ — $ 275 Total Controlled Affiliates $ 18,375 $ 22,066 $ ( 18,660 ) $ ( 14,414 ) $ ( 7,367 ) $ — $ 275 Non-Controlled Affiliates Goldman Sachs Financial Square Government Fund $ — $ 328,935 $ ( 328,935 ) $ — $ — $ — $ 93 Animal Supply Holdings, LLC 6,569 382 — — ( 6,951 ) — 380 ATX Networks Corp. 6,039 195 ( 633 ) — 3,458 9,059 623 Collaborative Imaging, LLC (dba Texas Radiology Associates) 5,491 — — — ( 565 ) 4,926 289 Conergy Asia & ME Pte. LTD 400 — — — ( 400 ) — — Elah Holdings, Inc. 5,396 — — — — 5,396 — Iracore International Holdings, Inc. 7,596 — — — 1,039 8,635 265 Kawa Solar Holdings Limited 1,328 — — — ( 45 ) 1,283 — Southeast Mechanical, LLC (dba. SEM Holdings, LLC) — 11,601 ( 54 ) — 145 11,692 538 Total Non-Controlled Affiliates $ 32,819 $ 341,113 $ ( 329,622 ) $ — $ ( 3,319 ) $ 40,991 $ 2,188 Total Affiliates $ 51,194 $ 363,179 $ ( 348,282 ) $ ( 14,414 ) $ ( 10,686 ) $ 40,991 $ 2,463 For the Year Ended December 31, 2021 Controlled Affiliates Bolttech Mannings, Inc. $ 19,810 $ 4,974 $ — $ — $ ( 6,409 ) $ 18,375 $ 1,486 Total Controlled Affiliates $ 19,810 $ 4,974 $ — $ — $ ( 6,409 ) $ 18,375 $ 1,486 Non-Controlled Affiliates Goldman Sachs Financial Square Government Fund $ — $ 809,929 $ ( 809,929 ) $ — $ — $ — $ 2 Animal Supply Holdings, LLC 16,838 723 — ( 756 ) ( 10,236 ) 6,569 723 ATX Networks Corp. — 6,133 — — ( 94 ) 6,039 196 CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) 48,741 — ( 48,494 ) 35,916 ( 36,163 ) — ( 6 ) Collaborative Imaging, LLC (dba Texas Radiology Associates) 4,365 — — — 1,126 5,491 307 Conergy Asia & ME Pte. LTD 334 — — — 66 400 — Elah Holdings, Inc. 5,396 — — — — 5,396 — Iracore International Holdings, Inc. 10,178 — — — ( 2,582 ) 7,596 926 Kawa Solar Holdings Limited 1,359 — — — ( 31 ) 1,328 — Total Non-Controlled Affiliates $ 87,211 $ 816,785 $ ( 858,423 ) $ 35,160 $ ( 47,914 ) $ 32,819 $ 2,148 Total Affiliates $ 107,021 $ 821,759 $ ( 858,423 ) $ 35,160 $ ( 54,323 ) $ 51,194 $ 3,634 (1) Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category. (2) Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category. Due to Affiliates The Investment Adviser pays certain general and administrative expenses on behalf of the Company in the ordinary course of business. As of December 31, 2022 and December 31, 2021, there were $ 542 and $ 585 included within Accrued expenses and other liabilities that were paid by the Investment Adviser and its affiliates on behalf of the Company. Co-investment Activity In certain circumstances, the Company can make negotiated co-investments pursuant to an order from the SEC permitting it to do so. On November 16, 2022, the SEC granted to the Investment Adviser, the BDCs advised by the Investment Adviser and certain other affiliated applicants exemptive relief on which the Company expects to rely to co-invest alongside certain other client accounts managed by our Investment Adviser (collectively with the Company, the “Accounts”), which may include proprietary accounts of Goldman Sachs, in a manner consistent with our investment objectives and strategies, certain Board-established criteria, the conditions of such exemptive relief and other pertinent factors (the “Relief”). Additionally, if the Investment Adviser forms other funds in the future, the Company may co-invest alongside such other affiliates, subject to compliance with the Relief, applicable regulations and regulatory guidance, as well as applicable allocation procedures. As a result of the Relief, there could be significant overlap in the Company’s investment portfolio and the investment portfolios of other Accounts, including, in some cases, proprietary accounts of Goldman Sachs. The Goldman Sachs Asset Management Private Credit Team is composed of investment professionals dedicated to the Company’s investment strategy and to other funds that share a similar investment strategy with the Company. The Goldman Sachs Asset Management Private Credit Team is responsible for identifying investment opportunities, conducting research and due diligence on prospective investments, negotiating and structuring the Company’s investments and monitoring and servicing the Company’s investments. The team works together with investment professionals who are primarily focused on investment strategies in syndicated, liquid credit. Under the terms of the Relief, a “required majority” (as defined in Section 57(o) of the Investment Company Act) of the Company’s independent directors must make certain conclusions in connection with a co-investment transaction, including that (1) the terms of the proposed transaction are reasonable and fair to the Company and the Company’s stockholders and do not involve overreaching in respect of the Company or its stockholders on the part of any person concerned, and (2) the transaction is consistent with the interests of the Company’s stockholders and is consistent with the then-current investment objectives and strategies of the Company. In addition, the Company has filed an application to amend the Relief to permit the Company to participate in follow-on investments in the Company's existing portfolio companies with certain affiliates covered by the Relief if such affiliates, that are not BDCs or registered investment companies, did not have an investment in such existing portfolio company. There can be no assurance if and when the Company will receive the amended exemptive order. |
Investments
Investments | 12 Months Ended |
Dec. 31, 2022 | |
Investments All Other Investments [Abstract] | |
Investments | 4. INVESTMENTS The Company’s investments (excluding investments in money market funds, if any) consisted of the following: December 31, 2022 December 31, 2021 Investment Type Cost Fair Value Cost Fair Value 1st Lien/Senior Secured Debt $ 3,174,534 $ 3,129,552 $ 2,930,047 $ 2,945,368 1st Lien/Last-Out Unitranche 120,253 116,230 157,768 162,532 2nd Lien/Senior Secured Debt 255,354 174,326 295,533 283,521 Unsecured Debt 8,787 7,630 2,558 1,733 Preferred Stock 48,258 42,377 48,258 52,655 Common Stock 82,006 35,490 71,777 30,784 Warrants 1,849 611 1,849 1,850 Total $ 3,691,041 $ 3,506,216 $ 3,507,790 $ 3,478,443 The industry composition of the Company’s investments at fair value and net assets was as follows: December 31, 2022 December 31, 2021 Industry Fair Value Net Assets Fair Value Net Assets Software 14.7 % 34.4 % 13.5 % 29.0 % Diversified Financial Services 11.3 26.3 9.2 19.9 Health Care Providers & Services 11.2 26.2 10.3 22.3 Professional Services 9.5 22.2 7.9 17.1 Health Care Technology 8.9 20.7 11.0 23.6 IT Services 7.0 16.4 5.8 12.6 Diversified Consumer Services 5.4 12.5 6.1 13.2 Real Estate Mgmt. & Development 4.5 10.5 5.8 12.5 Interactive Media & Services 3.4 8.0 5.2 11.1 Commercial Services & Supplies 3.3 7.6 3.3 7.1 Health Care Equipment & Supplies 3.2 7.5 3.2 6.9 Entertainment 2.1 5.0 2.2 4.7 Hotels, Restaurants & Leisure 1.6 3.8 1.6 3.4 Transportation Infrastructure 1.4 3.3 1.5 3.3 Chemicals 1.2 2.8 1.8 3.8 Road & Rail 1.2 2.8 1.2 2.7 Independent Power and Renewable Electricity Producers 1.2 2.7 0.7 1.6 Household Products 1.1 2.5 1.1 2.4 Internet & Direct Marketing Retail 1.0 2.4 1.1 2.4 Aerospace & Defense 1.0 2.3 1.0 2.2 Construction & Engineering 0.9 2.2 1.0 2.1 Beverages 0.9 2.2 1.0 2.2 Trading Companies & Distributors 0.8 1.8 0.7 1.5 Insurance 0.6 1.4 0.4 0.8 Pharmaceuticals 0.5 1.1 0.4 0.9 Auto Components 0.4 0.9 0.9 1.9 Containers & Packaging 0.3 0.7 0.3 0.7 Communications Equipment 0.3 0.6 0.2 0.4 Energy Equipment & Services 0.2 0.6 0.2 0.5 Textiles, Apparel & Luxury Goods 0.2 0.5 0.2 0.4 Specialty Retail 0.2 0.4 0.2 0.3 Air Freight & Logistics 0.2 0.4 0.2 0.4 Capital Markets 0.2 0.4 0.2 0.3 Food Products 0.1 0.2 0.1 0.1 Building Products — (1) 0.1 — (1) 0.1 Oil, Gas & Consumable Fuels — (1) — (1) — (1) — (1) Automobiles — (1) — (1) — (1) — (1) Distributors — (1) — (1) 0.2 0.4 Leisure Products — — 0.3 0.7 Total 100.0 % 233.4 % 100.0 % 215.5 % (1) Amount rounds to less than 0.1 %. The geographic composition of the Company’s investments at fair value was as follows: Geographic December 31, December 31, United States 95.3 % 96.5 % Canada 3.1 3.0 United Kingdom 1.6 0.5 Germany — (1) — (1) Singapore — (1) — (1) Total 100.0 % 100.0 % (1) Amount rounds to less than 0.1 %. |
Fair Value Measurement
Fair Value Measurement | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurement | 5. FAIR VALUE MEASUREMENT The fair value of a financial instrument is the amount that would be received to sell an asset or would be paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). The fair value hierarchy under ASC 820 prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The levels used for classifying investments are not necessarily an indication of the risk associated with investing in these securities. The three levels of the fair value hierarchy are as follows: Basis of Fair Value Measurement Level 1 – Inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The types of financial instruments included in Level 1 include unrestricted securities, including equities and derivatives, listed in active markets. Level 2 – Inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities and certain over-the-counter derivatives where the fair value is based on observable inputs. Level 3 – Inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in this category include investments in privately held entities and certain over-the-counter derivatives where the fair value is based on unobservable inputs. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Note 2 “Significant Accounting Policies” should be read in conjunction with the information outlined below. The table below presents the valuation techniques and the nature of significant inputs generally used in determining the fair value of Level 2 and Level 3 Instruments. Level 2 Instruments Valuation Techniques and Significant Inputs Equity and Fixed Income The types of instruments that trade in markets that are not considered to be active but are valued based on quoted market prices, broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency include commercial paper, most government agency obligations, most corporate debt securities, certain mortgage-backed securities, certain bank loans, less liquid publicly listed equities, certain state and municipal obligations, certain money market instruments and certain loan commitments. Valuations of Level 2 Equity and Fixed Income instruments can be verified to quoted prices, broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency. Consideration is given to the nature of the quotations (e.g. indicative or firm) and the relationship of recent market activity to the prices provided from alternative pricing sources. Derivative Contracts OTC derivatives (both centrally cleared and bilateral) are valued using market transactions and other market evidence whenever possible, including market-based inputs to models, calibration to market-clearing transactions, broker or dealer quotations, or other alternative pricing sources with reasonable levels of price transparency. Where models are used, the selection of a particular model to value an OTC derivative depends upon the contractual terms of, and specific risks inherent in, the instrument, as well as the availability of pricing information in the market. The Company generally uses similar models to value similar instruments. Valuation models require a variety of inputs, including contractual terms, market prices, yield curves, credit curves, measures of volatility, voluntary and involuntary prepayment rates, loss severity rates and correlations of such inputs. For OTC derivatives that trade in liquid markets, model inputs can generally be verified and model selection does not involve significant management judgment. OTC derivatives are classified within Level 2 of the fair value hierarchy when significant inputs are corroborated by market evidence. Level 3 Instruments Valuation Techniques and Significant Inputs Bank Loans, Corporate Debt, and Other Debt Obligations Valuations are generally based on discounted cash flow techniques, for which the significant inputs are the amount and timing of expected future cash flows, market yields and recovery assumptions. The significant inputs are generally determined based on relative value analyses, which incorporate comparisons both to credit default swaps that reference the same underlying credit risk and to other debt instruments for the same issuer for which observable prices or broker quotes are available. Other valuation methodologies are used as appropriate including market comparables, transactions in similar instruments and recovery/liquidation analysis. Equity Recent third-party investments or pending transactions are considered to be the best evidence for any change in fair value. When these are not available, the following valuation methodologies are used, as appropriate and available (i) Transactions in similar instruments; (ii) Discounted cash flow techniques; (iii) Third party appraisals; and (iv) Industry multiples and public comparables. Evidence includes recent or pending reorganizations (for example, merger proposals, tender offers and debt restructurings) and significant changes in financial metrics, including (i) Current financial performance as compared to projected performance; (ii) Capitalization rates and multiples; and (iii) Market yields implied by transactions of similar or related assets. The tables below present the ranges of significant unobservable inputs used to value the Company’s Level 3 assets as of December 31, 2022 and December 31, 2021 . These ranges represent the significant unobservable inputs that were used in the valuation of each type of instrument, but they do not represent a range of values for any one instrument. For example, the lowest discount rate in 1st Lien/Senior Secured Debt is appropriate for valuing that specific debt investment, but may not be appropriate for valuing any other debt investments in this asset class. Accordingly, the ranges of inputs presented below do not represent uncertainty in, or possible ranges of, fair value measurements of the Company’s Level 3 assets. Level 3 Instruments Fair Value (1)(2) Valuation Techniques (3) Significant Unobservable Range of Significant (4) Weighted (5) As of December 31, 2022 Bank Loans, Corporate Debt, and Other Debt Obligations 1st Lien/Senior Secured Debt $ 2,920,976 Discounted cash flows Discount Rate 7.4 % - 35.2 % 11.4 % 1,283 Collateral analysis Recovery Rate — 32.9 % 4,486 Comparable multiples EV/EBITDA (6) — 12.0 x 806 Comparable multiples EV/Revenue — 2.3 x 1st Lien/Last-Out Unitranche 116,230 Discounted cash flows Discount Rate 10.9 % - 15.0 % 14.1 % 2nd Lien/Senior Secured Debt 87,872 Discounted cash flows Discount Rate 12.7 % - 17.7 % 13.9 % 1,701 Comparable multiples EV/EBITDA (6) — 9.9 x Unsecured Debt 7,630 Discounted cash flows Discount Rate 13.5 % - 17.3 % 16.5 % Equity Preferred Stock $ 14,297 Comparable multiples EV/EBITDA (6) 14.4 x - 29.7 x 28.2 x 28,081 Comparable multiples EV/Revenue 0.8 x - 7.3 x 4.1 x Common Stock 10,322 Discounted cash flows Discount Rate 16.3 % - 30.0 % 24.6 % 20,391 Comparable multiples EV/EBITDA (6) 4.5 x - 18.3 x 9.7 x 3,784 Comparable multiples EV/Revenue 1.8 x - 15.2 x 12.6 x Warrants 611 Comparable multiples EV/Revenue — 4.0 x As of December 31, 2021 Bank Loans, Corporate Debt, and Other Debt Obligations 1st Lien/Senior Secured Debt $ 2,271,598 Discounted cash flows Discount Rate 7.1 % - 22.5 % 9.1 % 1,328 Collateral analysis Recovery Rate — 33.9 % 1st Lien/Last-Out Unitranche 162,532 Discounted cash flows Discount Rate 8.9 % - 10.1 % 9.4 % 2nd Lien/Senior Secured Debt 177,079 Discounted cash flows Discount Rate 9.7 % - 15.4 % 11.2 % 1,701 Comparable multiples EV/EBITDA (6) — 9.3 x Unsecured Debt 1,333 Discounted cash flows Discount Rate — 14.8 % 400 Collateral analysis Recovery Rate — 31.6 % Equity Preferred Stock $ 2,425 Comparable multiples EV/EBITDA (6) 10.5 x - 21.4 x 21.2 x 18,121 Comparable multiples EV/Revenue 1.5 x - 5.7 x 2.0 x Common Stock 10,887 Discounted cash flows Discount Rate 14.6 % - 31.1 % 24.1 % 12,871 Comparable multiples EV/EBITDA (6) 4.4 x - 19.2 x 10.3 x 4,002 Comparable multiples EV/Revenue 0.7 x - 18.9 x 14.9 x Warrants 1,850 Comparable multiples EV/Revenue — 8.2 x (1) As of December 31, 2022, included within the fair value of Level 3 assets of $ 3,341,847 is an amount of $ 123,377 for which the Investment Adviser did not develop the unobservable inputs (examples include single source broker quotations, third party pricing, and prior transactions). The income approach was used in the determination of fair value for $ 3,132,708 or 96.0 % of Level 3 bank loans, corporate debt, and other debt obligations . (2) As of December 31, 2021, included within the fair value of Level 3 assets of $ 3,270,660 is an amount of $ 604,533 for which the Investment Adviser did not develop the unobservable inputs (examples include single source broker quotations, third party pricing, and prior transactions). The income approach was used in the determination of fair value for $ 2,612,542 or 82.0 % of Level 3 bank loans, corporate debt, and other debt obligations. (3) The fair value of any one instrument may be determined using multiple valuation techniques. For example, market comparable and discounted cash flows may be used together to determine fair value. Therefore, the Level 3 balance encompasses both of these techniques. (4) The range for an asset category consisting of a single investment, if any, is not meaningful and therefore has been excluded. (5) Weighted average for an asset category consisting of multiple investments is calculated by weighting the significant unobservable input by the relative fair value of the investment. Weighted average for an asset category consisting of a single investment represents the significant unobservable input used in the fair value of the investment. (6) Enterprise value of portfolio company as a multiple of earnings before interest, taxes, depreciation and amortization (“EBITDA”). As noted above, the income and market approaches were used in the determination of fair value of certain Level 3 assets as of December 31, 2022 and December 31, 2021. The significant unobservable inputs used in the income approach are the discount rate or market yield used to discount the estimated future cash flows expected to be received from the underlying investment, which include both future principal and interest payments. An increase in the discount rate or market yield would result in a decrease in the fair value. Included in the consideration and selection of discount rates or market yields is risk of default, rating of the investment, call provisions and comparable company investments. The significant unobservable inputs used in the market approach are based on market comparable transactions and market multiples of publicly traded comparable companies. Increases or decreases in market comparable transactions or market multiples would result in an increase or decrease, in the fair value. The following is a summary of the Company’s assets categorized within the fair value hierarchy: December 31, 2022 December 31, 2021 Assets Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total 1st Lien/Senior Secured Debt $ — $ 78,623 $ 3,050,929 $ 3,129,552 $ — $ 102,358 $ 2,843,010 $ 2,945,368 1st Lien/Last-Out Unitranche — — 116,230 116,230 — — 162,532 162,532 2nd Lien/Senior Secured Debt — 84,753 89,573 174,326 — 104,741 178,780 283,521 Unsecured Debt — — 7,630 7,630 — — 1,733 1,733 Preferred Stock — — 42,377 42,377 — — 52,655 52,655 Common Stock 993 — 34,497 35,490 684 — 30,100 30,784 Warrants — — 611 611 — — 1,850 1,850 Total Assets $ 993 $ 163,376 $ 3,341,847 $ 3,506,216 $ 684 $ 207,099 $ 3,270,660 $ 3,478,443 Unrealized appreciation (depreciation) on foreign currency forward contracts $ — $ ( 484 ) $ — $ ( 484 ) $ — $ 100 $ — $ 100 The below table presents a summary of changes in fair value of Level 3 assets by investment type: Beginning Balance Purchases (1) Net Net Change in Sales and (2) Net Transfers (3) Transfers (3) Ending Net Change For the Year Ended December 31, 2022 1st Lien/Senior Secured Debt $ 2,843,010 $ 827,409 $ ( 4,696 ) $ ( 56,045 ) $ ( 595,922 ) $ 28,685 $ 8,488 $ — $ 3,050,929 $ ( 60,742 ) 1st Lien/Last-Out Unitranche 162,532 19,801 — ( 8,786 ) ( 61,297 ) 3,980 — — 116,230 ( 6,767 ) 2nd Lien/Senior Secured Debt 178,780 16,714 ( 14,414 ) ( 46,425 ) ( 47,859 ) 2,777 — — 89,573 ( 46,240 ) Unsecured Debt 1,733 6,182 — ( 332 ) — 47 — — 7,630 ( 332 ) Preferred Stock 52,655 — — ( 10,278 ) — — — — 42,377 ( 10,278 ) Common Stock 30,100 10,079 105 ( 5,682 ) ( 105 ) — — — 34,497 ( 5,682 ) Warrants 1,850 — — ( 1,239 ) — — — — 611 ( 1,239 ) Total Assets $ 3,270,660 $ 880,185 $ ( 19,005 ) $ ( 128,787 ) $ ( 705,183 ) $ 35,489 $ 8,488 $ — $ 3,341,847 $ ( 131,280 ) For the Year Ended December 31, 2021 1st Lien/Senior Secured Debt $ 2,384,944 $ 1,611,821 $ ( 942 ) $ ( 23,494 ) $ ( 1,152,967 ) $ 62,690 $ — $ ( 39,042 ) $ 2,843,010 $ 3,200 1st Lien/Last-Out Unitranche 143,231 31,138 — 492 ( 14,517 ) 2,188 — — 162,532 865 2nd Lien/Senior Secured Debt 407,872 31,550 ( 1,203 ) ( 11,826 ) ( 209,051 ) 14,109 — ( 52,671 ) 178,780 ( 8,457 ) Unsecured Debt 334 1,492 — ( 103 ) — 10 — — 1,733 ( 104 ) Preferred Stock 48,080 39,192 24,233 ( 23,812 ) ( 35,038 ) — — — 52,655 ( 5 ) Common Stock 65,284 10,218 19,223 ( 33,226 ) ( 31,399 ) — — — 30,100 ( 14,468 ) Warrants 1,024 1,849 ( 756 ) ( 267 ) — — — — 1,850 1 Total Assets $ 3,050,769 $ 1,727,260 $ 40,555 $ ( 92,236 ) $ ( 1,442,972 ) $ 78,997 $ — $ ( 91,713 ) $ 3,270,660 $ ( 18,968 ) (1) Purchases may include PIK, securities received in corporate actions and restructurings. (2) Sales and Settlements may include securities delivered in corporate actions and restructuring of investments. (3) Transfers in (out) of Level 3 are due to a decrease (increase) in the quantity and reliability of broker quotes obtained by the Investment Adviser. Debt Not Carried at Fair Value Fair value is estimated by discounting remaining payments using applicable current market rates, which take into account changes in the Company’s marketplace credit ratings, or market quotes, if available. If the Company’s debt obligations were carried at fair value, the fair value and level would have been as follows: As of Level December 31, 2022 December 31, 2021 Revolving Credit Facility 3 $ 1,161,401 $ 858,722 Convertible Notes (1) 2 $ — $ 158,116 2025 Notes 2 $ 348,120 $ 377,778 2026 Notes 2 $ 461,800 $ 513,037 (1) On April 1, 2022, the Convertible Notes matured and were paid in full. |
Debt
Debt | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt | 6. DEBT The Company is permitted to borrow amounts such that its asset coverage ratio, as defined in the Investment Company Act, is at least 150 % after such borrowing (if certain requirements are met). As of December 31, 2022 and December 31, 2021, the Company’s asset coverage ratio based on the aggregate amount outstanding of senior securities was 174 % and 186 %. The Company’s outstanding debt was as follows: As of December 31, 2022 December 31, 2021 Aggregate Amount Carrying (1) Aggregate Amount Carrying (1) Revolving Credit Facility (2) $ 1,695,000 $ 548,671 $ 1,161,401 $ 1,695,000 $ 837,164 $ 858,722 Convertible Notes (3) — — — 155,000 — 154,665 2025 Notes 360,000 — 357,076 360,000 — 355,735 2026 Notes 500,000 — 494,183 500,000 — 492,304 Total Debt $ 2,555,000 $ 548,671 $ 2,012,660 $ 2,710,000 $ 837,164 $ 1,861,426 (1) The carrying value is presented net of unamortized debt issuance costs and OID net of accretion as applicable. (2) Provides, under certain circumstances, a total borrowing capacity of $ 2,250,000 . The Company may borrow amounts in USD or certain other permitted currencies. Debt outstanding denominated in currencies other than USD has been converted to USD using the applicable foreign currency exchange rate as of the applicable reporting date. As of December 31, 2022, the Company had outstanding borrowings denominated in USD of $ 1,065,674 , in Euros (EUR) of EUR 37,700 , in British Pound (GBP) of GBP 45,300 and in Canadian Dollars (CAD) of CAD 820 . As of December 31, 2021, the Company had outstanding borrowings denominated in USD of $ 799,574 , in Euros (EUR) of EUR 37,700 , in British Pound (GBP) of GBP 11,900 and in Canadian Dollars (CAD) of CAD 150 . (3) On April 1, 2022, the Convertible Notes matured and were paid in full. The combined weighted average interest rate of the aggregate borrowings outstanding for the year ended December 31, 2022 and the year ended December 31, 2021 was 3.55 % and 2.90 %. The combined weighted average debt of the aggregate borrowings outstanding for the year ended December 31, 2022 and the year ended December 31, 2021 was $ 1,991,629 and $ 1,621,442 . Revolving Credit Facility On September 19, 2013, the Company entered into a senior secured revolving credit agreement (as amended, the “Revolving Credit Facility”) with various lenders. Truist Bank serves as administrative agent and Bank of America, N.A. serves as syndication agent under the Revolving Credit Facility. The Company has amended and restated the Revolving Credit Facility on numerous occasions between October 3, 2014 and May 5, 2022. The aggregate committed borrowing amount under the Revolving Credit Facility is $ 1,695,000 . The Revolving Credit Facility includes an uncommitted accordion feature that allows the Company, under certain circumstances, to increase the borrowing capacity of the Revolving Credit Facility to up to $ 2,250,000 . Borrowings denominated in USD, including amounts drawn in respect of letters of credit, bear interest (at the Company’s election) of either (i) term SOFR plus a margin of either (x) 2.00%, (y) 1.875% (subject to maintenance of certain long-term corporate debt ratings) or (z) 1.75% (subject to certain gross borrowing base conditions), in each case, plus an additional 0.10 % credit adjustment spread or (ii) an alternative base rate, which is the highest of (a) zero, (b) the highest of (i) the Prime Rate in effect on such day, (ii) the Federal Funds Effective Rate for such day plus 1/2 of 1.00% and (iii) the rate per annum equal to (x) the greater of (A) term SOFR for an interest period of one (1) month and (B) zero plus (y) 1.00%, plus a margin of either (x) 1.00%, (y) 0.875% (subject to maintenance of certain long-term corporate debt ratings) or (z) 0.75% (subject to certain gross borrowing base conditions). Borrowings denominated in non-USD bear interest of the applicable term benchmark rate or daily simple SONIA plus a margin of either 2.00%, 1.875% or 1.75% (subject to the conditions applicable to borrowings denominated in USD that bear interest based on the applicable term benchmark rate or daily simple SONIA) plus, in the case of borrowings denominated in Pound Sterling (GBP) only, an additional 0.1193 % credit adjustment spread. With respect to borrowings denominated in USD, the Company may elect either term SOFR, or an alternative base rate at the time of borrowing, and such borrowings may be converted from one benchmark to another at any time, subject to certain conditions. Interest is payable in arrears on the applicable interest payment date as specified therein. The Company pays a fee of 0.375 % per annum on committed but undrawn amounts under the Revolving Credit Facility, payable quarterly in arrears. Any amounts borrowed under the Revolving Credit Facility will mature, and all accrued and unpaid interest will be due and payable, on May 5, 2027 . The Revolving Credit Facility may be guaranteed by certain of the Company’s domestic subsidiaries, including any that are formed or acquired by the Company in the future. Proceeds from borrowings may be used for general corporate purposes, including the funding of portfolio investments. The Company’s obligations to the lenders under the Revolving Credit Facility are secured by a first priority security interest in substantially all of the Company’s portfolio of investments and cash, with certain exceptions. The Revolving Credit Facility contains certain covenants, including: (i) maintaining a minimum stockholder’s equity of $ 800,000 plus 25 % of net proceeds of the sale of equity interests of the Company after February 25, 2020, (ii) maintaining a minimum asset coverage ratio of at least 150 %, (iii) maintaining a minimum asset coverage ratio of 200 % with respect to the consolidated assets (with certain limitations on the contribution of equity in financing subsidiaries as specified therein) of the Company and its subsidiary guarantors to the secured debt of the Company and its subsidiary guarantors, and (iv) complying with restrictions on industry concentrations in the Company’s investment portfolio. As of December 31, 2022, the Company is in compliance with these covenants. Costs of $ 28,092 were incurred in connection with obtaining and amending the Revolving Credit Facility, which have been recorded as deferred financing costs on the Consolidated Statements of Assets and Liabilities and are being amortized over the life of the Revolving Credit Facility using the straight-line method. As of December 31, 2022 and December 31, 2021, deferred financing costs were $ 12,772 and $ 12,631 . The below table presents the summary information of the Revolving Credit Facility: For the Years Ended December 31, 2022 2021 2020 Borrowing interest expense $ 41,088 $ 12,143 $ 12,377 Facility fees 2,347 4,189 1,898 Amortization of financing costs 2,855 2,780 2,016 Total $ 46,290 $ 19,112 $ 16,291 Weighted average interest rate 3.76 % 2.00 % 2.43 % Average outstanding balance $ 1,093,410 $ 606,442 $ 509,927 Convertible Notes On October 3, 2016, the Company closed an offering of $ 115,000 aggregate principal amount of its 4.50 % unsecured convertible notes, which included $ 15,000 aggregate principal amount issued pursuant to the initial purchasers’ exercise in full of an over-allotment option (the “Initial Convertible Notes”). On July 2, 2018, the Company closed an additional offering of $ 40,000 aggregate principal amount of Convertible Notes (the “Additional Convertible Notes” and together with Initial Convertible Notes, the “Convertible Notes”). The Additional Convertible Notes had identical terms, and were part of the Initial Convertible Notes. The Convertible Notes were issued pursuant to an indenture between the Company and Computershare Trust Company, National Association, as Trustee (as successor to Wells Fargo Bank, National Association (“Wells Fargo”)). The Convertible Notes bore interest at a rate of 4.50 % per year, payable semi-annually in arrears on April 1 and October 1 of each year. The Convertible Notes matured and were fully repaid on April 1, 2022, in accordance with their terms, using proceeds from the Revolving Credit Facility. The below table presents the components of the carrying value of the Convertible Notes: December 31, December 31, Principal amount of debt $ — $ 155,000 OID, net of accretion — 118 Unamortized debt issuance costs — 217 Carrying Value $ — $ 154,665 Stated interest rate — % 4.50 % Effective interest rate (stated interest rate plus accretion of OID) — % 4.80 % The below table presents the components of interest and other debt expenses related to the Convertible Notes: For the Years Ended December 31, 2022 2021 2020 Borrowing interest expense $ 1,744 $ 6,975 $ 6,975 Accretion of OID 118 468 446 Amortization of debt issuance costs 216 1,214 1,217 Total $ 2,078 $ 8,657 $ 8,638 2025 Notes On February 10, 2020, the Company closed an offering of $ 360,000 aggregate principal amount of its 3.75 % unsecured notes due 2025 (the "2025 Notes"). The 2025 Notes were issued pursuant to an indenture between the Company and Computershare Trust Company, National Association, as Trustee (as successor to Wells Fargo). The 2025 Notes bear interest at a rate of 3.75% per year, payable semi-annually. The 2025 Notes will mature on February 10, 2025 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the indenture. The below table presents the components of the carrying value of the 2025 Notes: December 31, December 31, Principal amount of debt $ 360,000 $ 360,000 Unamortized debt issuance costs 2,924 4,265 Carrying Value $ 357,076 $ 355,735 The below table presents the components of interest and other debt expenses related to the 2025 Notes: For the Years Ended December 31, 2022 2021 2020 Borrowing interest expense $ 13,500 $ 13,500 $ 12,038 Amortization of debt issuance costs 1,342 1,404 1,254 Total $ 14,842 $ 14,904 $ 13,292 2026 Notes On November 24, 2020, the Company closed an offering of $ 500,000 aggregate principal amount of its 2.875 % unsecured notes due 2026 (the "2026 Notes"). The 2026 Notes were issued pursuant to an indenture between the Company and Computershare Trust Company, National Association, as Trustee (as successor to Wells Fargo). The 2026 Notes bear interest at a rate of 2.875% per year, payable semi-annually, commencing on July 15, 2021. The 2026 Notes will mature on January 15, 2026 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the indenture. The below table presents the components of the carrying value of the 2026 Notes: December 31, December 31, Principal amount of debt $ 500,000 $ 500,000 Unamortized debt issuance costs 5,817 7,696 Carrying Value $ 494,183 $ 492,304 The below table presents the components of interest and other debt expenses related to the 2026 Notes: For the Years Ended December 31, 2022 2021 2020 Borrowing interest expense $ 14,375 $ 14,375 $ 1,476 Amortization of debt issuance costs 1,879 1,940 203 Total $ 16,254 $ 16,315 1,679 |
Derivatives
Derivatives | 12 Months Ended |
Dec. 31, 2022 | |
Derivative Instruments And Hedging Activities Disclosure [Abstract] | |
Derivatives | 7. DERIVATIVES The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company may enter into an International Swaps and Derivatives Association, Inc. Master Agreement (“ISDA Master Agreement”) or a similar agreement with its derivative counterparties. An ISDA Master Agreement is a bilateral agreement between the Company and a counterparty that governs OTC derivatives, including foreign currency forward contracts, and typically contains, among other things, collateral posting terms and netting provisions in the event of a default and/or termination event. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of a default (close-out netting) or similar event, including the bankruptcy or insolvency of the counterparty. For financial reporting purposes, cash collateral that has been pledged to cover obligations of the Company and cash collateral received from the counterparty, if any, is included on the Consolidated Statements of Assets and Liabilities as other assets. The Company minimizes counterparty credit risk by only entering into agreements with counterparties that they believe to be of good standing and by monitoring the financial stability of those counterparties. For the years ended December 31, 2022 and 2021, the Company’s average USD notional exposure to foreign currency forward contracts was $ 2,431 and $ 2,829 . The Company’s net exposure to foreign currency forward contracts that are subject to ISDA Master Agreements or similar agreements presented on the Consolidated Statements of Assets and Liabilities, all of which are with Bank of America, N.A., was as follows: December 31, 2022 December 31, 2021 Gross Amount of Assets $ — $ 100 Gross Amount of Liabilities ( 484 ) — Net Amount of Assets or (Liabilities) $ ( 484 ) $ 100 Collateral (Received) Pledged (1) 290 — Net Amounts (2) $ ( 194 ) $ 100 (1) Amount excludes excess cash collateral paid, if any. (2) Net amount represents the net amount due (to) from counterparty in the event of a default based on the contractual setoff rights under the agreement. Net amount excludes any over-collateralized amounts. The effect of transactions in derivative instruments on the Consolidated Statements of Operations was as follows: For the Years Ended December 31, 2022 2021 2020 Net realized gain (loss) on foreign currency forward contracts $ 283 $ ( 234 ) $ 82 Net change in unrealized appreciation (depreciation) on foreign currency forward contracts ( 584 ) 455 ( 388 ) Total net realized and unrealized gains (losses) on foreign currency forward contracts $ ( 301 ) $ 221 $ ( 306 ) |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Commitments And Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 8. COMMITMENTS AND CONTINGENCIES Commitments The Company may enter into investment commitments through signed commitment letters. In many circumstances, borrower acceptance and final terms are subject to transaction-related contingencies. These are disclosed as commitments upon execution of a final agreement. As of December 31, 2022 , the Company believed that it had adequate financial resources to satisfy its unfunded commitments. The Company had the following unfunded commitments by investment types: Unfunded Commitment (1) December 31, 2022 December 31, 2021 1st Lien/Senior Secured Debt 1272775 B.C. LTD. (dba Everest Clinical Research) $ 163 $ 1,151 Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) 1,950 4,082 Acquia, Inc. 1,346 3,268 Admiral Buyer, Inc. (dba Fidelity Payment Services) 9,650 — Ansira Partners, Inc. 127 — Apptio, Inc. 2,154 3,230 AQ Helios Buyer, Inc. (dba SurePoint) 8,888 14,189 Assembly Intermediate LLC 7,478 12,757 Bigchange Group Limited 3,459 4,426 Broadway Technology, LLC 1,090 — BSI3 Menu Buyer, Inc (dba Kydia) 38 — Bullhorn, Inc. 726 4,601 Businessolver.com, Inc. 4,595 5,026 Capitol Imaging Acquisition Corp. 38 180 Checkmate Finance Merger Sub, LLC 3,140 3,140 Chronicle Bidco Inc. (dba Lexitas) 4,753 4,339 CivicPlus LLC 1,217 3,552 Clearcourse Partnership Acquireco Finance Limited 8,951 — CloudBees, Inc. 738 12,900 Coding Solutions Acquisition, Inc. 6,156 — CORA Health Holdings Corp 8,514 8,897 CorePower Yoga LLC 1,125 1,687 Coretrust Purchasing Group LLC 226 — CST Buyer Company (dba Intoxalock) 78 2,170 DECA Dental Holdings LLC 5,360 6,843 Diligent Corporation 2,170 3,100 Eptam Plastics, Ltd. 2,042 681 ESO Solutions, Inc 3,620 3,620 Experity, Inc. 81 3,332 Fullsteam Operations LLC 2,642 16,298 Gainsight, Inc. 5,320 5,320 GHA Buyer Inc. (dba Cedar Gate) 1,880 1,254 GovDelivery Holdings, LLC (dba Granicus, Inc.) 1,716 4,087 Governmentjobs.com, Inc. (dba NeoGov) 19,428 19,427 GS AcquisitionCo, Inc. (dba Insightsoftware) 982 4,180 HealthEdge Software, Inc. 13,300 18,330 Helios Buyer, Inc. (dba Heartland) 2,363 9,592 Honor HN Buyer, Inc 21,001 18,095 HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth) 2,344 4,688 HumanState Limited (dba PayProp) 11,932 — iCIMS, Inc. 15,910 — Intelligent Medical Objects, Inc. 4,192 — Internet Truckstop Group, LLC (dba Truckstop) 4,400 4,400 iWave Information Systems, Inc. 109 — Kaseya Inc. 2,200 — LCG Vardiman Black, LLC (dba Specialty Dental Brands) 113 — Lithium Technologies, Inc. 3,066 3,066 MerchantWise Solutions, LLC (dba HungerRush) 4,485 — Millstone Medical Outsourcing, LLC 1,774 2,144 MRI Software LLC 1,612 7,994 Unfunded Commitment (1) December 31, 2022 December 31, 2021 NFM & J, L.P. (dba the Facilities Group) $ 6,054 $ 11,219 One GI LLC 3,654 13,598 PDDS Holdco, Inc. (dba Planet DDS) 6,128 — Pioneer Buyer I, LLC 4,300 4,300 PlanSource Holdings, Inc. 7,824 8,728 Pluralsight, Inc 2,550 5,100 PPT Management Holdings, LLC. 123 — Premier Care Dental Management, LLC 3,602 9,982 Premier Imaging, LLC (dba Lucid Health) 4,110 5,778 Project Eagle Holdings, LLC (dba Exostar) 75 75 Prophix Software Inc. (dba Pound Bidco) 3,445 3,445 Qualawash Holdings, LLC 3,359 — Riverpoint Medical, LLC 4,094 4,094 Rodeo Buyer Company (dba Absorb Software) 3,048 3,387 Rubrik,Inc. 2,310 — Smarsh, Inc. 5,000 — Southeast Mechanical, LLC (dba. SEM Holdings, LLC) 9,300 — SpendMend, LLC 238 — Spotless Brands, LLC 33 — StarCompliance Intermediate, LLC 1,875 2,500 Sundance Group Holdings, Inc. (dba NetDocuments) 4,925 15,761 Sunstar Insurance Group, LLC 7,996 12,053 Superman Holdings, LLC (dba Foundation Software) 122 122 Sweep Purchaser LLC 3,724 8,105 The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) 2,467 9,069 Thrasio, LLC 14,686 14,686 Total Vision LLC 10,464 1,270 Trader Corporation 17 — USN Opco LLC (dba Global Nephrology Solutions) 5,880 3,593 Volt Bidco, Inc. (dba Power Factors) 6,612 4,357 VRC Companies, LLC (dba Vital Records Control) 944 3,799 WebPT, Inc. 4,225 9,861 Wellness AcquisitionCo, Inc. (dba SPINS) 6,600 2,600 Whitewater Holding Company LLC 3,944 9,652 Wine.com, LLC 1,541 — WorkForce Software, LLC 631 — Zarya Intermediate, LLC (dba iOFFICE) 7,987 6,757 Aria Systems, Inc. — 1,893 CFS Management, LLC (dba Center for Sight Management) — 1,058 Convene 237 Park Avenue, LLC (dba Convene) — 6,100 Cordeagle US Finco, Inc. (dba Condeco) — 11,506 Elemica Parent, Inc. — 409 LS Clinical Services Holdings, Inc (dba CATO) — 2,200 MMIT Holdings, LLC (dba Managed Markets Insight & Technology) — 5,183 PT Intermediate Holdings III, LLC (dba Parts Town) — 1,980 Purfoods, LLC — 150 Xactly Corporation — 3,874 Zodiac Intermediate, LLC (dba Zipari) — 7,500 Total 1st Lien/Senior Secured Debt $ 364,529 $ 441,790 1st Lien/Last-Out Unitranche EDB Parent, LLC (dba Enterprise DB) 6,516 — Total 1st Lien/Last-Out Unitranche $ 6,516 $ — Total $ 371,045 $ 441,790 (1) Unfunded commitments denominated in currencies other than USD have been converted to USD using the exchange rate as of the applicable reporting date. Contingencies In the normal course of business, the Company enters into contracts that provide a variety of general indemnifications. Any exposure to the Company under these arrangements could involve future claims that may be made against the Company. Currently, no such claims exist or are expected to arise and, accordingly, the Company has not accrued any liability in connection with such indemnifications. |
Net Assets
Net Assets | 12 Months Ended |
Dec. 31, 2022 | |
Assets Net [Abstract] | |
Net Assets | 9. NET ASSETS Equity Issuances The Company may from time to time issue and sell shares of its common stock through public or at-the-market (“ATM”) offerings. On May 26, 2022, the Company entered into (i) an equity distribution agreement by and among the Company, GSAM and Truist Securities, Inc. (“Truist”) and (ii) an equity distribution agreement by and among the Company, GSAM and SMBC Nikko Securities America, Inc. (“SMBC,” and together with Truist, the “Sales Agents”). The equity distribution agreements with the Sales Agents described in the preceding sentence are collectively referred to herein as the “Equity Distribution Agreements.” The Equity Distribution Agreements provide that the Company may from time to time issue and sell shares of its common stock, par value $ 0.001 per share, having an aggregate offering price of up to $ 200 million, through the Sales Agents, or to them as principal for their own respective accounts. Sales of the shares, if any, may be made in negotiated transactions or transactions that are deemed to be an ATM offering as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended, including sales made directly on or through the New York Stock Exchange or a similar securities exchange, sales made to or through a market maker other than on an exchange, at market prices related to prevailing market prices or negotiated prices, sales made through any other existing trading market or electronic communications network, or by any other method permitted by law, including but not limited to privately negotiated transactions, which may include block trades, as the Company and the Sales Agents may agree. The Sales Agents will receive a commission from the Company up to 1.00 % of the gross sales price of any shares sold through the Sales Agents under the Equity Distribution Agreements. In connection with the issuance of its common stock, the Company issued and sold the following shares of common stock: For the Years Ended December 31, 2022 2021 Gross Proceeds $ 14,156 $ — Underwriting/Offering Expenses ( 699 ) — Net Proceeds $ 13,457 $ — Number of Shares Issued 813,255 — Average Sales Price per Share $ 17.41 $ — Distributions The Company has adopted the DRIP that provides for the automatic reinvestment of all cash distributions declared by the Board of Directors, unless a stockholder elects to “opt out” of the DRIP. As a result, if the Board of Directors declares a cash distribution, then the stockholders who have not “opted out” of the DRIP will have their cash distributions automatically reinvested in additional shares of common stock, rather than receiving the cash distribution. The shares distributed by the Transfer Agent in the Company’s DRIP are either through (i) newly issued shares or (ii) acquired by the Transfer Agent through the purchase of outstanding shares on the open market. If, on the payment date for any distribution, the most recently computed NAV per share as of the DRIP is equal to or less than the closing market price plus estimated per share fees, the Transfer Agent will invest the distribution amount in newly issued shares. Otherwise, the Transfer Agent will invest the dividend amount in shares acquired by purchasing shares on the open market. The following table summarizes the distributions declared on shares of the Company’s common stock and shares distributed pursuant to the DRIP to stockholders who had not opted out of the DRIP: Date Declared Record Date Payment Date Amount Per Share Shares For the Year Ended December 31, 2022 February 23, 2022 March 31, 2022 April 27, 2022 $ 0.45 65,180 May 3, 2022 June 30, 2022 July 27, 2022 $ 0.45 86,741 August 3, 2022 September 30, 2022 October 27, 2022 $ 0.45 (1) 98,756 * November 2, 2022 December 30, 2022 January 27, 2023 $ 0.45 112,555 For the Year Ended December 31, 2021 November 4, 2020 (special) February 15, 2021 March 15, 2021 $ 0.05 6,849 February 24, 2021 March 31, 2021 April 27, 2021 $ 0.45 68,092 November 4, 2020 (special) May 14, 2021 June 15, 2021 $ 0.05 8,852 May 4, 2021 June 30, 2021 July 27, 2021 $ 0.45 69,917 November 4, 2020 (special) August 16, 2021 September 15, 2021 $ 0.05 7,717 August 5, 2021 September 30, 2021 October 27, 2021 $ 0.45 65,213 November 4, 2021 December 31, 2021 January 27, 2022 $ 0.45 66,602 For the Year Ended December 31, 2020 February 19, 2020 March 31, 2020 April 15, 2020 $ 0.45 37,741 * May 5, 2020 June 30, 2020 July 15, 2020 $ 0.45 46,407 August 4, 2020 September 30, 2020 October 15, 2020 $ 0.45 49,015 November 4, 2020 December 31, 2020 January 15, 2021 $ 0.45 57,801 (1) $ 0.29 is considered capital gain distribution. * In accordance with the Company’s DRIP, shares were purchased in the open market. |
Earnings (Loss) Per Share
Earnings (Loss) Per Share | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Earnings (Loss) Per Share | 10. EARNINGS (LOSS) PER SHARE The following information sets forth the computation of basic and diluted earnings per share: For the Years Ended December 31, 2022 2021 2020 Net increase (decrease) in net assets from operations $ 55,003 $ 192,427 $ 176,113 Weighted average shares outstanding 102,258,701 101,691,076 53,940,573 Basic and diluted earnings (loss) per share $ 0.54 $ 1.89 $ 3.26 For the purpose of calculating diluted earnings per common share, the average closing price of the Company’s common stock for the years ended December 31, 2022, 2021 and 2020 was less than the conversion price for the Convertible Notes, which matured and were fully repaid on April 1, 2022 in accordance with their terms. Therefore, for the years ended December 31, 2022, 2021 and 2020, diluted earnings per share equal basic earnings per share because the underlying shares for the intrinsic value of the embedded options in the Convertible Notes were not dilutive. |
Tax Information
Tax Information | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Tax Information | 11. TAX INFORMATION The tax character of distributions was as follows: For the Years Ended December 31, 2022 2021 2020 Distributions paid from: Ordinary Income $ 154,022 $ 198,332 $ 100,254 Net Long-Term Capital Gains 30,293 — — Total Taxable Distributions $ 184,315 $ 198,332 $ 100,254 The components of Accumulated Earnings (Losses) on a tax basis were as follows: December 31, 2022 December 31, 2021 December 31, 2020 Undistributed Ordinary Income—net $ 86,770 $ 35,189 $ 40,868 Undistributed Long-Term Capital Gains — 31,175 — Total Undistributed Earnings $ 86,770 $ 66,364 $ 40,868 Capital Loss Carryforward (1) : Perpetual Long-Term $ ( 112,858 ) $ ( 107,216 ) $ ( 117,733 ) Perpetual Short-Term $ ( 382 ) $ ( 382 ) $ ( 494 ) Total capital loss carryforwards $ ( 113,240 ) $ ( 107,598 ) $ ( 118,227 ) Timing Differences (Organizational Costs, Post-October Capital Loss Deferral and Late Year Ordinary Loss Deferral) $ ( 10,935 ) $ ( 313 ) $ ( 539 ) Unrealized Earnings (Losses)—net $ ( 168,797 ) $ ( 13,476 ) $ 72,545 Total Accumulated Earnings (Losses)—net $ ( 206,202 ) $ ( 55,023 ) $ ( 5,353 ) (1) For the year ended December 31, 2022 and December 31, 2020, the company did no t utilize any capital losses. For the year ended December 31, 2021, the Company utilized $ 10,629 of capital losses. The Company's ability to utilize its capital loss carryforwards is subject to an annual limitation under section 382 of the Code. The Company’s aggregate unrealized appreciation and depreciation on investments based on cost for U.S. federal income tax purposes were as follows: December 31, 2022 December 31, 2021 December 31, 2020 Tax cost $ 3,678,321 $ 3,492,053 $ 3,165,681 Gross unrealized appreciation $ 39,385 $ 77,992 $ 146,963 Gross unrealized depreciation $ ( 208,182 ) $ ( 91,468 ) $ ( 74,418 ) Net unrealized investment appreciation (depreciation) on investments $ ( 168,797 ) $ ( 13,476 ) $ 72,545 The difference between GAAP-basis and tax basis unrealized gains (losses) is attributable primarily to wash sales, net mark to market gains (losses) on foreign currency contracts, and differences in the tax treatment of underlying fund investments, partnership investments and material modification of debt securities. In order to present certain components of the Company’s capital accounts on a tax-basis, certain reclassifications have been recorded to the Company’s accounts. These reclassifications have no impact on the net asset value of the Company and result primarily from certain non-deductible expenses, and differences in the tax treatment of underlying fund investments. For the years ended December 31, 2022, 2021 and 2020, the Company reclassified $ 21,867 , $ 43,765 and $( 19,414 ) from total distributable earnings to paid-in capital in excess of par. The following reconciles net increase in net assets resulting from operations to taxable income: For the Years Ended December 31, 2022 2021 2020 Net increase in net assets resulting from operations $ 55,003 $ 192,427 $ 176,113 Adjustments: Net unrealized loss (gain) on investments and foreign currency forward contracts and translations 152,304 84,858 ( 109,922 ) Income not currently taxable ( 26,405 ) ( 47,243 ) 21,842 Income for tax but not book 351 2,913 ( 129 ) Expenses not currently deductible 4,562 1,202 1,539 Expenses for tax but not for book ( 613 ) ( 30 ) ( 5 ) Realized gain(loss) differences ( 92,839 ) ( 117,519 ) ( 110,478 ) Taxable income net of capital loss carryforward $ 92,363 $ 116,608 $ ( 21,040 ) Capital loss carryforward 113,240 107,598 118,227 Taxable income (1) $ 205,603 $ 224,206 $ 97,187 (1) Taxable income is an estimate and is not fully determined until the Company’s tax return is filed. ASC Topic 740, “Accounting for Uncertainty in Income Taxes” (“ASC 740”) provides guidance on the accounting for and disclosure of uncertainty in tax position. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Based on its analysis of its tax position for all open tax years (the current and prior years, as applicable), the Company has concluded that it does not have any uncertain tax positions that met the recognition or measurement criteria of ASC 740. Such open tax years remain subject to examination and adjustment by tax authorities. |
Financial Highlights
Financial Highlights | 12 Months Ended |
Dec. 31, 2022 | |
Statement Of Financial Position [Abstract] | |
Financial Highlights | 12. FINANCIAL HIGHLIGHTS Below presents the schedule of financial highlights of the Company: For the Years Ended December 31, 2022 2021 2020 2019 2018 Per Share Data: (1) NAV, beginning of period $ 15.86 $ 15.91 $ 16.75 $ 17.65 $ 18.09 Net investment income 2.24 2.33 2.04 1.98 2.06 Net realized and unrealized gains (losses) (2) ( 1.82 ) ( 0.43 ) ( 0.20 ) ( 1.08 ) ( 0.70 ) Income tax provision, realized and unrealized gains — (3) — (3) — (3) — (3) ( 0.02 ) Net increase in net assets from operations 0.42 1.90 1.84 0.90 1.34 Issuance of common stock in connection with the Merger — — ( 0.88 ) — — Issuance of common stock, net underwriting and offering costs 0.13 — — — — Equity component of convertible notes — — — — 0.02 Distributions declared ( 1.80 ) ( 1.95 ) ( 1.80 ) ( 1.80 ) ( 1.80 ) Total increase (decrease) in net assets ( 1.25 ) ( 0.05 ) ( 0.84 ) ( 0.90 ) ( 0.44 ) NAV, end of period $ 14.61 $ 15.86 $ 15.91 $ 16.75 $ 17.65 Market price, end of period $ 13.72 $ 19.16 $ 19.12 $ 21.28 $ 18.38 Shares outstanding, end of period 102,850,589 101,818,811 101,534,370 40,367,071 40,227,625 Weighted average shares outstanding 102,258,701 101,691,076 53,940,573 40,313,662 40,184,715 Total return based on NAV (4) 2.80 % 10.67 % 6.78 % 4.08 % 6.96 % Total return based on market value (5) ( 20.09 )% 11.26 % 1.00 % 26.98 % ( 9.16 )% Supplemental Data/Ratio: Net assets, end of period $ 1,502,394 $ 1,614,400 $ 1,615,141 $ 676,125 $ 709,892 Ratio of net expenses to average net assets 8.19 % 6.75 % 7.62 % 9.77 % 8.81 % Ratio of net expenses before voluntary waivers to average net assets 8.93 % 8.42 % 9.30 % — % — % Ratio of net expenses (without incentive fees and interest and other debt expenses) to average net assets 3.10 % 2.53 % 2.48 % 3.24 % 3.26 % Ratio of interest and other debt expenses to average net assets 5.05 % 3.63 % 4.82 % 5.25 % 3.62 % Ratio of net incentive fees to average net assets 0.04 % 0.59 % 0.32 % 1.28 % 1.93 % Ratio of total expenses to average net assets 8.93 % 8.70 % 12.09 % 9.82 % 8.81 % Ratio of net investment income to average net assets 14.52 % 14.62 % 13.28 % 11.53 % 11.42 % Portfolio turnover 20 % 48 % 24 % 45 % 26 % (1) The per share data was derived by using the weighted average shares outstanding during the applicable period, except for distributions declared and issuance of common stock in connection with the Merger , which reflects the actual amount per share for the applicable period. (2) The amount shown may not correspond for the period as it includes the effect of the timing of the distribution and the issuance of common stock. (3) Amount rounds to less than $ 0.01 . (4) Calculated as the change in NAV per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s DRIP. (5) Calculated as the change in market value per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s DRIP. |
Merger With GS MMLC
Merger With GS MMLC | 12 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Merger With GS MMLC | 13. MERGER WITH GS MMLC On October 12, 2020 , the Company completed its merger with GS MMLC pursuant to the Merger Agreement, dated as of June 11, 2020. The Company was the accounting survivor of the Merger. At the effective time of the Merger, each outstanding share of GS MMLC common stock was converted into the right to receive, for each share of GS MMLC common stock, that number of shares of the Company’s common stock, par value $ 0.001 per share, with a NAV equal to the NAV per share of GS MMLC common stock, in each case calculated as of October 9, 2020. As a result, the Company issued an aggregate of 61,037,311 shares of Common Stock to the former GS MMLC stockholders. The Merger was accounted for as an asset acquisition in accordance with ASC 805-50, Business Combinations—Related Issues. The consideration paid to GS MMLC’s stockholders was less than the aggregate fair values of the assets acquired and liabilities assumed, which resulted in a purchase discount (the “purchase discount”). The purchase discount was allocated to the cost of GS MMLC investments acquired by the Company on a pro-rata basis based on their relative fair values as of the closing date. Immediately following the Merger with GS MMLC, the investments were marked to their respective fair values and, as a result, the purchase discount allocated to the cost basis of the investments acquired was immediately recognized as unrealized appreciation on the Consolidated Statement of Operations. The purchase discount allocated to the loan investments acquired will amortize over the life of each respective loan through interest income with a corresponding adjustment recorded as unrealized depreciation on such loans acquired through their ultimate disposition. The purchase discount allocated to equity investments acquired will not amortize over the life of such investments through interest income and, assuming no subsequent change to the fair value of the equity investments acquired and disposition of such equity investments at fair value, the Company will recognize a realized gain with a corresponding reversal of the unrealized appreciation on disposition of such equity investments acquired. Amortization income of purchase discount for the year ended December 31, 2022, 2021 and 2020, was $ 13,469 , $ 42,448 and $ 10,109 . The Merger was considered a tax-free reorganization and the Company has elected to carry forward the historical cost basis of the GS MMLC investments for tax purposes. The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger: Common stock issued by the Company (1) $ 866,201 Total purchase price $ 866,201 Assets acquired: Investments, at fair value (amortized cost of $ 1,741,300 ) $ 1,691,263 Cash and cash equivalents 177,576 Other assets 18,986 Total assets acquired $ 1,887,825 Liabilities assumed: Debt $ 843,701 Distribution payable 75,000 Other liabilities (2) 18,963 Total liabilities assumed $ 937,664 Net assets acquired $ 950,161 Total purchase discount $ ( 83,960 ) (1) Based on the market price at closing of $ 15.26 , adjusted for a discount to reflect the impact of transfer restrictions applicable to the shares of the Company’s Common Stock issued to GS MMLC stockholders pursuant to the terms of the Merger, and the 61,037,311 shares of common stock issued by the Company. (2) Includes $ 4,159 of management fees and $ 6,672 of incentive fees accrued by GS MMLC pursuant to an investment management agreement between GS MMLC and Investment Adviser, which was terminated upon the closing of the Merger. The payable for these fees was assumed by the Company and paid by the Company to the Investment Adviser in November 2020. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Events | 14. SUBSEQUENT EVENTS Subsequent events after the date of the Consolidated Statements of Assets and Liabilities have been evaluated through the date the audited consolidated financial statements were issued. Other than the items discussed below, the Company has concluded that there is no impact requiring adjustment or disclosure on the consolidated financial statements. On February 22, 2023 , the Board of Directors declared a quarterly distribution of $ 0.45 per share payable on April 27, 2023 to holders of record as of March 31, 2023 . Goldman Sachs BDC, Inc. — Tax Information (unaudited) During the year ended December 31, 2022, the Company designated 100 % of its distributions from net investment income as interest-related dividends pursuant to Section 871(k) of the Internal Revenue Code. During the year ended December 31, 2022, the Company designated 100 % of the dividends paid from net investment company taxable income as Section 163(j) Interest Dividends. Pursuant to Section 852 of the Internal Revenue Code, the Company designated $ 30,292,670 , or if different, the maximum amount allowable, as capital gain dividends paid during the year ended December 31, 2022. During the year ended December 31, 2022, the Company designated $ 26,317,257 as short-term capital gain dividends pursuant to Section 871(k) of the Internal Revenue Code. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The Company’s functional currency is U.S. dollars (“USD”) and these consolidated financial statements have been prepared in that currency. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to Regulation S-X. This requires the Company to make certain estimates and assumptions that may affect the amounts reported on the consolidated financial statements and accompanying notes. These consolidated financial statements reflect normal and recurring adjustments that in the opinion of the Company are necessary for the fair statement of the results for the periods presented. Actual results may differ from the estimates and assumptions included on the consolidated financial statements. Certain prior period information has been reclassified to conform to the current period presentation. The reclassification has no effect on the Company’s consolidated financial position or the consolidated results of operations as previously reported. As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (“ASC”) Topic 946, Financial Services – Investment Companies (“ASC 946”) issued by the Financial Accounting Standards Board (“FASB”). |
Basis of Consolidation | Basis of Consolidation As provided under ASC 946, the Company will not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. Accordingly, the Company consolidated the financial position and results of operations of its wholly owned subsidiaries, BDC Blocker I, LLC (formerly known as My-On BDC Blocker, LLC), GSBD Blocker II, LLC, GSBD Wine I, LLC, GSBD Blocker III, LLC, GSBD Blocker IV, LLC, GSBD Blocker V, LLC, MMLC Blocker I, LLC, MMLC Blocker II, LLC, MMLC Wine I, LLC, and MMLC Blocker III, LLC. All significant intercompany transactions and balances have been eliminated in consolidation. |
Revenue Recognition | Revenue Recognition The Company records its investment transactions on a trade date basis, which is the date when the Company assumes the risks for gains and losses related to that instrument. Realized gains and losses are based on the specific identification method. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis. Discounts and premiums to par value on investments purchased are accreted and amortized into interest income over the life of the respective investment using the effective interest method. Loan origination fees, original issue discount (“OID”) and market discounts or premiums are capitalized and amortized into interest income using the effective interest method or straight-line method, as applicable. Exit fees that are receivable upon repayment of a loan or debt security are amortized into interest income over the life of the respective investment. Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income, for which the Company has earned the following: For the Years Ended December 31, 2022 2021 2020 Prepayment premiums $ 1,676 $ 3,224 $ 1,822 Accelerated amortization of upfront loan origination fees and unamortized discounts $ 12,536 $ 54,467 $ 9,494 Fees received from portfolio companies (directors’ fees, consulting fees, administrative fees, tax advisory fees and other similar compensation) are paid to the Company, unless, to the extent required by applicable law or exemptive relief, if any, therefrom, the Company only receives its allocable portion of such fees when invested in the same portfolio company as another account managed by the Investment Adviser. Dividend income on preferred equity investments is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity investments is recorded on the record date for private portfolio companies and on the ex-dividend date for publicly traded portfolio companies. Interest and dividend income are presented net of withholding tax, if any. Certain investments may have contractual payment-in-kind (“PIK”) interest or dividends. PIK represents accrued interest or accumulated dividends that are added to the principal amount or shares (if equity) of the investment on the respective interest or dividend payment dates rather than being paid in cash and generally becomes due at maturity or upon the investment being called by the issuer. PIK is recorded as interest or dividend income, as applicable. If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest or dividends are generally reversed through interest or dividend income. Certain structuring fees, amendment fees, syndication fees and commitment fees are recorded as other income when earned. Administrative agent fees received by the Company are recorded as other income when the services are rendered over time. |
Acquisition Accounting | Acquisition Accounting On October 12, 2020, the Company completed its merger with GS MMLC pursuant to the Merger Agreement, dated as of June 11, 2020. The Merger was accounted for as an asset acquisition in accordance with ASC 805-50, Business Combinations - Related Issues. See Note 13 “Merger with GS MMLC" for further details. |
Non-Accrual Investments | Non-Accrual Investments Investments are placed on non-accrual status when it is probable that principal, interest or dividends will not be collected according to the contractual terms. Accrued interest or dividends generally are reversed when an investment is placed on non-accrual status. Interest or dividend payments received on non-accrual investments may be recognized as income or applied to principal depending upon management’s judgment. Non-accrual investments are restored to accrual status when past due principal and interest or dividends are paid and, in management’s judgment, principal and interest or dividend payments are likely to remain current. The Company may make exceptions to this treatment if an investment has sufficient collateral value and is in the process of collection. As of December 31, 2022, the Company had certain investments held in eight portfolio companies on non-accrual status, which represented 2.1 % and 0.3 % of the total investments (excluding investments in money market funds, if any) at amortized cost and at fair value. As of December 31, 2021, the Company had certain investments held in four portfolio companies on non-accrual status, which represented 2.5 % and 1.8 % of the total investments (excluding investments in money market funds, if any) at amortized cost and at fair value. |
Investments | Investments The Company carries its investments in accordance with ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), issued by the FASB, which defines fair value, establishes a framework for measuring fair value and requires disclosures about fair value measurements. Fair value is generally based on quoted market prices provided by independent price sources. In the absence of quoted market prices, investments are measured at fair value as determined by the Investment Adviser, as the valuation designee ("Valuation Designee") designated by the board of directors of the Company (the “Board of Directors”or the “Board”), pursuant to Rule 2a-5 under the Investment Company Act. Due to the inherent uncertainties of valuation, certain estimated fair values may differ significantly from the values that would have been realized had a ready market for these investments existed, and these differences could be material. See Note 5 “Fair Value Measurement.” The Company generally invests in illiquid securities, including debt and equity investments, of middle-market companies. The Board of Directors has designated to the Investment Adviser day-to-day responsibilities for implementing and maintaining internal controls and procedures related to the valuation of the Company’s portfolio investments. Under valuation procedures approved by the Board of Directors and adopted by the Valuation Designee, market quotations are generally used to assess the value of the investments for which market quotations are readily available (as defined in Rule 2a-5). The Investment Adviser obtains these market quotations from independent pricing sources. If market quotations are not readily available, the Investment Adviser prices securities at the bid prices obtained from at least two brokers or dealers, if available; otherwise, the Investment Adviser obtains prices from a principal market maker or a primary market dealer. To assess the continuing appropriateness of pricing sources and methodologies, the Investment Adviser regularly performs price verification procedures and issues challenges as necessary to independent pricing sources or brokers, and any differences are reviewed in accordance with the valuation procedures. If the Valuation Designee believes any such market quotation does not reflect the fair value of an investment, it may independently value such investment in accordance with valuation procedures for investments for which market quotations are not readily available. With respect to investments for which market quotations are not readily available, or for which market quotations are deemed not reflective of the fair value, the valuation procedures approved by the Board of Directors and adopted by the Valuation Designee, contemplate a multi-step valuation process conducted by the Investment Adviser each quarter and more frequently as needed. As the valuation designee, the Investment Adviser is primarily responsible for the valuation of the Company’s assets, subject to the oversight of the Board of Directors, as described below: (1) The quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the valuation of the portfolio investment; (2) The Valuation Designee also engages independent valuation firms (the “Independent Valuation Advisors”) to provide independent valuations of the investments for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of an investment. The Independent Valuation Advisors independently value such investments using quantitative and qualitative information. The Independent Valuation Advisors also provide analyses to support their valuation methodology and calculations. The Independent Valuation Advisors provide an opinion on a final range of values on such investments to the Valuation Designee. The Independent Valuation Advisors define fair value in accordance with ASC 820 and utilize valuation approaches including the market approach, the income approach or both. A portion of the portfolio is reviewed on a quarterly basis, and all investments in the portfolio for which market quotations are not readily available, or are readily available, but deemed not reflective of the fair value of an investment, are reviewed at least annually by an Independent Valuation Advisor; (3) The Independent Valuation Advisor’s preliminary valuations are reviewed by the Investment Adviser and the Valuation Oversight Group (“VOG”), a team that is part of the controllers group of Goldman Sachs. The Independent Valuation Advisors’ valuation ranges are compared to the Investment Adviser’s valuations to ensure the Investment Adviser’s valuations are reasonable. VOG presents the valuations to the Asset Management Private Investment Valuation and Side Pocket Working Group of the Asset Management Valuation Committee (the “Asset Management Private Investment Valuation and Side Pocket Working Group”), which is comprised of a number of representatives from different functions and areas of expertise related to GSAM’s business and controls who are independent of the investment decision making process; (4) The Asset Management Private Investment Valuation and Side Pocket Working Group reviews and preliminarily approves the fair valuations and makes fair valuation recommendations to the Asset Management Valuation Committee; (5) The Asset Management Valuation Committee reviews the valuation information provided by the Asset Management Private Investment Valuation and Side Pocket Working Group, the VOG, the investment professionals of the Investment Adviser responsible for valuations, and the Independent Valuation Advisors. The Asset Management Valuation Committee then assesses such valuation recommendations; and (6) Through the Asset Management Valuation Committee, the Valuation Designee discusses the valuations, provides written reports to the Board of Directors on at least a quarterly basis, and, within the meaning of the Investment Company Act, determines the fair value of the investments in good faith, based on the inputs of the Asset Management Valuation Committee, the Asset Management Private Investment Valuation and Side Pocket Working Group, the VOG, the investment professionals of the Investment Adviser responsible for valuations, and the Independent Valuation Advisors. |
Money Market Funds | Money Market Funds Investments in money market funds are valued at NAV per share and are considered cash equivalents for the purposes of the management fee paid to the Investment Adviser. See Note 3 “Significant Agreements and Related Party Transactions.” |
Cash | Cash Cash consists of deposits held at a custodian bank. As of December 31, 2022 and December 31, 2021, the Company held an aggregate cash balance of $ 39,602 and $ 33,764 . Foreign currency of $ 1,037 and $ 2,614 (acquisition cost of $ 1,035 and $ 2,760 ) is included in cash as of December 31, 2022 and December 31, 2021. |
Foreign Currency Translation | Foreign Currency Translation Amounts denominated in foreign currencies are translated into USD on the following basis: (i) investments and other assets and liabilities denominated in foreign currencies are translated into USD based upon currency exchange rates effective on the last business day of the period; and (ii) purchases and sales of investments, borrowings and repayments of such borrowings, income, and expenses denominated in foreign currencies are translated into USD based upon currency exchange rates prevailing on the transaction dates. The Company does not isolate the portion of the results of operations resulting from changes in foreign exchange rates on investments from fluctuations arising from changes in market prices of securities held. Such fluctuations are included within the net realized and unrealized gains or losses on investments. Fluctuations arising from the translation of non-investment assets and liabilities, if any, are included with the net change in unrealized gains (losses) on foreign currency translations on the Consolidated Statements of Operations. Foreign securities and currency translations may involve certain considerations and risks not typically associated with investing in U.S. companies and U.S. government securities. These risks include, but are not limited to, currency fluctuations and revaluations and future adverse political, social and economic developments, which could cause investments in foreign markets to be less liquid and prices more volatile than those of comparable U.S. companies or U.S. government securities. |
Derivatives | Derivatives The Company may enter into foreign currency forward contracts to reduce the Company’s exposure to foreign currency exchange rate fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another, at a pre-determined price at a future date. Forward foreign currency contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Notional amounts of foreign currency forward contract assets and liabilities are presented separately on the Consolidated Schedules of Investments. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting and as such, the Company recognizes its derivatives at fair value, and records changes in the net unrealized appreciation (depreciation) on foreign currency forward contracts in the Consolidated Statements of Operations. |
Income Taxes | Income Taxes The Company recognizes tax positions in its consolidated financial statements only when it is more likely than not that the position will be sustained upon examination by the relevant taxing authority based on the technical merits of the position. A position that meets this standard is measured at the largest amount of benefit that will more likely than not be realized upon settlement. The Company reports any interest expense related to income tax matters in income tax expense and any income tax penalties under expenses on the Consolidated Statements of Operations. The Company’s tax positions have been reviewed based on applicable statutes of limitation for tax assessments, which may vary by jurisdiction, and based on such review, the Company has concluded that no additional provision for income tax is required on the consolidated financial statements. The Company is subject to potential examination by certain taxing authorities in various jurisdictions. The Company’s tax positions are subject to ongoing interpretation of laws and regulations by taxing authorities. The Company has elected to be treated as a RIC commencing with its taxable year ended December 31, 2013. So long as the Company maintains its status as a RIC, it will generally not be required to pay corporate-level U.S. federal income tax on any ordinary income or capital gains that it distributes at least annually to its stockholders as dividends. As a result, any U.S. federal income tax liability related to income earned and distributed by the Company represents obligations of the Company’s stockholders and will not be reflected on the consolidated financial statements of the Company. To maintain its tax treatment as a RIC, the Company must meet specified source-of-income and asset diversification requirements and timely distribute to its stockholders for each taxable year at least 90% of its investment company taxable income (generally, its net ordinary income plus the excess of its realized net short-term capital gains over realized net long-term capital losses, determined without regard to the dividends paid deduction). In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income as required. For the years ended December 31, 2022, 2021 and 2020 the Company accrued excise taxes of $ 4,519 , $ 1,254 and $ 1,443 . As of December 31, 2022, $ 3,494 of accrued excise taxes remained payable. Certain of the Company’s consolidated subsidiaries are subject to U.S. federal and state corporate-level income taxes. Income tax expense, if any, is included under the income category for which it applies on the Consolidated Statements of Operations. |
Distributions | Distributions Distributions from net investment income and net realized capital gains are determined in accordance with U.S. federal income tax regulations, which may differ from those amounts determined in accordance with GAAP. The Company may pay distributions in excess of its taxable net investment income. This excess would be a tax-free return of capital in the period and reduce the stockholder’s tax basis in its shares. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent they are charged or credited to paid-in capital in excess of par or distributable earnings, as appropriate, in the period that the differences arise. Temporary and permanent differences are primarily attributable to differences in the tax treatment of certain loans and the tax characterization of income and non-deductible expenses. These differences are generally determined in conjunction with the preparation of the Company’s annual RIC tax return. Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a distribution is determined by the Board of Directors each quarter and is generally based upon the earnings estimated by the Investment Adviser. The Company may pay distributions to its stockholders in a year in excess of its net ordinary income and capital gains for that year and, accordingly, a portion of such distributions may constitute a return of capital for U.S. federal income tax purposes. The Company intends to timely distribute to its stockholders substantially all of its annual taxable income for each year, except that the Company may retain certain net capital gains for reinvestment and, depending upon the level of the Company’s taxable income earned in a year, the Company may choose to carry forward taxable income for distribution in the following year and pay any applicable tax. The specific tax characteristics of the Company’s distributions will be reported to stockholders after the end of the calendar year. All distributions will be subject to available funds, and no assurance can be given that the Company will be able to declare such distributions in future periods. The Company has a voluntary dividend reinvestment plan (the “DRIP”) that provides for the automatic reinvestment of all cash distributions declared by the Board of Directors unless a stockholder elects to “opt out” of the plan. As a result, if the Board of Directors declares a cash distribution, then the stockholders who have not “opted out” of the DRIP will have their cash distributions automatically reinvested in additional shares of common stock, rather than receiving the cash distribution. If the distribution is subject to withholding tax as described above, only the net after-tax amount will be reinvested in additional Shares. Stockholders who receive distributions in the form of shares of common stock will generally be subject to the same U.S. federal, state and local tax consequences as if they received cash distributions and, for this purpose, stockholders receiving distributions in the form of stock will generally be treated as receiving distributions equal to the fair market value of the stock received through the plan; however, since their cash distributions will be reinvested, those stockholders will not receive cash with which to pay any applicable taxes. Due to regulatory considerations, GS Group Inc. has opted out of the dividend reinvestment plan, and GS & Co. has opted out of the dividend reinvestment plan in respect of shares of the Company’s common stock acquired through the 10b5-1 Plan. |
Deferred Financing and Debt Issuance Costs | Deferred Financing and Debt Issuance Costs Deferred financing and debt issuance costs consist of fees and expenses paid in connection with the closing of and amendments to the Company’s borrowings. The aforementioned costs are amortized using the straight-line method over each instrument’s term. Deferred financing costs related to a revolving credit facility is presented separately as an asset on the Company’s Consolidated Statements of Assets and Liabilities. Deferred debt issuance costs related to any notes are presented net against the outstanding debt balance on the Consolidated Statements of Assets and Liabilities. |
Equity Offering Costs | Equity Offering Costs Offering costs consist of fees and expenses paid in connection with equity offerings. Offering costs are charged against the proceeds from equity offerings when proceeds are received. |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Schedule of Interest Income | Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income, for which the Company has earned the following: For the Years Ended December 31, 2022 2021 2020 Prepayment premiums $ 1,676 $ 3,224 $ 1,822 Accelerated amortization of upfront loan origination fees and unamortized discounts $ 12,536 $ 54,467 $ 9,494 |
Significant Agreements and Re_2
Significant Agreements and Related Party Transactions (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Related Party Transactions [Abstract] | |
Schedule of Affiliated Investments | The table below presents the Company’s affiliated investments: Beginning Fair Value Balance Gross (1) Gross (2) Net Realized Net Change in Ending Fair Value Balance Dividend, For the Year Ended December 31, 2022 Controlled Affiliates Bolttech Mannings, Inc. $ 18,375 $ 22,066 $ ( 18,660 ) $ ( 14,414 ) $ ( 7,367 ) $ — $ 275 Total Controlled Affiliates $ 18,375 $ 22,066 $ ( 18,660 ) $ ( 14,414 ) $ ( 7,367 ) $ — $ 275 Non-Controlled Affiliates Goldman Sachs Financial Square Government Fund $ — $ 328,935 $ ( 328,935 ) $ — $ — $ — $ 93 Animal Supply Holdings, LLC 6,569 382 — — ( 6,951 ) — 380 ATX Networks Corp. 6,039 195 ( 633 ) — 3,458 9,059 623 Collaborative Imaging, LLC (dba Texas Radiology Associates) 5,491 — — — ( 565 ) 4,926 289 Conergy Asia & ME Pte. LTD 400 — — — ( 400 ) — — Elah Holdings, Inc. 5,396 — — — — 5,396 — Iracore International Holdings, Inc. 7,596 — — — 1,039 8,635 265 Kawa Solar Holdings Limited 1,328 — — — ( 45 ) 1,283 — Southeast Mechanical, LLC (dba. SEM Holdings, LLC) — 11,601 ( 54 ) — 145 11,692 538 Total Non-Controlled Affiliates $ 32,819 $ 341,113 $ ( 329,622 ) $ — $ ( 3,319 ) $ 40,991 $ 2,188 Total Affiliates $ 51,194 $ 363,179 $ ( 348,282 ) $ ( 14,414 ) $ ( 10,686 ) $ 40,991 $ 2,463 For the Year Ended December 31, 2021 Controlled Affiliates Bolttech Mannings, Inc. $ 19,810 $ 4,974 $ — $ — $ ( 6,409 ) $ 18,375 $ 1,486 Total Controlled Affiliates $ 19,810 $ 4,974 $ — $ — $ ( 6,409 ) $ 18,375 $ 1,486 Non-Controlled Affiliates Goldman Sachs Financial Square Government Fund $ — $ 809,929 $ ( 809,929 ) $ — $ — $ — $ 2 Animal Supply Holdings, LLC 16,838 723 — ( 756 ) ( 10,236 ) 6,569 723 ATX Networks Corp. — 6,133 — — ( 94 ) 6,039 196 CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) 48,741 — ( 48,494 ) 35,916 ( 36,163 ) — ( 6 ) Collaborative Imaging, LLC (dba Texas Radiology Associates) 4,365 — — — 1,126 5,491 307 Conergy Asia & ME Pte. LTD 334 — — — 66 400 — Elah Holdings, Inc. 5,396 — — — — 5,396 — Iracore International Holdings, Inc. 10,178 — — — ( 2,582 ) 7,596 926 Kawa Solar Holdings Limited 1,359 — — — ( 31 ) 1,328 — Total Non-Controlled Affiliates $ 87,211 $ 816,785 $ ( 858,423 ) $ 35,160 $ ( 47,914 ) $ 32,819 $ 2,148 Total Affiliates $ 107,021 $ 821,759 $ ( 858,423 ) $ 35,160 $ ( 54,323 ) $ 51,194 $ 3,634 (1) Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category. (2) Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category. |
Investments (Tables)
Investments (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Investments All Other Investments [Abstract] | |
Schedule of Investments Excluding Investments in Money Market Funds | The Company’s investments (excluding investments in money market funds, if any) consisted of the following: December 31, 2022 December 31, 2021 Investment Type Cost Fair Value Cost Fair Value 1st Lien/Senior Secured Debt $ 3,174,534 $ 3,129,552 $ 2,930,047 $ 2,945,368 1st Lien/Last-Out Unitranche 120,253 116,230 157,768 162,532 2nd Lien/Senior Secured Debt 255,354 174,326 295,533 283,521 Unsecured Debt 8,787 7,630 2,558 1,733 Preferred Stock 48,258 42,377 48,258 52,655 Common Stock 82,006 35,490 71,777 30,784 Warrants 1,849 611 1,849 1,850 Total $ 3,691,041 $ 3,506,216 $ 3,507,790 $ 3,478,443 |
Schedule of Investments at Fair Value and Net Assets | The industry composition of the Company’s investments at fair value and net assets was as follows: December 31, 2022 December 31, 2021 Industry Fair Value Net Assets Fair Value Net Assets Software 14.7 % 34.4 % 13.5 % 29.0 % Diversified Financial Services 11.3 26.3 9.2 19.9 Health Care Providers & Services 11.2 26.2 10.3 22.3 Professional Services 9.5 22.2 7.9 17.1 Health Care Technology 8.9 20.7 11.0 23.6 IT Services 7.0 16.4 5.8 12.6 Diversified Consumer Services 5.4 12.5 6.1 13.2 Real Estate Mgmt. & Development 4.5 10.5 5.8 12.5 Interactive Media & Services 3.4 8.0 5.2 11.1 Commercial Services & Supplies 3.3 7.6 3.3 7.1 Health Care Equipment & Supplies 3.2 7.5 3.2 6.9 Entertainment 2.1 5.0 2.2 4.7 Hotels, Restaurants & Leisure 1.6 3.8 1.6 3.4 Transportation Infrastructure 1.4 3.3 1.5 3.3 Chemicals 1.2 2.8 1.8 3.8 Road & Rail 1.2 2.8 1.2 2.7 Independent Power and Renewable Electricity Producers 1.2 2.7 0.7 1.6 Household Products 1.1 2.5 1.1 2.4 Internet & Direct Marketing Retail 1.0 2.4 1.1 2.4 Aerospace & Defense 1.0 2.3 1.0 2.2 Construction & Engineering 0.9 2.2 1.0 2.1 Beverages 0.9 2.2 1.0 2.2 Trading Companies & Distributors 0.8 1.8 0.7 1.5 Insurance 0.6 1.4 0.4 0.8 Pharmaceuticals 0.5 1.1 0.4 0.9 Auto Components 0.4 0.9 0.9 1.9 Containers & Packaging 0.3 0.7 0.3 0.7 Communications Equipment 0.3 0.6 0.2 0.4 Energy Equipment & Services 0.2 0.6 0.2 0.5 Textiles, Apparel & Luxury Goods 0.2 0.5 0.2 0.4 Specialty Retail 0.2 0.4 0.2 0.3 Air Freight & Logistics 0.2 0.4 0.2 0.4 Capital Markets 0.2 0.4 0.2 0.3 Food Products 0.1 0.2 0.1 0.1 Building Products — (1) 0.1 — (1) 0.1 Oil, Gas & Consumable Fuels — (1) — (1) — (1) — (1) Automobiles — (1) — (1) — (1) — (1) Distributors — (1) — (1) 0.2 0.4 Leisure Products — — 0.3 0.7 Total 100.0 % 233.4 % 100.0 % 215.5 % (1) Amount rounds to less than 0.1 %. |
Schedule of Geographic Composition of Investments at Fair Value | The geographic composition of the Company’s investments at fair value was as follows: Geographic December 31, December 31, United States 95.3 % 96.5 % Canada 3.1 3.0 United Kingdom 1.6 0.5 Germany — (1) — (1) Singapore — (1) — (1) Total 100.0 % 100.0 % (1) Amount rounds to less than 0.1 %. |
Fair Value Measurement (Tables)
Fair Value Measurement (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Summary of Ranges of Significant Unobservable Inputs Used to Value Level 3 Assets | The tables below present the ranges of significant unobservable inputs used to value the Company’s Level 3 assets as of December 31, 2022 and December 31, 2021 . Level 3 Instruments Fair Value (1)(2) Valuation Techniques (3) Significant Unobservable Range of Significant (4) Weighted (5) As of December 31, 2022 Bank Loans, Corporate Debt, and Other Debt Obligations 1st Lien/Senior Secured Debt $ 2,920,976 Discounted cash flows Discount Rate 7.4 % - 35.2 % 11.4 % 1,283 Collateral analysis Recovery Rate — 32.9 % 4,486 Comparable multiples EV/EBITDA (6) — 12.0 x 806 Comparable multiples EV/Revenue — 2.3 x 1st Lien/Last-Out Unitranche 116,230 Discounted cash flows Discount Rate 10.9 % - 15.0 % 14.1 % 2nd Lien/Senior Secured Debt 87,872 Discounted cash flows Discount Rate 12.7 % - 17.7 % 13.9 % 1,701 Comparable multiples EV/EBITDA (6) — 9.9 x Unsecured Debt 7,630 Discounted cash flows Discount Rate 13.5 % - 17.3 % 16.5 % Equity Preferred Stock $ 14,297 Comparable multiples EV/EBITDA (6) 14.4 x - 29.7 x 28.2 x 28,081 Comparable multiples EV/Revenue 0.8 x - 7.3 x 4.1 x Common Stock 10,322 Discounted cash flows Discount Rate 16.3 % - 30.0 % 24.6 % 20,391 Comparable multiples EV/EBITDA (6) 4.5 x - 18.3 x 9.7 x 3,784 Comparable multiples EV/Revenue 1.8 x - 15.2 x 12.6 x Warrants 611 Comparable multiples EV/Revenue — 4.0 x As of December 31, 2021 Bank Loans, Corporate Debt, and Other Debt Obligations 1st Lien/Senior Secured Debt $ 2,271,598 Discounted cash flows Discount Rate 7.1 % - 22.5 % 9.1 % 1,328 Collateral analysis Recovery Rate — 33.9 % 1st Lien/Last-Out Unitranche 162,532 Discounted cash flows Discount Rate 8.9 % - 10.1 % 9.4 % 2nd Lien/Senior Secured Debt 177,079 Discounted cash flows Discount Rate 9.7 % - 15.4 % 11.2 % 1,701 Comparable multiples EV/EBITDA (6) — 9.3 x Unsecured Debt 1,333 Discounted cash flows Discount Rate — 14.8 % 400 Collateral analysis Recovery Rate — 31.6 % Equity Preferred Stock $ 2,425 Comparable multiples EV/EBITDA (6) 10.5 x - 21.4 x 21.2 x 18,121 Comparable multiples EV/Revenue 1.5 x - 5.7 x 2.0 x Common Stock 10,887 Discounted cash flows Discount Rate 14.6 % - 31.1 % 24.1 % 12,871 Comparable multiples EV/EBITDA (6) 4.4 x - 19.2 x 10.3 x 4,002 Comparable multiples EV/Revenue 0.7 x - 18.9 x 14.9 x Warrants 1,850 Comparable multiples EV/Revenue — 8.2 x (1) As of December 31, 2022, included within the fair value of Level 3 assets of $ 3,341,847 is an amount of $ 123,377 for which the Investment Adviser did not develop the unobservable inputs (examples include single source broker quotations, third party pricing, and prior transactions). The income approach was used in the determination of fair value for $ 3,132,708 or 96.0 % of Level 3 bank loans, corporate debt, and other debt obligations . (2) As of December 31, 2021, included within the fair value of Level 3 assets of $ 3,270,660 is an amount of $ 604,533 for which the Investment Adviser did not develop the unobservable inputs (examples include single source broker quotations, third party pricing, and prior transactions). The income approach was used in the determination of fair value for $ 2,612,542 or 82.0 % of Level 3 bank loans, corporate debt, and other debt obligations. (3) The fair value of any one instrument may be determined using multiple valuation techniques. For example, market comparable and discounted cash flows may be used together to determine fair value. Therefore, the Level 3 balance encompasses both of these techniques. (4) The range for an asset category consisting of a single investment, if any, is not meaningful and therefore has been excluded. (5) Weighted average for an asset category consisting of multiple investments is calculated by weighting the significant unobservable input by the relative fair value of the investment. Weighted average for an asset category consisting of a single investment represents the significant unobservable input used in the fair value of the investment. (6) Enterprise value of portfolio company as a multiple of earnings before interest, taxes, depreciation and amortization (“EBITDA”). |
Summary of Assets Categorized Within Fair Value Hierarchy | The following is a summary of the Company’s assets categorized within the fair value hierarchy: December 31, 2022 December 31, 2021 Assets Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total 1st Lien/Senior Secured Debt $ — $ 78,623 $ 3,050,929 $ 3,129,552 $ — $ 102,358 $ 2,843,010 $ 2,945,368 1st Lien/Last-Out Unitranche — — 116,230 116,230 — — 162,532 162,532 2nd Lien/Senior Secured Debt — 84,753 89,573 174,326 — 104,741 178,780 283,521 Unsecured Debt — — 7,630 7,630 — — 1,733 1,733 Preferred Stock — — 42,377 42,377 — — 52,655 52,655 Common Stock 993 — 34,497 35,490 684 — 30,100 30,784 Warrants — — 611 611 — — 1,850 1,850 Total Assets $ 993 $ 163,376 $ 3,341,847 $ 3,506,216 $ 684 $ 207,099 $ 3,270,660 $ 3,478,443 Unrealized appreciation (depreciation) on foreign currency forward contracts $ — $ ( 484 ) $ — $ ( 484 ) $ — $ 100 $ — $ 100 |
Summary of Changes in Fair Value of Level 3 Assets By Investment Type | The below table presents a summary of changes in fair value of Level 3 assets by investment type: Beginning Balance Purchases (1) Net Net Change in Sales and (2) Net Transfers (3) Transfers (3) Ending Net Change For the Year Ended December 31, 2022 1st Lien/Senior Secured Debt $ 2,843,010 $ 827,409 $ ( 4,696 ) $ ( 56,045 ) $ ( 595,922 ) $ 28,685 $ 8,488 $ — $ 3,050,929 $ ( 60,742 ) 1st Lien/Last-Out Unitranche 162,532 19,801 — ( 8,786 ) ( 61,297 ) 3,980 — — 116,230 ( 6,767 ) 2nd Lien/Senior Secured Debt 178,780 16,714 ( 14,414 ) ( 46,425 ) ( 47,859 ) 2,777 — — 89,573 ( 46,240 ) Unsecured Debt 1,733 6,182 — ( 332 ) — 47 — — 7,630 ( 332 ) Preferred Stock 52,655 — — ( 10,278 ) — — — — 42,377 ( 10,278 ) Common Stock 30,100 10,079 105 ( 5,682 ) ( 105 ) — — — 34,497 ( 5,682 ) Warrants 1,850 — — ( 1,239 ) — — — — 611 ( 1,239 ) Total Assets $ 3,270,660 $ 880,185 $ ( 19,005 ) $ ( 128,787 ) $ ( 705,183 ) $ 35,489 $ 8,488 $ — $ 3,341,847 $ ( 131,280 ) For the Year Ended December 31, 2021 1st Lien/Senior Secured Debt $ 2,384,944 $ 1,611,821 $ ( 942 ) $ ( 23,494 ) $ ( 1,152,967 ) $ 62,690 $ — $ ( 39,042 ) $ 2,843,010 $ 3,200 1st Lien/Last-Out Unitranche 143,231 31,138 — 492 ( 14,517 ) 2,188 — — 162,532 865 2nd Lien/Senior Secured Debt 407,872 31,550 ( 1,203 ) ( 11,826 ) ( 209,051 ) 14,109 — ( 52,671 ) 178,780 ( 8,457 ) Unsecured Debt 334 1,492 — ( 103 ) — 10 — — 1,733 ( 104 ) Preferred Stock 48,080 39,192 24,233 ( 23,812 ) ( 35,038 ) — — — 52,655 ( 5 ) Common Stock 65,284 10,218 19,223 ( 33,226 ) ( 31,399 ) — — — 30,100 ( 14,468 ) Warrants 1,024 1,849 ( 756 ) ( 267 ) — — — — 1,850 1 Total Assets $ 3,050,769 $ 1,727,260 $ 40,555 $ ( 92,236 ) $ ( 1,442,972 ) $ 78,997 $ — $ ( 91,713 ) $ 3,270,660 $ ( 18,968 ) (1) Purchases may include PIK, securities received in corporate actions and restructurings. (2) Sales and Settlements may include securities delivered in corporate actions and restructuring of investments. (3) Transfers in (out) of Level 3 are due to a decrease (increase) in the quantity and reliability of broker quotes obtained by the Investment Adviser. |
Summary of Debt Obligations Carried at Fair Value | If the Company’s debt obligations were carried at fair value, the fair value and level would have been as follows: As of Level December 31, 2022 December 31, 2021 Revolving Credit Facility 3 $ 1,161,401 $ 858,722 Convertible Notes (1) 2 $ — $ 158,116 2025 Notes 2 $ 348,120 $ 377,778 2026 Notes 2 $ 461,800 $ 513,037 (1) On April 1, 2022, the Convertible Notes matured and were paid in full. |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Debt Instrument [Line Items] | |
Schedule of Outstanding Debt | The Company’s outstanding debt was as follows: As of December 31, 2022 December 31, 2021 Aggregate Amount Carrying (1) Aggregate Amount Carrying (1) Revolving Credit Facility (2) $ 1,695,000 $ 548,671 $ 1,161,401 $ 1,695,000 $ 837,164 $ 858,722 Convertible Notes (3) — — — 155,000 — 154,665 2025 Notes 360,000 — 357,076 360,000 — 355,735 2026 Notes 500,000 — 494,183 500,000 — 492,304 Total Debt $ 2,555,000 $ 548,671 $ 2,012,660 $ 2,710,000 $ 837,164 $ 1,861,426 (1) The carrying value is presented net of unamortized debt issuance costs and OID net of accretion as applicable. (2) Provides, under certain circumstances, a total borrowing capacity of $ 2,250,000 . The Company may borrow amounts in USD or certain other permitted currencies. Debt outstanding denominated in currencies other than USD has been converted to USD using the applicable foreign currency exchange rate as of the applicable reporting date. As of December 31, 2022, the Company had outstanding borrowings denominated in USD of $ 1,065,674 , in Euros (EUR) of EUR 37,700 , in British Pound (GBP) of GBP 45,300 and in Canadian Dollars (CAD) of CAD 820 . As of December 31, 2021, the Company had outstanding borrowings denominated in USD of $ 799,574 , in Euros (EUR) of EUR 37,700 , in British Pound (GBP) of GBP 11,900 and in Canadian Dollars (CAD) of CAD 150 . (3) On April 1, 2022, the Convertible Notes matured and were paid in full. |
Schedule of Revolving Credit Facility | The below table presents the summary information of the Revolving Credit Facility: For the Years Ended December 31, 2022 2021 2020 Borrowing interest expense $ 41,088 $ 12,143 $ 12,377 Facility fees 2,347 4,189 1,898 Amortization of financing costs 2,855 2,780 2,016 Total $ 46,290 $ 19,112 $ 16,291 Weighted average interest rate 3.76 % 2.00 % 2.43 % Average outstanding balance $ 1,093,410 $ 606,442 $ 509,927 |
2025 Notes | |
Debt Instrument [Line Items] | |
Schedule of Outstanding Debt | The below table presents the components of the carrying value of the 2025 Notes: December 31, December 31, Principal amount of debt $ 360,000 $ 360,000 Unamortized debt issuance costs 2,924 4,265 Carrying Value $ 357,076 $ 355,735 |
Components of Interest and Other Debt Expenses | The below table presents the components of interest and other debt expenses related to the 2025 Notes: For the Years Ended December 31, 2022 2021 2020 Borrowing interest expense $ 13,500 $ 13,500 $ 12,038 Amortization of debt issuance costs 1,342 1,404 1,254 Total $ 14,842 $ 14,904 $ 13,292 |
2026 Notes | |
Debt Instrument [Line Items] | |
Schedule of Outstanding Debt | The below table presents the components of the carrying value of the 2026 Notes: December 31, December 31, Principal amount of debt $ 500,000 $ 500,000 Unamortized debt issuance costs 5,817 7,696 Carrying Value $ 494,183 $ 492,304 |
Components of Interest and Other Debt Expenses | The below table presents the components of interest and other debt expenses related to the 2026 Notes: For the Years Ended December 31, 2022 2021 2020 Borrowing interest expense $ 14,375 $ 14,375 $ 1,476 Amortization of debt issuance costs 1,879 1,940 203 Total $ 16,254 $ 16,315 1,679 |
Convertible Notes | |
Debt Instrument [Line Items] | |
Components of Carrying Value | The below table presents the components of the carrying value of the Convertible Notes: December 31, December 31, Principal amount of debt $ — $ 155,000 OID, net of accretion — 118 Unamortized debt issuance costs — 217 Carrying Value $ — $ 154,665 Stated interest rate — % 4.50 % Effective interest rate (stated interest rate plus accretion of OID) — % 4.80 % |
Components of Interest and Other Debt Expenses | The below table presents the components of interest and other debt expenses related to the Convertible Notes: For the Years Ended December 31, 2022 2021 2020 Borrowing interest expense $ 1,744 $ 6,975 $ 6,975 Accretion of OID 118 468 446 Amortization of debt issuance costs 216 1,214 1,217 Total $ 2,078 $ 8,657 $ 8,638 |
Derivatives (Tables)
Derivatives (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Derivative Instruments And Hedging Activities Disclosure [Abstract] | |
Schedule of Foreign Currency Forward Contracts | The Company’s net exposure to foreign currency forward contracts that are subject to ISDA Master Agreements or similar agreements presented on the Consolidated Statements of Assets and Liabilities, all of which are with Bank of America, N.A., was as follows: December 31, 2022 December 31, 2021 Gross Amount of Assets $ — $ 100 Gross Amount of Liabilities ( 484 ) — Net Amount of Assets or (Liabilities) $ ( 484 ) $ 100 Collateral (Received) Pledged (1) 290 — Net Amounts (2) $ ( 194 ) $ 100 (1) Amount excludes excess cash collateral paid, if any. (2) Net amount represents the net amount due (to) from counterparty in the event of a default based on the contractual setoff rights under the agreement. Net amount excludes any over-collateralized amounts. |
Schedule of Effect of Transactions in Derivative Instruments | The effect of transactions in derivative instruments on the Consolidated Statements of Operations was as follows: For the Years Ended December 31, 2022 2021 2020 Net realized gain (loss) on foreign currency forward contracts $ 283 $ ( 234 ) $ 82 Net change in unrealized appreciation (depreciation) on foreign currency forward contracts ( 584 ) 455 ( 388 ) Total net realized and unrealized gains (losses) on foreign currency forward contracts $ ( 301 ) $ 221 $ ( 306 ) |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Commitments And Contingencies Disclosure [Abstract] | |
Schedule of Unfunded Commitments by Investment Types | The Company had the following unfunded commitments by investment types: Unfunded Commitment (1) December 31, 2022 December 31, 2021 1st Lien/Senior Secured Debt 1272775 B.C. LTD. (dba Everest Clinical Research) $ 163 $ 1,151 Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) 1,950 4,082 Acquia, Inc. 1,346 3,268 Admiral Buyer, Inc. (dba Fidelity Payment Services) 9,650 — Ansira Partners, Inc. 127 — Apptio, Inc. 2,154 3,230 AQ Helios Buyer, Inc. (dba SurePoint) 8,888 14,189 Assembly Intermediate LLC 7,478 12,757 Bigchange Group Limited 3,459 4,426 Broadway Technology, LLC 1,090 — BSI3 Menu Buyer, Inc (dba Kydia) 38 — Bullhorn, Inc. 726 4,601 Businessolver.com, Inc. 4,595 5,026 Capitol Imaging Acquisition Corp. 38 180 Checkmate Finance Merger Sub, LLC 3,140 3,140 Chronicle Bidco Inc. (dba Lexitas) 4,753 4,339 CivicPlus LLC 1,217 3,552 Clearcourse Partnership Acquireco Finance Limited 8,951 — CloudBees, Inc. 738 12,900 Coding Solutions Acquisition, Inc. 6,156 — CORA Health Holdings Corp 8,514 8,897 CorePower Yoga LLC 1,125 1,687 Coretrust Purchasing Group LLC 226 — CST Buyer Company (dba Intoxalock) 78 2,170 DECA Dental Holdings LLC 5,360 6,843 Diligent Corporation 2,170 3,100 Eptam Plastics, Ltd. 2,042 681 ESO Solutions, Inc 3,620 3,620 Experity, Inc. 81 3,332 Fullsteam Operations LLC 2,642 16,298 Gainsight, Inc. 5,320 5,320 GHA Buyer Inc. (dba Cedar Gate) 1,880 1,254 GovDelivery Holdings, LLC (dba Granicus, Inc.) 1,716 4,087 Governmentjobs.com, Inc. (dba NeoGov) 19,428 19,427 GS AcquisitionCo, Inc. (dba Insightsoftware) 982 4,180 HealthEdge Software, Inc. 13,300 18,330 Helios Buyer, Inc. (dba Heartland) 2,363 9,592 Honor HN Buyer, Inc 21,001 18,095 HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth) 2,344 4,688 HumanState Limited (dba PayProp) 11,932 — iCIMS, Inc. 15,910 — Intelligent Medical Objects, Inc. 4,192 — Internet Truckstop Group, LLC (dba Truckstop) 4,400 4,400 iWave Information Systems, Inc. 109 — Kaseya Inc. 2,200 — LCG Vardiman Black, LLC (dba Specialty Dental Brands) 113 — Lithium Technologies, Inc. 3,066 3,066 MerchantWise Solutions, LLC (dba HungerRush) 4,485 — Millstone Medical Outsourcing, LLC 1,774 2,144 MRI Software LLC 1,612 7,994 Unfunded Commitment (1) December 31, 2022 December 31, 2021 NFM & J, L.P. (dba the Facilities Group) $ 6,054 $ 11,219 One GI LLC 3,654 13,598 PDDS Holdco, Inc. (dba Planet DDS) 6,128 — Pioneer Buyer I, LLC 4,300 4,300 PlanSource Holdings, Inc. 7,824 8,728 Pluralsight, Inc 2,550 5,100 PPT Management Holdings, LLC. 123 — Premier Care Dental Management, LLC 3,602 9,982 Premier Imaging, LLC (dba Lucid Health) 4,110 5,778 Project Eagle Holdings, LLC (dba Exostar) 75 75 Prophix Software Inc. (dba Pound Bidco) 3,445 3,445 Qualawash Holdings, LLC 3,359 — Riverpoint Medical, LLC 4,094 4,094 Rodeo Buyer Company (dba Absorb Software) 3,048 3,387 Rubrik,Inc. 2,310 — Smarsh, Inc. 5,000 — Southeast Mechanical, LLC (dba. SEM Holdings, LLC) 9,300 — SpendMend, LLC 238 — Spotless Brands, LLC 33 — StarCompliance Intermediate, LLC 1,875 2,500 Sundance Group Holdings, Inc. (dba NetDocuments) 4,925 15,761 Sunstar Insurance Group, LLC 7,996 12,053 Superman Holdings, LLC (dba Foundation Software) 122 122 Sweep Purchaser LLC 3,724 8,105 The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) 2,467 9,069 Thrasio, LLC 14,686 14,686 Total Vision LLC 10,464 1,270 Trader Corporation 17 — USN Opco LLC (dba Global Nephrology Solutions) 5,880 3,593 Volt Bidco, Inc. (dba Power Factors) 6,612 4,357 VRC Companies, LLC (dba Vital Records Control) 944 3,799 WebPT, Inc. 4,225 9,861 Wellness AcquisitionCo, Inc. (dba SPINS) 6,600 2,600 Whitewater Holding Company LLC 3,944 9,652 Wine.com, LLC 1,541 — WorkForce Software, LLC 631 — Zarya Intermediate, LLC (dba iOFFICE) 7,987 6,757 Aria Systems, Inc. — 1,893 CFS Management, LLC (dba Center for Sight Management) — 1,058 Convene 237 Park Avenue, LLC (dba Convene) — 6,100 Cordeagle US Finco, Inc. (dba Condeco) — 11,506 Elemica Parent, Inc. — 409 LS Clinical Services Holdings, Inc (dba CATO) — 2,200 MMIT Holdings, LLC (dba Managed Markets Insight & Technology) — 5,183 PT Intermediate Holdings III, LLC (dba Parts Town) — 1,980 Purfoods, LLC — 150 Xactly Corporation — 3,874 Zodiac Intermediate, LLC (dba Zipari) — 7,500 Total 1st Lien/Senior Secured Debt $ 364,529 $ 441,790 1st Lien/Last-Out Unitranche EDB Parent, LLC (dba Enterprise DB) 6,516 — Total 1st Lien/Last-Out Unitranche $ 6,516 $ — Total $ 371,045 $ 441,790 (1) Unfunded commitments denominated in currencies other than USD have been converted to USD using the exchange rate as of the applicable reporting date. |
Net Assets (Tables)
Net Assets (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Assets Net [Abstract] | |
Schedule of Issuance of Common Stock | In connection with the issuance of its common stock, the Company issued and sold the following shares of common stock: For the Years Ended December 31, 2022 2021 Gross Proceeds $ 14,156 $ — Underwriting/Offering Expenses ( 699 ) — Net Proceeds $ 13,457 $ — Number of Shares Issued 813,255 — Average Sales Price per Share $ 17.41 $ — |
Schedule of Distributions Declared on Common Stock | The following table summarizes the distributions declared on shares of the Company’s common stock and shares distributed pursuant to the DRIP to stockholders who had not opted out of the DRIP: Date Declared Record Date Payment Date Amount Per Share Shares For the Year Ended December 31, 2022 February 23, 2022 March 31, 2022 April 27, 2022 $ 0.45 65,180 May 3, 2022 June 30, 2022 July 27, 2022 $ 0.45 86,741 August 3, 2022 September 30, 2022 October 27, 2022 $ 0.45 (1) 98,756 * November 2, 2022 December 30, 2022 January 27, 2023 $ 0.45 112,555 For the Year Ended December 31, 2021 November 4, 2020 (special) February 15, 2021 March 15, 2021 $ 0.05 6,849 February 24, 2021 March 31, 2021 April 27, 2021 $ 0.45 68,092 November 4, 2020 (special) May 14, 2021 June 15, 2021 $ 0.05 8,852 May 4, 2021 June 30, 2021 July 27, 2021 $ 0.45 69,917 November 4, 2020 (special) August 16, 2021 September 15, 2021 $ 0.05 7,717 August 5, 2021 September 30, 2021 October 27, 2021 $ 0.45 65,213 November 4, 2021 December 31, 2021 January 27, 2022 $ 0.45 66,602 For the Year Ended December 31, 2020 February 19, 2020 March 31, 2020 April 15, 2020 $ 0.45 37,741 * May 5, 2020 June 30, 2020 July 15, 2020 $ 0.45 46,407 August 4, 2020 September 30, 2020 October 15, 2020 $ 0.45 49,015 November 4, 2020 December 31, 2020 January 15, 2021 $ 0.45 57,801 (1) $ 0.29 is considered capital gain distribution. * In accordance with the Company’s DRIP, shares were purchased in the open market. |
Earnings (Loss) Per Share (Tabl
Earnings (Loss) Per Share (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Basic and Diluted Earnings Per Share | The following information sets forth the computation of basic and diluted earnings per share: For the Years Ended December 31, 2022 2021 2020 Net increase (decrease) in net assets from operations $ 55,003 $ 192,427 $ 176,113 Weighted average shares outstanding 102,258,701 101,691,076 53,940,573 Basic and diluted earnings (loss) per share $ 0.54 $ 1.89 $ 3.26 |
Tax Information (Tables)
Tax Information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of Tax Character of Distributions | The tax character of distributions was as follows: For the Years Ended December 31, 2022 2021 2020 Distributions paid from: Ordinary Income $ 154,022 $ 198,332 $ 100,254 Net Long-Term Capital Gains 30,293 — — Total Taxable Distributions $ 184,315 $ 198,332 $ 100,254 |
Components of Accumulated Earnings (Losses) on Tax Basis | The components of Accumulated Earnings (Losses) on a tax basis were as follows: December 31, 2022 December 31, 2021 December 31, 2020 Undistributed Ordinary Income—net $ 86,770 $ 35,189 $ 40,868 Undistributed Long-Term Capital Gains — 31,175 — Total Undistributed Earnings $ 86,770 $ 66,364 $ 40,868 Capital Loss Carryforward (1) : Perpetual Long-Term $ ( 112,858 ) $ ( 107,216 ) $ ( 117,733 ) Perpetual Short-Term $ ( 382 ) $ ( 382 ) $ ( 494 ) Total capital loss carryforwards $ ( 113,240 ) $ ( 107,598 ) $ ( 118,227 ) Timing Differences (Organizational Costs, Post-October Capital Loss Deferral and Late Year Ordinary Loss Deferral) $ ( 10,935 ) $ ( 313 ) $ ( 539 ) Unrealized Earnings (Losses)—net $ ( 168,797 ) $ ( 13,476 ) $ 72,545 Total Accumulated Earnings (Losses)—net $ ( 206,202 ) $ ( 55,023 ) $ ( 5,353 ) (1) For the year ended December 31, 2022 and December 31, 2020, the company did no t utilize any capital losses. For the year ended December 31, 2021, the Company utilized $ 10,629 of capital losses. |
Schedule of Aggregate Unrealized Appreciation and Depreciation on Investments | The Company’s aggregate unrealized appreciation and depreciation on investments based on cost for U.S. federal income tax purposes were as follows: December 31, 2022 December 31, 2021 December 31, 2020 Tax cost $ 3,678,321 $ 3,492,053 $ 3,165,681 Gross unrealized appreciation $ 39,385 $ 77,992 $ 146,963 Gross unrealized depreciation $ ( 208,182 ) $ ( 91,468 ) $ ( 74,418 ) Net unrealized investment appreciation (depreciation) on investments $ ( 168,797 ) $ ( 13,476 ) $ 72,545 |
Schedule of Reconciles Net Increase in Net Assets Resulting from Operations to Taxable Income | The following reconciles net increase in net assets resulting from operations to taxable income: For the Years Ended December 31, 2022 2021 2020 Net increase in net assets resulting from operations $ 55,003 $ 192,427 $ 176,113 Adjustments: Net unrealized loss (gain) on investments and foreign currency forward contracts and translations 152,304 84,858 ( 109,922 ) Income not currently taxable ( 26,405 ) ( 47,243 ) 21,842 Income for tax but not book 351 2,913 ( 129 ) Expenses not currently deductible 4,562 1,202 1,539 Expenses for tax but not for book ( 613 ) ( 30 ) ( 5 ) Realized gain(loss) differences ( 92,839 ) ( 117,519 ) ( 110,478 ) Taxable income net of capital loss carryforward $ 92,363 $ 116,608 $ ( 21,040 ) Capital loss carryforward 113,240 107,598 118,227 Taxable income (1) $ 205,603 $ 224,206 $ 97,187 (1) Taxable income is an estimate and is not fully determined until the Company’s tax return is filed. |
Financial Highlights (Tables)
Financial Highlights (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Statement Of Financial Position [Abstract] | |
Schedule of Financial Highlights of the Company | Below presents the schedule of financial highlights of the Company: For the Years Ended December 31, 2022 2021 2020 2019 2018 Per Share Data: (1) NAV, beginning of period $ 15.86 $ 15.91 $ 16.75 $ 17.65 $ 18.09 Net investment income 2.24 2.33 2.04 1.98 2.06 Net realized and unrealized gains (losses) (2) ( 1.82 ) ( 0.43 ) ( 0.20 ) ( 1.08 ) ( 0.70 ) Income tax provision, realized and unrealized gains — (3) — (3) — (3) — (3) ( 0.02 ) Net increase in net assets from operations 0.42 1.90 1.84 0.90 1.34 Issuance of common stock in connection with the Merger — — ( 0.88 ) — — Issuance of common stock, net underwriting and offering costs 0.13 — — — — Equity component of convertible notes — — — — 0.02 Distributions declared ( 1.80 ) ( 1.95 ) ( 1.80 ) ( 1.80 ) ( 1.80 ) Total increase (decrease) in net assets ( 1.25 ) ( 0.05 ) ( 0.84 ) ( 0.90 ) ( 0.44 ) NAV, end of period $ 14.61 $ 15.86 $ 15.91 $ 16.75 $ 17.65 Market price, end of period $ 13.72 $ 19.16 $ 19.12 $ 21.28 $ 18.38 Shares outstanding, end of period 102,850,589 101,818,811 101,534,370 40,367,071 40,227,625 Weighted average shares outstanding 102,258,701 101,691,076 53,940,573 40,313,662 40,184,715 Total return based on NAV (4) 2.80 % 10.67 % 6.78 % 4.08 % 6.96 % Total return based on market value (5) ( 20.09 )% 11.26 % 1.00 % 26.98 % ( 9.16 )% Supplemental Data/Ratio: Net assets, end of period $ 1,502,394 $ 1,614,400 $ 1,615,141 $ 676,125 $ 709,892 Ratio of net expenses to average net assets 8.19 % 6.75 % 7.62 % 9.77 % 8.81 % Ratio of net expenses before voluntary waivers to average net assets 8.93 % 8.42 % 9.30 % — % — % Ratio of net expenses (without incentive fees and interest and other debt expenses) to average net assets 3.10 % 2.53 % 2.48 % 3.24 % 3.26 % Ratio of interest and other debt expenses to average net assets 5.05 % 3.63 % 4.82 % 5.25 % 3.62 % Ratio of net incentive fees to average net assets 0.04 % 0.59 % 0.32 % 1.28 % 1.93 % Ratio of total expenses to average net assets 8.93 % 8.70 % 12.09 % 9.82 % 8.81 % Ratio of net investment income to average net assets 14.52 % 14.62 % 13.28 % 11.53 % 11.42 % Portfolio turnover 20 % 48 % 24 % 45 % 26 % (1) The per share data was derived by using the weighted average shares outstanding during the applicable period, except for distributions declared and issuance of common stock in connection with the Merger , which reflects the actual amount per share for the applicable period. (2) The amount shown may not correspond for the period as it includes the effect of the timing of the distribution and the issuance of common stock. (3) Amount rounds to less than $ 0.01 . (4) Calculated as the change in NAV per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s DRIP. (5) Calculated as the change in market value per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s DRIP. |
Merger With GS MMLC (Tables)
Merger With GS MMLC (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Summary of Allocation of Purchase Price to Assets Acquired and Liabilities Assumed | The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger: Common stock issued by the Company (1) $ 866,201 Total purchase price $ 866,201 Assets acquired: Investments, at fair value (amortized cost of $ 1,741,300 ) $ 1,691,263 Cash and cash equivalents 177,576 Other assets 18,986 Total assets acquired $ 1,887,825 Liabilities assumed: Debt $ 843,701 Distribution payable 75,000 Other liabilities (2) 18,963 Total liabilities assumed $ 937,664 Net assets acquired $ 950,161 Total purchase discount $ ( 83,960 ) (1) Based on the market price at closing of $ 15.26 , adjusted for a discount to reflect the impact of transfer restrictions applicable to the shares of the Company’s Common Stock issued to GS MMLC stockholders pursuant to the terms of the Merger, and the 61,037,311 shares of common stock issued by the Company. (2) Includes $ 4,159 of management fees and $ 6,672 of incentive fees accrued by GS MMLC pursuant to an investment management agreement between GS MMLC and Investment Adviser, which was terminated upon the closing of the Merger. The payable for these fees was assumed by the Company and paid by the Company to the Investment Adviser in November 2020. |
Organization - Additional Infor
Organization - Additional Information (Details) - $ / shares | Oct. 12, 2020 | Dec. 31, 2022 | Dec. 31, 2021 |
Business Acquisition [Line Items] | |||
Common stock, par value | $ 0.001 | $ 0.001 | |
Goldman Sach Middle Market Lending Corp | |||
Business Acquisition [Line Items] | |||
Common stock, par value | $ 0.001 | ||
Acquisition date | Oct. 12, 2020 | ||
Shares issued | 61,037,311 |
Significant Accounting Polici_4
Significant Accounting Policies - Schedule of Interest Income (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | |||
Prepayment premiums | $ 1,676 | $ 3,224 | $ 1,822 |
Accelerated amortization of upfront loan origination fees and unamortized discounts | $ 12,536 | $ 54,467 | $ 9,494 |
Significant Accounting Polici_5
Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Significant Accounting Policies [Line Items] | |||
Percentage of non-accrual investment at amortized cost | 2.10% | 2.50% | |
Percentage of non-accrual investment at fair value | 0.30% | 1.80% | |
Cash | $ 39,602 | $ 33,764 | |
Excise taxes | 4,519 | 1,254 | $ 1,443 |
Accrued excise taxes | 3,494 | ||
Foreign Currency [Member] | |||
Significant Accounting Policies [Line Items] | |||
Cash | 1,037 | 2,614 | |
Acquisition cost | $ 1,035 | $ 2,760 |
Significant Agreements and Re_3
Significant Agreements and Related Party Transactions - Additional Information (Details) | 12 Months Ended | ||||
Dec. 31, 2022 USD ($) Component | Dec. 31, 2021 USD ($) $ / shares | Dec. 31, 2020 USD ($) | Nov. 30, 2021 USD ($) | Nov. 30, 2020 USD ($) | |
Related Party Transaction [Line Items] | |||||
Annual management fee percentage | 1% | ||||
Management fee percentage per quarter | 0.25% | ||||
Management fee | $ 35,996,000 | $ 32,611,000 | $ 16,846,000 | ||
Investment adviser voluntary agreed waive of management fees | 346,000 | 500,000 | 3,806,000 | ||
Management fees payable | $ 9,063,000 | 8,370,000 | |||
Number of components included in incentive fees | Component | 2 | ||||
Hurdle rate for incentive fee purpose | 1.75% | ||||
Incentive fee if no excess income amount | $ 0 | ||||
Percentage of ordinary income considered for incentive If that exceeds hurdle amount | 100% | ||||
Percentage of Catch-up Amount Multiplied by NAV | 2.1875% | ||||
Percentage ordinary income considered for incentive if that exceeds catchup amount | 20% | ||||
Percentage of incentive fee cap | 20% | ||||
Percentage of incentive fee If capital gains positive | 20% | ||||
Incentive fees | $ 12,023,000 | 40,697,000 | 35,845,000 | ||
Incentive fees payable | 0 | 760,000 | |||
Accrual or payment of incentive fees based on capital gain | 0 | $ 0 | 0 | ||
Minimum net investment income per weighted share for considering of waive of Incentive Fee based on income | $ / shares | $ 0.48 | ||||
Investment adviser contractually waived incentive fee based on income | 11,378,000 | $ 4,544,000 | 23,070,000 | ||
Investment adviser voluntarily waived incentive fee based on income | 26,534,000 | 10,110,000 | |||
Incurred expenses for services provided by Administrator and Custodian fees | (2,094,000) | (1,954,000) | (1,151,000) | ||
Administration and custodian fees payable | 518,000 | ||||
Incurred expenses for services provided by transfer agent | 38,000 | $ 38,000 | $ 25,000 | ||
Transfer agent fees payable | $ 25,000 | ||||
Percentage of ownership of common stock by Affiliates | 6.30% | 6.40% | |||
Accrued Expenses And Other Liabilities | |||||
Related Party Transaction [Line Items] | |||||
Due to Affiliate | $ 542,000 | $ 585,000 | |||
2020 Common Stock Repurchase Plan | |||||
Related Party Transaction [Line Items] | |||||
Stock repurchase program effective date | Nov. 09, 2020 | ||||
Stock repurchase program expiration date | Nov. 09, 2021 | ||||
2020 Common Stock Repurchase Plan | Maximum | |||||
Related Party Transaction [Line Items] | |||||
Stock repurchase plan, authorized amount | $ 75,000,000 | ||||
Common Stock Repurchase Plans | |||||
Related Party Transaction [Line Items] | |||||
Stock repurchase program commencement date | Sep. 16, 2022 | ||||
Stock repurchase program expiration date | Aug. 17, 2023 | ||||
Common Stock Repurchase Plans | Maximum | |||||
Related Party Transaction [Line Items] | |||||
Stock repurchase plan, authorized amount | $ 75,000,000 |
Significant Agreements And Re_4
Significant Agreements And Related Party Transactions - Schedule of Affiliated Investments (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | $ 51,194 | $ 107,021 |
Gross Additions | 363,179 | 821,759 |
Gross Reductions | (348,282) | (858,423) |
Net Realized Gain(Loss) | (14,414) | 35,160 |
Net Change in Unrealized Appreciation (Depreciation) | (10,686) | (54,323) |
Ending Fair Value Balance | 40,991 | 51,194 |
Dividend, Interest, PIK and Other Income | 2,463 | 3,634 |
Controlled Affiliates | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 18,375 | 19,810 |
Gross Additions | 22,066 | 4,974 |
Gross Reductions | (18,660) | |
Net Realized Gain(Loss) | (14,414) | |
Net Change in Unrealized Appreciation (Depreciation) | (7,367) | (6,409) |
Ending Fair Value Balance | 18,375 | |
Dividend, Interest, PIK and Other Income | 275 | 1,486 |
Controlled Affiliates | Bolttech Mannings, Inc. | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 18,375 | 19,810 |
Gross Additions | 22,066 | 4,974 |
Gross Reductions | (18,660) | |
Net Realized Gain(Loss) | (14,414) | |
Net Change in Unrealized Appreciation (Depreciation) | (7,367) | (6,409) |
Ending Fair Value Balance | 18,375 | |
Dividend, Interest, PIK and Other Income | 275 | 1,486 |
Non-Controlled Affiliates | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 32,819 | 87,211 |
Gross Additions | 341,113 | 816,785 |
Gross Reductions | (329,622) | (858,423) |
Net Realized Gain(Loss) | 35,160 | |
Net Change in Unrealized Appreciation (Depreciation) | (3,319) | (47,914) |
Ending Fair Value Balance | 40,991 | 32,819 |
Dividend, Interest, PIK and Other Income | 2,188 | 2,148 |
Non-Controlled Affiliates | Goldman Sachs Financial Square Government Fund | ||
Schedule Of Investments [Line Items] | ||
Gross Additions | 328,935 | 809,929 |
Gross Reductions | (328,935) | (809,929) |
Dividend, Interest, PIK and Other Income | 93 | 2 |
Non-Controlled Affiliates | Animal Supply Holdings, LLC | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 6,569 | 16,838 |
Gross Additions | 382 | 723 |
Net Realized Gain(Loss) | (756) | |
Net Change in Unrealized Appreciation (Depreciation) | (6,951) | (10,236) |
Ending Fair Value Balance | 6,569 | |
Dividend, Interest, PIK and Other Income | 380 | 723 |
Non-Controlled Affiliates | ATX Networks Corp. | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 6,039 | |
Gross Additions | 195 | 6,133 |
Gross Reductions | (633) | |
Net Change in Unrealized Appreciation (Depreciation) | 3,458 | (94) |
Ending Fair Value Balance | 9,059 | 6,039 |
Dividend, Interest, PIK and Other Income | 623 | 196 |
Non-Controlled Affiliates | CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 48,741 | |
Gross Reductions | (48,494) | |
Net Realized Gain(Loss) | 35,916 | |
Net Change in Unrealized Appreciation (Depreciation) | (36,163) | |
Dividend, Interest, PIK and Other Income | (6) | |
Non-Controlled Affiliates | Collaborative Imaging, LLC (dba Texas Radiology Associates) | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 5,491 | 4,365 |
Net Change in Unrealized Appreciation (Depreciation) | (565) | 1,126 |
Ending Fair Value Balance | 4,926 | 5,491 |
Dividend, Interest, PIK and Other Income | 289 | 307 |
Non-Controlled Affiliates | Conergy Asia & ME Pte. LTD. | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 400 | 334 |
Net Change in Unrealized Appreciation (Depreciation) | (400) | 66 |
Ending Fair Value Balance | 400 | |
Non-Controlled Affiliates | Elah Holdings, Inc. | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 5,396 | 5,396 |
Ending Fair Value Balance | 5,396 | 5,396 |
Non-Controlled Affiliates | Iracore International Holdings, Inc. | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 7,596 | 10,178 |
Net Change in Unrealized Appreciation (Depreciation) | 1,039 | (2,582) |
Ending Fair Value Balance | 8,635 | 7,596 |
Dividend, Interest, PIK and Other Income | 265 | 926 |
Non-Controlled Affiliates | Kawa Solar Holdings Limited | ||
Schedule Of Investments [Line Items] | ||
Beginning Fair Value Balance | 1,328 | 1,359 |
Net Change in Unrealized Appreciation (Depreciation) | (45) | (31) |
Ending Fair Value Balance | 1,283 | $ 1,328 |
Non-Controlled Affiliates | Southeast Mechanical, LLC (dba. SEM Holdings, LLC) | ||
Schedule Of Investments [Line Items] | ||
Gross Additions | 11,601 | |
Gross Reductions | (54) | |
Net Change in Unrealized Appreciation (Depreciation) | 145 | |
Ending Fair Value Balance | 11,692 | |
Dividend, Interest, PIK and Other Income | $ 538 |
Investments - Schedule of Inves
Investments - Schedule of Investments Excluding Investments in Money Market Funds (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | |
Schedule Of Investments [Line Items] | |||
Cost | $ 3,691,041 | $ 3,507,790 | [1] |
Fair Value | 3,506,216 | 3,478,443 | |
1st Lien/Senior Secured Debt | |||
Schedule Of Investments [Line Items] | |||
Cost | 3,174,534 | 2,930,047 | |
Fair Value | 3,129,552 | 2,945,368 | |
1st Lien/Last-Out Unitranche | |||
Schedule Of Investments [Line Items] | |||
Cost | 120,253 | 157,768 | |
Fair Value | 116,230 | 162,532 | |
2nd Lien/Senior Secured Debt | |||
Schedule Of Investments [Line Items] | |||
Cost | 255,354 | 295,533 | |
Fair Value | 174,326 | 283,521 | |
Unsecured Debt | |||
Schedule Of Investments [Line Items] | |||
Cost | 8,787 | 2,558 | |
Fair Value | 7,630 | 1,733 | |
Preferred Stock | |||
Schedule Of Investments [Line Items] | |||
Cost | 48,258 | 48,258 | |
Fair Value | 42,377 | 52,655 | |
Common Stock | |||
Schedule Of Investments [Line Items] | |||
Cost | 82,006 | 71,777 | |
Fair Value | 35,490 | 30,784 | |
Warrants | |||
Schedule Of Investments [Line Items] | |||
Cost | 1,849 | 1,849 | |
Fair Value | $ 611 | $ 1,850 | |
[1] Assets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt.” |
Investments - Schedule of Inv_2
Investments - Schedule of Investments at Fair Value and Net Assets (Details) | Dec. 31, 2022 | Dec. 31, 2021 | ||
Schedule Of Investments [Line Items] | ||||
Fair Value | 100% | 100% | ||
Investment owned, percent of net assets | 233.38% | [1],[2] | 215.46% | [3] |
Software | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 14.70% | 13.50% | ||
Investment owned, percent of net assets | 34.40% | 29% | ||
Health Care Providers & Services | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 11.20% | 10.30% | ||
Investment owned, percent of net assets | 26.20% | 22.30% | ||
Diversified Financial Services | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 11.30% | 9.20% | ||
Investment owned, percent of net assets | 26.30% | 19.90% | ||
Health Care Technology | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 8.90% | 11% | ||
Investment owned, percent of net assets | 20.70% | 23.60% | ||
Professional Services | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 9.50% | 7.90% | ||
Investment owned, percent of net assets | 22.20% | 17.10% | ||
Diversified Consumer Services | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 5.40% | 6.10% | ||
Investment owned, percent of net assets | 12.50% | 13.20% | ||
IT Services | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 7% | 5.80% | ||
Investment owned, percent of net assets | 16.40% | 12.60% | ||
Real Estate Mgmt. & Development | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 4.50% | 5.80% | ||
Investment owned, percent of net assets | 10.50% | 12.50% | ||
Interactive Media & Services | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 3.40% | 5.20% | ||
Investment owned, percent of net assets | 8% | 11.10% | ||
Commercial Services & Supplies | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 3.30% | 3.30% | ||
Investment owned, percent of net assets | 7.60% | 7.10% | ||
Health Care Equipment & Supplies | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 3.20% | 3.20% | ||
Investment owned, percent of net assets | 7.50% | 6.90% | ||
Entertainment | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 2.10% | 2.20% | ||
Investment owned, percent of net assets | 5% | 4.70% | ||
Hotels, Restaurants & Leisure | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 1.60% | 1.60% | ||
Investment owned, percent of net assets | 3.80% | 3.40% | ||
Chemicals | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 1.20% | 1.80% | ||
Investment owned, percent of net assets | 2.80% | 3.80% | ||
Transportation Infrastructure | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 1.40% | 1.50% | ||
Investment owned, percent of net assets | 3.30% | 3.30% | ||
Road & Rail | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 1.20% | 1.20% | ||
Investment owned, percent of net assets | 2.80% | 2.70% | ||
Independent Power & Renewable Electricity Producers | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 1.20% | 0.70% | ||
Investment owned, percent of net assets | 2.70% | 1.60% | ||
Household Products | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 1.10% | 1.10% | ||
Investment owned, percent of net assets | 2.50% | 2.40% | ||
Internet & Direct Marketing Retail | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 1% | 1.10% | ||
Investment owned, percent of net assets | 2.40% | 2.40% | ||
Aerospace & Defense | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 1% | 1% | ||
Investment owned, percent of net assets | 2.30% | 2.20% | ||
Construction & Engineering | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.90% | 1% | ||
Investment owned, percent of net assets | 2.20% | 2.10% | ||
Trading Companies & Distributors | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.80% | 0.70% | ||
Investment owned, percent of net assets | 1.80% | 1.50% | ||
Beverages | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.90% | 1% | ||
Investment owned, percent of net assets | 2.20% | 2.20% | ||
Insurance | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.60% | 0.40% | ||
Investment owned, percent of net assets | 1.40% | 0.80% | ||
Pharmaceuticals | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.50% | 0.40% | ||
Investment owned, percent of net assets | 1.10% | 0.90% | ||
Auto Components | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.40% | 0.90% | ||
Investment owned, percent of net assets | 0.90% | 1.90% | ||
Containers & Packaging | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.30% | 0.30% | ||
Investment owned, percent of net assets | 0.70% | 0.70% | ||
Leisure Products | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.30% | |||
Investment owned, percent of net assets | 0.70% | |||
Energy Equipment & Services | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.20% | 0.20% | ||
Investment owned, percent of net assets | 0.60% | 0.50% | ||
Communications Equipment | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.30% | 0.20% | ||
Investment owned, percent of net assets | 0.60% | 0.40% | ||
Textiles, Apparel & Luxury Goods | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.20% | 0.20% | ||
Investment owned, percent of net assets | 0.50% | 0.40% | ||
Air Freight & Logistics | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.20% | 0.20% | ||
Investment owned, percent of net assets | 0.40% | 0.40% | ||
Specialty Retail | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.20% | 0.20% | ||
Investment owned, percent of net assets | 0.40% | 0.30% | ||
Capital Markets | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.20% | 0.20% | ||
Investment owned, percent of net assets | 0.40% | 0.30% | ||
Distributors | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.20% | |||
Investment owned, percent of net assets | 0.40% | |||
Food Products | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.10% | 0.10% | ||
Investment owned, percent of net assets | 0.20% | 0.10% | ||
Building Products | ||||
Schedule Of Investments [Line Items] | ||||
Investment owned, percent of net assets | 0.10% | 0.10% | ||
[1] Percentages are based on net assets. ssets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt”. Assets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt.” |
Investments - Schedule of Inv_3
Investments - Schedule of Investments at Fair Value and Net Assets (Parenthetical) (Details) | Dec. 31, 2022 | Dec. 31, 2021 | ||
Schedule Of Investments [Line Items] | ||||
Fair Value | 100% | 100% | ||
Investment owned, percent of net assets | 233.38% | [1],[2] | 215.46% | [3] |
Maximum | ||||
Schedule Of Investments [Line Items] | ||||
Fair Value | 0.10% | 0.10% | ||
Investment owned, percent of net assets | 0.10% | 0.10% | ||
[1] Percentages are based on net assets. ssets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt”. Assets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt.” |
Investments - Schedule of Geogr
Investments - Schedule of Geographic Composition of Investments at Fair Value (Details) | Dec. 31, 2022 | Dec. 31, 2021 |
Schedule Of Investments [Line Items] | ||
Fair Value | 100% | 100% |
United States | ||
Schedule Of Investments [Line Items] | ||
Fair Value | 95.30% | 96.50% |
Canada | ||
Schedule Of Investments [Line Items] | ||
Fair Value | 3.10% | 3% |
United Kingdom | ||
Schedule Of Investments [Line Items] | ||
Fair Value | 1.60% | 0.50% |
Investments - Schedule of Geo_2
Investments - Schedule of Geographic Composition of Investments at Fair Value (Parenthetical) (Details) | Dec. 31, 2022 | Dec. 31, 2021 |
Schedule Of Investments [Line Items] | ||
Fair Value | 100% | 100% |
Maximum | ||
Schedule Of Investments [Line Items] | ||
Fair Value | 0.10% | 0.10% |
Fair Value Measurement - Summar
Fair Value Measurement - Summary of Ranges of Significant Unobservable Inputs Used to Value Level 3 Assets (Details) $ in Thousands | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 3,506,216 | $ 3,478,443 |
1st Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 3,129,552 | 2,945,368 |
1st Lien/Last-Out Unitranche | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 116,230 | 162,532 |
2nd Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 174,326 | 283,521 |
Unsecured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 7,630 | 1,733 |
Preferred Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 42,377 | 52,655 |
Common Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 35,490 | 30,784 |
Level 3 | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 3,341,847 | 3,270,660 |
Level 3 | 1st Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 3,050,929 | 2,843,010 |
Level 3 | 1st Lien/Last-Out Unitranche | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 116,230 | 162,532 |
Level 3 | 2nd Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 89,573 | 178,780 |
Level 3 | Unsecured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 7,630 | 1,733 |
Level 3 | Preferred Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 42,377 | 52,655 |
Level 3 | Common Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 34,497 | 30,100 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 1st Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 2,920,976 | $ 2,271,598 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 1st Lien/Senior Secured Debt | Minimum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.074 | 0.071 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 1st Lien/Senior Secured Debt | Maximum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.352 | 0.225 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 1st Lien/Senior Secured Debt | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.114 | 0.091 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 1st Lien/Last-Out Unitranche | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 116,230 | $ 162,532 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 1st Lien/Last-Out Unitranche | Minimum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.109 | 0.089 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 1st Lien/Last-Out Unitranche | Maximum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.150 | 0.101 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 1st Lien/Last-Out Unitranche | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.141 | 0.094 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 2nd Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 87,872 | $ 177,079 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 2nd Lien/Senior Secured Debt | Minimum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.127 | 0.097 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 2nd Lien/Senior Secured Debt | Maximum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.177 | 0.154 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | 2nd Lien/Senior Secured Debt | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.139 | 0.112 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | Unsecured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 7,630 | $ 1,333 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | Unsecured Debt | Minimum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.135 | |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | Unsecured Debt | Maximum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.173 | |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | Unsecured Debt | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.165 | 0.148 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Collateral Analysis | Measurement Input, Recovery Rate | 1st Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 1,283 | $ 1,328 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Collateral Analysis | Measurement Input, Recovery Rate | 1st Lien/Senior Secured Debt | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.329 | 0.339 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Collateral Analysis | Measurement Input, Recovery Rate | Unsecured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 400 | |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation Technique, Collateral Analysis | Measurement Input, Recovery Rate | Unsecured Debt | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 0.316 | |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation, Comparable Multiples | Measurement Input, EV/EBITDA | 1st Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 4,486 | |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation, Comparable Multiples | Measurement Input, EV/EBITDA | 1st Lien/Senior Secured Debt | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 12 | |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation, Comparable Multiples | Measurement Input, EV/EBITDA | 2nd Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 1,701 | $ 1,701 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation, Comparable Multiples | Measurement Input, EV/EBITDA | 2nd Lien/Senior Secured Debt | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 9.9 | 9.3 |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation, Comparable Multiples | Measurement Input, Revenue Multiple | 1st Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 806 | |
Bank Loans, Corporate Debt and Other Debt Obligations | Level 3 | Valuation, Comparable Multiples | Measurement Input, Revenue Multiple | 1st Lien/Senior Secured Debt | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt Investments, Range of Significant Unobservable Inputs | 2.3 | |
Equity | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | Common Stock | Minimum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Fair Value | $ 10,322 | $ 10,887 |
Equity, Range of Significant Unobservable Inputs | 0.163 | 0.146 |
Equity | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | Common Stock | Maximum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Range of Significant Unobservable Inputs | 0.300 | 0.311 |
Equity | Level 3 | Valuation Technique, Discounted Cash Flow | Measurement Input, Discount Rate | Common Stock | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Range of Significant Unobservable Inputs | 0.246 | 0.241 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, EV/EBITDA | Preferred Stock | Minimum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Fair Value | $ 14,297 | $ 2,425 |
Equity, Range of Significant Unobservable Inputs | 14.4 | 10.5 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, EV/EBITDA | Preferred Stock | Maximum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Range of Significant Unobservable Inputs | 29.7 | 21.4 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, EV/EBITDA | Preferred Stock | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Range of Significant Unobservable Inputs | 28.2 | 21.2 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, EV/EBITDA | Common Stock | Minimum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Fair Value | $ 20,391 | $ 12,871 |
Equity, Range of Significant Unobservable Inputs | 4.5 | 4.4 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, EV/EBITDA | Common Stock | Maximum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Range of Significant Unobservable Inputs | 18.3 | 19.2 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, EV/EBITDA | Common Stock | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Range of Significant Unobservable Inputs | 9.7 | 10.3 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, Revenue Multiple | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants, Fair Value | $ 611 | $ 1,850 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, Revenue Multiple | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants, Range of Significant Unobservable Inputs | 8.2 | |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, Revenue Multiple | Preferred Stock | Minimum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Fair Value | $ 28,081 | $ 18,121 |
Equity, Range of Significant Unobservable Inputs | 0.8 | 1.5 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, Revenue Multiple | Preferred Stock | Maximum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Range of Significant Unobservable Inputs | 7.3 | 5.7 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, Revenue Multiple | Preferred Stock | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Range of Significant Unobservable Inputs | 4.1 | 2 |
Warrants, Range of Significant Unobservable Inputs | 4 | |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, Revenue Multiple | Common Stock | Minimum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Fair Value | $ 3,784 | $ 4,002 |
Equity, Range of Significant Unobservable Inputs | 1.8 | 0.7 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, Revenue Multiple | Common Stock | Maximum | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Range of Significant Unobservable Inputs | 15.2 | 18.9 |
Equity | Level 3 | Valuation, Comparable Multiples | Measurement Input, Revenue Multiple | Common Stock | Weighted Average | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity, Range of Significant Unobservable Inputs | 12.6 | 14.9 |
Fair Value Measurement - Summ_2
Fair Value Measurement - Summary of Ranges of Significant Unobservable Inputs Used to Value Level 3 Assets (Parenthetical) (Details) $ in Thousands | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 3,506,216 | $ 3,478,443 |
Level 3 | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | 3,341,847 | 3,270,660 |
Income Approach | Level 3 | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 3,132,708 | $ 2,612,542 |
Fair value of debt investments percentage using income approach | 0.960 | 0.820 |
Investment Adviser did not Develop Unobservable Inputs | Level 3 | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt investments, Fair Value | $ 123,377 | $ 604,533 |
Fair Value Measurement - Summ_3
Fair Value Measurement - Summary of Assets Categorized Within Fair Value Hierarchy (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | $ 3,506,216 | $ 3,478,443 | |
Unrealized appreciation (depreciation) on foreign currency forward contracts | (168,797) | (13,476) | $ 72,545 |
Foreign Currency Forward Contracts | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Unrealized appreciation (depreciation) on foreign currency forward contracts | (484) | 100 | |
1st Lien/Senior Secured Debt | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 3,129,552 | 2,945,368 | |
1st Lien/Last-Out Unitranche | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 116,230 | 162,532 | |
2nd Lien/Senior Secured Debt | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 174,326 | 283,521 | |
Unsecured Debt | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 7,630 | 1,733 | |
Preferred Stock | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 42,377 | 52,655 | |
Common Stock | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 35,490 | 30,784 | |
Warrants | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 611 | 1,850 | |
Level 1 | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 993 | 684 | |
Level 1 | Common Stock | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 993 | 684 | |
Level 2 | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 163,376 | 207,099 | |
Level 2 | Foreign Currency Forward Contracts | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Unrealized appreciation (depreciation) on foreign currency forward contracts | (484) | 100 | |
Level 2 | 1st Lien/Senior Secured Debt | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 78,623 | 102,358 | |
Level 2 | 2nd Lien/Senior Secured Debt | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 84,753 | 104,741 | |
Level 3 | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 3,341,847 | 3,270,660 | |
Level 3 | 1st Lien/Senior Secured Debt | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 3,050,929 | 2,843,010 | |
Level 3 | 1st Lien/Last-Out Unitranche | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 116,230 | 162,532 | |
Level 3 | 2nd Lien/Senior Secured Debt | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 89,573 | 178,780 | |
Level 3 | Unsecured Debt | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 7,630 | 1,733 | |
Level 3 | Preferred Stock | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 42,377 | 52,655 | |
Level 3 | Common Stock | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | 34,497 | 30,100 | |
Level 3 | Warrants | |||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
Debt investments, Fair Value | $ 611 | $ 1,850 |
Fair Value Measurement - Summ_4
Fair Value Measurement - Summary of Changes in Fair Value of Level 3 Assets By Investment Type (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Net Change in Unrealized Appreciation (Depreciation) for assets still held | $ (131,280) | $ (18,968) |
1st Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Net Change in Unrealized Appreciation (Depreciation) for assets still held | (60,742) | 3,200 |
1st Lien/Last-Out Unitranche | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Net Change in Unrealized Appreciation (Depreciation) for assets still held | (6,767) | 865 |
2nd Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Net Change in Unrealized Appreciation (Depreciation) for assets still held | (46,240) | (8,457) |
Unsecured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Net Change in Unrealized Appreciation (Depreciation) for assets still held | (332) | (104) |
Preferred Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Net Change in Unrealized Appreciation (Depreciation) for assets still held | (10,278) | (5) |
Common Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Net Change in Unrealized Appreciation (Depreciation) for assets still held | (5,682) | (14,468) |
Warrants | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Net Change in Unrealized Appreciation (Depreciation) for assets still held | (1,239) | 1 |
Level 3 | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Beginning Balance | 3,270,660 | 3,050,769 |
Purchases | 880,185 | 1,727,260 |
Net Realized Gain (Loss) | (19,005) | 40,555 |
Net Change in Unrealized Appreciation (Depreciation) | (128,787) | (92,236) |
Sales and Settlements | (705,183) | (1,442,972) |
Net Amortization of Premium/Discount | 35,489 | 78,997 |
Transfers In | 8,488 | |
Transfers Out | (91,713) | |
Ending Balance | 3,341,847 | 3,270,660 |
Level 3 | 1st Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Beginning Balance | 2,843,010 | 2,384,944 |
Purchases | 827,409 | 1,611,821 |
Net Realized Gain (Loss) | (4,696) | (942) |
Net Change in Unrealized Appreciation (Depreciation) | (56,045) | (23,494) |
Sales and Settlements | (595,922) | (1,152,967) |
Net Amortization of Premium/Discount | 28,685 | 62,690 |
Transfers In | 8,488 | |
Transfers Out | (39,042) | |
Ending Balance | 3,050,929 | 2,843,010 |
Level 3 | 1st Lien/Last-Out Unitranche | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Beginning Balance | 162,532 | 143,231 |
Purchases | 19,801 | 31,138 |
Net Change in Unrealized Appreciation (Depreciation) | (8,786) | 492 |
Sales and Settlements | (61,297) | (14,517) |
Net Amortization of Premium/Discount | 3,980 | 2,188 |
Ending Balance | 116,230 | 162,532 |
Level 3 | 2nd Lien/Senior Secured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Beginning Balance | 178,780 | 407,872 |
Purchases | 16,714 | 31,550 |
Net Realized Gain (Loss) | (14,414) | (1,203) |
Net Change in Unrealized Appreciation (Depreciation) | (46,425) | (11,826) |
Sales and Settlements | (47,859) | (209,051) |
Net Amortization of Premium/Discount | 2,777 | 14,109 |
Transfers Out | (52,671) | |
Ending Balance | 89,573 | 178,780 |
Level 3 | Unsecured Debt | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Beginning Balance | 1,733 | 334 |
Purchases | 6,182 | 1,492 |
Net Change in Unrealized Appreciation (Depreciation) | (332) | (103) |
Net Amortization of Premium/Discount | 47 | 10 |
Ending Balance | 7,630 | 1,733 |
Level 3 | Preferred Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Beginning Balance | 52,655 | 48,080 |
Purchases | 39,192 | |
Net Realized Gain (Loss) | 24,233 | |
Net Change in Unrealized Appreciation (Depreciation) | (10,278) | (23,812) |
Sales and Settlements | (35,038) | |
Ending Balance | 42,377 | 52,655 |
Level 3 | Common Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Beginning Balance | 30,100 | 65,284 |
Purchases | 10,079 | 10,218 |
Net Realized Gain (Loss) | 105 | 19,223 |
Net Change in Unrealized Appreciation (Depreciation) | (5,682) | (33,226) |
Sales and Settlements | (105) | (31,399) |
Ending Balance | 34,497 | 30,100 |
Level 3 | Warrants | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Beginning Balance | 1,850 | 1,024 |
Purchases | 1,849 | |
Net Realized Gain (Loss) | (756) | |
Net Change in Unrealized Appreciation (Depreciation) | (1,239) | (267) |
Ending Balance | $ 611 | $ 1,850 |
Fair Value Measurement - Summ_5
Fair Value Measurement - Summary of Debt Obligations Carried at Fair Value (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Level 3 | Revolving Credit Facility | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Debt instrument, Fair Value | $ 1,161,401 | $ 858,722 |
Level 2 | Convertible Notes | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Debt instrument, Fair Value | 158,116 | |
Level 2 | 2025 Notes | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Debt instrument, Fair Value | 348,120 | 377,778 |
Level 2 | 2026 Notes | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Debt instrument, Fair Value | $ 461,800 | $ 513,037 |
Debt - Additional Information (
Debt - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |||||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Nov. 24, 2020 | Feb. 10, 2020 | Jul. 02, 2018 | Oct. 03, 2016 | ||
Line Of Credit Facility [Line Items] | ||||||||
Debt, Current borrowing capacity | $ 2,555,000 | $ 2,710,000 | ||||||
Cost incurred in obtaining revolving credit facility | 8,741 | 12,296 | ||||||
Deferred financing costs | 12,772 | 12,631 | ||||||
2025 Notes | ||||||||
Line Of Credit Facility [Line Items] | ||||||||
Aggregate principal amount | $ 360,000 | 360,000 | $ 360,000 | |||||
Interest rate | 3.75% | |||||||
Debt Instrument, Maturity Date, Description | The 2025 Notes bear interest at a rate of 3.75% per year, payable semi-annually. The 2025 Notes will mature on February 10, 2025 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the indenture. | |||||||
2026 Notes | ||||||||
Line Of Credit Facility [Line Items] | ||||||||
Aggregate principal amount | $ 500,000 | 500,000 | $ 500,000 | |||||
Interest rate | 2.875% | |||||||
Debt Instrument, Maturity Date, Description | The 2026 Notes bear interest at a rate of 2.875% per year, payable semi-annually, commencing on July 15, 2021. The 2026 Notes will mature on January 15, 2026 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the indenture. | |||||||
Convertible Notes | ||||||||
Line Of Credit Facility [Line Items] | ||||||||
Aggregate principal amount | $ 115,000 | |||||||
4.50% Unsecured Convertible Notes | ||||||||
Line Of Credit Facility [Line Items] | ||||||||
Interest rate | 4.50% | |||||||
Initial Convertible Notes | ||||||||
Line Of Credit Facility [Line Items] | ||||||||
Aggregate principal amount | $ 15,000 | |||||||
Additional Convertible Notes | ||||||||
Line Of Credit Facility [Line Items] | ||||||||
Aggregate principal amount | $ 40,000 | |||||||
Revolving Credit Facility | ||||||||
Line Of Credit Facility [Line Items] | ||||||||
Average outstanding balance | $ 1,093,410 | 606,442 | $ 509,927 | |||||
Debt, Current borrowing capacity | [1] | 1,695,000 | 1,695,000 | |||||
Maximum borrowing capacity | $ 2,250,000 | |||||||
Revolving credit facility interest rate description | Borrowings denominated in USD, including amounts drawn in respect of letters of credit, bear interest (at the Company’s election) of either (i) term SOFR plus a margin of either (x) 2.00%, (y) 1.875% (subject to maintenance of certain long-term corporate debt ratings) or (z) 1.75% (subject to certain gross borrowing base conditions), in each case, plus an additional 0.10% credit adjustment spread or (ii) an alternative base rate, which is the highest of (a) zero, (b) the highest of (i) the Prime Rate in effect on such day, (ii) the Federal Funds Effective Rate for such day plus 1/2 of 1.00% and (iii) the rate per annum equal to (x) the greater of (A) term SOFR for an interest period of one (1) month and (B) zero plus (y) 1.00%, plus a margin of either (x) 1.00%, (y) 0.875% (subject to maintenance of certain long-term corporate debt ratings) or (z) 0.75% (subject to certain gross borrowing base conditions). Borrowings denominated in non-USD bear interest of the applicable term benchmark rate or daily simple SONIA plus a margin of either 2.00%, 1.875% or 1.75% (subject to the conditions applicable to borrowings denominated in USD that bear interest based on the applicable term benchmark rate or daily simple SONIA) plus, in the case of borrowings denominated in Pound Sterling (GBP) only, an additional 0.1193% credit adjustment spread. With respect to borrowings denominated in USD, the Company may elect either term SOFR, or an alternative base rate at the time of borrowing, and such borrowings may be converted from one benchmark to another at any time, subject to certain conditions. Interest is payable in arrears on the applicable interest payment date as specified therein. The Company pays a fee of 0.375% per annum on committed but undrawn amounts under the Revolving Credit Facility, payable quarterly in arrears. Any amounts borrowed under the Revolving Credit Facility will mature, and all accrued and unpaid interest will be due and payable, on May 5, 2027. | |||||||
Additional credit adjustment | 0.10% | |||||||
Credit adjustment spread | 0.1193% | |||||||
Line of credit facility, commitment fee percentage | 0.375% | |||||||
Unpaid interest will be due and payable | May 05, 2027 | |||||||
Debt covenants minimum stockholders equity | $ 800,000 | |||||||
Net proceeds of the sale of equity interests | 25% | |||||||
Cost incurred in obtaining revolving credit facility | $ 28,092 | |||||||
Deferred financing costs | $ 12,772 | $ 12,631 | ||||||
Revolving Credit Facility | Minimum | ||||||||
Line Of Credit Facility [Line Items] | ||||||||
Asset coverage ratio | 150% | |||||||
Asset coverage ratio with respect to consolidated assets | 200% | |||||||
Debt | ||||||||
Line Of Credit Facility [Line Items] | ||||||||
Asset coverage ratio requirement, description | Investment Company Act, is at least 150% after such borrowing (if certain requirements are met). As of December 31, 2022 and December 31, 2021, the Company’s asset coverage ratio based on the aggregate amount outstanding of senior securities was 174% and 186%. | |||||||
Asset coverage ratio | 174% | 186% | ||||||
Weighted average interest rates | 3.55% | 2.90% | ||||||
Average outstanding balance | $ 1,991,629 | $ 1,621,442 | ||||||
Maximum borrowing capacity | $ 2,250,000 | |||||||
[1] Provides, under certain circumstances, a total borrowing capacity of $ 2,250,000 . The Company may borrow amounts in USD or certain other permitted currencies. Debt outstanding denominated in currencies other than USD has been converted to USD using the applicable foreign currency exchange rate as of the applicable reporting date. As of December 31, 2022, the Company had outstanding borrowings denominated in USD of $ 1,065,674 , in Euros (EUR) of EUR 37,700 , in British Pound (GBP) of GBP 45,300 and in Canadian Dollars (CAD) of CAD 820 . As of December 31, 2021, the Company had outstanding borrowings denominated in USD of $ 799,574 , in Euros (EUR) of EUR 37,700 , in British Pound (GBP) of GBP 11,900 and in Canadian Dollars (CAD) of CAD 150 . |
Debt - Schedule of Outstanding
Debt - Schedule of Outstanding Debt (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | |
Line Of Credit Facility [Line Items] | |||
Aggregate Borrowing Amount Committed | $ 2,555,000 | $ 2,710,000 | |
Amount Available | 548,671 | 837,164 | |
Carrying Value | [1] | 2,012,660 | 1,861,426 |
Revolving Credit Facility | |||
Line Of Credit Facility [Line Items] | |||
Aggregate Borrowing Amount Committed | [2] | 1,695,000 | 1,695,000 |
Amount Available | [2] | 548,671 | 837,164 |
Carrying Value | [1],[2] | 1,161,401 | 858,722 |
Convertible Notes | |||
Line Of Credit Facility [Line Items] | |||
Aggregate Borrowing Amount Committed | [3] | 155,000 | |
Carrying Value | [1],[3] | 154,665 | |
2025 Notes | |||
Line Of Credit Facility [Line Items] | |||
Aggregate Borrowing Amount Committed | 360,000 | 360,000 | |
Carrying Value | [1] | 357,076 | 355,735 |
2026 Notes | |||
Line Of Credit Facility [Line Items] | |||
Aggregate Borrowing Amount Committed | 500,000 | 500,000 | |
Carrying Value | [1] | $ 494,183 | $ 492,304 |
[1] The carrying value is presented net of unamortized debt issuance costs and OID net of accretion as applicable. Provides, under certain circumstances, a total borrowing capacity of $ 2,250,000 . The Company may borrow amounts in USD or certain other permitted currencies. Debt outstanding denominated in currencies other than USD has been converted to USD using the applicable foreign currency exchange rate as of the applicable reporting date. As of December 31, 2022, the Company had outstanding borrowings denominated in USD of $ 1,065,674 , in Euros (EUR) of EUR 37,700 , in British Pound (GBP) of GBP 45,300 and in Canadian Dollars (CAD) of CAD 820 . As of December 31, 2021, the Company had outstanding borrowings denominated in USD of $ 799,574 , in Euros (EUR) of EUR 37,700 , in British Pound (GBP) of GBP 11,900 and in Canadian Dollars (CAD) of CAD 150 . On April 1, 2022, the Convertible Notes matured and were paid in full. |
Debt - Schedule of Outstandin_2
Debt - Schedule of Outstanding Debt (Parenthetical) (Details) - Debt € in Thousands, £ in Thousands, $ in Thousands, $ in Thousands | 12 Months Ended | |||||||
Dec. 31, 2022 USD ($) | Dec. 31, 2022 EUR (€) | Dec. 31, 2022 GBP (£) | Dec. 31, 2022 CAD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2021 EUR (€) | Dec. 31, 2021 GBP (£) | Dec. 31, 2021 CAD ($) | |
Line Of Credit Facility [Line Items] | ||||||||
Maximum borrowing capacity | $ 2,250,000 | |||||||
Outstanding borrowings | $ 1,065,674 | € 37,700 | £ 45,300 | $ 820 | $ 799,574 | € 37,700 | £ 11,900 | $ 150 |
Debt - Schedule of Revolving Cr
Debt - Schedule of Revolving Credit Facility (Details) - Revolving Credit Facility $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | |
Line Of Credit Facility [Line Items] | |||
Borrowing interest expense | $ 41,088 | $ 12,143 | $ 12,377 |
Facility fees | 2,347 | 4,189 | 1,898 |
Amortization of financing costs | 2,855 | 2,780 | 2,016 |
Total | $ 46,290 | $ 19,112 | $ 16,291 |
Weighted average interest rate | 0.0376 | 0.0200 | 0.0243 |
Average outstanding balance | $ 1,093,410 | $ 606,442 | $ 509,927 |
Debt - Components of Carrying V
Debt - Components of Carrying Value (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Line Of Credit Facility [Line Items] | ||
Carrying Value | $ 2,012,660 | $ 1,861,426 |
Convertible Notes | ||
Line Of Credit Facility [Line Items] | ||
Principal amount of debt | 155,000 | |
OID, net of accretion | 118 | |
Unamortized debt issuance costs | 217 | |
Carrying Value | $ 154,665 | |
Stated interest rate | 4.50% | |
Effective interest rate (stated interest rate plus accretion of OID) | 4.80% |
Debt - Components of Interest a
Debt - Components of Interest and Other Debt Expenses (Details) - Convertible Notes - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Line Of Credit Facility [Line Items] | |||
Borrowing interest expense | $ 1,744 | $ 6,975 | $ 6,975 |
Accretion of OID | 118 | 468 | 446 |
Amortization of debt issuance costs | 216 | 1,214 | 1,217 |
Total | $ 2,078 | $ 8,657 | $ 8,638 |
Debt - Components of Carrying_2
Debt - Components of Carrying Value of 2025 Notes (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Feb. 10, 2020 |
Line Of Credit Facility [Line Items] | |||
Carrying Value | $ 2,012,660 | $ 1,861,426 | |
2025 Notes | |||
Line Of Credit Facility [Line Items] | |||
Principal amount of debt | 360,000 | 360,000 | $ 360,000 |
Unamortized debt issuance costs | 2,924 | 4,265 | |
Carrying Value | $ 357,076 | $ 355,735 |
Debt - Components of Interest_2
Debt - Components of Interest and Other Debt Expenses Related to 2025 Notes (Details) - 2025 Notes - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Line Of Credit Facility [Line Items] | |||
Borrowing interest expense | $ 13,500 | $ 13,500 | $ 12,038 |
Amortization of debt issuance costs | 1,342 | 1,404 | 1,254 |
Total | $ 14,842 | $ 14,904 | $ 13,292 |
Debt - Components of Carrying_3
Debt - Components of Carrying Value of 2026 Notes (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Nov. 24, 2020 |
Line Of Credit Facility [Line Items] | |||
Carrying Value | $ 2,012,660 | $ 1,861,426 | |
2026 Notes | |||
Line Of Credit Facility [Line Items] | |||
Principal amount of debt | 500,000 | 500,000 | $ 500,000 |
Unamortized debt issuance costs | 5,817 | 7,696 | |
Carrying Value | $ 494,183 | $ 492,304 |
Debt - Components of Interest_3
Debt - Components of Interest and Other Debt Expenses Related to 2026 Notes (Details) - 2026 Notes - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Line Of Credit Facility [Line Items] | |||
Borrowing interest expense | $ 14,375 | $ 14,375 | $ 1,476 |
Amortization of debt issuance costs | 1,879 | 1,940 | 203 |
Total | $ 16,254 | $ 16,315 | $ 1,679 |
Derivatives - Additional Inform
Derivatives - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
U.S. Dollar | ||
Derivative [Line Items] | ||
Average notional exposure to foreign currency forward contracts | $ 2,431 | $ 2,829 |
Derivatives - Schedule of Forei
Derivatives - Schedule of Foreign Currency Forward Contracts (Details) - Bank Of America N A - Foreign Currency Forward Contracts - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | |
Derivative [Line Items] | |||
Gross Amount of Assets | $ 100 | ||
Gross Amount of Liabilities | $ (484) | ||
Net Amount of Assets or (Liabilities) | (484) | 100 | |
Collateral (Received) Pledged | [1] | 290 | |
Net Amounts | [2] | $ (194) | $ 100 |
[1] Amount excludes excess cash collateral paid, if any. Net amount represents the net amount due (to) from counterparty in the event of a default based on the contractual setoff rights under the agreement. Net amount excludes any over-collateralized amounts. |
Derivatives - Schedule of Effec
Derivatives - Schedule of Effect of Transactions in Derivative Instruments (Details) - Foreign Currency Forward Contracts - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Derivative [Line Items] | |||
Net realized gain (loss) on foreign currency forward contracts | $ 283 | $ (234) | $ 82 |
Net change in unrealized appreciation (depreciation) on foreign currency forward contracts | (584) | 455 | (388) |
Total net realized and unrealized gains (losses) on foreign currency forward contracts | $ (301) | $ 221 | $ (306) |
Commitments and Contingencies -
Commitments and Contingencies - Schedule of Unfunded Commitments by Investment Types (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Loss Contingencies [Line Items] | ||
Unfunded Commitment | $ 371,045 | $ 441,790 |
1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 364,529 | 441,790 |
1st Lien/Last-Out Unitranche | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 6,516 | |
1272775 B.C. LTD. (dba Everest Clinical Research) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 163 | 1,151 |
Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,950 | 4,082 |
Acquia, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,346 | 3,268 |
Admiral Buyer, Inc. (dba Fidelity Payment Services) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 9,650 | |
Ansira Partners, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 127 | |
Apptio, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,154 | 3,230 |
AQ Helios Buyer, Inc. (dba SurePoint) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 8,888 | 14,189 |
Assembly Intermediate LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 7,478 | 12,757 |
Bigchange Group Limited | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,459 | 4,426 |
Broadway Technology, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,090 | |
BSI3 Menu Buyer, Inc (dba Kydia) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 38 | |
Bullhorn, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 726 | 4,601 |
Businessolver.com, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 4,595 | 5,026 |
Capitol Imaging Acquisition Corp. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 38 | 180 |
Checkmate Finance Merger Sub, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,140 | 3,140 |
Chronicle Bidco Inc. (dba Lexitas) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 4,753 | 4,339 |
CivicPlus LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,217 | 3,552 |
Clearcourse Partnership Acquireco Finance Limited | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 8,951 | |
CloudBees, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 738 | 12,900 |
Coding Solutions Acquisition, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 6,156 | |
CORA Health Holdings Corp | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 8,514 | 8,897 |
CorePower Yoga LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,125 | 1,687 |
Coretrust Purchasing Group LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 226 | |
CST Buyer Company (dba Intoxalock) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 78 | 2,170 |
DECA Dental Holdings LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 5,360 | 6,843 |
Diligent Corporation | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,170 | 3,100 |
EDB Parent, LLC (dba Enterprise DB) | 1st Lien/Last-Out Unitranche | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 6,516 | |
Eptam Plastics, Ltd. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,042 | 681 |
ESO Solutions, Inc | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,620 | 3,620 |
Experity, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 81 | 3,332 |
Fullsteam Operations LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,642 | 16,298 |
Gainsight, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 5,320 | 5,320 |
GHA Buyer Inc. (dba Cedar Gate) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,880 | 1,254 |
GovDelivery Holdings, LLC (dba Granicus, Inc.) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,716 | 4,087 |
Governmentjobs.com, Inc. (dba NeoGov) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 19,428 | 19,427 |
GS AcquisitionCo, Inc. (dba Insightsoftware) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 982 | 4,180 |
HealthEdge Software, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 13,300 | 18,330 |
Helios Buyer, Inc. (dba Heartland) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,363 | 9,592 |
Honor HN Buyer, Inc | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 21,001 | 18,095 |
HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,344 | 4,688 |
HumanState Limited (dba PayProp) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 11,932 | |
iCIMS, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 15,910 | |
Intelligent Medical Objects, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 4,192 | |
Internet Truckstop Group, LLC (dba Truckstop) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 4,400 | 4,400 |
iWave Information Systems, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 109 | |
Kaseya Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,200 | |
LCG Vardiman Black, LLC (dba Specialty Dental Brands) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 113 | |
Lithium Technologies, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,066 | 3,066 |
MerchantWise Solutions, LLC (dba HungerRush) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 4,485 | |
Millstone Medical Outsourcing, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,774 | 2,144 |
MRI Software LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,612 | 7,994 |
NFM & J, L.P. (dba the Facilities Group) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 6,054 | 11,219 |
One GI LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,654 | 13,598 |
PDDS Holdco, Inc. (dba Planet DDS) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 6,128 | |
Pioneer Buyer I, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 4,300 | 4,300 |
PlanSource Holdings, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 7,824 | 8,728 |
Pluralsight, Inc | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,550 | 5,100 |
PPT Management Holdings, LLC. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 123 | |
Premier Care Dental Management, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,602 | 9,982 |
Premier Imaging, LLC (dba Lucid Health) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 4,110 | 5,778 |
Project Eagle Holdings, LLC (dba Exostar) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 75 | 75 |
Prophix Software Inc. (dba Pound Bidco) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,445 | 3,445 |
Qualawash Holdings, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,359 | |
Riverpoint Medical, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 4,094 | 4,094 |
Rodeo Buyer Company (dba Absorb Software) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,048 | 3,387 |
Rubrik Inc | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,310 | |
Smarsh, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 5,000 | |
Southeast Mechanical, LLC (dba. SEM Holdings, LLC) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 9,300 | |
SpendMend, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 238 | |
Spotless Brands, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 33 | |
StarCompliance Intermediate, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,875 | 2,500 |
Sundance Group Holdings, Inc. (dba NetDocuments) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 4,925 | 15,761 |
Sunstar Insurance Group, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 7,996 | 12,053 |
Superman Holdings, LLC (dba Foundation Software) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 122 | 122 |
Sweep Purchaser LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,724 | 8,105 |
The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,467 | 9,069 |
Thrasio, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 14,686 | 14,686 |
Total Vision LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 10,464 | 1,270 |
Trader Corporation | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 17 | |
USN Opco LLC (dba Global Nephrology Solutions) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 5,880 | 3,593 |
Volt Bidco, Inc. (dba Power Factors) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 6,612 | 4,357 |
VRC Companies, LLC (dba Vital Records Control) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 944 | 3,799 |
WebPT, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 4,225 | 9,861 |
Wellness AcquisitionCo, Inc. (dba SPINS) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 6,600 | 2,600 |
Whitewater Holding Company LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,944 | 9,652 |
Wine.com, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,541 | |
WorkForce Software, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 631 | |
Zarya Intermediate, LLC (dba iOFFICE) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | $ 7,987 | 6,757 |
Aria Systems, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,893 | |
CFS Management, LLC (dba Center for Sight Management) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,058 | |
Convene 237 Park Avenue, LLC (dba Convene) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 6,100 | |
Cordeagle US Finco, Inc. (dba Condeco) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 11,506 | |
Elemica Parent, Inc. | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 409 | |
LS Clinical Services Holdings, Inc (dba CATO) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 2,200 | |
MMIT Holdings, LLC (dba Managed Markets Insight & Technology) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 5,183 | |
PT Intermediate Holdings III, LLC (dba Parts Town) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 1,980 | |
Purfoods, LLC | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 150 | |
Xactly Corporation | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | 3,874 | |
Zodiac Intermediate, LLC (dba Zipari) | 1st Lien/Senior Secured Debt | ||
Loss Contingencies [Line Items] | ||
Unfunded Commitment | $ 7,500 |
Net Assets - Additional Informa
Net Assets - Additional Information (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | May 26, 2022 | Dec. 31, 2021 | |
Class Of Stock [Line Items] | |||
Common stock, par value | $ 0.001 | $ 0.001 | |
Equity Distribution Agreement [Member] | Sales Agent [Member] | |||
Class Of Stock [Line Items] | |||
Common stock, par value | $ 0.001 | ||
Aggregate offering price | $ 200,000,000 | ||
Percentage of maximum commission receivable by sales agent | 1% |
Net Assets - Schedule of Issuan
Net Assets - Schedule of Issuance of Common Stock (Details) $ / shares in Units, $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) $ / shares shares | |
Assets Net [Abstract] | |
Gross Proceeds | $ 14,156 |
Underwriting/Offering Expenses | (699) |
Net Proceeds | $ 13,457 |
Number of Shares Issued | shares | 813,255 |
Average Sales Price per Share | $ / shares | $ 17.41 |
Net Assets - Schedule of Distri
Net Assets - Schedule of Distributions Declared on Common Stock (Details) - $ / shares | 12 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | ||
February 23, 2022 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Feb. 23, 2022 | |||
Record Date | Mar. 31, 2022 | |||
Payment Date | Apr. 27, 2022 | |||
Amount Per Share | $ 0.45 | |||
Shares | 65,180 | |||
May 3, 2022 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | May 03, 2022 | |||
Record Date | Jun. 30, 2022 | |||
Payment Date | Jul. 27, 2022 | |||
Amount Per Share | $ 0.45 | |||
Shares | 86,741 | |||
August 3, 2022 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Aug. 03, 2022 | |||
Record Date | Sep. 30, 2022 | |||
Payment Date | Oct. 27, 2022 | |||
Amount Per Share | [1] | $ 0.45 | ||
Shares | [2] | 98,756 | ||
November 2, 2022 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Nov. 02, 2022 | |||
Record Date | Dec. 30, 2022 | |||
Payment Date | Jan. 27, 2023 | |||
Amount Per Share | $ 0.45 | |||
Shares | 112,555 | |||
November 4, 2020 (special) | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Nov. 04, 2020 | |||
Record Date | Feb. 15, 2021 | |||
Payment Date | Mar. 15, 2021 | |||
Amount Per Share | $ 0.05 | |||
Shares | 6,849 | |||
February 24, 2021 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Feb. 24, 2021 | |||
Record Date | Mar. 31, 2021 | |||
Payment Date | Apr. 27, 2021 | |||
Amount Per Share | $ 0.45 | |||
Shares | 68,092 | |||
November 4, 2020 (special) | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Nov. 04, 2020 | |||
Record Date | May 14, 2021 | |||
Payment Date | Jun. 15, 2021 | |||
Amount Per Share | $ 0.05 | |||
Shares | 8,852 | |||
May 4, 2021 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | May 04, 2021 | |||
Record Date | Jun. 30, 2021 | |||
Payment Date | Jul. 27, 2021 | |||
Amount Per Share | $ 0.45 | |||
Shares | 69,917 | |||
November 4, 2020 (special) | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Nov. 04, 2020 | |||
Record Date | Aug. 16, 2021 | |||
Payment Date | Sep. 15, 2021 | |||
Amount Per Share | $ 0.05 | |||
Shares | 7,717 | |||
August 5, 2021 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Aug. 05, 2021 | |||
Record Date | Sep. 30, 2021 | |||
Payment Date | Oct. 27, 2021 | |||
Amount Per Share | $ 0.45 | |||
Shares | 65,213 | |||
November 4, 2021 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Nov. 04, 2021 | |||
Record Date | Dec. 31, 2021 | |||
Payment Date | Jan. 27, 2022 | |||
Amount Per Share | $ 0.45 | |||
Shares | 66,602 | |||
February 19, 2020 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Feb. 19, 2020 | |||
Record Date | Mar. 31, 2020 | |||
Payment Date | Apr. 15, 2020 | |||
Amount Per Share | $ 0.45 | |||
Shares | [2] | 37,741 | ||
May 5, 2020 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | May 05, 2020 | |||
Record Date | Jun. 30, 2020 | |||
Payment Date | Jul. 15, 2020 | |||
Amount Per Share | $ 0.45 | |||
Shares | 46,407 | |||
August 4, 2020 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Aug. 04, 2020 | |||
Record Date | Sep. 30, 2020 | |||
Payment Date | Oct. 15, 2020 | |||
Amount Per Share | $ 0.45 | |||
Shares | 49,015 | |||
November 4, 2020 | ||||
Class Of Stock [Line Items] | ||||
Date Declared | Nov. 04, 2020 | |||
Record Date | Dec. 31, 2020 | |||
Payment Date | Jan. 15, 2021 | |||
Amount Per Share | $ 0.45 | |||
Shares | 57,801 | |||
[1] $ 0.29 is considered capital gain distribution. In accordance with the Company’s DRIP, shares were purchased in the open market. |
Net Assets - Schedule of Dist_2
Net Assets - Schedule of Distributions Declared on Common Stock (Parenthetical) (Details) | Dec. 31, 2022 $ / shares |
August 3, 2022 | |
Class Of Stock [Line Items] | |
Capital gain distribution amount per share | $ 0.29 |
Earnings (Loss) Per Share - Sch
Earnings (Loss) Per Share - Schedule of Basic and Diluted Earning Per Unit (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |||
Net increase (decrease) in net assets from operations | $ 55,003 | $ 192,427 | $ 176,113 |
Weighted average shares outstanding, basic | 102,258,701 | 101,691,076 | 53,940,573 |
Weighted average shares outstanding, diluted | 102,258,701 | 101,691,076 | 53,940,573 |
Basic earnings (loss) per share | $ 0.54 | $ 1.89 | $ 3.26 |
Diluted earnings (loss) per share | $ 0.54 | $ 1.89 | $ 3.26 |
Tax Information - Schedule of T
Tax Information - Schedule of Tax Character of Distributions (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Distributions paid from: | |||
Ordinary Income | $ 154,022 | $ 198,332 | $ 100,254 |
Net Long-Term Capital Gains | 30,293 | ||
Total Taxable Distributions | $ 184,315 | $ 198,332 | $ 100,254 |
Tax Information - Components of
Tax Information - Components of Accumulated Earnings (Losses) on Tax Basis (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Retained Earnings (Accumulated Deficit) [Abstract] | |||
Undistributed ordinary income -net | $ 86,770 | $ 35,189 | $ 40,868 |
Undistributed long-term capital gains | 31,175 | ||
Total Undistributed Earnings | 86,770 | 66,364 | 40,868 |
Capital Loss Carryforwards [Abstract] | |||
Perpetual Long-Term | (112,858) | (107,216) | (117,733) |
Perpetual Short-Term | (382) | (382) | (494) |
Total capital loss carryforwards | (113,240) | (107,598) | (118,227) |
Timing Differences (Organizational Costs, Post-October Capital Loss Deferral and Late Year Ordinary Loss Deferral) | (10,935) | (313) | (539) |
Unrealized Earnings (Losses)-net | (168,797) | (13,476) | 72,545 |
Total Accumulated Earnings (Losses) - net | $ (206,202) | $ (55,023) | $ (5,353) |
Tax Information - Components _2
Tax Information - Components of Accumulated Earnings (Losses) on Tax Basis (Parenthetical) (Details) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Retained Earnings (Accumulated Deficit) [Abstract] | |||
Utilized capital losses | $ 0 | $ 10,629,000 | $ 0 |
Tax Information - Schedule of A
Tax Information - Schedule of Aggregate Unrealized Appreciation and Depreciation on Investments (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Investment Owned, Unrecognized Unrealized Appreciation (Depreciation), Net [Abstract] | |||
Tax cost | $ 3,678,321 | $ 3,492,053 | $ 3,165,681 |
Gross unrealized appreciation | 39,385 | 77,992 | 146,963 |
Gross unrealized depreciation | (208,182) | (91,468) | (74,418) |
Net unrealized investment appreciation (depreciation) on investments | $ (168,797) | $ (13,476) | $ 72,545 |
Tax Information - Additional In
Tax Information - Additional Information (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Income Tax Disclosure [Abstract] | |||
Distributable earnings to paid-in capital in excess of par | $ 21,867 | $ 43,765 | $ (19,414) |
Tax Information - Schedule of R
Tax Information - Schedule of Reconciles Net Increase in Net Assets Resulting from Operations to Taxable Income (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | ||
Income Tax Disclosure [Abstract] | ||||
Net increase in net assets resulting from operations | $ 55,003 | $ 192,427 | $ 176,113 | |
Adjustments: | ||||
Net unrealized loss (gain) on investments and foreign currency forward contracts and translations | 152,304 | 84,858 | (109,922) | |
Income not currently taxable | (26,405) | (47,243) | 21,842 | |
Income for tax but not book | 351 | 2,913 | (129) | |
Expenses not currently deductible | 4,562 | 1,202 | 1,539 | |
Expenses for tax but not for book | (613) | (30) | (5) | |
Realized gain(loss) differences | (92,839) | (117,519) | (110,478) | |
Taxable income net of capital loss carryforward | 92,363 | 116,608 | (21,040) | |
Capital loss carryforward | 113,240 | 107,598 | 118,227 | |
Taxable income | [1] | $ 205,603 | $ 224,206 | $ 97,187 |
[1] Taxable income is an estimate and is not fully determined until the Company’s tax return is filed. |
Financial Highlights - Schedule
Financial Highlights - Schedule of Financial Highlights of the Company (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | ||
Per Share Data: | ||||||
NAV, beginning of period | [1] | $ 15.86 | $ 15.91 | $ 16.75 | $ 17.65 | $ 18.09 |
Net investment income | [1] | 2.24 | 2.33 | 2.04 | 1.98 | 2.06 |
Net realized and unrealized gains (losses) | [1],[2] | (1.82) | (0.43) | (0.20) | (1.08) | (0.70) |
Income tax provision, realized and unrealized gains | [1] | (0.02) | ||||
Net increase in net assets from operations | [1] | 0.42 | 1.90 | 1.84 | 0.90 | 1.34 |
Issuance of common stock in connection with the Merger | [1] | (0.88) | ||||
Issuance of common stock, net underwriting and offering costs | [1] | 0.13 | ||||
Equity component of convertible notes | [1] | 0.02 | ||||
Distributions declared | [1] | (1.80) | (1.95) | (1.80) | (1.80) | (1.80) |
Total increase (decrease) in net assets | [1] | (1.25) | (0.05) | (0.84) | (0.90) | (0.44) |
NAV, end of period | [1] | 14.61 | 15.86 | 15.91 | 16.75 | 17.65 |
Market price, end of period | [1] | $ 13.72 | $ 19.16 | $ 19.12 | $ 21.28 | $ 18.38 |
Shares outstanding, end of period | 102,850,589 | 101,818,811 | 101,534,370 | 40,367,071 | 40,227,625 | |
Weighted average shares outstanding | 102,258,701 | 101,691,076 | 53,940,573 | 40,313,662 | 40,184,715 | |
Total return based on NAV | [3] | 2.80% | 10.67% | 6.78% | 4.08% | 6.96% |
Total return based on market value | [4] | (20.09%) | 11.26% | 1% | 26.98% | (9.16%) |
Supplemental Data/Ratio: | ||||||
Net assets, end of period | $ 1,502,394 | $ 1,614,400 | $ 1,615,141 | $ 676,125 | $ 709,892 | |
Ratio of net expenses to average net assets | 8.19% | 6.75% | 7.62% | 9.77% | 8.81% | |
Ratio of net expenses before voluntary waivers to average net assets | 8.93% | 8.42% | 9.30% | |||
Ratio of net expenses (without incentive fees and interest and other debt expenses) to average net assets | 3.10% | 2.53% | 2.48% | 3.24% | 3.26% | |
Ratio of interest and other debt expenses to average net assets | 5.05% | 3.63% | 4.82% | 5.25% | 3.62% | |
Ratio of net incentive fees to average net assets | 0.04% | 0.59% | 0.32% | 1.28% | 1.93% | |
Ratio of total expenses to average net assets | 8.93% | 8.70% | 12.09% | 9.82% | 8.81% | |
Ratio of net investment income to average net assets | 14.52% | 14.62% | 13.28% | 11.53% | 11.42% | |
Portfolio turnover | 20% | 48% | 24% | 45% | 26% | |
[1] The per share data was derived by using the weighted average shares outstanding during the applicable period, except for distributions declared and issuance of common stock in connection with the Merger , which reflects the actual amount per share for the applicable period. The amount shown may not correspond for the period as it includes the effect of the timing of the distribution and the issuance of common stock. Calculated as the change in NAV per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s DRIP. Calculated as the change in market value per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s DRIP. |
Financial Highlights - Schedu_2
Financial Highlights - Schedule of Financial Highlights of the Company (Parenthetical) (Details) - $ / shares | 12 Months Ended | |||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | ||
Income tax provision, realized and unrealized gains | [1] | $ (0.02) | ||||
Maximum | ||||||
Income tax provision, realized and unrealized gains | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | ||
[1] The per share data was derived by using the weighted average shares outstanding during the applicable period, except for distributions declared and issuance of common stock in connection with the Merger , which reflects the actual amount per share for the applicable period. |
Merger With GS MMLC - Additiona
Merger With GS MMLC - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||
Oct. 12, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Business Acquisition [Line Items] | ||||
Common stock, par value | $ 0.001 | $ 0.001 | ||
Goldman Sach Middle Market Lending Corp | ||||
Business Acquisition [Line Items] | ||||
Common stock, par value | $ 0.001 | |||
Acquisition date | Oct. 12, 2020 | |||
Shares issued | 61,037,311 | |||
Amortization income of purchase discount | $ 13,469 | $ 42,448 | $ 10,109 |
Merger With GS MMLC - Summary o
Merger With GS MMLC - Summary of Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Details) - Goldman Sach Middle Market Lending Corp $ in Thousands | Oct. 12, 2020 USD ($) | |
Business Acquisition [Line Items] | ||
Common stock issued by the Company | $ 866,201 | [1] |
Total purchase price | 866,201 | |
Assets acquired: | ||
Investments, at fair value (amortized cost of $1,741,300) | 1,691,263 | |
Cash and cash equivalents | 177,576 | |
Other assets | 18,986 | |
Total assets acquired | 1,887,825 | |
Liabilities assumed: | ||
Debt | 843,701 | |
Distribution payable | 75,000 | |
Other liabilities | 18,963 | [2] |
Total liabilities assumed | 937,664 | |
Net assets acquired | 950,161 | |
Total purchase discount | $ (83,960) | |
[1] Based on the market price at closing of $ 15.26 , adjusted for a discount to reflect the impact of transfer restrictions applicable to the shares of the Company’s Common Stock issued to GS MMLC stockholders pursuant to the terms of the Merger, and the 61,037,311 shares of common stock issued by the Company. Includes $ 4,159 of management fees and $ 6,672 of incentive fees accrued by GS MMLC pursuant to an investment management agreement between GS MMLC and Investment Adviser, which was terminated upon the closing of the Merger. The payable for these fees was assumed by the Company and paid by the Company to the Investment Adviser in November 2020. |
Merger With GS MMLC - Summary_2
Merger With GS MMLC - Summary of Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Parenthetical) (Details) - Goldman Sach Middle Market Lending Corp $ / shares in Units, $ in Thousands | Oct. 12, 2020 USD ($) $ / shares shares |
Business Acquisition [Line Items] | |
Investments, amortized cost | $ 1,741,300 |
Market price | $ / shares | $ 15.26 |
Shares issued | shares | 61,037,311 |
Business combination, management fees | $ 4,159 |
Business combination, incentive fees | $ 6,672 |
Subsequent Events - Additional
Subsequent Events - Additional Information (Details) - USD ($) | 12 Months Ended | |
Feb. 22, 2023 | Dec. 31, 2022 | |
Internal Revenue Service (IRS) | ||
Subsequent Event [Line Items] | ||
Percentage of designated distributions | 100% | |
Percentage of designated dividends | 100% | |
Designated payment of capital gain dividends | $ 30,292,670 | |
Designated short-term capital gain dividends | $ 26,317,257 | |
Subsequent Events | ||
Subsequent Event [Line Items] | ||
Quarterly distribution, declared date | Feb. 22, 2023 | |
Quarterly distribution, per share | $ 0.45 | |
Quarterly distribution, payable date | Apr. 27, 2023 | |
Quarterly distribution, date of record | Mar. 31, 2023 |